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Summary 
 
Gliotoxin is an epipolythiodioxopiperazine (ETP) produced by the opportunistic fungal 
pathogen Aspergillus fumigatus. It contains an intact disulphide bridge, which mediates 
its toxic effects via redox cycling. Like many other ETPs, a bisthiomethylated form is 
also produced. In the case of gliotoxin, bis(methyl)gliotoxin is formed for unknown 
reasons by a cryptic enzyme. The work presented uncovered the S-adenosylmethionine 
dependent gliotoxin bis-thiomethyltransferase (GtmA), which converts dithiol gliotoxin 
to bis(methyl)gliotoxin. Disruption of this non-gli cluster encoded methyltransferase 
completely abrogated organismal ability to biosynthesize and secrete 
bis(methyl)gliotoxin, while gliotoxin production and secretion were increased 
(p=0.0056). Label-free quantitative (LFQ) proteomics of A. fumigatus wild-type, ΔgtmA, 
and gtmAC strains cultured in Czapek-Dox media revealed an elevated abundance of gli 
cluster encoded enzymes in the ΔgtmA mutant strain. Phylogenetic analysis of this 
enzyme revealed that there are 124 GtmA homologs within the Ascomycota phylum. 
Furthermore, through the characterisation of changes in SAM homoeostasis within A. 
fumigatus, this work also illuminates a direct link between gliotoxin biosynthesis and 
primary metabolic processes. Recombinant GtmA was shown to bismethylate dithiol GT 
using S-adenosyl methionine (SAM) as a methyl donor. Additionally, the crystal structure 
of GtmA was solved by multiple-wavelength anomalous diffraction to 2.3 Å resolution. 
This information was used to identify GtmA structural homologs, to uncover residues in 
involved in GtmA substrate binding and to facilitate targeted engineering of this enzyme. 
We now propose that the purpose of GtmA mediated bis(methyl)gliotoxin formation 
primarily serves to attenuate gliotoxin biosynthesis. This appears to be the first example 
of postbiosynthetic regulation of nonribosomal peptide synthesis in any organism.  
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Chapter 1 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1 General Characteristics of Aspergillus fumigatus  
Aspergillus fumigatus is an opportunistic human pathogen found in the Ascomycota 
Phylum (Dagenais and Keller, 2009). It is one of the most ubiquitous of the airborne 
saprophytic fungi and plays an important role in recycling environmental carbon and 
nitrogen (Latgé, 1999). A. fumigatus has achieved worldwide distribution due to the 
production of small buoyant spores called conidia which have an average size of 2-3.5 
µm. Due to their remarkable hydrophobicity these conidia are capable of dispersing in 
the air and persisting in the atmosphere (O’Gorman, 2011). They also have the ability to 
survive prolonged periods of freezing or dehydration (Kwon-Chung and Sugui, 2013). In 
addition to airborne dispersal, conidia which are imbedded in soil may be effectively 
transported to favourable growth conditions by swarming soil bacteria such as 
Paenibacillus vortex (Ingham et al., 2011). As a major component of the biomass in a 
self-heating compost pile A. fumigatus grows optimally at 37°C and a pH 3.7 to 7.6, but 
it can be isolated when temperatures range between 12° and 65°C and the pH ranges 
between 2.1–8.8 (Kwon-Chung and Sugui, 2013). In contrast, most other fungi are 
mesophilic, displaying temperature optima in the range of 25–35°C (Bhabhra and Askew, 
2005).  
A. fumigatus reproduction is predominantly asexual and is mediated by the 
abundant production of haploid conidia (Rokas, 2013). The asexual life cycle of A. 
fumigatus is initiated by germination of these conidia into mycelia composed of hyphal 
cells. After a period of vegetative growth, conidiophores develop from these hyphae 
which are dandelion head-like structures bearing long chains of conidia (Ward et al., 
2005). A. fumigatus also possesses a fully functional sexual reproductive cycle. It was 
shown to produce mature cleistothecia (sexual bodies containing the sexual spores called 
ascospores) in cultures grown on oatmeal agar plates at 30°C in the dark after a 6 month 
incubation period (O’Gorman et al., 2009).  
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1.2 Pathogenesis of Aspergillus fumigatus 
Among the human pathogenic species of Aspergillus, A. fumigatus is the primary causative 
agent of human infections. It is followed by A. flavus, A. terreus, A. niger, and A. nidulans 
(Dagenais and Keller, 2009). A. fumigatus attacks immunocompromised patients: 
particularly those who are suffering from prolonged neutropenia or severe haematological 
malignancies, transplant recipients and, also, individuals with genetic immunodeficiencies 
such as chronic granulomatous disease (CGD) are particularly sensitive (Edmond et al., 
1999; Bodey et al., 1992; Pfaffenbach et al., 1994). The susceptible patient population is 
expanding due to the increased use of transplantation for end organ disease, the 
development of immunosuppressive and myeloablative therapies for autoimmune and 
neoplastic disease and the human immunodeficiency virus/AIDS pandemic (Hohl and 
Feldmesser, 2007). The primary route of human infection is via the inhalation of airborne 
conidia which is followed by conidial deposition in the bronchioles or alveolar spaces 
(Pandey et al., 2013). Aspergillus primarily affects the lungs and causes the following four 
main syndromes: allergic bronchopulmonary aspergillosis (ABPA), chronic necrotizing 
Aspergillus pneumonia, aspergilloma and invasive aspergillosis (IA) (Pathak et al., 2011). 
` IA is the most common invasive mould disease worldwide and this devastating 
illness has been associated with high rates of mortality (Dagenais and Keller, 2009). IA is 
usually seen in the lungs as invasive pulmonary aspergillosis (IPA) which is defined as an 
invasion of the pulmonary parenchyma by the growing hyphae of Aspergillus. This is 
further refined as angioinvasive IPA if there is evidence of vascular invasion by the hyphae 
(Hope et al., 2005). In 10%–25% of cases dissemination is reported to occur from 
pulmonary sites to other tissues. These include the central nervous system (CNS), sinuses, 
bone, heart, kidney, eye, blood and skin (Johnson et al., 2014).  Mortality rates range from 
40% to 90% in high-risk populations and are dependent on factors such as the host’s 
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immune status, the site of infection and the treatment regimen applied (Lin et al., 2001). A 
recent study suggested that respiratory failure is the most frequent cause of IA related death 
and that 83.9% of IA-related deaths occurred within 21 days following diagnosis (Garcia-
Vidal et al., 2015) 
The inhalation of A. fumigatus conidia rarely has an adverse effect on 
immunocompetent individuals as innate immune mechanisms such as mucociliary 
clearance and alveolar macrophages efficiently remove the conidia. Conidia that evade 
macrophage killing and germinate become the target of infiltrating neutrophils which are 
able to destroy hyphae. Conversely, in the case of immunosuppressed patients, inhaled 
conidia adhere to airway epithelial cells or pulmonary macrophages, are internalized and 
undergo germination (Latgé, 1999). As shown in Figure 1.1, hyphal growth occurs by 
apical extension with the angiogenic properties giving the fungus access to the vascular 
compartment. Dissemination occurs via the bloodstream, colonizing other organs 
(Dagenais and Keller, 2009). The fungus appears to sense the bloodstream and adapts to it 
within hours. It shuts down all unnecessary pathways in order to obscure itself for as long 
as is viable in the blood and then escapes as quickly as possible (Irmer et al., 2015). This 
results in the dissemination and invasion of deep tissues whereby A. fumigatus can cause 
severe, and usually fatal, invasive infections.  
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Figure 1.1. Infectious life cycle of A. fumigatus. Aspergillus is ubiquitous in the 
environment and asexual reproduction leads to the production of airborne conidia. 
Inhalation by specific immunosuppressed patient groups results in conidium establishment 
in the lung which is followed by germination and either PMN-mediated fungal control with 
significant inflammation (corticosteroid therapy) or uncontrolled hyphal growth with a lack 
of PMN infiltrates and, in severe cases, dissemination (neutropenia) (Dagenais and Keller, 
2009).  
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1.3 Virulence factors of Aspergillus fumigatus 
Virulence factors are defined as any factor that causes damage to the infected host 
(Rhodes, 1988). As illustrated in Figure 1.2, the genes and molecules related to A. 
fumigatus virulence can be classified according to the process they are involved in, e.g., 
thermotolerance; cell wall composition and maintenance; resistance to the immune 
response; toxins; nutrient uptake during invasive growth and response to stress conditions 
(Abad et al., 2010). 
Reflecting elevated temperatures present in composting substrates, A. fumigatus is 
well adapted to temperature stress and displays an exquisite thermotolerance of up to 70 °C 
(Bhabhra and Askew, 2005). This metabolic adaptation means that A. fumigatus  is capable 
of growing at 37°C, the actual body temperature of humans, which represents an essential 
characteristic for pathogenicity (Amich and Krappmann, 2012). Several lines of evidence 
suggest that high temperature is a significant stress for the process of ribosome biogenesis. 
Consequently, deletion of the A. fumigatus gene encoding nucleolar protein CgrA was 
shown to impair thermotolerant growth and reduce the virulence of this organism (Bhabhra 
et al., 2004). Additionally, trehalose synthesis was shown to play an important role in 
mediating thermotolerance in A. fumigatus (Al-Bader et al., 2010). 
The cell wall (CW) is the main line of defense of the fungus against a hostile 
environment. It provides both structural integrity and physical protection to the cell. The 
fungal cell wall is also responsible for the interaction with the host and its components are 
often the targets of the host immune system during fungal infections (Abad et al., 2010). In 
A. fumigatus, the cell wall is mainly composed of the polysaccharides β-glucan, chitin, 
galactomannan, α-glucan and a variety of proteins (Gastebois et al., 2009). Several of these 
cell wall components and associated pathways have been targeted by gene deletion studies. 
Of the current A. fumigatus mutant strains which have a defect in the CW, more than 20 
5  
were affected in virulence (Valiante et al., 2015). Surprisingly, many mutant strains with 
defects in CW biosynthesis enzymes were still virulent in the applied infection models. As 
an example, both of the α-1,3-glucan synthase mutant strains (Δags1, and Δags2) were still 
pathogenic despite their α-1,3-glucan content being reduced by 50% when compared to the 
wild-type strain (Beauvais et al., 2005). However, the deletion of the genes encoding for a 
β-1,3-glucanosyltransferase (gel2) and a α-1,2-mannosyltransferase (mnt1) resulted in a 
decrease of virulence (Mouyna et al., 2005; Wagener et al., 2008).  
Mammalian organisms present a broad variety of microenvironments in which A. 
fumigatus must survive in order to cause disease and these environmental conditions are 
subject to rapid change depending on the current stage of infection (Abad et al., 2010). 
Among micronutrients of the environment iron is an essential nutrient for Aspergillus sp. 
and a key component of several enzymes that participate in a variety of cellular processes 
(Haas et al., 2008). The iron sequestration is an important factor in host defence against 
invading fungi since it prevents in vivo fungal development. Low-molecular mass iron-
specific chelators called siderophores are employed by the fungus to regulate iron load 
which is of great importance in fungal virulence (Schrettl et al., 2007; Sales-Campos et al., 
2013). Additionally, the concentration of free zinc in living tissues is much lower than that 
required for optimal fungal growth in vitro because most of it is tightly bound to proteins 
(Outten and O’Halloran, 2001). To efficiently obtain zinc from a living host, A. 
fumigatus uses the zinc transporters ZrfA, ZrfB, and ZrfC. The ZrfA transcriptional 
regulator induces the expression of all these transporters and is essential for virulence 
(Moreno et al., 2007; Vicentefranqueira et al., 2015). 
The environmental conditions found by pathogenic fungi in the colonization and 
infection of the host are different to those found in their normal environmental niche. A. 
fumigatus must be able to adapt to stress in the microenvironment during host invasion and 
6  
systemic spread. Several regulatory mechanisms have been studied in A. fumigatus. These 
include mitogen-activated protein kinase (MAPK) pathways and signal transduction 
pathways which are activated by G-proteins, Ras proteins, histidine kinases, calcium 
signaling and others (Abad et al., 2010). The high-osmolarity glycerol (HOG) mitogen-
activated protein kinase (MAPK) signaling pathway is a key element in regulating 
morphology, growth and adaptation to stress and virulence in A. fumigatus (Ma and Li, 
2012).  
A. fumigatus has a combination of characteristics that helps the fungus to evade or 
interfere with the immune response (Heinekamp et al., 2015). Genes and molecules 
involved in the resistance to the host immune response could be considered defensive 
virulence factors (Abad et al., 2010). Dihydroxynaphtalene (DHN)-melanin pigmentation 
on A. fumigatus conidial surface has been shown to affect virulence by limiting C3 
complement deposition and neutrophil activation (Langfelder et al., 1998). Also, the rodlet 
layer, composed by the hydrophobic RodA protein and the pigment DHN-melanin on the 
surface of resting A. fumigatus conidia, renders the conidia largely inert towards recognition 
by the immune system (Aimanianda et al., 2009). This surface protein was also shown to 
enhance fungal survival in the cornea during fungal keratitis (de Jesus Carrion et al., 2012).  
Mycotoxins are a group of chemically diverse, low molecular mass compounds 
which are produced by fungi as secondary metabolites. They  are formed in the hyphae 
during growth and may be actively expelled into the environment or released after the death 
of the hyphae (Richard, 2007). Toxins are apparently produced by the fungus as competitive 
weapons which are used against predators and competitors in its ecological niche. However, 
they could also contribute to A. fumigatus pathogenesis by modulating the disease progress 
(Scharf et al., 2014b).  Fungal toxins have also been shown to act as interspecies signals, 
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affecting filamentous fungal development via oxidative stress regulation (Zheng et al., 
2014).  
A fumigatus produces a wealth of potent mycotoxins including gliotoxin, 
festuclavine, fumigaclavines A–C, helvolic acid and pseurotin A (Frisvad and Larsen, 
2015). Gliotoxin will be discussed in detail in Section 1.4. The ergot alkaloids are a complex 
family of indole derivatives with diverse biological activities (Wallwey et al., 2010). Due 
to their ability to act as partial agonists or antagonists at different adrenaline, noradrenaline, 
dopamine, and serotonin receptors they affect nervous, circulatory, reproductive, and 
immune systems. This results in a large variety of symptoms including changes in blood 
pressure, lowered immune response, hallucinations and gangrene of the limbs (Mulinti et 
al., 2014). The ergot alkaloids festuclavine and fumigaclavines A–C are present in, or on, 
conidia of A. fumigatus (Mulinti et al., 2014). Two other toxins which are produced by A. 
fumigatus are helvolic acid and fumagillin. Helvolic acid is part of a small family of 
steroidal antibiotics known as fusidanes (Mitsuguchi et al., 2009). At high concentrations 
it can affect the oxidative burst of macrophages, the metabolism of low density lipoproteins 
and, in vivo, it induces ciliostasis and rupture of epithelial cells (Mitchell et al., 1997). 
Fumagillin is a monoterpenoid antibiotic which inhibits angiogenesis and, in vitro, directly 
inhibits endothelial cell proliferation and cilial movement in respiratory epithelium (Lin et 
al., 2013; Amitani et al., 1995). 
 
. 
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 Figure 1.2.  Sum
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olecules associated w
ith the virulence of Aspergillus fum
igatus  (A
bad et al., 2010).
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1.4 Gliotoxin 
Gliotoxin is a non-ribosomally synthesised, redox-active metabolite which is secreted 
by several fungal species (Figure 1.3). It was the first antibiotic to be utilised in the 
control of plant diseases and was purified prior to the discovery of penicillin (Anitha and 
Murugesan, 2005). This metabolite also significantly contributes to the virulence of the 
human fungal pathogen A. fumigatus (Dagenais and Keller, 2009). Gliotoxin is an 
epipolythiodioxopiperazine (ETP) class fungal toxin equipped with a transannular 
disulphide bridge which mediates its toxic effects via redox cycling as shown in Figure 
1.4 (Kwon-Chung and Sugui, 2008). 
 
 
 
Figure 1.3. The structure of gliotoxin (C13H14N2O4S2). 
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 Figure 1.4. Interconversion of gliotoxin betw
een the reduced (dithiol) and oxidized (disulfide) form
s. 
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1.4.1 Gliotoxin Biosynthesis 
The in silico identification of the gli cluster in A. fumigatus (Figure 1.5) (Gardiner and 
Howlett, 2005; Schrettl et al., 2010) paved the way for multiple functional genomic 
studies which have revealed that the gli cluster, comprising 13 genes, encodes the key 
enzymes responsible for gliotoxin biosynthesis. The Zn(II)2-Cys(6) binuclear cluster 
domain transcription factor gliZ was confirmed as the regulator of the gli cluster (Bok et 
al., 2006) as deletion of this gene abrogated the expression of key biosynthetic genes and 
concomitant gliotoxin biosynthesis. Interestingly, upon gliZ reconstitution in A. 
fumigatus ∆gliZ, the biosynthesis of unrelated natural products was induced. The non-
ribosomal peptide synthetase, GliP, catalyzes the formation of cyclo-phenylalanyl-serine, 
the first biosynthetic intermediate in the gliotoxin biosynthetic pathway (Balibar and 
Walsh, 2006) and multiple groups undertook gliP deletion, which results in complete loss 
of gliotoxin biosynthesis (Cramer et al., 2006; Kupfahl et al., 2006; Spikes and Xu, 2008; 
Sugui et al., 2007) (Figure 1.6). Interestingly, Cramer et al. observed that exogenous 
gliotoxin induced gli cluster gene expression in A. fumigatus, which was somewhat 
attenuated in A. fumigatus ∆gliP (Cramer et al., 2006). Although not unheard of, it is 
certainly unusual for a fungal natural product to induce its own biosynthesis and the 
biological significance of this phenomenon is only beginning to emerge. Cyclo-
phenylalanyl-serine is subsequently converted to a highly reactive acyl imine 
intermediate prior to bis-glutathionylation. GliC has been shown to catalyze 
hydroxylation of the α-carbon of L-Phe in cyclo-phenylalanyl-serine prior to bis-
glutathionylation (Chang et al., 2013). The demonstration that gliG encodes a glutathione 
S-transferase (GST) which conjugates two glutathione (GSH) molecules to a biosynthetic 
intermediate to form a bis-glutathionylated biosynthetic intermediate (Figure 1.6), and 
which is therefore responsible for the sulfurization of gliotoxin, was an important finding 
as it was one of the first demonstrations that GSTs played a biosynthetic, as opposed to 
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detoxification, role in fungi (Davis et al., 2011; Scharf et al., 2011). The bis-
glutathionylated intermediate is subsequently processed by GliK, a γ-glutamyl 
cyclotransferase, to remove both γ-glutamyl moieties (Gallagher et al., 2012; Scharf et 
al., 2013). Subsequent processing via GliI (Scharf et al., 2012) yields a biosynthetic 
intermediate, which is N-methylated via the N-methyltransferase GliN, prior to the 
gliotoxin oxidoreductase GliT-mediated disulfide bridge closure (Figure 1.6) (Scharf et 
al., 2013, 2014a). Gliotoxin secretion from A. fumigatus ensues and is now known to be 
facilitated in part, or completely, by the MFS transporter GliA (Wang et al., 2014; Owens 
et al., 2015).  
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 Figure 1.5. In A. fum
igatus, the gli cluster w
hich encodes gliotoxin biosynthesis and consists of 13 genes (in colour and labelled w
ith their last letter) is 
located on chrom
osom
e 6 (G
ardiner and H
ow
lett, 2005; Schrettl et al., 2010). M
ultiple m
etabolites are produced via the activity of the gliotoxin 
biosynthetic pathw
ay (show
n at the bottom
 of the figure). These include Bm
G
T (indicated by an asterisk) (Forseth et al., 2011).
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 Figure 1.6. Gliotoxin biosynthesis and secretion. The GliP enzyme catalyzes the 
formation of the diketopiperazine (DKP) cyclo(l-Phe-l- Ser) (1) from phenylalanine and 
serine. GliC, a cytochrome P450 monooxygenase is responsible for the twofold 
hydroxylation of the DKP (2). This step a prerequisite for subsequent sulfuration of 2 by 
the dedicated glutathione S-transferase GliG, resulting in the cis-bis(glutathione) DKP 3. 
The γ-glutamate cyclotransferase GliK is responsible for processing 3 to an intermediate 
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Cys-Gly adduct 4 and pyroglutamate. Subsequently, GliJ, a di-peptidase, removes the two 
glycine fragments to generate the unstable bis(cysteinyl) DKP 5. GliI, a pyridoxal 
phosphate dependent C-S lyase, led to conversion of 5 into epidithiol 6. GliN was shown 
to be an N-methyltransferase responsible for the conversion of 7 to 8. GliT was found to 
be capable of forming the disulfide bridge in gliotoxin (9) from dithiol gliotoxin (8), 
which is subsequently secreted by GliA. The precise order of some reaction steps and 
gliM/H involvement have yet to be fully elucidated (Dolan et al., 2015). 
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1.4.2 Regulation of Gliotoxin Biosynthesis 
Interestingly, apart from gliZ, many other transcription factors and regulatory genes 
influence gliotoxin biosynthesis (Table 1.1). The C2H2 transcription factor gipA regulates 
gliA interdependently with gliZ (Schoberle et al., 2014). Additionally, it is well-
established that laeA, a global regulator of secondary metabolism, which interacts with 
the Velvet proteins VeA and VelB in the nucleus (Perrin et al., 2007; Bayram et al., 2008; 
Bok and Keller, 2004; Bok et al., 2005), augments gliotoxin biosynthesis because either 
laeA or veA deletion results in impaired gliotoxin production in A. fumigatus (Dhingra et 
al., 2012; Bok and Keller, 2004). Other transcription factors found to regulate the gli 
cluster include mtfA (a C2H2 transcription factor (Smith and Calvo, 2014)), rsmA (a bZIP 
transcription factor (Sekonyela et al., 2013)), and stuA (an APSES family transcription 
factor (Gravelat et al., 2008; Twumasi-Boateng et al., 2009)) (Table 1.1). The 
developmental regulators flbB and flbE positively influence gliotoxin biosynthesis as 
deletion mutants exhibit reduced or abolished gliotoxin production (Kim and Shin, 2013; 
Xiao et al., 2010; Kwon et al., 2010). The MAP kinase, mpkA, and the class 2 histone 
deacetylase, hdaA, also positively regulate gliotoxin biosynthesis while the histone 
methyltransferase, cclA, negatively regulates gliotoxin production as increased gliotoxin 
levels were evident in ∆cclA, consequent to increased gliZ expression (Palmer et al., 
2013) (Table 1.1). As such, it is now apparent that regulation of gliotoxin biosynthesis is 
a hierarchical, multi-factorial process which is affected by many regulatory elements, and 
which is highly integrated into A. fumigatus metabolism.  
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T
able 1.1. Transcriptional regulators w
hich im
pact upon gli cluster gene expression and gliotoxin biosynthesis 
T
ranscriptional 
R
egulator 
E
ffect on G
liotoxin B
iosynthesis 
O
ther Phenotypes 
R
eference 
G
liZ 
(Zn
2 C
ys
6  binuclear 
transcription factor) 
Essential for gliotoxin biosynthesis. 
D
eletion results in loss of expression of som
e of the 
other gli cluster genes (e.g. gliI). 
gliZ regulates the production of other secondary 
m
etabolites (SM
) e.g. O
EgliZ produced helvolic acid 
at 37 °C
 unlike w
ild-type. 
ΔgliZ virulence in a m
ouse m
odel is not significantly 
different to w
ild-type although slightly decreased. 
Involved in apoptotic but not necrotic cell death 
(B
ok et al., 2006) 
G
ipA
 
(C
2 H
2  transcription 
factor) 
R
egulates gliotoxin biosynthesis genes; deletion of 
gipA results in decreased expression of gliA, gliZ, 
gliP, and gliT, w
hile conversely, overexpression of 
gipA led to increased expression of said genes. 
Reduced gliotoxin production in ∆gipA. 
The gli genes (except gliM
) contain potential G
ipA
 
binding sites. 
G
ipA
 cannot induce gliA or gliP independent of gliZ, 
w
hile gliZ induction of gliA is G
ipA
 dependent.  
G
ipA
 potentially induces other SM
 clusters as at least 
one gene from
 18 SM
 clusters w
as increased in 
expression in an O
EgipA strain. 
(Schoberle et al., 
2014) 
LaeA
 
(transcriptional 
regulator) 
Positively regulates gliotoxin biosynthesis as im
paired 
gliotoxin production in ∆laeA. 
G
lobal regulator of SM
 production in A. fum
igatus as 
in ∆laeA reduced expression of 13/22 SM
 clusters w
as 
observed. 
∆laeA had reduced virulence in a m
ouse m
odel of IA
. 
∆laeA conidia had increased susceptibility to 
m
acrophage phagocytosis, w
hile hyphae displayed 
decreased ability to kill neutrophils. 
∆laeA dem
onstrated im
paired conidia and 
conidiophore production in liquid shake culture. 
∆laeA conidia w
ere defective in rodlet production. 
(B
ok and K
eller, 
2004; B
ok et al., 
2005) 
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V
eA
 
(regulatory gene) 
Positively regulates gliotoxin biosynthesis as there is 
reduced gliotoxin production in ∆veA.  
gliZ and gliP expression is decreased in ∆veA. 
V
eA
 predom
inantly positively regulates other SM
 
clusters; fum
agillin, fum
itrem
orgin G
, fum
igaclavine 
C and glionitrin A
 production is reduced in ∆veA. 
V
eA
 regulates developm
ent; ∆veA dem
onstrates 
reduced conidiation but increased pigm
entation of 
conidia, reduced protease activity, and increased 
expression of brlA (a developm
ental activator) during 
developm
ent com
pared to w
ild-type.  
V
eA
 is dispensable for virulence in a neutropenic 
m
ouse infection m
odel. 
V
eA
 is highly conserved; veA from
 A. nidulans 
com
plem
ents deletion in A. fum
igatus. 
(D
hingra et al., 
2012, 2013; Park 
et al., 2012) 
FlbA
 
(regulator of G
-
protein signalling 
protein) 
D
oes not affect gliotoxin biosynthesis, how
ever, 
expression of gliT and secretion of G
liT is increased 
in ∆flbA. Consequently, ∆flbA displays enhanced 
tolerance to exogenous gliotoxin. 
laeA expression is reduced in ∆flbA suggesting that 
other SM
 clusters m
ay be effected by FlbA
.  
FlbA
 is necessary for norm
al cell death progression 
and autolysis in subm
erged cultures. 
D
eletion of flbA results in increased SO
D
 and catalase 
activity and dem
onstrated enhanced resistance to 
m
enadione and paraquat. 
FlbA
 dow
nregulates hyphal differentiation by 
inactivating G
paA
 and thus induces asexual 
developm
ent. 
(Shin et al., 2013; 
M
ah and Y
u, 
2006)  
M
pkA
 
(M
ap K
inase) 
R
egulates gliotoxin production w
hich is reduced in 
∆m
pkA com
pared to w
ild-type. 
Expression of gliN
 and gliT is decreased in ∆m
pkA.  
M
pkA
 is activated by iron starvation and acts in 
response by reshuffling the am
ino acid pool (increased 
ornithine levels) leading to increased siderophore 
biosynthesis. 
∆m
pkA exhibits increased sensitivity to m
enadione and 
diam
ide but decreased sensitivity to H
2 O
2 . 
Involved in cell w
all integrity signalling. 
(V
aliante et al., 
2008; Jain et al., 
2011) 
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M
tfA
 
(C
2 H
2  transcription 
factor) 
G
liotoxin levels w
ere increased in a O
Em
tfA strain, 
but w
ere not changed in ∆m
tfA. 
Expression of gliZ and gliP w
as increased in O
Em
tfA. 
Involved in grow
th and developm
ent; reduced grow
th 
and conidiation w
as observed in ∆m
tfA and O
Em
tfA. 
Positive regulator of protease production 
∆m
tfA exhibited attenuated virulence in G
alleria 
m
ellonella. 
(Sm
ith and C
alvo, 
2014) 
R
sm
A
  
(restorer of 
secondary 
m
etabolism
 A
 – 
bZIP transcription 
factor)  
The production of tw
elve gli cluster m
etabolites w
ere 
increased 2-100 fold in the O
Ersm
A strain com
pared 
to w
ild-type. 
Involved in grow
th and oxidative stress resistance; 
O
Ersm
A exhibits a grow
th defect at low
 grow
th 
tem
perature (25°C
). O
Ersm
A m
utants show
 increased 
resistance to m
enadione.  
  (Sekonyela et al., 
2013) 
  
C
clA
 
(H
istone 
m
ethyltransferase) 
   
Increased gliotoxin production in ΔcclA m
ediated by a 
substantial increase in gliZ transcription.  
Increased production of other unidentified secondary 
m
etabolites. Severe grow
th defects and sensitivity to 
6-A
zauracil (6A
U
); an inhibitor of guanine nucleotide 
synthesis and an indicator of transcriptional defects.  
(Palm
er et al., 
2013) 
FlbB
 
(D
evelopm
ental 
R
egulator containing 
a basic leucine 
zipper dom
ain 
(bZIP)  
D
rastically reduced gliotoxin production (approx. 85 
%
) in the ΔflbB m
utant com
pared to w
ild-type. 
D
elayed/R
educed sporulation; precocious cell death; 
lack of conidiophore developm
ent in subm
erged 
culture, reduced (approx. 90%
) fum
agillin production.   
(X
iao et al., 2010; 
K
im
 et al., 2013) 
FlbE 
(D
evelopm
ental 
R
egulator Interacts 
w
ith FlbB
) 
 
G
liotoxin production w
as abolished in the ΔflbE 
deletion strain.  
C
ontrols asexual developm
ent: D
eletion results in 
reduced conidiation, delayed expression of brlA and 
vosA. N
ecessary for salt-induced developm
ent in liquid 
subm
erged culture.  
 
(K
w
on et al., 
2010; K
im
 et al., 
2013) 
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H
daA
 
(C
lass 2 histone 
deacetylase) 
D
eletion of the hdaA gene decreased gliotoxin 
production and over-expression of hdaA increased 
gliotoxin production.  
ΔhdaA dem
onstrated a reduction in both germ
ination 
rate and vegetative grow
th; altered colony m
orphology 
and increased expression of several N
R
PS genes. 
(Lee et al., 2009) 
StuA
 
(A
PSES fam
ily 
transcription factor) 
gliP expression, and likely gliotoxin production, is 
dependent on StuA
 in vivo. 
  
ΔstuA had severely im
paired conidiation; six 
secondary m
etabolite clusters w
ere found to be 
regulated by StuA
p. 
(G
ravelat et al., 
2008; Tw
um
asi-
B
oateng et al., 
2009) 
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1.4.3 Gliotoxin Toxicity 
Gliotoxin and related epipolythiodioxopiperazines (ETPs) directly inactivate multiple 
enzymes and proteins in animal cells, including nuclear factor-kappaB (NF-kB), NADPH 
oxidase and glutaredoxin by conjugation to thiol groups (Pahl et al., 1996; Tsunawaki et 
al., 2004; Srinivasan et al., 2006). It has been conclusively demonstrated that gliotoxin is 
taken up by animal cells in a GSH-dependent manner whereby this normally protective 
molecular species facilitates the concentration of gliotoxin within animal cells (Bernardo 
et al., 2003). Specifically upon uptake, intracellular gliotoxin is reduced to the dithiol 
form (Figure 1.4), resulting in GSH depletion and concomitant formation of GSSG. 
Apoptosis ensues and is followed by the oxidation of dithiol gliotoxin to re-form gliotoxin 
(Bernardo et al., 2003). Gliotoxin then effluxes from the cell in a pseudocatalytic manner 
and may be taken up by adjacent cells to continue its cytocidal effects. In addition to 
having an essential role in gliotoxin biosynthesis as a sulfur donor (Davis et al., 2011; 
Scharf et al., 2011), GSH has also been shown to have an important role in mediating 
gliotoxin-induced cytotoxicity in animal cells and fungi. It is worth noting that the 
diminution of intracellular GSH levels using L-buthionine-sulfoxamine (BSO), a specific 
inhibitor of GSH synthesis, significantly attenuated the cytotoxic effect of gliotoxin 
towards human neuroblastoma SH-SY5Y cells, possibly due to a deficit in GSH-mediated 
cleavage of the disulfide bridge of gliotoxin to produce reactive dithiol gliotoxin 
(Axelsson et al., 2006). This study highlighted the seemingly contradictory effects of 
antioxidants in enhancing cellular sensitivity to disulfide compounds.  
Peroxiredoxins (Prxs) constitute a ubiquitous family of antioxidant enzymes that 
catalyze the reduction of peroxides. This is achieved with 2 electrons derived from 
NADPH via an electron-conveying system comprising thioredoxin and thioredoxin 
reductase. Nanomolar levels of gliotoxin can protect against oxidative damage by 
converting H2O2 to water in HeLa cells, where it functions to accept electrons from 
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NADPH in the thioredoxin redox system (Choi et al., 2007). Gliotoxin could, in turn, 
attenuate H2O2-induced angiogenesis in a dose-dependent manner, thereby acting as an 
anti-angiogenic agent. The anti-angiogenic effect of A. fumigatus was completely 
attenuated by deletion of laeA, the global regulator of secondary metabolism (Ben-Ami 
et al., 2009). These studies also revealed that gliotoxin was responsible for approximately 
50% of this anti-angiogenic activity since culture extracts from A. fumigatus ∆gliP, 
deficient in gliotoxin biosynthesis only, did not abolish angiogenesis. In murine 
melanoma cells, Prx II silencing enhanced lung metastasis in vivo. Gliotoxin, due to its 
ability to exert a Prx-like activity, inhibited the proliferation and migration as well as lung 
metastasis of Prx II-deficient melanoma cells. This in vivo study implicated the Prx II 
mimetic ability of gliotoxin as a promising therapeutic drug for preventing melanoma 
metastasis (Lee et al., 2013a). 
Further studies have dissected the molecular basis and investigated applications 
of ETP-mediated anti-angiogenesis. Tumor cells must adapt to a hypoxic environment in 
order to survive and grow. This is mediated by hypoxia-inducible factor (HIF-1), whereby 
the O2-regulated HIF-1α subunit of the HIF-1 transcription factor is required for the 
activation of multiple genes involved in tumor progression and angiogenesis (Reece et 
al., 2014). Under hypoxic conditions, HIF-1α undergoes nuclear translocation where it 
interacts with HIF-1β and binds to target DNA sequences. Upon recruitment of additional 
proteins (e.g., p300), gene expression is activated to mount an adaptive response to 
hypoxia (Palazon et al., 2014). It has been speculated that disruption of this hypoxic 
response could form an effective anti-cancer strategy. Interestingly, gliotoxin and the 
ETPs chaetocin and chetomin can inhibit the HIF-1α–p300 interaction by ejecting an 
essential Zn2+ co-factor from p300 via the formation of a Zn2+(ETP)2 moiety (Cook et al., 
2009). Moreover, exposure to gliotoxin resulted in anti-proliferative effects on cultured 
tumor cells, which was reversible by Zn2+ supplementation. Furthermore, Zn2+ can protect 
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HepG2 cells against toxicity of the ETP sporidesmin from Pithomyces chartarum which 
causes facial eczema in sheep (Duncan et al., 2005). Indeed, Zn2+ supplementation of 
ruminant diets is an effective prophylactic treatment for this disease (Munday et al., 2001) 
and it is tempting to speculate that this could be effected via disruption of the HIF-1α–
p300 adaptive response. More recently it has been shown that gliotoxin, chaetocin, and 
chetomin could significantly decrease tumor growth in a prostate cancer xenograft model 
system (Reece et al., 2014). Although, gliotoxin exposure did not impact on the 
expression of HIF-1α regulated genes, these authors speculated that the anti-tumor 
activity of gliotoxin could be mediated via farnesyltransferase inhibition, as inhibition of 
this enzyme can attenuate angiogenesis by interfering with endothelial cell migration 
(Peng et al., 2012). 
 As described in Figure 1.7, gliotoxin induces apoptotic cell death by activating 
the pore-forming proapoptotic Bcl-2 family member Bak to elicit ROS generation, the 
mitochondrial release of apoptogenic factors, and caspase-3 activation. As such, not only 
has this work elucidated the mechanism of gliotoxin-induced apoptosis, but it also has 
uncovered the molecular mechanisms of Bcl-2 family initiation (Geissler et al., 2013; 
Häcker, 2013). It is possible that induction of gliotoxin-dependent apoptosis could impact 
on the severity and course of Aspergillus infection by destroying lung epithelium or by 
killing alveolar macrophages (Pardo et al., 2006). NF-κB is a ubiquitously expressed 
proinflammatory transcription factor composed of different combinations of members of 
the Rel family of proteins. As shown in Figure 1.7 gliotoxin has been well-characterised 
as an inhibitor of NF-κB activation (Pahl et al., 1996) which has then led to a plethora of 
studies which utilize gliotoxin as a specific NF-κB inhibitor (Fitzpatrick et al., 2002; 
Herfarth et al., 2000; Ward et al., 1999). Gliotoxin has also been utilized to demonstrate 
that NF-κB inhibition reverses tumor necrosis factor-α (TNF-α)-induced eosinophil 
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survival, highlighting the major role of NF-κB in TNF-α induced inhibition of eosinophil 
apoptosis (Kankaanranta et al., 2014).
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 Figure 1.7. G
liotoxin induction of apoptosis in m
am
m
alian cells through various specific cellular targets. U
pstream
 of the pore-form
ing proapoptotic 
B
cl-2 fam
ily m
em
ber B
ak, gliotoxin-m
ediated apoptosis requires the c-Jun N
-term
inal kinase 1 and 2 (JN
K
1/2)-m
ediated phosphorylation of the B
H
3-
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only protein B
im
EL at three sites (S100, T112, and S114). This triple phosphorylation increases the stability of B
im
EL, increases its binding affinity for 
B
cl-2-like survival factors and activates B
ak m
ore effectively. N
otably, triple-m
utated B
im
 is unable to transduce the gliotoxin-JN
K
-initiated apoptotic 
stim
ulus to B
ak. C
om
pared to w
ild-type, m
ice lacking B
ak w
ere significantly less susceptible to A. fum
igatus infection w
hich dem
onstrates the in vivo 
relevance of this gliotoxin-induced apoptotic pathw
ay (G
eissler et al., 2013; Pardo et al., 2006; H
äcker, 2013). In resting cells, N
F-kB
 is localized to the 
cytoplasm
 because of binding to inhibitory protein IkB
. U
pon activation, N
F-κB inducing kinase (N
IK
) is activated, w
hich in turn activates a com
plex 
of specific IkB
 kinases (IK
K
s) resulting in IkB
 phosphorylation. Phosphorylation of IkB
 leads to a rapid ubiquitination w
hich m
akes it a substrate for 
the proteasom
e. The active N
F-κB com
plex then translocates to the nucleus and initiates the expression of target genes. G
liotoxin inhibits N
F-κB 
activation by preventing IκB degradation (Pahl et al., 1996). G
liotoxin also suppresses N
F-κB activation by inhibiting the linear ubiquitin (U
b) chain 
assem
bly com
plex (LU
B
A
C
). This is the first selective sm
all-m
olecule inhibitor of this com
plex to be identified (Sakam
oto et al., 2014). A
bbreviations: 
ILK
, Integrin-linked kinase; Src, Sarcom
a fam
ily nonreceptor protein tyrosine kinase; FLK
, Focal adhesion kinase; A
paf1, A
poptotic protease activating 
factor 1; N
EM
O
, N
F-κB essential m
odulator; H
O
IL-1L, H
aem
-oxidized IR
P2 ubiquitin ligase-1; H
O
IP, H
O
IL-1L Interacting Protein; SH
A
R
PIN
, 
SH
A
N
K
-associated R
H
 dom
ain interacting protein  (D
olan et al., 2015).
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1.5 Epipolythiodioxopiperazine (ETP) type toxins 
Nearly twenty distinct families of ETP fungal metabolites have been reported since the 
seminal discovery of gliotoxin in 1936 (Welch and Williams, 2014). This unique class of 
natural products is characterized by a sulfur-bridged dioxopiperazine, a feature generally 
requisite for the potent biological activity prevalent among the class (Patron et al., 2007). 
All natural epidithiodioxopiperazines which have been discovered are derived from at 
least one aromatic amino acid. Representative ETPs are shown in Figure 1.8. Besides 
gliotoxin, the gene clusters responsible for the biosynthesis of the ETPs sirodesmin and 
acetylaranotin have been identified in the organisms L. maculans and A. terreus, 
respectively (Gardiner et al., 2004; Guo et al., 2013). ETP clusters have been inherited 
relatively intact and are believed to have a single origin (Patron et al., 2007). As shown 
in Figure 1.9, the distribution of ETP clusters in ascomycetes is discontinuous. Also, the 
relationship of cluster subclades does not always reflect the relationship of organisms. In 
the case of some closely related species, one taxon had a cluster whilst the other taxon 
did not. Although several Aspergilli species have ETP-like clusters, A. nidulans does not 
(Patron et al., 2007). 
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Figure 1.8. Representative epidithiodioxopiperazines derived from tyrosine, tryptophan 
and/or phenylalanine (Welch and Williams, 2014).  
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Figure 1.9. Phylogenetic relationships between ascomycetes derived from 18S 
ribosomal DNA sequences showing the presence and subclade type of ETP-like gene 
clusters. Cluster genes are coloured according to position within the phylogeny. xN 
indicates present coverage of the genome sequence. Consistent cluster relationships 
across the six proteins are indicated by orange (subclade I), pink (subclade II) and light 
and dark green (subclades IIIA and IIIB, respectively). Proteins encoded in clusters 
outside of the main cluster clade are on blue branches (Patron et al., 2007).
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1.5.1 Bis(methyl)gliotoxin and Thiomethylated ETPs 
Several mono- and bismethylthio derivatives of gliotoxin have also been discovered in 
various fungi. Bis(methyl)gliotoxin is the most well characterised of these gliotoxin 
derivatives (Forseth et al., 2011). First identified in Gliocladium deliquescens, 
bis(methyl)gliotoxin appears to be formed by the irreversible disulfide bridge reduction 
and S-methylation of exogenous gliotoxin; this is demonstrated by feeding [14C]-gliotoxin 
to G. deliquescens (Kirby et al., 1980). The enzyme which catalyses this 
biotransformation and the purpose of the functionality have remained elusive. 
Bis(methyl)gliotoxin has also been detected in A. fumigatus (Amitani et al., 1995), 
Colletotrichum gloeosporioides (Guimarães et al., 2010), Penicillium sp. BCC16054 
(Intaraudom et al., 2013), FO2047 (Van der Pyl et al., 1992), JMF034 (Sun et al., 2011), 
Pseudallescheria sp. MFB165 (Li et al., 2006) and several other fungi. 
Methylthio-derivatives of ETP-type fungal toxins (i.e., hyalodendrin (Boente and 
Kirby, 1991), sporidesmin (Taylor, 1963), rostratin (Tan et al., 2004), haematocin (Suzuki 
et al., 2000), leporizine (Reategui et al., 2013), epicoccin (Guo et al., 2009), glionitrin 
(Park et al., 2011), etc.) have been identified in the majority of ETP-producing fungi 
(Figure 1.10). S-methylation of dithiol metabolites also extends to bacteria as 
Streptomyces clavuligerus has been shown to produce a bisthiomethylated derivative of 
the dithiolpyrrolone antibiotic, holomycin (Li et al., 2012).  
 Although initially regarded as inactive versions of toxic ETPs, there has been a 
renewed interest in the biological properties of ETP bisthiomethyl derivatives. Five of 
seven bisthiomethyl ETP derivatives tested for the ability to eliminate trypanosomes 
(trypanocidal potential) displayed positive responses and bis(methyl)gliotoxin showed 
moderate trypanocidal activity (IC50 = 40.2 ±5.2 μM), while appearing to be non-toxic 
towards T-cell leukemia cells (Watts et al., 2010). Bis(methyl)gliotoxin has also been 
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shown to display anti-angiogenic activity (Lee et al., 2001), antibacterial activity against 
both methicillin-resistant and multidrug-resistant Staphylococcus aureus (Li et al., 2006). 
It has also demonstrated the ability to specifically inhibit platelet activating factor (PAF) 
induced platelet aggregation (Okamoto et al., 1986). Compellingly, glionitrin B (the non-
toxic bis-thiomethyl derivative of the ETP, glionitrin A) caused the suppression of DU145 
(human prostate cancer cell line) invasion whereas the disulfide-containing glionitrin A 
and gliotoxin exhibited significant cytotoxicity therefore eliminating their use in a clinical 
setting. This highlights the potential of these derivatives as antimetastatic agents (Park et 
al., 2011).  
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 Figure 1.10 Selected bis-thiom
ethyl m
etabolites (ETPs) biosynthesized by fungi. N
o data are available on the enzym
e(s) required for, or m
echanism
 
of, bis-thiom
ethylated ETP form
ation.  
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1.6 Self-protection against ETPs 
Resistance genes are required to allow a toxin producer to grow in the presence of its own 
metabolic weaponry and ETPs are no exception to this rule (Carberry et al., 2012). Indeed 
one of the genes in the gliotoxin biosynthetic gene cluster in A. fumigatus, gliT, is required 
for self-protection against the toxin. Deletion of this gene renders A. fumigatus sensitive 
to exogenous gliotoxin. In addition, heterologous expression of gliT in Saccharomyces 
cerevisiae and A. nidulans facilitated resistance to gliotoxin (Schrettl et al., 2010). This 
sensitivity is thought to occur through the accumulation of dithiol gliotoxin, the 
immediate biosynthetic precursor to gliotoxin in the fungal cytosol (Scharf et al., 2010). 
In bacteria, thiomethylation has been posited as an additional or backup strategy, to 
disulfide bridge closure, for self-protection during holomycin biosynthesis, and it has 
been proposed that S-methylation of biosynthetic intermediates, or possibly shunt 
metabolites, protects cellular components against these reactive species (Guo et al., 2013; 
Li et al., 2012).  
O’Keeffe et al. (2014) have demonstrated that an intact gliotoxin self-protection 
mechanism (Schrettl et al., 2010; Scharf et al., 2010), which is mediated by GliT, is 
essential to regulate the biosynthesis of apparently unrelated metabolites such as 
pseurotin A, fumagillin and fumitremorgins. Specifically, using RNA-seq these authors 
have demonstrated that gene cluster expression encoding the biosynthesis of helvolic 
acid, pseurotin A, fumagillin and fumitremorgins is significantly attenuated in A. 
fumigatus ∆gliT upon gliotoxin exposure. Unexpectedly, alterations in the expression of 
genes involved in siderophore-mediated iron transport and siderophore biosynthesis was 
also observed, which was suggestive of a deficiency in iron-sensing. This leads to the 
question of how exactly the modification of a single fungal secondary metabolite pathway 
leads to downstream effects on apparently unrelated secondary metabolite clusters.  
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1.7 Interactions between Primary and Secondary Metabolism 
Non-ribosomal peptide synthesis (NRPS) in fungi is mediated by a combination of large 
multi-functional enzymes known as non-ribosomal peptide (NRP) synthetases: these 
include adenylation, thiolation, condensation and, sometimes, tailoring domains. NRP 
synthetases require post-translational modification via 4’-phosphopantetheinylation, 
mediated by 4’-phosphopanteheinyl transferase (4’-PPTase), to yield the active holo-NRP 
synthetase. This modification, which requires Coenzyme A (CoA) as the 4’-
phosphopantetheine source, requires that each Thiolation domain within an NRP 
synthetase is modified at a specific serine residue (Stack et al., 2007). In addition, so-
called decorating enzymes or domains are responsible for the modification of non-
ribosomal peptide biosynthetic intermediates, which may be either tethered to, or released 
from, the NRP synthetase during the modification process. Likewise, polyketides are 
biosynthesized from acyl CoA precursors (e.g., malonyl CoA) by multi-modular enzymes 
consisting of essential ketosynthase, acyl carrier protein and acyltransferase, amongst 
other, domains (Weissman, 2015). As shown for Streptomyces spp. intracellular ATP 
levels may also affect non-ribosomal peptide production in fungi (Li et al., 2008). Unlike 
polyketide synthases (PKS), NRPS require ATP for their catalysed reactions. 
Both proteogenic and non-proteogenic amino acids (e.g., ornithine) may be 
essential precursor substrates for non-ribosomal peptide formation and during NRPS they 
are generally conjugated together via peptide bond formation. Moreover, substrate amino 
acids can be modified either prior to, or during, NRPS (Chocklett and Sobrado, 2010; 
Thykaer and Nielsen, 2003). Furthermore, many other cellular components which are 
more commonly associated with primary metabolism are required for NRPS and PKS. 
These include, amongst others, S-adenosylmethionine (SAM), isoprenyl and mevalonyl 
moieties, NADPH, glutathione (GSH), malonyl CoA and acetyl CoA (Davis et al., 2011; 
Scharf et al., 2011; Haas, 2012; Yasmin et al., 2012). This suggests a significant interplay 
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between what is currently considered to be primary and secondary metabolism. As a result 
of this, essential re-consideration must be given to the integration of these two 
historically-defined discrete systems.  
In fungi, the biosynthesis of a specific non-ribosomal peptide is generally encoded 
by genes located within a gene cluster (Figure 1.5). These are often located in the sub-
telomeric regions of chromosomes (McDonagh et al., 2008). The activity of these 
secondary metabolite (SM) gene clusters is controlled by local chromatin structure – this 
is effected via histone post-translational modification (e.g., methylation or acetylation). 
The influence of histone modifying enzymes on SM production was first reported for 
sterigmatocystin (ST) production and gene regulation in A. nidulans. The authors 
uncovered that the histone deacetylase mutant ΔhdaA bypassed the requirement for the 
general SM activator LaeA, resulting in overproduction of the subtelomeric metabolites 
ST and penicillin (Shwab et al., 2007). In the endophytic filamentous fungus Epichloё 
festucae, the gene clusters responsible for the production of bioprotective lolitrems and 
ergot alkaloids were shown to be derepressed following deletion of the genes encoding 
either the H3K9- (ClrD) or H3K27- (EzhB) histone methyltransferases. A further 
enhancement of cluster expression was evident when both of these methyltransferases 
were deleted (Chujo and Scott, 2014). Indeed, the production of many SM in Aspergillus 
spp. is controlled by a methyltransferase, laeA, and orthologs of this gene are found in 
numerous fungi (Bok and Keller, 2004). It is interesting to note that LaeA has been shown 
to counteract the establishment of heterochromatic marks thus activating SM production. 
Deletion of laeA in A. nidulans resulted in highly elevated H3K9 methylation levels 
suggesting that LaeA counteracts H3K9 trimethylation and, therefore heterochromatin 
formation at the ST locus (Reyes-Dominguez et al., 2010). The Velvet complex, which is 
comprised of the light-dependent regulators VeA and VelB, also regulates SM production 
and serves to coordinate SM production and fungal development. It is now clear that the 
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VelB–VeA–LaeA complex coordinates fungal sexual development and secondary 
metabolism (Bayram et al., 2008). 
As such, it appears that a truly phenomenal degree of cross-talk exists between 
so-called primary and secondary metabolism, with the involvement of genetic regulation, 
which facilitates non-ribosomal peptide and polyketide and, indeed, other SM, 
production. Primary metabolism is required to provide the essential biosynthetic 
precursors for NRPS, many non-ribosomal peptides share substrate amino acids and 
additional co-substrates. Evidence is also emerging that NRPS pathways interact such 
that alterations in the biosynthesis of specific non-ribosomal peptides may impact on the 
production of apparently unrelated metabolites  (O’Keeffe et al., 2014; Wiemann et al., 
2014). 
1.7.1  Primary metabolite involvement in SM biosynthesis 
It is essential to consider the sources of primary metabolites used during fungal NRPS 
and PKS in order to begin to see why there may be interactions between apparently 
independent biosynthetic pathways.  
SAM is the major source of methyl groups for cellular reactions involving 
methylation, and is directly synthesized via the action of SAM synthetase (Sauter et al., 
2013). In fungi, the methionine cycle enables SAM biosynthesis; L-homocysteine is 
converted to L-methionine via methionine synthase and, in turn, SAM is formed via SAM 
synthetase which requires ATP (Sieńko et al., 2009). Cellular methylation reactions (e.g., 
NRPS and PKS) then consume SAM to produce S-adenosylhomocysteine (SAH). This is 
then converted to L-homocysteine, thereby completing the methionine cycle (Liao et al., 
2012). In A. nidulans, a SAM synthetase, SasA, has been demonstrated to affect SAM 
availability which is important for the production of sterigmatocystin, and may also play 
a role in coordinating fungal secondary metabolism and development (Gerke et al., 2012). 
SAM availability is essential for the biosynthesis of a range of polyketides and non-
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ribosomal peptides including gliotoxin, where it acts as a methyl source for the N-
methyltransferase GliN (Scharf et al., 2014). SAM is also the provider of methyl groups 
for the biosynthesis of many other non-ribosomal peptides and polyketides such as 
butyrolactone III (Guo et al., 2013a). Forseth et al. (2011) identified a plethora of 
methylated biosynthetic intermediates/shunt metabolites associated with gliotoxin 
biosynthesis which allowed the authors to speculate about the complex reactions required 
within this metabolic pathway.  
The biosynthesis of gliotoxin, acetylaranotin and related ETP compounds requires 
biosynthetic intermediate sulfurization and it has been established that GSH is this sulfur 
source (Davis et al., 2011; Scharf et al., 2011; Guo et al., 2013b). Furthermore, Atanasova 
et al. (2013) have noted an elevated expression of genes predicted to be involved in GSH 
formation, possibly as a precursor to enable the biosynthesis of gliotoxin in Trichoderma 
virens. In any case, during gliotoxin biosynthesis a gene cluster-encoded glutathione S-
transferase (GST) mediates GSH conjugation to a highly reactive acyl imine intermediate 
which results in a bis-glutathionylated product. This is subsequently processed by a suite 
of enzymes, initially by a γ-glutamyl cyclotransferase (GliK in the case of gliotoxin 
biosynthesis) to the final product (Davis et al., 2011; Gallagher et al., 2012; Scharf et al., 
2011, 2013).   
1.7.2 Enzyme and cluster cross-talk in Fungal Secondary Metabolism 
In addition to the clear interactions between primary and secondary metabolism described 
above, there are also several examples of cross-talk amongst gene clusters which are 
responsible for the synthesis of fungal SMs. Over-expression of the silent inp putative 
secondary metabolism cross-pathway regulator gene (scpR) in A. nidulans resulted in the 
overproduction of both the inp gene cluster (encoding the interacting NRPSs inpA and 
inpB) and also production of the polyketide, asperfuranone. As no link had previously 
been described between these unrelated metabolites, this work highlighted some 
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additional complexity in the regulatory cross-talk within fungal secondary metabolism 
(Bergmann et al., 2010). Furthermore, recent findings are changing previously held views 
of distinct SM clusters encoding for single classes, or closely related groups of secondary 
metabolites. A FAD-dependent monooxygenase (FqzB) which is encoded by the 
fumiquinazoline biosynthetic pathway in A. fumigatus was also shown to catalyse spiro-
carbon formation in the indole alkaloid spirotryprostatin A via an epoxidation route. The 
authors speculated that the interactions between unrelated fungal SM-encoding cluster 
genes may be a strategy employed by natural product producers to generate structural 
diversity (Tsunematsu et al., 2013).  
The A. fumigatus genes psoF (putative dual function methyltransferase and 
monooxygenase) or psoG (hypothetical protein) were predicted to be required for 
fumagillin biosynthesis due to their proximity to the characterised fumagillin encoding 
genes fmaA and fmaB. Surprisingly, deletion of psoF and psoG resulted in the abolition 
of pseurotin A biosynthesis. The ∆psoF strain accumulated a demethyl-deepoxy-
synerazol (m/z 384.1447) compound instead of pseurotin A which agrees with the 
putative role of this enzyme (Wiemann et al., 2013). PsoF was recently characterised by 
Tsunematsu et al. (2014). One of the most dramatic examples of cross-talk between 
fungal metabolites at the genetic level has been elucidated by Wiemann et al. (2013) in 
A. fumigatus. Here, the gene clusters encoding fumagillin and the non-ribosomal 
peptide/polyketide hybrid, pseurotin A, are physically intertwined and co-regulated by 
LaeA via the Zn(II)2Cys6 Transcription Factor, FapR. In addition, fumitremorgin is also 
encoded by this supercluster. However, the genes encoding the biosynthesis of 
fumitremorgin are distinct from the intertwined region. It is worth noting that although 
this supercluster is not present in completely intact form in related fungal species, there 
is a sufficient co-localization of orthologs to allow Wiemann et al. to speculate that co-
production of the aforementioned metabolites confers survival advantages on producing 
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species. It is tempting to speculate that the products of this supercluster act synergistically 
or in a complementary manner, almost like subunits of a heteromeric enzyme, to effect 
survival of A. fumigatus, and related species in defined ecological niches. 
The efflux of secondary metabolites is another aspect of secondary metabolism 
where evidence exists of the occurrence of cross-metabolite interactions. The rice 
pathogen Magnaporthe grisea produces the PKS-NRPS fusion natural product ACE1 
from a 15-gene cluster. Although this cluster encodes a transporter for the MFS 
superfamily (MFS1), it has been shown that MFS1 is not involved in the efflux of ACE1 
as this gene has a deletion of a single base pair which results in an early stop codon. 
Therefore, it has been suggested that ACE1 must rely on another transporter which is 
encoded outside of the ACE1 gene cluster (Coleman and Mylonakis, 2009). Moreover, 
deletion of the sirodesmin ABC transporter gene sirA from Leptosphaeria maculans 
actually resulted in an increase (39%) of sirodesmin production and secretion when 
compared to the wild-type strain. The production of deacetyl sirodesmin in the ∆sirA 
mutant also increased 27% when compared to the wild-type. This seemingly 
contradictory result may be explained by the presence of alternate efflux mechanisms for 
these metabolites or by a degree of redundancy across SM transporters. These alternate 
efflux mechanisms may be more effective than SirA, resulting in differential sirodesmin 
cluster feedback regulation which leads to the overexpression of this NRPS cluster 
(Gardiner et al., 2005). In contrast, deletion of gliA from the gliotoxin gene cluster 
significantly decreased gliotoxin efflux, indicating that some ETP-producing fungi may 
not have compensatory mechanisms to mediate natural product efflux (Wang et al., 2014; 
Owens et al., 2015). Evidence also exists to suggest that the MFS transporter DotC 
encoded within the dothistromin gene cluster of Dothistroma septosporum is not the only 
mechanism of toxin efflux in this organism (Bradshaw et al., 2009). 
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Recent data have also described what may be cross-talk of natural products from 
different organisms. Culturing A. fumigatus MBC-F1-10 in the presence of Streptomyces 
bullii leads to the production of a diversity of A. fumigatus metabolites; these include 
ergosterol and the seven diketopiperazine (DKP) class of alkaloids. Production of the 
antibiotic-antitumor metabolite glionitrin was induced in A. fumigatus following co-
culture with a Sphingomonas isolate KMK-001 derived from mine-drainage system 
(Rateb et al., 2013). Moreover, physical interaction between the Streptomyces 
rapamycinicus and A. fumigatus resulted in the activation of a silent PKS gene cluster 
encoding fumicycline A (König et al., 2013). Bacterial metabolites have also been 
demonstrated to act as precursors of fungal metabolites, whereby phenazine metabolites 
from Pseudomonas aeruginosa were converted by A. fumigatus into new molecular 
species with enhanced toxicity and additional properties (Moree et al., 2012). It is likely 
that further examples of inter-kingdom interactions, which describe cross-talk leading to 
metabolite production, will be described as the focus on the impacts of co-culturing of 
microorganisms receives increasing attention. 
In summary, it is clear that significant cross-talk exists between (i) primary and 
secondary metabolism, (ii) different fungal metabolites, (iii) the enzymes involved in 
synthesizing different metabolites and (iv) various metabolite-encoding gene clusters. 
Indeed cross-talk even exists between kingdoms.  
1.8 Natural Product Methyltransferases (NPMTs) 
Methylation is a ubiquitous biotransformation in nature which is used throughout all 
branches of metabolism and is often key to metabolic homeostasis. These transformations 
modulate diverse biological processes such as cell signaling and the biosynthesis of 
complex and specialized metabolites (Liscombe et al., 2012). These reactions are most 
often catalysed by methyltransferases that rely on the co-substrate S-adenosyl-L-
methionine (SAM). S-Adenosyl-methionine (SAM)-dependent methyltransferases 
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(MTases) catalyse the transfer of methyl groups from SAM to a large variety of acceptor 
substrates ranging from small metabolites to bio-macromolecules and generate S-
adenosyl-homocysteine (SAH) as the by-product (Figure 1.11). 
 Natural product methyltransferases (NPMTs) participate in the biosynthesis and 
modification of bioactive molecules derived from several branches of primary and 
secondary metabolism; these include membrane components, cofactors, prosthetic 
groups, pigments and signaling and defense compounds. Surprisingly, all currently 
known NPMT structures belong to either of two (Class I and Class III) currently 
recognized protein fold superfamilies of SAM-binding proteins. However, the vast 
majority belong to the Class I or Rossmann-like fold family (Liscombe et al., 2012). 
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 Figure 1.11. NPMTs use S-Adenosyl-L-methionine (SAM) co-substrate as a reactive 
electron deficient methyl group (green) donor for transfer to a electron-rich methyl 
acceptor (Nu:). In addition to the methylated product, S-adenosyl-L-homocysteine (SAH) 
forms and is a potent inhibitor of SAM-dependent MTs (Liscombe et al., 2012). 
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1.8.1 MTase Classification and Motifs. 
All MTases (EC 2.1.1.-) are classified according to the substrate atom that accepts the 
methyl group - usually O (54% of EC subclass), N (23%), or C (18%). The S-directed 
MTs (3% of EC subclass) and NPMTs which accommodate other acceptors such as 
halides (2%) are rare but notable (Liscombe et al., 2012). The enzymatic methylation of 
arsenic compounds is well established in certain bacteria, fungi and animals. The structure 
of CmArsM, an As(III) S-adenosylmethionine methyltransferase from the thermophilic 
eukaryotic alga Cyanidioschyzon merolae has provided insight into this transformation 
(Ajees et al., 2012). Some NPMTs have multiple acceptor atoms: AtHTMT, a 
promiscuous halide methyltransferase from Arabidopsis thaliana was shown to have a 
preference for thiocyanate despite being responsible for halomethane production 
(Schmidberger et al., 2010). 
Few S-directed NPMTs have been identified and characterized to date. Human 
thiopurine S-MTs (TPMT) participate in the detoxification of xenobiotics. A NPMT 
isolated from Brassica oleracea L (cTMT1) was shown to methylate thiocyanate. As 
thiocyanate is an extremely reactive product of glucosinolate degradation, cTMT1 is most 
likely responsible for enzymatic detoxification within this pathway (Attieh et al., 2000). 
PpSABATH1, a TMT from the moss Physcomitrella patens showed a high level of 
activity towards thiobenzoic acid. Interestingly, the expression of PpSABATH1 was 
induced by the treatment of P. patens with thiobenzoic acid. Additionally, the constitutive 
expression of PpSABATH1 in tobacco plants resulted in an enhanced tolerance to 
thiobenzoic acid. These results suggest that PpSABATH1 may have a role in the 
detoxification of xenobiotic thiols (Zhao et al., 2012). The Madagascar periwinkle 
(Catharanthus roseus) O-methyltransferase CrSMT1, the true biological function of 
which remains unknown, has been shown to methylate a wide range of aliphatic and aryl 
alcohols and thiols (Coiner et al., 2006). Remarkably, S-methyltransferases have only 
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been definitively classified in relation to detoxification mechanisms and primary 
metabolism, although the activity have long been implicated in numerous secondary 
metabolite pathways (Boente and Kirby, 1991; Kirby et al., 1980; Taylor, 1963). The 
Streptomyces lasaliensis SAM dependent methyltransferase Ecm18 was shown to 
catalyze the conversion of  a disulfide bond in the precursor antibiotic triostatin A to the 
thioacetal bridge of the nonribosomal dipsipeptide echinomycin (Hotta et al., 2014). This 
appears to be the only published example of a thiol-directed methyltransferase involved 
in secondary metabolism.  
The NPMTs vary in length, typically spanning 200–500 amino acid residues 
corresponding to monomeric molecular masses of ca. 25–55 kDa. Almost all of the 
NPMTs which have been isolated to date possess an α/β structure: alternating α-helices 
and β-strands along the length of the polypeptide chain. A series of conserved motifs h 
which are shared among SAM-dependent MTs have been identified. Motifs I–VI reside 
in regions associated with SAM co-substrate binding and they are generally arranged in 
sequential order across the core MT domain. These motifs, which are shown in Figure 
1.12 and 1.13, are widely conserved across NPMTs and are considered to be defining 
features of SAM-dependent MTs (Liscombe et al., 2012). 
Motif I is present in the majority of MTs. This motif spans the loop preceding the 
first β-strand (β1) of the core Rossmann fold leading into the following α-helix (αA). It 
includes a nine-residue amino acid block with the consensus sequence 
(V/I/L)(L/V)(D/E)(V/I)- G(G/C)G(T/P)G. This nine-residue structure incorporates the 
glycine-rich ‘‘GxGxG’’ signature sequence, the hallmark of a nucleotide binding site 
(Loenen, 2006). Although none of the three glycines of the GxGxG motif are universally 
conserved, substitutions typically encompass small sidechains. Motif II spans β2 and the 
adjoining turn. Only two residues, DA, are common to both consensus sequences with 
the aspartate residue reflecting the conservation of an acidic residue near the C-terminus 
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of β2. Motif III spans β3 and is followed by Motif IV spanning β4 and the adjoining loops. 
Both motifs include a partially-conserved acidic residue at the C-terminus. Motif V, 
occurring in the helix (αC) following Motif IV, sometimes harbours hydrophobic residues 
which sandwich the adenine moiety of SAM. A well-conserved glycine residue is 
characteristic of Motif VI, which corresponds to β5 and the loop between αC and β5 
(Liscombe et al., 2012).  
 
 
 
 
Figure 1.12. A schematic diagram of the primary and secondary structure of a typical 
NPMT, emphasizing conserved motifs used to identify a putative MT. N- and C- termini 
are shown in black circles. α-Helices are shown in red, β-strands in yellow and adjoining 
loops are green. Conserved residues are stacked for each motif (I–VI), and the highly-
conserved ‘‘GxGxG’’ motif is in bold fonts (Liscombe et al., 2012). 
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 Figure 1.13. Topologies and folds of NPMTs. (A) Typical topology of a Class I, 
Rossmann-like NPMT. (B) Tertiary structure of catechol-O-methyltransferase (COMT) 
with bound SAH, representative of the Class I fold. (C) Topology and (D) Tertiary 
structure of cobalt-precorrin-4 C(11)-methyltransferase (CbiF) with bound SAH illustrate 
the typical Class III NPMTs. The diverse N-terminal region of Class I NPMTs is shown 
in grey. The SAM/SAH binding site is highlighted in orange, bound SAH ligands are 
shown in light blue, and conserved motifs are indicated with Roman numerals (I, II, III). 
α-Helices are shown in red, β-strands in yellow, and adjoining loops are green (Liscombe 
et al., 2012). 
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1.8.2 Biotechnological Applications of NPMTs 
NPMTs have significant potential for application in biotechnology and, also, in emerging 
areas of chemical biology and synthetic biology such as metabolic engineering. The 
structural and functional diversity of this family of enzymes means that they can be 
applied for the biocatalytic methylation of a diverse range of synthetic and natural 
compounds which are necessary for the production of pharmaceuticals, agrochemicals 
and fine chemicals through to bulk chemicals such as biofuels (Struck et al., 2012). 
Following cofactor supply modifications, a key O-methyltransferase in vanillin 
biosynthesis was overexpressed in yeast resulting in a 30% increase in the production of 
this flavouring agent (Brochado and Patil, 2013). 
MTases are amongst the enzymes most commonly found in the biosynthetic 
pathways of all major classes of natural products; these include the polyketides, 
nonribosomal peptides, terpenoids, alkaloids and flavonoids. The presence or absence of 
specific methyl groups within natural product scaffolds can dramatically affect their 
properties (Scharf et al., 2014a). Consequently, considerable effort has been focused on 
characterising MTases from natural product biosynthetic pathways. This has led to the 
development of biosynthetic and metabolic engineering methods which alter the 
methylation patterns of natural products, with the aim of improving their properties for 
therapeutic and other applications (McCarthy and McCarthy, 2007). 
Traditionally, methylation reactions are carried out with methyl iodide. However, 
the harsh reaction conditions together with the environmental and safety considerations 
associated with the use of methyl iodide are far from ideal (Struck et al., 2012). In 
addition, such chemical methylation reactions often lack selectivity and this in turn leads 
to the use of complex and expensive synthetic strategies. The major advantage of 
chemoenzymatic synthesis lies in the ability of enzymes to perform regio- and 
stereoselective transformations on complex molecules. Advances in chemoenzymatic 
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methods and microbial engineering will offer avenues to new synthetic designs and 
ultimately expand our access to bio-based materials and therapeutics (Lipson et al., 2013).  
1.9 Current Detection and Treatment of Invasive Aspergillosis 
In addition to the biotechnological applications of secondary metabolite pathway 
enzymes, the products of these pathways may have significant potential for the specific 
diagnosis of fungal infection. Invasive aspergillosis (IA) is the most common of invasive 
mould diseases and is a major source of mortality in immunocompromised individuals. 
Incidence of IA has increased markedly over recent years (Perfect, 2013). Despite the fact 
that early initiation of antifungal therapy is key to a favourable outcome, early diagnosis 
of this condition poses many challenges. Unlike many infections, blood culture is almost 
always negative for A. fumigatus (Duthie and Denning, 1995). Bronchoalveolar lavage 
sampling of the lower respiratory tract secretions for A. fumigatus is also a low sensitivity 
technique. These caveats of diagnosis have led to the adoption of an empirical system in 
many treatment centres whereby even in the absence of fungal pathogen identification 
early antifungal treatment is commenced. This pre-emptive implementation is known to 
result in the administration of antifungal therapies to patients without invasive fungal 
disease (Valerio et al., 2014). As a result of this, several attempts have been made to 
develop sensitive nonculture-based diagnostic mechanisms to rapidly detect the onset of 
infection and permit the rational administration of antifungal drugs. The success of this 
strategy is dependent on the development of reliable biomarker assays or imaging 
techniques. 
In recent years attention has focused on the detection of signature molecules of 
fungal infection. These include the targeting of fungal antigens such as galactomannan or 
1, 3-β-D-glucan by ELISA or lateral flow devices (LFDs), detection of siderophores and 
the amplification of fungal nucleic acids from tissue and body fluids as well as application 
of mass spectrometry (Johnson et al., 2014). 
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Galactomannan (GM) is a carbohydrate molecule which is composed of a 
backbone of mannose residues with side chains of β 1–5 linked galactofuranosyl residues. 
It is a major cell wall component in Aspergillus species. Detection of this molecule is 
carried out using a monoclonal antibody (EB-AB) which was raised in rats (Stynen et al., 
1992). Pure GM is readily released from Aspergillus sp. during in vitro growth as a 
molecule of about 20 kDa in size. GM release in vivo is thought to occur following cell 
lysis as nutrients are limited and growth is restricted by the host response. It has been 
suggested that GM is not released into circulation during infection until the fungus 
invades the endothelial compartment. This also means that serum GM levels may act as 
a marker for this stage of host colonisation (Hope et al., 2007).  
A double-sandwich ELISA, the Platelia™ Aspergillus enzyme immunoassay 
(Bio-Rad, France), has been developed. This uses the EBA2 monoclonal antibody both 
as detector and acceptor for GM. The test has been commercially available in Europe 
since the mid-1990s and was approved by the US Food and Drug Administration in 2003 
(Maertens et al., 2007). It can detect as little as 0.5 μg/ml of GM and a positive result can 
be obtained in 65% of patients approximately 5–8 days before clinical signs of IA develop 
(Wheat, 2003). 
Nevertheless, there are some doubts about the clinical utility of recording a serum-
positive GM result in the nonculture-based diagnosis of IA. Although early reports 
indicate both high sensitivity and specificity, more recent studies have found a lower 
sensitivity, ranging from 40 to 50%, particularly in the setting of antifungal agents 
(Patterson, 2011). Other studies challenge the specificity of the GM ELISA and suggest 
that it may actually more suitable for the detection of non-fumigatus species (Hachem et 
al., 2009). It detects a soluble antigen produced during infection with Geotrichum 
capitatum, with no evidence of aspergillosis, cross-reacts with other opportunistic fungi 
in some other fungal infections (such as histoplasmosis) and may react with antigens from 
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Cryptococcus neoformans in patients with cryptococcosis (Giacchino et al., 2006; Min et 
al., 2012). Furthermore, false-positive Aspergillus GM tests have been reported in patients 
taking certain antibiotics (e.g. piperacillin–tazobactam and amoxicillin–clavulanate) 
(Boonsarngsuk et al., 2010). Antibodies to GM can also develop and this has been 
suggested as a cause of false negative serum GM results in patients with IA (Herbrecht et 
al., 2002) 
1,3-β-D-glucan (BDG) is a carbohydrate moiety in the cell walls of most fungal 
species, with the exception of Zygomyces and Cryptococcus spp. (Marty and Koo, 2009).  
Similar to GM, BDG is excreted into the culture fluid of A. fumigatus (Odabasi et al., 
2006). The measurement of BDG using the Fungitell assay (Associates of Cape Cod, Inc.) 
is based on the Limulus test that has traditionally be used for the detection of bacterial 
endotoxin (Miyazaki et al., 1995). BDG activates factor G, a serine protease zymogen of 
the Limulus amebocyte lysate, which is extracted from amebocytes of the horseshoe crab 
species. This in turn activates a coagulation cascade. The activity of this reaction can be 
measured with use of the colorimetric or turbidimetric methods (Pickering et al., 2005). 
A positive BDG result in serum, along with the presence of appropriate host factors, 
clinical features and other mycological evidence, allows possible IFI to be upgraded to 
probable IFI in the revised criteria of both the European Organization for Research and 
Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National 
Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) (De 
Pauw et al., 2008). The major limitations of BG testing are the false-positive results which 
can occur with interfering substances. Gauze dressings, dialysis, and some bacteria have 
been shown to result in highly elevated BDG values (Onishi et al., 2012; Kanamori et al., 
2009). Despite these major limitations, combining GM and BG assays may strengthen IA 
diagnosis (Sulahian et al., 2014).  
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Aspergillus spp. produces a range of extracellular enzymes as well as primary and 
secondary metabolites which may serve as specific biomarkers of infection. Although 
ELISA methodology has traditionally dominated for the detection of biomarkers, the 
flexibility of MS to analyze all kinds of molecules under optimal conditions makes it 
likely that it can soon be used for the detection of Aspergillus-specific metabolites and 
nucleic acids. A recent study highlights the potential of thermal desorption-gas 
chromatography/mass spectrometry to diagnose IA based on the detection of exogenous 
fungal metabolites in breath (Koo et al., 2014). 
Siderophore detection is emerging as a potential strategy for IA diagnosis. Iron, 
an indispensable cofactor for many cellular processes including electron transport, amino 
acid metabolism and biosynthesis of DNA, is a key nutrient for most organisms, including 
Aspergillus (Schrettl and Haas, 2011). However, since iron excess can catalyze the 
formation of reactive oxygen species, Aspergillus has evolved complex mechanisms to 
balance its acquisition, storage and consumption. Under iron-limited conditions one 
strategy involves the biosynthesis of siderophores, which are low molecular mass iron 
chelators that acquire iron from the environment (Haas et al., 2008). Fusarinine C (FsC) 
and triacetylfusarinine C (TAFC), the major siderophores produced by A. fumigatus to 
mobilize extracellular iron are produced within hours of spore germination and, along 
with the intracellular siderophore ferricrocin, are essential for its virulence (Schrettl et al., 
2007). In a rat infection model, radiolabelled TAFC shows highly selective accumulation 
in infected lung tissue and good correlation with severity of disease, strongly suggesting 
that it is a promising agent for A. fumigatus infection imaging (Petrik et al., 2010). 
The detection of nonribosomal cyclic peptides and depsipeptides by MS may 
serve as highly specific fungal markers (Jegorov and Hajduch, 2006). Gliotoxin is 
produced by most A. fumigatus strains and is present both in plasma and serum. The 
inactive gliotoxin derivative bis(methylthio)gliotoxin has been shown to be recoverable 
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from blood (Domingo et al., 2012). A recent report describes the MS detection of a 
gliotoxin precursor cyclo (L-Phe-L-Ser) in the lungs of mice colonised by A. fumigatus. 
This metabolite may serve as an alternative marker for the diagnosis of invasive 
aspergillosis (Sekonyela et al., 2013). Immunodetection of human IgG directed against 
the Aspergillus gliotoxin oxidoreductase may have potential as a diagnostic biomarker of 
IA in nonimmunocompromised individuals (Shi et al., 2012). 
Overall, this section summarises the important role of fungal secondary 
metabolites during infection, the complex biosynthetic routes by which these molecules 
are produced, and finally the commercial and diagnostic potential of both the enzymes 
involved in these pathways and the metabolites themselves.  
1.10 Thesis rationale and objectives 
As such, the overall work objectives presented in this thesis are as follows: 
(i) The identification and targeted deletion of the thiol methyltransferase responsible 
for gliotoxin bismethylation in A. fumigatus ATCC26933.  
(ii) Phenotypic and metabolomic characterisation of the A. fumigatus gene deletion 
mutant in response to various stresses and the abolition of any identified 
phenotype through restoration of gene functionality via complementation. 
(iii) Biochemical and structural characterisation of this methyltransferase. 
(iv) Development of antibodies reactive to bis(methyl)gliotoxin in order to develop a 
competitive ELISA for the detection of this metabolite.  
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Chapter 2 
Materials and Methods 
 
 
 
 
 
 
 
 
  
 
2.1 Materials 
All chemicals were purchased from Sigma-Aldrich Chemical Co. Ltd. (U.K.), unless 
otherwise stated. 
 Aspergillus Media and Agar 
2.1.1.1 Sabouraud Agar 
Sabouraud agar (65 g) (Oxoid, Cambridge, UK) was added to 1 L dH2O and dissolved. 
The solution was autoclaved, and allowed to cool to ~50 °C. Agar (25 ml) was 
subsequently poured into 90 mm petri dishes, under sterile conditions. The plates were 
allowed to set and stored at 4 °C. 
2.1.1.2 Malt Extract Agar 
Malt extract agar (50 g) (Difco, Maryland, USA) was added to 1 L dH2O and dissolved. 
The solution was autoclaved, and allowed to cool to ~50 °C. Agar (25 ml) was then poured 
into 90 mm petri dishes, under sterile conditions. The plates were allowed to set and stored 
at 4 °C. 
2.1.1.3 Czapeks Dox Broth 
DifcoTM Czapeks Dox powder (35 g) (BD Biosciences) was dissolved in 1 L of dH2O and 
autoclaved at 121 °C for 15 min. 
2.1.1.4 Czapeks Dox Agar 
Agar (18 g) (Scharlau Chemie S.A., Barcelona, Spain) was added to 1L of Czapeks Dox 
broth. The solution was autoclaved at 121 °C for 15 min and allowed to cool to ~50 °C 
before being poured into 90 mm petri dishes under sterile conditions. The plates were 
allowed to set and were stored at 4 °C. 
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2.1.1.5 Yeast Glucose Broth 
Yeast extract (5 g) (Oxoid Ltd., Basinstoke, Hampshire, England) and glucose (20 g) were 
added to 800 ml dH2O and dissolved. The solution was brought to 1 L with dH2O, 
autoclaved at 121 °C for 15 min and stored at 4 ºC. 
2.1.1.6 Aspergillus Minimal Media 
2.1.1.6.1 50 X Salt Solution 
KCl (26 g), MgSO4.7H2O (26 g), and KH2PO4 (76 g) was dissolved in 1 L dH2O and 
autoclaved at 105 °C for 30 min. The solution was stored at 4 °C. 
2.1.1.6.2 100 X Ammonium Tartrate 
Ammonium Tartrate (92 g) was dissolved in 1 L dH2O. The solution was 105 °C for 30 
min and stored at room temperature. 
2.1.1.6.3 Trace Elements 
Na2B4O7.7H2O (40 mg), CuSO4.5H2O (400 mg), FeSO4.7H2O (800 mg), 
Na2MoO.2H2O (800 mg), and ZnSO4.7H2O (8 g) were dissolved in 800 ml dH2O 
allowing each to dissolve completely before addition of the next component. A few drops 
of conc. HCl was added to maintain the solution. The solution was then brought up to 1 
L with dH2O and filter sterilised. 
2.1.1.7 Aspergillus Minimal Media (AMM) Liquid 
2.1.1.7.1 AMM with Ammonium Tartrate 
Salt solution (50 X; 20 ml), Ammonium tartrate (100 X, 10 ml) and glucose (10 g) were 
added to 800 ml dH2O. Trace elements containing iron (1 ml) (Section 2.1.1.6.3) were 
added and the pH of the solution was adjusted to pH 6.8. The solution was brought to 1 
L with dH2O, mixed and autoclaved at 105 °C for 30 min. The solution was stored at 
room temperature. 
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2.1.1.8 Aspergillus Minimal Media Agar 
2.1.1.8.1 AMM Agar with Ammonium Tartrate 
Agar (18 g) was added to 1 L of AMM liquid medium with ammonium tartrate (Section 
2.1.1.6.2). The solution was autoclaved at 105 °C for 30 min and allowed to cool to about 
50 °C and the agar mixture (25 ml) was poured into 90 mm petri dishes under sterile 
conditions and stored at 4 °C. 
2.1.1.9 Regeneration Agar 
2.1.1.9.1 1.8 % (w/v) Regeneration Agar 
Aspergillus salt solution (50 X; 20 ml), ammonium tartrate (100 X; 10 ml), and trace 
elements (1 ml) (Section 2.1.1.6.3) were added to 800 ml dH2O and dissolved. The 
solution was adjusted to pH 6.8. Sucrose (342 g) was added and the solution was made 
up to 1 L dH2O. Agar (18 g) was added to the solution. The solution was autoclaved at 
105 °C for 30 min and kept at 65 °C until required. 
2.1.1.9.2 0.7% (w/v) Regeneration Agar 
Aspergillus salt solution (50 X; 20 ml), ammonium tartrate (100 X; 10 ml), and trace 
elements (1 ml) (Section 2.1.1.6.3) were added to 800 ml dH2O and dissolved. The pH of 
the solution was adjusted to pH 6.8. Sucrose (342 g) was added and the solution was made 
up to 1 L dH2O. Agar (7 g) was added to the solution. The solution was autoclaved at 105 
°C for 30 min and kept at 65 °C until required. 
 E. coli Media and Agar 
2.1.2.1 Luria-Bertani Broth 
LB Broth (25 g) (Difco, Maryland, USA) was dissolved in 1 L dH2O and dissolved. The 
solution was autoclaved at 121 °C for 15 min and stored at 4 °C. 
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2.1.2.2 Luria-Bertani Agar 
LB Agar (40 g) (Difco, Maryland, USA) was dissolved in 1 L dH2O. The solution was 
autoclaved at 121 °C for 15 min, and allowed to cool to ~50 °C. Agar (25 ml) was then 
poured into 90 mm petri dishes, under sterile conditions and allowed to set. They were 
stored at 4 °C. 
2.1.2.3 Terrific Broth  
Terrific Broth (47.6 g) (Fluka) and 8 ml glycerol was dissolved in 1 L dH2O. The solution 
was autoclaved at 121 °C for 15 min and stored at 4 °C. 
2.1.2.4 M9 Minimal Media Components 
2.1.2.4.1 5x M9 Salts 
64 g Na2HPO4.7H2O, 15 g KH2PO4, 2.5 g NaCl and 5 g NH4Cl were dissolved in 800 
ml dH2O. The pH was adjusted to 7.2 and the volume was adjusted to 1 L with dH2O. 
The solution was autoclaved at 121 °C for 15 min.  
2.1.2.4.2 20% Glucose 
10 g glucose was dissolved in 40 ml dH2O. This was then brought to 50 ml with dH2O 
and filter sterilised with a 0.22 µm syringe filter. The solution was stored at room 
temperature. 
2.1.2.4.3 1M MgSO4 
4.8 g MgSO4 (1M) was dissolved in 40 ml dH2O. The solution was filter sterilised using 
a 0.22 µm syringe filter and stored at room temperature. 
2.1.2.4.4 1M CaCl2 
4.4 g MgSO4 (1M) was dissolved in 40 ml dH2O. The solution was filter sterilised using 
a 0.22 µm syringe filter and stored at room temperature. 
 56    
2.1.2.4.5 1000x Trace Metals Solution 
0.60 g CaCl2.H2O, 0.60 g FeSO4.7H2O, 0.12 g MnCl2.4H2O, 0.08 g CoCl2.6H2O, 0.07 
g ZnSO4.7H2O, 0.03 g CuCl2.2H2O, 2 mg Boric acid, 25 mg (NH4)6Mo7O24.4H2O and 
0.50 g EDTA was added to 100 ml of dH2O in a 500 ml Erlenmeyer flask in the stated order. 
Each compound was fully dissolved by stirring before adding the next.  The solution was filter 
sterilised and stored in the dark at room temperature. 
2.1.2.4.6 Amino Acid Mix  
100 mg Lysine, 100 mg Phenylalanine, 100 mg Threonine, 50 mg Isoleucine, 50 mg 
Leucine and 50 mg Valine were added to a 2 ml eppendorf immediately before use.  
2.1.2.5 M9 Minimal Media 
780 ml deionized water (ddH2O) was autoclaved in a 3-liter flask. To this solution 200 ml 5x 
M9 Salts, 20 ml 20% Glucose, 2 ml 1M MgSO4, 100 µl 1M CaCl2 and 200 µl 1000x Trace 
Metals (Section 2.1.2.4.5) were added. 
 Solutions for pH Adjustment 
2.1.3.1 5 M Hydrochloric Acid (HCl) 
Deionised water (40 ml) and hydrochloric acid (43.64 ml) were added slowly to a 
graduated cylinder (glass). The final volume was adjusted to 100 ml. The solution was 
stored at room temperature. 
2.1.3.2 5 M Sodium Hydroxide (NaOH) 
NaOH pellets (20 g) were added to ddH2O (80 ml) and dissolved using a magnetic stirrer. 
The final volume was adjusted to 100 ml. The solution was stored at room temperature. 
 Phosphate Buffer Saline 
One PBS tablet (Oxoid, Cambridge, UK) was added to 200 ml of dH2O, and dissolved 
by stirring. The solution was autoclaved and stored at room temperature. 
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 Phosphate Buffer Saline-Tween 20 (PBST) 
Tween-20 (0.5 ml) was added to 1 L PBS (Section 2.1.4). The solution was stored at room 
temperature. 
 Antibiotics and Supplements 
All antibiotics and supplements were prepared as stock solutions in water or methanol 
and filter sterilised. All were stored at – 20 °C. Further information is provided in Table 
2.1. 
 80 % (v/v) Glycerol 
Glycerol (80 ml) was added to 20 ml ddH2O. The solution was autoclaved at 121 °C for 
15 min and stored at 4 °C. 
 Molecular Biology Reagents 
2.1.8.1 Agarose Gel Electrophoresis Reagents 
2.1.8.1.1 0.5 M Ethylenediaminetetraacetic acid (EDTA) 
Ethylenediaminetetraacetic acid disodium salt dihydrate (186.12 g) was dissolved in 800 
ml dH2O. The pH was adjusted to pH 8.0 using 5 M NaOH (Section 2.1.3.2) and the final 
volume was brought up to 1 L. 
2.1.8.1.2 50 X Tris-Acetate Buffer (TAE) 
Trizma base (242 g) was added to 57.1 ml glacial acetic acid and 100 ml of 0.5 M EDTA, 
pH 8.0 (Section 2.1.8.1.1). The volume was adjusted to 1 L with dH2O. The solution was 
stored at room temperature. 
2.1.8.1.3 1 X Tris-Acetate Buffer (TAE) 
50 X TAE (20 ml) (Section 2.1.8.1.2) was added to dH2O (980 ml). The solution was 
stored at room temperature. 
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2.1.8.1.4 Ethidium Bromide 
Ethidium bromide (Sigma-Aldrich) was supplied at 1 mg/ml of which 4 µl was used per 
100 ml agarose gel. 
2.1.8.1.5 6 X DNA Loading Dye 
Loading dye (Promega, Southampton, UK) was used at the concentration supplied. 
2.1.8.1.6 1 % (w/v) Agarose Gel 
Agarose powder (1 g) was dissolved into 100 ml 1 X TAE (Section 2.1.8.1.3). This 
mixture was heated in a microwave oven until the agarose had dissolved and the mixture 
was molten. Ethidium Bromide solution (Section 2.1.8.1.4) was added. The gel was left 
to set for at least 30 minutes.  
2.1.8.1.7 Roche molecular weight marker VII 
 
 
 
Figure 2.1. Image of the Roche molecular weight marker VII. 
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2.1.8.1.8 New England BioLabs (NEB) 1 kb DNA Ladder 
 
 
 
Figure 2.2. Image of the NEB 1 kb DNA Ladder 
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  T
able 2.1. A
dditives and antibiotics used during this study. 
 
 
C
ondition T
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oncentration
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xidative Stress 
H
2 O
2 
1 M
 (prepared in H
2 O
)  
0.25 - 2 m
M
G
liotoxin Sensitivity 
G
liotoxin 
1 m
g/m
l (prepared in m
ethanol) 
2.5 -20 µg/m
l      
 
Pyrithiam
ine R
esistance 
Pyrithiam
ine H
ydrochloride 
0.1 m
g/m
l (prepared in H
2 O
) 
0.1 µg/m
l 
Phleom
ycin R
esistance 
Phleom
ycin 
25 m
g/m
l (prepared in H
2 O
) 
40 µg/m
l 
  
H
ygrom
ycin R
esistance 
H
ygrom
ycin B
 
100 m
g/m
l (prepared in H
2 O
) 
100 µg/m
l 
 A
m
picillin R
esistance 
A
m
picillin 
100 m
g/m
l (prepared in H
2 O
) 
0.1 µg/m
l 
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 Aspergillus Transformation Reagents 
2.1.9.1 0.7 M Potassium Chloride 
KCl (26.1 g) was dissolved in 500 ml dH2O. The solution was autoclaved and stored at 
room temperature. 
2.1.9.2 25 mM Potassium Phosphate Monobasic 
KH2PO4 (1.7 g) was dissolved in 500 ml dH2O. 
2.1.9.3 25 mM Potassium Phosphate Dibasic 
K2HPO4 (0.87 g) was dissolved in 200 ml dH2O. 
2.1.9.4 Lysis Buffer 
KCl (26.1 g) was dissolved in 25 mM KH2PO4 (350 ml) (Section 2.1.9.2). The pH was 
adjusted to pH 5.8 with 25 mM K2HPO4 (Section 2 .1 .9 .3). The solution was brought to 
500 ml with dH2O. 
2.1.9.5 Lytic Enzymes solution for protoplast generation 
Lytic enzymes from Trichoderma harzianum (Sigma Aldrich) (0.45 g) were added to 15 
ml lysis buffer (Section 2.1.9.4) and filter sterilised with a 0.45 µm filter. 
2.1.9.6 Buffer L6 
Sorbitol (1 M), Tris-HCl (10 mM), and CaCl2 anhydrous (10 mM) was prepared by 
dissolving sorbitol (72.88 g), Tris-HCl (0.484 g), and CaCl2 (0.444 g) in dH2O. The pH 
was adjusted to pH 7.5 before the final volume was adjusted to 400 ml with dH2O. The 
solution was autoclaved and stored at room temperature. 
2.1.9.7 Buffer L7 
PEG 6000 (60 g) was dissolved in dH2O (40 ml). Tris-HCl (0.157 g) and CaCl2 anhydrous 
(0.444 g) was added and the solution was heated gently whilst covered with tin foil until 
completely dissolved. After dissolution the solution was placed on a cool plate. To 
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adjust the pH, concentrated HCl was added dropwise. This was done over a time period 
of 1 – 2 h until the pH was 7.5. The solution was autoclaved and stored at room 
temperature.  
 Southern Blot Reagents 
2.1.10.1 Southern Transfer Buffer 
Sodium hydroxide (0.6 M; 16 g) and Sodium chloride (0.4 M; 35.07 g) were dissolved 
in 800 ml dH2O. The volume was adjusted to 1 L with dH2O. 
2.1.10.2 20 X SSC 
Sodium chloride (175.3 g) and sodium citrate (88.2 g) were added to dH2O (800 
ml). The pH was adjusted to pH 7 and the volume brought up to 1 L dH2O. The 
solution was autoclaved and stored at room temperature. 
2.1.10.3 2 X SSC 
SSC (100 ml, 20 X) (Section 2.1.10.2) was added to 900 ml dH2O and stored at room 
temperature. 
2.1.10.4 10 % SDS (w/v) 
SDS (10 g) was dissolved into 1 L dH2O. The solution was stored at room temperature. 
2.1.10.5 0.1 % (w/v) SDS / 1 X SSC 
20 X SSC (50 ml) (Section 2 . 1 . 1 0 . 2 ) and 10 ml of SDS 10 % (w/v) (Section 
2.1.10.4) were dissolved in 1 L dH2O. The solution was stored at room temperature. 
2.1.10.6 Digoxigenin (DIG) Detection Buffers 
2.1.10.6.1 10 % (w/v) Lauroylsarcosine 
Lauroylsarcosine (1 g) was dissolved in 10 ml dH2O. 
2.1.10.6.2 Membrane Pre-hybridisation Buffer 
SDS (35 g), formamide (250 ml), 100 ml 10 % Blocking reagent (Roche Applied 
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Science, Mannheim, Germany), 5 ml 10 % (w/v) laurylosarcosine were dissolved in 
500 ml dH2O. The solution was prepared under sterile conditions and stirred well 
before storage at 4 °C. Before use the solution was pre-heated at 65 oC for 15 min. 
2.1.10.6.3 DIG Buffer 1 (1 X)  
Maleic Acid (2.32 g) (0.1 M) and NaCl (1.75 g) (0.15 M) were added to 180 ml dH2O. 
The pH was adjusted to pH 7.5 before the final volume was adjusted to 200 ml with dH2O. 
The solution was filter sterilised and stored at room temperature for up to one month. 
2.1.10.6.4 Antibody Blocking Reagent 
Blocking reagent (0.4 g) (Roche Applied Science, Mannheim, Germany) was dissolved 
in 40 ml of DIG Buffer 1 (Section 2 . 1 . 1 0 . 6 . 3 ) at 50 °C. The solution was 
prepared fresh on the day. 
2.1.10.6.5 DIG Buffer 3 
Tris-HCl (1.575 g) (0.1 M), NaCl (0.584 g) (0.1 M) and MgCl2.6H20 (1.02 g) (50 
mM) were dissolved in dH2O (80 ml). The pH was adjusted to pH 9.5 and the final 
volume brought up to 100 ml. The solution was filtered sterilised and then stored at room 
temperature for up to one month. 
2.1.10.6.6 DIG Wash Buffer 
Tween 20 (0.15 g) was dissolved in DIG Buffer 1 (50 ml) (Section 2.1.10.6.3). The 
solution was mixed and filter sterilised before being stored at room temperature. 
2.1.10.6.7 Anti-Digoxigenin-Alkaline Phosphatase (AP), Fab fragment conjugate 
Anti-Digoxigenin- AP, Fab fragments (Roche, Mannheim, Germany) (1 µl) was added 
to 10 ml antibody blocking reagent (Section 2.1.10.6.4). 
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2.1.10.6.8  Chemiluminescent substrate phosphatase detection (CSPD) Substrate 
CSPD (50 µl) (Roche, Mannheim, Germany) was added to DIG Buffer 3 (4.95 ml) 
(Section 2.1.10.6.5). 
2.1.10.6.9  DIG-labelled deoxynucleotide Triphosphates (dNTPs) 
Pre-mixed DIG-labelled dNTPs were purchased from Roche and used according to 
the manufacturers guidelines for the generation of DIG-labelled probes for Southern 
detection probes. 
2.1.10.6.10 Developer Solution 
Developer (Kodak) was diluted 1/4 in dH2O and stored in a tinfoil covered Duran in a 
dark room. 
2.1.10.6.11 Fixer Solution 
The fixer solution (Kodak) was diluted 1/5 in dH2O and stored in a tinfoil covered Duran 
in a dark room. 
 E. coli Lysis Buffer 
50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 10 % Glycerol, pH 8.0. Autoclave and 
store at 4 °C. Immediately before use add 0.4 % Sodium Deoxycholate (Make 5% stock 
in ddH2O), 1 mM PMSF (250 mM Stock in ethanol), 1 µg/ml Pepstatin A (1 mg/ml stock 
in ethanol), 1 µg/ml Leupeptin (1 mg/ml stock in ethanol), 300 µg/ml Lysozyme (10 
mg/ml stock solution in 10 mM Tris-HCl, pH 8.0). 
 SAM and SAH Extraction Buffer 
4 ml 5 M HCl (Section 2.1.3.1) was added to 196 ml ddH2O resulting in a 0.1 M HCl 
solution. This was stored at room temperature. 
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 Reverse-Phase High Performance Liquid Chromatography (RP-HPLC) 
Solvents 
2.1.13.1.1  Solvent A: 0.1 % (v/v) Trifluoroacetic acid (TFA) in HPLC grade water 
TFA (1 ml) was added to HPLC Grade Water (1 L) in a darkened Duran. 
2.1.13.1.2  Solvent B: 0.1 % (v/v) TFA in HPLC grade Acetonitrile 
TFA (1 ml) was added to HPLC Grade Acetonitrile (1 L) in a darkened Duran. 
 AKTA FPLC Buffers and Reagents 
2.1.14.1 Gel Filtration Calibrant Mixture 
Thyroglobulin (25 mg/ml) (200 µl), Aldolase (25 mg/ml) (160 µl) and RNAse A (25 
mg/ml) (160 µl) were brought to 1 ml with PBS (Section 2.1.4). The solution was 
stored at 4 °C. All calibrants used were included in the HMW gel filtration calibration 
kit (GE Healthcare). 
2.1.14.2 Glutathione Affinity Chromatography Buffers 
The Equilibration/Wash Buffer: 50 mM Tris-HCl (7.88 g), 100 mM NaCl (5.84 g) and 10 
% Glycerol (100 ml) was added to 800 ml dH2O. The pH of the solution was adjusted to 
pH 8.0 and volume was brought to 1 L with dH2O. The solution was autoclaved and store 
at 4 °C. The Sample Elution Buffer was prepared as described above and brought to 10 
mM reduced glutathione which was added immediately before use. 
2.1.14.3 Q-Sepharose Ion Exchange Chromatography (IEX) Buffers 
The IEX Equilibration Buffer; 20 mM Tris-HCl (3.14 g) and 20 mM NaCl (1.17 g) were 
added to 800 ml dH2O. The pH of the solution was adjusted to pH 8.5. The volume was 
brought to 1 L with dH2O. The solution was autoclaved and store at 4 °C. The IEX Sample 
Elution Buffer was prepared as described above with 1 M NaCl (58.44 g) instead of 20 
mM NaCl. 
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2.1.14.4 GtmA Gel Filtration Buffer 
50 mM Tris-HCl (7.88 g) and 50 mM NaCl (2.92 g) were added to 800 ml ddH2O. The 
pH of the solution was adjusted to pH 7.4. The volume was brought to 1 L with ddH2O. 
The solution was autoclaved and store at 4 °C. The buffer was degassed using vacuum 
filtration before use.  
 SDS-PAGE and Western Blotting Reagents 
2.1.15.1 10 % (w/v) Sodium Dodecyl Sulfate (SDS) 
SDS (10 g) was added to 80 ml of dH2O and dissolved. The solution was adjusted to 
100 ml with dH2O and stored at room temperature. 
2.1.15.2 1.5 M Tris-HCl pH 8.3 
Trizma-hydrochloride (23.64 g) was dissolved in 60 ml dH2O. The pH was adjusted to 
8.3 using 5 M NaOH (Section 2.1.3.2). The volume was adjusted to 100 ml with dH2O 
and stored at 4 °C. 
2.1.15.3 0.5 M Tris-HCl pH 6.8 
Trizma-hydrochloride (7.88 g) was dissolved in 60 ml dH2O. The pH was adjusted to 
6.8 using 5 M NaOH (Section 2.1.3.2). The volume was adjusted to 100 ml with dH2O 
and stored at 4 °C. 
2.1.15.4 10% (w/v) Ammonium Persulfate (APS) 
Ammonium persulfate (0.1 g) was added to 1 ml dH2O. The solution was stored at 4 
°C and used within 8 h. 
2.1.15.5 5 X Solubilisation Buffer 
Trizma-hydrochloride (23.64 g) was dissolved in 60 ml dH2O. The pH was adjusted to 
8.3 using 5 M NaOH (Section 2.1.3.2). The volume was adjusted to 100 ml with dH2O 
and stored at 4 °C. 
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2.1.15.6 5 X SDS Electrode running buffer 
Trizma base (30 g), glycine (144 g) and SDS (10 g) were added to 1600 ml dH2O, 
and dissolved using a magnetic stirrer. The pH was adjusted to between 8.6 and 8.8. The 
final volume was adjusted to 2 L. The solution was stored at room temperature. 
2.1.15.7 1 X SDS Electrode running buffer 
5 X SDS Electrode running buffer (200 ml) (Section 2.1.15.6) was added to 800 ml 
dH2O. 
2.1.15.8 Coomassie® Blue Stain Solution 
dH2O (600 ml), glacial acetic acid (100 ml) and methanol (300 ml) were added to a 
glass bottle containing 1 g Coomassie® Brilliant Blue R. The solution was stored at 
room temperature. 
2.1.15.9 Destain Solution 
Glacial acetic acid (100 ml) was added to dH2O (600 ml) and methanol (300 ml). The 
solution was stored at room temperature. 
2.1.15.10 Towbin Electrotransfer Buffer for Semi-Dry Transfer 
Trizma base (6.06 g) and glycine (28.8 g) were added to dH2O (600 ml) and methanol 
(200 ml). The final volume was adjusted to 1 L with dH2O. The solution was stored at 
room temperature. 
2.1.15.11 Blocking Solution 
Marvel® powdered milk (5 g) was added to 100 ml PBST (Section 2.1.5) 100 ml PBST 
(Section 2.1.5) 
2.1.15.12 Antibody Buffer 
Marvel® (powdered milk) (1 g) was added to 100 ml PBST (Section 2.1.5) 
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2.1.15.13 DAB Substrate Buffer 
Trizma-HCl (15.76 g) was added to 700 ml dH2O and the pH was adjusted to 7.6 
with 5 M NaOH (Section 2.1.3.2). The final volume was adjusted to 1 L. 
 Mass Spectrometry Reagents 
2.1.16.1 A. fumigatus Whole Protein Lysate Extraction Buffer 
100 mM Tris-HCl (15.7 g), 50 mM NaCl (2.92 g), 20 mM EDTA (5.85 g), 10% (v/v) 
Glycerol (100 ml) was added to 800 ml dH2O. The pH was adjusted to 8.0 and the solution 
was brought to 1 L with dH2O. Autoclave and store at 4 °C. Immediately before use 1 
mM PMSF (Section 2.1.16.2), 1 µg/ml Pepstatin A (Section 2.1.16.3) and 1 mM DTT 
(final concentrations) were added to the buffer.  
2.1.16.2 100 mM Phenylmethylsulfonyl fluoride (PMSF) 
PMSF (17.4 mg) was dissolved in 1 ml methanol. The solution was stored at room 
temperature. 
2.1.16.3 Pepstatin A (1 mg/ml) 
Pepstatin A (10 mg) was brought to 10 ml with ethanol. The solution was split into 1 ml 
aliquots and stored at -20 °C. 
2.1.16.4 100 % (w/v) TCA 
Trichloroacetic acid (100 g) was added to 45.4 ml dH2O and dissolved. The solution was 
stored in the dark at 4 °C. 
2.1.16.5 50 mM Ammonium bicarbonate (NH4HCO3) 
100 mM ammonium bicarbonate (Section 2.1.16.5) (5 ml) was added to 5 ml of ddH2O. 
The solution was prepared fresh on day of use. 
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2.1.16.6 0.5 M Dithiotreitol (DTT) 
DTT (77 mg) was dissolved in 100 mM ammonium bicarbonate (Section 2 . 1 . 1 6 . 5 ) (1 
ml). The solution was prepared fresh on day of use. 
2.1.16.7 0.55 M Iodoacetamide 
Iodoacetamide (50.8 mg) was dissolved in 100 mM ammonium bicarbonate (Section 
2.1.16.5) (.5 ml). The solution was prepared fresh on day of use. 
2.1.16.8 Protein Resuspension Buffer 
1.21 g Tris-HCl (100 mM) was dissolved in 50 ml ddH2O. 36 g Urea (6 M) and 15.2 g 
Thiourea (2 M) were then dissolved. The pH was adjusted to 8.0 and the volume was 
brought to 100 ml with ddH2O. The solution was filtered with a 0.22 µm filter and stored 
at room temperature. 
2.1.16.9 Trypsin 
Immediately before use a vial containing 20 µg Sequencing Grade Modified Trypsin 
(Promega) was resuspended in 20 µl Trypsin Resuspension Buffer (1 mg/ml). The vial 
was kept on ice until use. Remaining trypsin was snap frozen and stored at – 20 °C.  
2.1.16.10 Trypsin Diluent 
100 mM ammonium bicarbonate (Section 2.1.16.5) (1 ml) and acetonitrile (1 ml) were 
brought to 10 ml with distilled water. The solution was prepared fresh on day of use. 
2.1.16.11 0.1 % (v/v) Formic Acid  
Formic Acid (1 ml) was added to LC-MS grade water (1 L). 
2.1.16.12 ProteaseMAX Surfactant Trypsin Enhancer 
Immediately before use a vial containing 1 mg ProteaseMAX was resuspended in 50 mM 
ammonium bicarbonate (Section 2.1.16.5). The vial was kept on ice until use. Remaining 
ProteaseMAX was snap frozen and stored at – 20 °C. 
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 Enzyme Linked Immunoassay (ELISA) Reagents 
2.1.17.1 Carbonate Buffer (5 X) 
200 ml of 250 mM Na2CO3 (5.3 g in ddH2O) was added to 400 ml of 250 mM NaHCO3 
(8.4 g/ 400 ml ddH2O) pH 9.6.  
2.1.17.2 ELISA Wash Buffer 
Biotrin Wash Buffer was used for all ELISA wash steps  
2.1.17.3 ELISA Sera and Calibrator Diluent 
1 % (w/v) BSA (1 g) was added to 100 ml PBST (Section 2.1.5). The solution was stirred 
gently and sorted at 4 °C.  
2.1.17.4 3,3′,5,5′-Tetramethylbenzidine (TMB) Liquid Substrate 
TMB Substrate was purchased from MOSS Inc.  
2.1.17.5 ELISA Blocking Solution 
1% BSA (w/v) (1 g) and 10% sucrose (10 g) was added to 100 ml PBST. The solution 
was stirred gently and sorted at 4 °C. 
2.1.17.6 ELISA Stop Solution 
13.5 ml of an 18.4 M H2SO4 stock solution (Sigma Aldrich) was added to 486.5 ml 
ddH2O to prepare a 0.5 M H2SO4 solution.  
 
 
 
 
71 
 
2.2 Methods 
 Microbiological Methods – Strain Storage and Growth 
Fungal and bacterial strains used in this study are listed in Table 2.2 and Table 2.3. 
 
Table 2.2. A. fumigatus strains used in the study. 
 
 
Strain      Reference 
 
A. fumigatusATCC26933   http://www.atcc.org/ 
 
A. fumigatus ∆gliT26933   Schrettl et al., 2010 
 
A. fumigatus ∆gliK26933   Gallagher et al., 2012 
 
A. fumigatus ∆gliA26933   Owens et al., 2015 
 
A. fumigatus ∆gtmA26933   This work 
 
A. fumigatus ∆gtmA::gtmA (gtmAc)  This work 
 
A. fumigatus ∆gliT::∆gtmA26933  This work 
 
A. fumigatus ∆gliA:: ∆gtmA26933  This work 
 
 
Table 2.3. Bacterial strains used, including antibiotics and supplements used. 
 
Species  Strain   Antibiotics/Supplements 
 
E. coli   TOP10   Ampicillin (100 μg/ml) 
 
E. coli   DH5αTM  Ampicillin (100 μg/ml) 
 
E. coli   pSK275  Pyrithiamine (100 ng/ml) 
 
E. coli   pAN7-1  Hygromycin (100 μg/ml) 
 
E. coli   pUCGH  Hygromycin (100 μg/ml) 
 
E. coli   H2A::mRFP  Phleomycin (40 μg/ml) 
 
E. coli   pEX-N-GST  Ampicillin (100 μg/ml) 
 
E.coli   Pet19m  Ampicillin (100 μg/ml) 
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2.2.1.1 A. fumigatus Growth, Maintenance and Storage 
 A. fumigatus strains were maintained on MEA (Section 2.1.1.2). A single 
inoculation loop of  spores  from  a  stock  spore  solution  was  streaked  onto  a  plate  
and incubated at 37 oC in a static incubator for 5 days. Conidia were harvested from 
the plate by adding sterile PBST (10 ml) (Section  2.1.5)  to  the  conidia  and  rubbing  
the  surface  with  a sterile inoculation loop to dislodge the spores. The spore solution 
was centrifuged at 2000 x g for 5 min. The supernatant was removed and the spore 
pellet was resuspended in sterile PBS (5 ml) (Section 2.1.4). This was repeated. The 
spores were counted using a haemocytometer to determine the spore density 
(spores/ml). The spore solution was stored at 4 oC until required. 
2.2.1.2 E. coli Growth, Maintenance and Storage 
E. coli strains were grown on Luria-Bertani agar (Section 2.1.2.2) overnight at 37 oC or 
in Luria-Bertani broth (Section 2.1.2.1) at 37 oC overnight, shaking at 200 rpm. Where 
appropriate, media was supplemented with suitable antibiotics. 
 Molecular Biological Methods 
2.2.2.1 Isolation of Genomic DNA from A. fumigatus 
A. fumigatus conidia were harvested described in Section 2.2.1. An aliquot of the 
resulting conidial suspension (100 µl) was used to inoculate 50 ml cultures of 
Sabouraud Dextrose broth. The cultures were incubated at 37 oC for 24 h with constant 
agitation. The cultures were then filtered through autoclaved miracloth and the mycelia 
was collected, flash frozen in liquid nitrogen and ground to a fine powder using a pestle 
and mortar. The DNA extractions were carried out using the ZR Fungal/Bacterial DNA 
k i t  s u p p l i e d  by Zymo Research (California, U.S.A). All buffers and reagents were 
supplied with the kit. For each sample, mycelia (100 mg) was added to 750 µl DNA 
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buffer in the ZR Bead Bashing tube. DNA extraction was carried out according to 
the product protocol.   
2.2.2.2 Polymerase Chain Reaction (PCR) 
Polymerase chain Reaction (PCR) was used to amplify fragments of DNA for cloning, 
transformation constructs, DIG-labelled probes and colony PCR. Reactions were carried 
out using AccuTaq LA polymerase (Sigma-Aldrich). Annealing temperatures were 
estimated as ca. 4 oC below the melting temperature (Tm) of the primers used. Extension 
times used were ca. 1 min/kb of DNA to be synthesised. Reactions were carried out using 
the G-Storm PCR (Roche) System. Primers used in this study are listed in Table 2.4. 
The general reaction constitutes for AccuTaq LA polymerase used was as follows:  
10X reaction buffer  2 µl 
dNTP mix (10 µm)  2 µl 
Primer 1 (100 pmol/µl) 1 µl 
Primer 2 (100 pmol/µl) 1 µl 
DMSO    0.8 µl 
DNA template   10 – 100 ng 
AccuTaq   0.2 µl 
Sterile water   to a total of 20 µl 
The following reaction cycle was used unless otherwise stated:  
95 °C (denaturing) 5 min 
95 °C (denaturing) 1 min 
55 °C (annealing) 1 min 30 sec  x 30-35 cycles 
68 °C (extending) 1 min 
68 °C (extending) 10 min 
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Table 2.4. Oligonucleotide primers used in the study. Restriction sites are underlined. 
 
Primer Name Sequence (5’ to 3’) 
calm-qPCR-F CCGAGTACAAGGAAGCTTTCTC 
calm-qPCR-R GAATCATCTCGTCAACTTCGTCGTCAGT 
gtmA-qPCR-F CGTCTGGAAAGATCTGGAAG 
gtmA-qPCR-R CGTCTGGAAAGATCTGGAAG 
PTRoptrA1 GAGGACCTGGACAAGTACCAT 
PTRoptrA2 CATCGTGACCAGTGGTAC 
HYoptrA1 GCTCCATACAAGCCAACCAC      
YGoptrA2 GTCCTGCGGGTAAATAGCTG     
ΔgtmA-P1 ACCCTCATAGCTGCGACTTC 
ΔgtmA-P2 GCACCGGTGGTCAACAAAGCTCTTGGTC 
ΔgtmA-P3 GCGGTACCAAGACACCTATGGGGCGAAT 
ΔgtmA-P4 GCAAAGCACTGAACAGCAAC     
ΔgtmA-P5 CGGTTTGCGACTAAGCAGTT    
ΔgtmA-P6 ACAGTGACAGTCCCGACGTT    
ΔgtmAHYG-P2 GACTCGAGGGTCAACAAAGCTCTTGGTC 
ΔgtmAHYG-P3 GACCTGCAGGAAGACACCTATGGGGCGAAT     
gtmA_eGFP_F TAGGTACCCGGTTTGCGACTAAGCAGT 
gtmA_eGFP_R TACCCGGGTCTGGGCTTGAGGCCGGTT 
rGtmA-HindIII GCAAGCTTATGTCCAAGTCAGACTACATCCA 
rGtmA-XhoI ATCTCGAGCTAGGGCTTGAGGCCG 
GtmA_W157V_F GGAATCCAGTTGAAGTTCTGCACTGTTGAGCTTGCAAGTATAC 
GtmA_W157V_R  GTATACTTGCAAGCTCAACAGTGCAGAACTTCAACTGGATTCC 
GtmA_W162V_F GCGGCTTTCATAATTGGAATCACGTTGAAGTTCTGCCATGTTG 
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GtmA_W162V_R CAACATGGCAGAACTTCAACGTGATTCCAATTATGAAAGCCGC 
GtmA_N159V_F CATAATTGGAATCCAGTTGAAGACCTGCCATGTTGAGCTTGCAAG 
GtmA_N159V_R CTTGCAAGCTCAACATGGCAGGTCTTCAACTGGATTCCAATTATG 
GtmA_F185G_F CGGCGTTGTGAAGAGCGATGCCCTCTTTCTGTGTTGGAAAC 
GtmA_F159G_R GTTTCCAACACAGAAAGAGGGCATCGCTCTTCACAACGCCG 
GtmA_F127V_F AAGCTCTGGAAGCCACCAGCGACAAAAACGTGCGTATAATG 
GtmA_F127V_R CATTATACGCACGTTTTTGTCGCTGGTGGCTTCCAGAGCTT 
 
2.2.2.3 DNA Gel Electrophoresis 
2.2.2.4 Preparation of Agarose Gel 
Agarose gel electrophoresis was used to visualise restriction digest reactions, to separate 
DNA for Southern analysis, to separate differently sized DNA fragments prior to 
purification and for estimation of DNA yield. Agarose gels were cast and run using Bio-
Rad electrophoresis equipment. Agarose gels of between 0.7 – 2 % (w/v) in 1X TAE 
buffer (Section 2.1.8.1.3) were used, although for the majority of applications a 1 % (w/v) 
agarose content was suitable. Powdered agarose was added to the appropriate volume of 
1X TAE buffer in a 200 ml flask with loose stopper. This was then gently heated in a 
microwave, with frequent mixing, until the agarose had dissolved. While allowing the gel 
to cool, a mould was prepared by inserting the casting unit in a casting holder and sealed. 
A gel comb was inserted. After allowing the gel to cool to 40 – 50 oC, ethidium bromide 
(Section 2.1.8.1.4). The molten gel was then poured into casting unit, and allowed to set 
on a level surface. Once set, the gel comb was removed gently, and the gel casting unit 
containing the set gel was placed into the gel tank, with the wells nearer the negative 
(black) electrode. 1 X TAE buffer (Section 2.1.8.1.3) was then poured into the gel tank 
to fully submerge the gel. 
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2.2.2.5 Loading and Running Samples 
DNA samples were prepared for loading by adding 5 volumes of DNA sample to 1 
volume of 6 X loading dye (Section 2.1.8.1.5). DNA fragment size was estimated by 
running molecular weight markers alongside the unknown samples. Two different 
molecular weight markers were used throughout this study; marker VII (Roche) and 50 
bp ladder (Roche). Gels were electrophoresed at 60 – 120 volts for 30 – 90 min. 
2.2.2.6 DNA Gel Extraction 
DNA gel extraction was carried out using the QIA quick gel extraction kit (Qiagen, UK). 
All reagents and columns were supplied with the kit and the procedure was carried 
out according to the manufacturer’s instructions. DNA was eluted in 30 µl of sterile 
molecular grade water. 
2.2.2.7 Restriction Enzyme Digest 
Restriction enzymes, 10 X reaction buffers, and bovine serum albumin (BSA) were 
obtained from Promega. Reactions were carried out according to the manufacturer’s 
instructions as follows: 
DNA          1- 5 µg 
Enzyme           1 µl 
10 X Buffer  2.5/5 µl 
10 X BSA  2.5/5 µl 
 
Sterile water     to a total of 25/50 µl 
 
2.2.2.8 Ligation of DNA Fragments 
Ligation of DNA fragments was required for the generation of gene disruption constructs. 
DNA was digested (Section 2.2.2.7) to produce compatible fragments. These fragments 
were then separated by DNA gel electrophoresis (Section 2.2.2.3). Ligation of DNA 
fragments was carried out using the Ligafast Rapid DNA Ligation System (Promega) 
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which employs T4 DNA ligase. Ligations were carried out as per manufacturer’s 
instructions. Restriction digests either produce a DNA fragment with an overhang of 
single-stranded DNA at either end of the double-stranded section, called a cohesive end 
or where no overhangs exist, called a blunt end. For cohesive ended ligation, the preferred 
molecular ration of insert to backbone is 3:1. This was estimated based off the size of the 
DNA fragment using the following formula. Ligations were carried out using 50 – 200 
ng of vector DNA. T4 DNA ligase (1 µl), and 2X Rapid ligation buffer. For ligations 
where inserts were ligated to vectors, a control ligation was also carried out where the 
insert DNA was omitted from the reaction. For the generation of complementation 
constructs a ratio of insert to backbone of 3 : 1 was used. This was estimated based on the 
above formula.  
2.2.2.9 Transformation of DNA into Competent DH5α Cells 
LB agar plates (Section 2.1.2.2) containing Ampicillin (Section 2.1.6) were pre-heated to 
37 oC for at least 1 h. For DH5α transformation, competent cells (50 µl) were removed 
from -70 oC freezer and were defrosted on ice for 2 min. DNA (1-10 ng) was added to the 
DH5α cells. The mixture was incubated on ice for 5 min. The mixture was spread onto 
the agar plates as quickly as possible and the plates were incubated at 37 °C overnight. 
2.2.2.10 TOPO TA Cloning 
One step cloning of PCR products were carried out using the TOPO TA Cloning kit from 
Invitrogen, according to the manufacturer’s instructions. The principle behind one step 
Cloning is based on the non-template dependent activity of Taq polymerase that results 
in the addition of a single deoxyadenosine (A) to the 3’ ends of the PCR products. The 
linearised cloning vector has single 3’ deoxythymidine (T) residues therefore facilitating 
PCR inserts to ligate efficiently with the vector. The TOPO TA Cloning kit contains TOP 
10 One Shot competent E. coli cells, Super Optimal Catabolite repression (SOC) media, 
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TOPO vector and salt solution. Prior to cloning, TOP10 cells were thawed on ice and LB 
agar plates (Section 2.1.2.2) containing 100 µg/ml Ampicillin (Section 2.1.6) pre- 
warmed in a 37 °C incubator. Genomic DNA PCR product (4 µl), Salt solution (1 µl) and 
TOPO vector (1 µl) were added to a sterile 0.5 ml tube and left at room temperature for 
30 min. A 2 µl aliquot of this reaction mixture was added to a vial of TOP10 E. coli cells 
and placed on ice for 30 min. Cells were heat shocked at 42 °C for 30 s in a water bath 
and pre-warmed SOC media (200 µl) was added to the vial. The cell suspension was 
transferred to a 15 ml tube and incubated at 37 oC for 1 h with constant agitation (200 
rpm). During this incubation period, 32 µl of 5-bromo-4-chloro-3-indolyl-beta-D- 
galactopyranoside (X-gal) (Promega) (Southampton, UK) (40 mg/ml) was spread over 
the pre-warmed agar plates using a sterile glass spreader and the plates were returned to 
the incubator. This reagent facilitates blue/white colony screening which greatly aids in 
the identification of desired clones. A 50 µl aliquot of the cell suspension was spread on 
the selection plates using a sterile disposable spreader and the plates were incubated 
overnight at 37 °C. White colonies were selected and sub-cultured on to LB agar plates 
(Section 2.1.2.2) with Ampicillin (100 µg/ml) (Section 2.1.6). Restriction digest (Section 
2.2.2.7) was carried out to verify the presence and orientation of the desired insert in the 
vector of the sample clones. 
2.2.2.11 Small Scale Plasmid Purification 
Plasmid purification was carried out according to the Qiagen Plasmid purification manual 
using the QIA prep Mini-prep kit. All buffers and columns were supplied with the kit and 
details of buffer constituents are outlined in the Qiagen Plasmid Purification Handbook. 
An isolated colony was picked aseptically and used to inoculate LB broth (Section 
2.1.2.1) (10 ml) containing 100 µg/ml Ampicillin (Section 2.1.6). Cultures was grown 
overnight at 37 °C and the cells harvested by centrifugation at 13,000 x g for 10 min at 4 
°C. Procedures were then carried out according to the manufacturer’s guidelines. Purified 
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plasmids were subsequently analysed by restriction digestion followed by DNA gel 
electrophoresis (Section 2.2.2.3). 
 Generation of A. fumigatus ΔgtmA Mutant Strains 
2.2.3.1 Generation of Constructs for A. fumigatus gtmA Gene Deletion 
The bipartite gene disruption strategy was employed for the generation of A. fumigatus 
mutant strains in this study (Nielsen et al., 2006). Briefly, this strategy involved the 
generation of two constructs which each contain a partial fragment to the pyrithiamine 
(PT) resistance gene (ptrA) from A. oryzae (Kubodera et al., 2000) which is ligated to 
respective 5’ and 3’ flanking regions of A. fumigatus gtmA. This facilitates overlapping 
of the two constructs and reconstitution of the deletion cassette in vivo. The ptrA gene 
was excised from a plasmid vector pSK275 (a kind gift from Prof. Sven Krappmann, 
Göttingen, Germany), using two restriction enzymes. Both the 5’ and 3’ flanking regions 
of A. fumigatus gtmA were amplified from A. fumigatus genomic DNA by PCR (Section 
2.2.2.2), where restriction sites were incorporated to the PCR products. This facilitates 
cloning of the PCR products to ptrA. About 1.0 – 1.2 kb of the flanking region were 
amplified. The resulting PCR products were digested with the same restriction enzymes 
as ptrA to make the ends compatible for ligation (Section 2.2.2.8). The ligation products 
were used as template for a subsequent second round of PCR, where nested primers 
amplified the majority of the flanking region and only a partial section of ptrA. Schematic 
representation of the bipartite gene deletion strategy is illustrated in (Chapter 3, Figure 
3.1). All primers used in this study are listed in Table 2.4. Both first and second round 
PCR were performed with AccuTaq (Section 2.2.2.2). PCR products were extracted from 
1 % (w/v) agarose gels and purified using a Qiagen gel extraction kit (Section 2.2.2.6). 
Successful transformation of A. fumigatus protoplasts generated potential A. fumigatus 
transformants which had the ability to grow on pyrithiamine (PT) selection plates. This 
ability only occurred with the successful integration of a fully reconstituted ptrA. These 
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transformants were then screened by Southern blot analysis where a single homologous 
integration of ptrA in place of A. fumigatus gtmA was desired. 
2.2.3.2 Constructs for Complementation Transformations 
To restore A. fumigatus gtmA back into the genome of A. fumigatus ΔgtmA, a construct 
containing a new selectable marker gene and the full gtmA sequence with the respective 
5’and 3’ flanking regions was generated. The primers used for the complemented 
construct are listed in Table 2.4. The gtmA coding sequence was PCR amplified from 
wild-type genomic DNA with ΔgtmA-P5 and ΔgtmA-P6. The PCR products were cloned 
into the TOPO vector. For the selection marker, the hygromycin resistance plasmid, 
pAN7-1 was used where the hygromycin resistance gene (hph )  was excised using 
BamHI and MfeI. This was then cloned into the topogtmA plasmid via the single EcoRII 
site in this plasmid. A diagnostic restriction digest was performed using NcoI to confirm 
the correct orientation of hph. This vector, topogtmAhph, was then linearised using a 
restriction enzyme that had a unique site in the sequence. In this case, NotI was 
chosen. The linearised plasmid was then transformed into protoplasts of A. fumigatus 
ΔgtmA. The selection marker used to complement ΔgtmA was hph. Hygromycin is also 
lethal to A. fumigatus, however with the insertion of hph, growth in the presence of 
hygromycin is possible. In this study it was possible to generate a complementation 
construct that contained both gtmA and hph, allowing for the targeted insertion of hph 
with gtmA. 
2.2.3.3 A. fumigatus Protoplast Preparation 
A. fumigatus conidia were harvested from 5 day old plates grown on AMM agar (Section 
2.2.1.1). A 500 ml conical flask containing AMM medium (100 ml) (Section 2.1.1.6) was 
inoculated with A. fumigatus conidia. The culture was incubated overnight at 37 °C, 
whilst shaking at 200 rpm. The mycelia were harvested by filtering through sterile 
81 
 
miracloth and washed with sterile dH2O. Excess water was removed by gentle blotting. 
Mycelia (1.5 g) was weighed out in duplicate, and each was added to 15 ml Lysis buffer 
(Section 2.1.9.4) containing lytic enzymes (Section 2.1.9.5). The tubes were inverted 
vigorously to ensure that all mycelial clumps were removed. The tubes were then 
incubated laying down flat at 30 °C while shaking at 100 rpm for 3 h. The samples were 
placed on ice for 5 min to inhibit the lytic enzymes therefore terminating the lysis. The 
mycelial solution was centrifuged at 132 x g for 18 min with the brake off. The 
supernatant was filtered through sterile filter paper and brought up to 40 ml with 0.7 M 
KCl (Section 2.1.9.1). The solution was centrifuged at 1769 x g for 12 min with the brake 
off. The supernatant was poured off and discarded. The pellet was resuspended in 10 ml 
0.7 M KCl (Section 2.1.9.1). The solution was centrifuged at 1769 x g for 12 min with 
the brake off. The supernatant was poured off and discarded. The tubes were then left 
upside down on sterile tissue for 1 min. The pellet was resuspended in 70 µl of Buffer L6 
(Section 2.1.9.6) by gentle pipetting and swirling the resuspended pellet. The samples 
were centrifuged at 58 x g for 1 min with the brake off to gather the entire protoplast 
suspension in the bottom of the tube. Duplicate protoplast solutions were pooled at this 
point. Finally, the protoplasts were viewed on a haemocytometer to ensure adequate yield 
and viability was assessed prior to the transformation. The protoplasts were stored on ice 
for up to 1 h before use in transformation experiments. 
2.2.3.4 A. fumigatus Protoplast Transformation 
For each transformation event approximately 5 µg of 5’ and 3’ constructs were mixed 
together in a 50 ml sterile tube and the final volume was brought up to 50 µl with Buffer 
L6 (Section 2.1.9.6). A. fumigatus protoplasts (150 µl), of at least 1 x 107 / ml were added 
to the constructs. Buffer L7 (50 µl) (Section 2.1.9.7) was added to the protoplast / DNA 
mixture. This was mixed by gentle swirling and placed on ice for 20 min. Once on ice. 
Buffer L7 (1 ml) (Section 2.1.9.7) was added to the mixture and left at room temperature 
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for 5 min, to allow for recovery of protoplasts. Buffer L6 (5 ml) (Section 2.1.9.6) was 
added, and the mixture was left on ice until required for plating. This incubation time on 
ice did not exceed 30 min. Control plates were set up simultaneously where Buffer L6 
(185 µl) was added to A. fumigatus protoplasts (15 µl). The tube was swirled gently before 
the addition of Buffer L7 (50 µl). 
2.2.3.5 Plating of Transformation Protoplasts 
Regeneration agar (1.8% (w/v), 25 ml) (Section 2.1.1.9.1) containing pyrithiamine (0.1 
µg/ml) or hygromycin (100 µg/ml) (Section 2.1.6) was poured into 90 mm petri dishes 
on the transformation day. These plates were stored at room temperature until required 
for use. For each transformation, six plates containing the selective reagent were prepared 
and two plates without this reagent were prepared. The two plates without the selective 
reagent were used for the protoplast viability check. For the negative control, protoplasts 
(1.25 ml) were added to a sterile tube, which was brought to 6 ml with the 0.7 % (w/v) 
regeneration agar (Section 2.1.1.9.2). This was then poured onto one of the transformation 
plates that contained  the selective  agent.  For the protoplast viability control plate 
dilutions of the  protoplasts were plated for a viable titration. To do this two protoplast 
dilutions were prepared in fresh 50 ml tubes. One of these contained 1.25 ml of the A. 
fumigatus protoplast suspension and the other contained 1.25 µl of the A. fumigatus 
protoplast suspension. Independently, the protoplast dilutions were brought to 6 ml with 
the 0.7 % (w/v) regeneration agar (Section 2.1.1.9.2). These were then separately poured 
onto transformation plates that contained no selective agent. Finally, transformed A. 
fumigatus protoplasts were topped up to 30 ml with the 0.7 % (w/v) regeneration agar. 
This was mixed by inversion once and then 5 ml was poured onto each of the five 
transformation plates that contained the selective agent. All the plates were left upright at 
room temperature overnight (as long as the room temperature did not drop below 20 °C). 
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2.2.3.6 Overlaying of Transformation Plates 
0.7 % (w/v) regeneration agar (50 ml) (Section 2.1.1.9.2) containing pyrithiamine (0.1 
µg/ml) or hygromycin (40 µg/ml) (Section 2.1.6) was mixed and 6 ml was poured over 
the 5 transformation plates, and the negative control plate. For the positive control 
plates, 6 ml of 0.7 % (w/v) regeneration agar (Section 2.1.1.9.2) without pyrithiamine 
or hygromycin was added to each of the plates. Once the agar had set, all the plates were 
incubated upside down in a 37 oC static incubator for approximately 5 – 7 days or until 
colonies were observed through the top of the overlay layer. The appearance of colonies 
on the protoplast viability plates after 2 – 3 days confirmed viable protoplasts had been 
generated. 
2.2.3.7 Isolation of A. fumigatus Transformants after Transformation 
Potential transformants exhibited the ability to grow on the transformation plates, which 
contained the selective agent. Spores from the transformants were picked aseptically 
from the transformation plates and point inoculated onto fresh selective plates (Section 
2.1.1.1) which contained the selective agent (Section 2.1.6). The plates were then 
incubated at 37 °C in a static incubator until colonies were observed. The individual 
potential transformant colonies were aseptically excised from the plates by plugging with 
the base of a blue pipette tip. The plug was transferred to an Eppendorf tube containing 
PBST (750 µl) (Section 2.1.5). The tubes were then vortexed vigorously to release the 
conidia from the agar and into the solution. The conidial suspensions were stored at 
4 oC until required. Putative transformant conidial suspensions (500 µl) were inoculated 
into Sabouraud Dextrose Broth (20 ml) in a 50 ml conical flask. The cultures were 
incubated overnight at 37 oC, whilst shaking at 200 rpm. The cultures were then 
harvested and DNA extraction (Section 2.2.2.1) was performed for Southern blot 
analysis (Section 2.2.4). 
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2.2.3.8 Single Spore Isolation of Transformant Colonies 
Following a first round of Southern blot analysis, transformants which showed the correct 
signal on the Southern blot were selected for single spore isolation. This was to ensure 
that a transformant contained a homogenous single nucleus and that it was not a 
heterokaryon. Potential transformants were diluted by serial dilutions ranging from 10-2 
to 10-6 in filter sterilised PBST (Section 2.1.5). One-hundred µl of the dilutions were 
spread onto AMM plates (Section 2.1.1.6) containing pyrithiamine (0.1 µg/ml) or 
hygromycin (100 µg/ml) (Section 2.1.6) and incubated at 37 °C in a static incubator until 
conidiation of colonies were observed. The individual colonies were numbered and 
isolated in PBST (Section 2.1.5) as described in Section 2.2.3.7 and were then subjected 
to a second round of Southern blot analysis (Section 2.2.4). 
2.2.3.9 Synthesis of DIG-labelled Probes 
The probes used in the Southern analysis (Table 2.2) were generated by PCR (Section 
2 . 2 . 2 . 2 ) with the incorporation of DIG-labelled dNTP’s. PCR products were 
resolved on a 1 % agarose gel and excised as previously described (Section 2.2.2.3). 
DNA was denatured by heating at 95 °C for 10 min on a heating block. The DNA was 
centrifuged for 1 min under a quick spin before it was placed on ice. The DNA 
(400 ng) was added to membrane pre-hybridisation buffer (10 ml) (Section 2.1.10.6.2) 
which had been pre-heated to 65 °C for at least 30 min. The probe was stored at – 20 
°C and always heated at 65 °C for at least 30 min before use in Southern blot analysis. 
 Southern Blot Analysis 
2.2.4.1 Southern Blot Analysis – DNA Transfer 
Southern blot analysis was performed to determine whether the gene of interest has been 
deleted of replaced. Genomic DNA was isolated from the potential transformants (Section 
2.2.2.1) and a restriction digest was performed using a suitable enzyme (Section 2.2.2.7). 
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The choice of enzyme depended on the sequence of the A. fumigatus wild-type and 
transformed strain. The enzyme of choice would cut upstream to the 5’ or 3’ flanking 
region and once within the gene of interest for the wild-type loci and it would also cut 
once within the replacement gene for the mutant loci. This digestion would generate one 
signal on the blot of different sizes in the wild-type and mutant strain. The digested DNA 
was resolved on 0.7 % (w/v) agarose gels (Section 2.2.2.3). After the digested DNA had 
resolved sufficiently. The gel was placed on a UV cross- linking machine (Strategene, La 
Jolla, CA) and pulsed at 800 ΚJ to nick the DNA which aids transfer to the nylon 
membrane. Following the DNA nicking the Southern tower was set up (Figure 2.3). A 
Bio-Rad electrophoresis tank was used for this procedure where the two reservoirs on 
each side of the tank were filled with Southern transfer buffer (Section 2.1.10.1). Two 
large sheets of Whatman filter paper were draped from reservoir to reservoir across the 
tank and left until they were soaked in the transfer buffer. On top of these, the DNA gel 
was placed with the loaded side face down. A piece of nylon membrane (H+ Bond Nylon 
Membrane, GE Electric) cut to the exact size of the gel was placed on top of the gel. Once 
contact was made with the gel, the membrane was not moved. Three pieces of filter paper 
cut to gel size were placed on top, followed by three stacks of pocket-sized tissue. A glass 
plate was placed on top of the stack and a duran bottle containing approximately 400 ml 
of water was used to balance the tower. The Southern blot was left overnight at room 
temperature (as long as room temperature was consistent and did not drop below 20 °C). 
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Figure 2.3. Schematic illustration of a Southern transfer tower. 
 
2.2.4.2 Disassembly of the Southern Tower 
The Southern Blot tower (Section 2.2.4.1) was taken apart and the membrane and gel 
were removed together and placed on a clean glass plate. The position of the wells was 
marked onto the corresponding place on the membrane, and the gel was peeled away 
from the membrane. The membrane was then washed in SSC buffer (2 X, 40 ml) 
(Section 2 . 1 . 1 0 . 3 ), and rocked gently for 10 min. The membrane was removed and 
placed on clean tissue paper to remove excess buffer. The membrane was then placed 
in a UV crosslinker (Strategene, La Jolla, CA) and crosslinked at 1200 µJ for 20 – 50 
sec in order to fix the DNA onto the membrane. 
2.2.4.3 Pre-hybridisation of the Nylon Membrane 
After UV crosslinking the membrane was placed in a Hybaid tube (which had been 
heated to 42 °C) with the DNA side facing inwards. Pre-hybridisation buffer (20 ml) 
(Section 2.1.12.7.2), which had been heated to 65 °C was poured into the tube. The 
tubes were incubated at 42 °C in a Hybaid oven whilst rotating for 4 – 5 h to block 
the membrane. 
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2.2.4.4 Addition of DIG-labelled Probe to Southern Blots 
After pre-hybridisation of Southern blots (Section 2.2.4.3), the pre- hybridisation 
buffer was removed. The DIG-labelled probe which had been heated to 65 °C was 
then poured into the tube. The tubes were then incubated overnight at 42 °C whilst 
rotating in a Hybaid oven to allow the probe to hybridise to regions of homology 
on the membrane. After probing the probe was removed from the tube and stored at – 
20 °C. 
2.2.4.5 DIG Detection 
The membrane was removed from the Hybaid tube and washed with 0.1 % (w/v) SDS / 
1 X SSC solution (Section 2.1.10.5) for 5 min. The Buffer was discarded and replaced 
again and the wash was repeated for another 5 min. The blot was placed in a clean Hybaid 
tube (which had been heated to 65 °C) and half filled with 0.1 % (w/v) SDS / 1 X SSC 
solution (Section 2.1.10.5). The membrane was rotated in the Hybaid oven for 15 min at 
65 °C. The solution was discarded and replaced and the membrane was rotated for 15 min 
at 65 °C. Between each wash step the tubes were allowed to drip dry on clean tissue paper. 
The solution was poured off from the tube and DIG Wash Buffer (10 ml) (Section 
2.1.10.6.6) was poured in with the membrane. The membrane was rotated for 5 min in 
the Hybaid oven at 25 °C. The buffer was poured off from the tube and the blots were 
blocked with Antibody Blocking buffer (Section 2.1.10.6.4) whilst rotating for 30 min at 
25 °C. The Buffer was poured off from the tube and the Anti-Digoxigenin-Fab AP 
conjugate (10 ml) (Section 2.1.10.6.7) was added. The membrane was rotated for 30 min 
at 25 °C. The solution was poured off from the tube and DIG Wash Buffer (10 ml) 
(Section 2.1.10.6.6) was added to the tube. The membrane was rotated for 15 min at 25 
°C. The wash step was repeated. The buffer was poured off from the tube and DIG Buffer 
3 (10 ml) (Section 2.1.10.6.5) was added and the membrane was rotated at 25 °C for 5 
min. The buffer was poured off from the tube and CSPD Substrate (5 ml) (Section 
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2.1.10.6.8) was added. The membrane was rotated at 25 °C for 5 min. The CSPD 
Substrate was collected from the tube covered in tinfoil and kept at 4 °C to be reused 
within one week. The membrane was removed  from  the  Hybaid  tube  and  placed  on  
a  clean  tissue  briefly.  The membrane was carefully wrapped in a single layer of cling 
film and incubated at 37 °C for 15 min. This incubation step was performed to enhance 
the signal on the Southern blot. 
2.2.4.6 Developing the Southern Blot membrane 
The cling film wrapped membrane was taped into a photo developer case and an in the 
dark an X-ray film was placed over the membrane. Exposure time usually ranged 
between 1 – 3 h initially and an overnight exposure was usually performed also. After 
this, the X-ray film was removed from the case in complete darkness and placed into 
developer solution (Section 2.1.10.6.10) for a couple of seconds or until signals began 
to appear. The film was rinsed with water and then placed into Fixer Solution (Section 
2 . 1 . 1 0 . 6 . 1 1 ). The film was then thoroughly rinsed with water and left to dry. 
 RNA Analysis 
2.2.5.1 RNA Isolation 
A. fumigatus liquid cultures which were incubated at the required temperature and time 
were filtered through autoclaved miracloth and the mycelia collected. Mycelia were then 
flash frozen in liquid Nitrogen and ground to a fine powder in a mortar by pestle. The 
RNA was isolated using the RNeasy plant mini kit supplied by Qiagen, according to the 
manufacturer’s instructions. All buffers and columns were supplied with the kit, details 
of which are outlined in the kit handbook. β-mercaptoethanol (10 µl) was added to Buffer 
RLC (1 ml) before RNA extraction. For each sample, mycelia (100 mg) was placed in 
sterile microcentrifuge tubes. The procedure was then carried out as per manufacturer’s 
guidelines. RNase-free water (50 µl) was added to the columns and the RNA was eluted 
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by centrifuging the column at 10,000 x g for 1 min. To increase RNA concentration, the 
eluent was passed through the RNeasy spin column for a second time and centrifuged at 
10,000 x g for 1 min. The RNA samples were stored at – 20 °C up to 6 months and at – 
70 °C long term. 
2.2.5.2 DNase Treatment of RNA 
A DNase kit (Sigma) was used to DNase treat RNA samples. RNA samples (Section 
2 . 2 . 5 . 1 ) (500 ng) were adjusted to a final volume of 8 µl in Molecular Grade 
H2O. 10 X Reaction Buffer (1 µl) and DNase (1 µl) were added to the RNA samples 
and the mixture was left to incubate at room temperature for 15 min. Stop Solution (1 
µl) was added to the reaction and they were then incubated at 70 °C for 10 min. The 
samples were chilled on ice and stored at – 70 °C if not for immediate use. 
2.2.5.3 cDNA Synthesis 
cDNA synthesis was performed using the qScript™ cDNA SuperMix (Quanta 
BioSciences) using the supplied reagents in the kit and following the manufacturer’s 
instructions.   
2.2.5.4 Semi-quantitative RT-PCR 
PCR was carried out on the cDNA samples (Section 2.2.5.3) as described in Section 
2.2.2.3 using the primers 5’ gtmA RT-PCR and 3’ gtmA RT-PCR (Table 2.4). The A. 
fumigatus calmodulin (calm) gene (Afu4g10050) was used as a housekeeping gene 
(Burns  et  al . ,  2005)The primers calmF and calmR (Table 2.4) span an intronic 
region in calm, resulting in an amplicon size of 617 bp from gDNA and an amplicon 
size of 314 bp from cDNA. This allows the detection of any contaminating gDNA 
in the cDNA samples. The RT-PCR amplicons were resolved on a 2 % (w/v) Agarose 
Gel (Section 2.1.8.1.6) and visualised using a Syngene G:Box. 
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 A. fumigatus Plate Assays 
A. fumigatus wild-type and mutant strains were grown on MEA agar for 5 days at 37 °C 
after which conidia were harvested (Section 2.2.1.1). Conidia was serially diluted to 10-
2 and 10-4 in PBS. Aliquots (5 µl) of each dilution was spotted onto agar plates containing 
various additives (Section 2.1.6). Plates were incubated at 37 °C and growth was 
monitored at specific time intervals by measuring the diameter of radial growth (cm) of 
each colony. Two-way ANOVA analysis was performed to determine the statistical 
significance between strains on the various additives. 
 GtmA Recombinant Expression in E. coli using PEX-N-GST and Pet19m  
The PCR product of the gtmA gene was integrated into the expression vectors PEX-N-
GST (Figure 2.4) and Pet19m by linearising the vector within the multiple cloning site 
and ligation of the free ends of the linearised vector and the digested PCR product 
together. The orientation of the ligation was restricted to only the correct one by ensuring 
that that linearizing digestion was conducted with two incompatible enzymes. The PCR 
that created the gtmA product had add-on nucleotides that ensured that the ligation did 
not shift any of the subsequential amino acid expression. 
 
Figure 2.4. pEX-N-GST Vector for GST-GtmA Expression 
91 
 
 2.2.7.1 Small scale induction of the recombinant pEX-N-GST-GtmA and 
Pet19m-GtmA  
Once it was verified that the pEX-N-GST-GtmA vector had transformed correctly into E. 
coli, small-scale inductions were carried out to confirm GtmA production. A 10 ml LB 
broth (Section 2.1.2.1) culture was set up containing 100 μg/ml ampicillin (Section 2.1.6) 
which was then inoculated with the pEX-N-GST-GtmA plasmid and incubated overnight 
at 37 °C whilst shaking at 200 rpm. This culture was then used to inoculate a 50 ml LB 
broth culture (Section 2.1.2.1) containing 100 μg/ml ampicillin (Section 2.1.6). The 
culture was incubated at 37 °C whilst shaking at 200 rpm until an OD600 value of 0.5 – 
0.7 was reached. Once the culture had reached the target growth level, a 1 ml aliquot was 
removed and kept as an un-induced aliquot used for reference. The expression was 
induced by adding IPTG (1 M stock) to a final concentration of 1 mM and the culture was 
incubated further, and at the time points, 1, 2 and 3 h, 1 ml aliquots were removed, and 
kept as post induced time-point samples. The remaining culture was centrifuged at 3200 
x g at 4 oC, for 20 min and the sample aliquots were centrifuged at 17900 x g for 1 min. 
The supernatants were discarded and the pellets were kept at -20 °C until required. 
2.2.7.2 Site-Directed Mutagenesis 
The previously described vector Pet19m_gtmA (Section 2.2.7) served as a template for 
in vitro site-directed mutagenesis using the QuikChange® XL Site-Directed Mutagenesis 
Kit (Stratagene) and oligonucleotides listed in Table 2.4. Mutagenesis was carried out as 
stated in the supplied protocol. Hereby, the plasmids Pet19m_GtmA_W157V, 
Pet19m_GtmA_W162V, Pet19m_GtmA_N159V, Pet19m_GtmA_F185G and 
Pet19m_GtmA_F127V were created. The resulting plasmids were propagated in E. coli 
DH5α cells. The DNA sequence was verified by sequencing and the vectors were 
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introduced into E. coli BL21(DE3) cells for protein overproduction as described in 
Section 2.2.7.1. 
2.2.7.3 Protein extraction from pEX-N-GST-GtmA cultures 
Lysis Buffer (9 ml) (Section 2.1.11) was added to every 2 g of pelleted cells. The 
samples were sonicated whilst sitting on ice. Lysozyme (80 μl) (Section 9.1.22.3) was 
added per 2 g of pellet, and the sample was incubated at 20 oC for 1 h constantly shaking. 
The samples were sonicated on ice. The samples were centrifuged at 12000 x g for 10 
min at 4 oC. An aliquot (1 ml) was removed from the supernatant, and the rest of the 
supernatant was discarded. The pellets were resuspended in 1X Solubilisation buffer 
(Section 2.1.15.5) per original 1 g. The samples and aliquots were stored at -20 oC until 
required. 
 Analysis of GtmA-eGFP by Confocal Microscopy 
The gtmA-eGFP strain transformed with H2A::mRFP (1x104 conidia) was inoculated into 
400 µl Czapeks dox media in a Lab-Tek Chambered Borosilicate Coverglass System.  
The chamber was incubated at 37°C for 21h and then gliotoxin (5 µg/ml final) was added 
to the chambers. An equivalent volume of MeOH was added to the control wells. As a 
second control a well containing ΔgtmA with gliotoxin was also prepared. Samples were 
viewed with an Olympus Flouview 1000 confocal microscope under the supervision of 
Dr. Ica Dix, Biology Dept., Maynooth University. 
 Sequence data and phylogenetic methods 
The fungal protein dataset consisted of 103 genomes and 1001217 individual genes. 
Information on the sources of genome data are as in (Medina et al., 2011)). Using BlastP 
(Altschul et al., 1997), with an expectation (E) value of 10-5, A. fumigatus GtmA 
(AFUA_2G11120) was searched against each individual fungal genome to locate all 
putative fungal homologs. Top significant hits were also searched back against the A. 
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fumigatus genome and reciprocal top hits to A. fumigatus GtmA were putatively labelled 
as orthologs. All GtmA homologs were aligned using MUSCLE (Edgar, 2004), with the 
default settings. Obvious alignment ambiguities were manually corrected. Phylogenetic 
relationships were inferred using maximum likelihood methods and the appropriate 
protein models of substitution were selected using the Bayesian information criterion 
implemented in ProtTest (Darriba et al., 2011). One hundred bootstrap replicates were 
then carried out with the appropriate protein model using the software program PHYML 
(Guindon and Gascuel, 2003) and summarized using the majority-rule consensus method. 
 Protein Characterisation Methods 
2.2.10.1 Bradford Protein Assay 
Bio-Rad protein assay dye was diluted 1/5 in sample buffer prior to use. The sample to 
be assayed was also diluted appropriately. 20 µl of the sample was added to 980 µl of the 
diluted Bio-Rad protein assay dye and mixed thoroughly. The final sample (1 ml) was 
transferred to a 1 ml plastic cuvette and incubated for 5 min at room temperature. The 
absorbance at 595nm was read relative to a blank and the protein concentration was 
determined based on values obtained from a standard curve. All samples were prepared 
and analysed in duplicate. 
2.2.10.2 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
SDS-PAGE gels, both stacking and resolving, were prepared according to Table 2.5 and 
Table 2.6 respectively. The gels were cast using the Mini-Protean II gel casting apparatus 
(BioRad, CA, USA) according to the manufacturer’s guidelines. Samples were prepared 
by adding one volume of 5X solubilisation buffer (Section 2.1.15.5) to every 4 volumes 
of sample in a 1.5 ml microfuge tube. The samples were boiled for 5 min and centrifuged 
briefly to collect the sample to the bottom of the tube. An appropriate volume of sample 
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was loaded onto the gel. A molecular mass marker was run alongside samples in order to 
estimate the relative size of observed proteins. The molecular mass marker used 
throughout this study ranged from 10-170 kDa (SM0671, Fermentas, Figure 2.5). The 
electrophoresis tank was filled with 1X SDS electrode running buffer (Section 2.1.15.7). 
Electrophoresis was carried out initially at 80 V for 30 min, followed by electrophoresis 
at 120 V until the dye front reached the bottom of the gel.  
 
Figure 2.5. Protein ladder used in this thesis - Fermentas PageRuler™ Prestained 
Protein Ladder 
 
Table 2.5. Reagents composition for SDS-PAGE Resolving Gels. 
% Acrylamide 10% 10% 12% 12% 15% 
Number of Minigels 5 8 5 8 5 
1.5 M Tris-HCl pH 8.3 7.0 ml 10.5 ml 7.0 ml 10.5 ml 7.0 ml 
10 % SDS 280 µl 420 µl 280 µl 420 µl 280 µl 
30 % Acrylamide, 0.8 % Methylene 
bis Acrylamide 
9.3 ml 13.9 ml 11.3 ml 16.9 ml 13.9 ml 
Distilled water 12.3 ml 18.4 ml 9.3 ml 13.9 ml 6.3 ml 
10 % Ammonium persulfate  100 µl 150 µl 100 µl 150 µl 100 µl 
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TEMED 23 µl 35 µl 23 µl 35 µl 23 µl 
 
 
Table 2.6. Reagents composition for SDS-PAGE Stacking Gels. 
Number of Minigels 2 5 8 
0.5 M Tris-HCl pH 6.8  
 
2.5 ml 4.0 ml 5.2 ml 
 
 
10 % SDS 100 µl 160 µl 210 µl 
30 % Acrylamide, 0.8 % Methylene        
bis Acrylamide 
 
 
 
1.0 ml 1.5 ml 2.0 ml 
Distilled water 6.4 ml 9.6 ml 12.8 ml 
10 % Ammonium persulfate 100 µl 150 µl 200 µl 
TEMED 10 µl 15 µl 20 µl 
 
 
2.2.10.3 Semi-dry transfer of proteins to NCP 
Nitrocellulose paper (NCP) and six sheets of filter paper were cut to the appropriate size 
of the gel and pre-soaked in Towbin Transfer Buffer (Section 2.1.15.10) for 15 min. The 
protein gels were removed carefully from the electrophoresis unit and assembled on the 
transfer unit in a NCP “sandwich” consisting of 3 sheets of saturated filter paper, soaked 
NCP, protein gel and an additional 3 sheets of saturated filter paper. Transfer was carried 
out at 18 V for 20 min using a semi-dry transfer unit. Ponceau S solution was applied to 
NCP to detect protein transfer with excess stain removed through washing with dH2O. 
2.2.10.4 Western Blot Analysis 
Protein transferred to NCP using semi-dry transfer (Section 2.2.10.3) was used to carry 
out Western blot analysis. Blocking buffer (Section 2.1.15.11) was applied to the NCP 
and incubated for 1 h at room temperature with gentle rocking. The blocking buffer was 
poured off the blot and primary antibody, diluted in Antibody buffer (Section 2.1.15.12), 
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was added to the blot. This was incubated for 1 h at room temperature with gentle rocking. 
Three 10 min PBST (Section 2.1.5) washes were carried out on the blot. The secondary 
antibody was diluted in antibody buffer (Section 2.1.15.12) and incubated with the blot 
for 1 h at room temperature with gentle rocking. Three 10 min PBST washes were carried 
out and the blot was developed using 3, 3’-diaminobenzidine tetrachloride hydrate (DAB) 
(10 mg) was dissolved in DAB Substrate buffer (Section 2.1.15.13) (15 ml). Hydrogen 
peroxide (7 µl) was added to the substrate solution which was then applied to blots. Blots 
were allowed to develop for 10 min and dH2O was applied to stop the reaction and reduce 
background staining. 
2.2.10.5 Dialysis of protein samples 
Dialysis tubing was pre-soaked in the appropriate buffer for 10 min. Protein sample was 
added to the dialysis tubing with an additional 50% free space included to allow for 
sample volume expansion. The sealed tubing, containing the sample, was dialysed against 
50 volumes. Dialysis was carried out at 4 °C with stirring. A minimum of three buffer 
changes were carried out at 3 h intervals. 
 AKTA FPLC Methods 
2.2.11.1 Glutathione Sepharose Affinity Chromatography 
Glutathione Sepharose Affinity Chromatography was carried out using an ÄKTA purifier 
coupled with a XK 16/20 column (GE Healthcare, Germany) packed with 10 ml 
Glutathione Sepharose 4B  (GE Healthcare, Germany). The column was first equilibrated 
with 2 column volumes (CV) of Equilibration/Wash Buffer (Section 2.1.14.2) at a flow 
rate of 4 ml/min.  E. coli cell lysates containing GST-GtmA were passed through a 0.45 
µm syringe filter to remove particulate matter then passed over the GSH-Sepharose 
column at 1 ml/min. As the GSH-GST interaction is flow-rate dependent, the flow-rate 
was not increased higher than 1 ml/min during binding to maximise the resin capacity. 
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After all the lysate was loaded the column was washed with 3 CV of Equilibration/Wash 
Buffer (Section 2.1.14.2) at 4 ml/min. The absorbance was monitored at 280 nm to ensure 
that it returned to the baseline after the wash step. The GST-GtmA was then eluted from 
the column using 3 CV of Sample Elution Buffer (Section 2.1.14.2) and the eluted GST-
GtmA was collected in 1 ml fractions. Fractions containing protein were pooled and 
analysed using SDS-PAGE. 
2.2.11.2 Anion Exchange Chromatography 
Anion Exchange Chromatography was carried out using an ÄKTA purifier coupled with 
(i) a XK 16/20 column (GE Healthcare, Germany) packed with 10 ml Q-Sepharose High 
Performance  (GE Healthcare, Germany). The column was first equilibrated with 2 
column volumes (CV) of Equilibration/Wash Buffer (Section 2.1.14.2) at a flow rate of 
2 ml/min.  A solution containing TEV cleaved GST and GtmA was injected onto the Q-
Sepharose column at 1 ml/min. After all the sample was loaded the column was washed 
with 2 CV of Equilibration/Wash Buffer (Section 2.1.14.2) at 2 ml/min. The absorbance 
was monitored at 280 nm to ensure that it returned to the baseline after the wash step. A 
linear gradient of 0-60 % Elution Buffer (Section 2.1.14.2) over 30 min was then used to 
elute the protein from the column. Due to their different isoelectric points, the GtmA and 
GST were eluted from the column as two separate peaks. The eluted GtmA was collected 
in .5 ml fractions. Fractions containing GtmA were pooled and analysed using SDS-
PAGE. 
2.2.11.3 Gel Filtration Chromatography 
Gel filtration chromatography was carried out using an ÄKTA purifier coupled with a 
Superdex 200 10/300 GL column (GE Healthcare, Germany). Lines were purged prior to 
use and the column was equilibrated with GtmA Gel Filtration Buffer (Section 2.1.14.4). 
Samples were centrifuged at 10000 x g for 10 min to remove particulates prior to injection 
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onto column. A selection of molecular weight calibrants were applied to the column in 
order to prepare a standard curve based on molecular weight versus elution volume (Ve) 
(Section 2.1.14.1). The flow rate was set to 0.2 ml/min, with absorbance monitored at 
215, 254 and 280 nm. Fractions were collected if required for further analysis. 
 Small Scale Organic Extraction of A. fumigatus Culture Supernatants 
A. fumigatus culture supernatants (20 ml) were added to chloroform (20 ml) in 50 ml 
Falcon tubes. The mixtures were then placed on a rotating wheel for 1 h. The mixtures 
were removed and centrifuged for 10 min at 2000 x g. The top aqueous layers were 
removed and discarded and the bottom organic layers were stored at -20 oC until required. 
 Rotary evaporation of Organic Extraction Samples 
Organic extracts (Section 2.2.12) were placed in an evaporation bulb and the bulb was 
evaporated under vacuum whilst sitting in a water bath set to 37 oC (Stuart RE300DB 
digital water bath). The chloroform evaporated leaving the dried organic extract in the 
bulb. The extracts were resuspended in HPLC grade methanol (200 – 500 µl) until all the 
dried material was fully resuspended. The resuspended extract was centrifuged at 13,000 
x g for 5 min and then transferred to clean 1.5 ml eppendorf and stored at – 20 oC. 
 S-Adenosyl Methionine (SAM) Extraction and Quantification in A. 
fumigatus 
Czapeks Dox media was inoculated with 106/ml conidia in triplicate, and incubated at 37 
°C, shaking 200 rpm, for 21 h. Gliotoxin (5 µg/ml final) or methanol control was added 
and the cultures were incubated for a further 3 h before mycelia were harvested and snap 
frozen in liquid N2. Mycelia was then ground to a fine powder using a pestle and mortar 
(Section 2.2.2.1). 100 mg of ground mycelia was weighed into an eppendorf and 250 µl 
of 0.1 M HCl (Section 2.1.12) was added to the sample. The sample was vortexed and 
incubated on ice for 60 min, with regular vortexing. The sample was then centrifuged at 
99 
 
13,000 x g for 10 min at 4 °C. The supernatant was transferred to a new eppendorf. Protein 
was removed from the supernatant by TCA precipitation (10% final TCA). Samples were 
diluted in 0.1 % (v/v) formic acid and analysed by LC-MS/MS using a porous graphitized 
carbon (PGC) Chip on an Agilent 6340 Ion-trap LC Mass Spectrometer (Agilent 
Technologies) using electrospray ionization. Quantification was enabled using 
commercially available SAM obtained from Sigma-Aldrich.  
 Metabolome Analysis using RP - HPLC 
Organic extracts from supernatants (Section 2.2.13) were analysed by RP-HPLC with UV 
detection (Agilent 1200 system), using a C18 RP-HPLC column (Agilent Zorbax Eclipse 
XDB-C18 Semi-Preparative; 5 mm particle size; 4.6 x 250 mm) at a flow rate of 1 ml/min. 
A mobile phase of water (Section 2.1.13.1.1) and acetonitrile (Section 2.1.13.1.2) with 
TFA, was used under various gradient conditions. Injection volume was either 20 or 100 
µl. 
 Mass Spectrometry Methods 
2.2.16.1 In-gel Digestion of SDS-PAGE Samples 
In-gel digestion of SDS-PAGE samples was carried out according to the protocol of 
(Shevchenko et al., 2006). Briefly, selected bands or spots from SDS-PAGE gels were 
excised and placed in individual 1.5 ml microfuge tubes. Gel pieces were destained by 
the addition of 100 µl of 100 mM ammonium bicarbonate (Section 2.1.16.5): acetonitrile 
(1:1 v/v). Samples were vortexed periodically for 30 min. Acetonitrile (500 µl) was added 
to samples, followed by vortexing until the gel pieces became white and shrunk. 
Acetonitrile was removed and replaced with 50 µl of trypsin, diluted to 13 ng/µl in trypsin 
buffer (Section 2.1.16.10). Samples were incubated at 4 °C for 2 h, with additional trypsin 
added to cover gel pieces if required. Samples were then incubated at 37 °C overnight. 
Gel pieces were subsequently placed in a sonication bath for 10 min followed by transfer 
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of the digest supernatant to fresh microfuge tubes. Samples were dried to completion 
using a speedy vac (DNA Speedy Vac Concentrator, Thermo Scientific) and resuspended 
in 0.1% formic acid (Section 2.1.3.8) (20 µl). The samples were filtered through 0.22 µm 
Cellulose Spin-filters (Costar) before transfer to polypropylene vials. Care was taken to 
ensure there was no air trapped in the vials. 
2.2.16.2 LC-MS/MS Analysis of Peptide Mixtures 
Peptide mixtures generated from in-gel digestion of protein spots or bands from SDS-
PAGE (Section 2.2.16.1) were analysed using a 6340 Model Ion Trap LC-Mass 
Spectrometer (Agilent Technologies, Ireland) using electrospray ionisation. Samples (1 - 
5 µl) were loaded onto a Zorbax 300 SB C-18 Nano-HPLC Chip (150 mm x 75 µm) with 
0.1 % (v/v) formic acid at a flow rate of 4 µl/min. Peptides were eluted using the 
appropriate gradient with a post run of 5 min. The eluted peptides were ionised and 
analysed by the mass spectrometer. MSn analysis was carried out on the 3 most abundant 
peptide precursor ions at each time point, as selected automatically by the mass 
spectrometer. Singly charged ions were excluded from analysis by the mass spectrometer. 
2.2.16.3 Database Search 
MASCOT MS/MS Ion search, with interrogation of the NCBI (National Centre for 
Biotechnology Information, http://www.ncbi.nlm.nih.gov) database, was used for 
protein identification. Criterion for each search was set at (i) Taxonomy: Fungi, (ii) two 
missed cleavages by trypsin, (iii) fixed modification: carboxymethylation of cysteines, 
(iv) variable modification: oxidation of methionine, (i) mass tolerance of precursor ions 
± 2Da and product ions ± 1Da. 
2.2.16.4 LC-MS/MS Analysis of A. fumigatus Metabolites 
Metabolites isolated by (i) organic extraction from culture supernatants of A. fumigatus 
(Section 2.2.12) or (ii) fractionation following RP-HPLC analysis were analysed by LC-
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MS/MS. Samples were diluted in 0.1 % (v/v) formic acid (Section 2.1.16.11) prior to 
mass spectrometry and were loaded onto a Zorbax 300 SB C-18 Nano-HPLC Chip (150 
mm x 75 µm) at a flow rate of 4 µl/min. Metabolites were eluted using the appropriate 
gradient with a post run of 5 min. MSn was carried out on the 3 most abundant precursor 
ions at each timepoint, with n ranging from 2 to 5, depending on the analysis. Singly 
charged ions were not excluded from analysis, with the precursor range adjusted to 
include ions with m/z between 15 and 2200. 
2.2.16.5 Q-Exactive Mass Spectrometry 
2.2.16.5.1 A. fumigatus Protein Extraction for Q-Exactive Mass Spectrometry 
Harvested mycelia was snap frozen in liquid nitrogen and crushed into a fine powder 
using liquid nitrogen and a pestle. Mycelia powder (200 mg) was weighed into a 2 ml 
tube. Excess mycelial powder was collected and stored immediately at -70 °C.  A. 
fumigatus Whole Protein Lysate Extraction Buffer (Section 2.1.16.1) (500 µl) was added 
to the mycelial powder. The suspension was sonicated using sonication probe MS72 at 
10% power, cycle 6 for 10 sec. This was repeated two more times with the sample being 
cooled on ice between each sonication. The suspension was then sonicated using 
sonication probe MS73 at 10% power, cycle 6 for 10 sec. Lysates were incubated on ice 
for 1 h, followed by centrifugation at 12,000 x g for 10 min at 4 °C. The supernatants 
were transferred to new tubes and the centrifugation step was repeated to obtain clarified 
lysates. A Bradford assay was carried out to determine the protein concentration in each 
sample. Samples (1 mg) were brought to 15 % TCA by addition of the appropriate volume 
of cold 100 % TCA solution (Section 2.1.16.4), vortexed briefly, and incubated on ice for 
30 min. Samples were centrifuged at 12,000 x g, 10 min, 4 °C and the supernatant was 
discarded. 500 µl of ice-cold acetone was added to the protein pellet, this was pipetted 
briefly and incubated at -20 °C for 2 h. Samples were centrifuged at 12,000 x g, 10 min, 
4 °C and the supernatant was discarded. Pellets were washed twice with 500 µl of ice-
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cold acetone. Acetone was removed after the final wash and the pellet was allowed to dry 
for no more than 5 min before resuspension with 80 µl of Protein Resuspension Buffer. 
A Bradford assay (Section 2.2.10.1) was carried out to determine the protein 
concentration in each sample. 
2.2.16.5.2 Protein Digestion for Q-Exactive Mass Spectrometry 
Samples (15 µl; 50 µg) in Protein Resuspension Buffer (Section 2.1.16.8) were brought 
to room temperature for 10 min to ensure urea was in solution. Ammonium bicarbonate 
(78.5 µl; 50 mM) was added to the samples. 1 µl DTT was added to the samples, followed 
by incubation at 56 °C for 20 min. Samples were allowed to cool to room temperature 
and 2.7 µl of IAA (Section 2.1.16.7) was added, followed by incubation at room 
temperature for 15 min in the dark. Following reduction and alkylation, 1 µl of 
ProteaseMAX stock and 1.8 µl of trypsin were added to each of the samples, followed by 
incubation at 37 °C overnight. The next day samples were spun briefly to collect any 
condensate and acidified by adding 1 µl of TFA, vortexed briefly, and incubated at room 
temperature for 5 min. Samples were centrifuged at 13,000 x g for 10 min at room 
temperature and the supernatant was aliquoted into 0.2 ml tubes and snap-frozen in liquid 
nitrogen. Samples were stored at -20 °C. 
2.2.16.5.3 ZipTip® Pipette Tip Protocol 
The sample was first resuspended with 20 µl Resuspension Buffer and sonicated for 2 
minutes in a sonication bath to help resuspend the pellet. The sample was then centrifuged 
briefly. The ZipTip was then wet by aspirating and dispensing 10 µl wetting solution into 
the tip. This step was repeated 5 times. The ZipTip was then equilibrated by aspirating 
and dispensing 10 µl Equilibration Solution onto the tip. This was repeated 5 times. To 
bind the sample to the ZipTip, 10 µl of the resuspended sample was aspirated and 
dispensed. This step was repeated 10 times. The ZipTip was then washed by aspirating 
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and dispensing 10 µl of Washing Solution from the tip to a waste eppendorf. This step 
was repeated 5 times. To elute the peptide sample from the ZipTip 10 µl of Elution 
Solution was aspirated and dispensed from the tip into a new 1.5 ml eppendorf. This step 
was repeated 5 times. The eluted sample was then dried down with a SpeedVac and 
resuspended in 15 µl Q-Exactive Loading Buffer. The samples were stored at 4 °C until 
analysis.   
Table 2.7. Solutions for ZipTip Protocol 
Solution Composition Volume (µl) 
Acetonitrile 
Volume (µl) 
ddH2O 
Volume (µl) 
TFA 
Total 
Volume 
(µl) 
Resuspension 
Buffer 
0.5% TFA in 
ddH2O 
0 995 5 1000 
Equilibration 
& Washing 
Solution 
0.1% TFA in 
ddH2O 
0 999 1 1000 
Wetting 
Solution 
0.1% TFA in 80% 
Acetonitrile 
800 199 1 1000 
Elution 
Solution 
0.1% TFA in 60% 
Acetonitrile 
600 399 1 1000 
  
2.2.16.5.4  A fumigatus Q-Exactive Mass Spectrometry Method 
All peptide mixtures were analysed via a Thermo Fisher Q-Exactive mass spectrometer 
coupled to a Dionex RSLCnano. LC gradients ran from 4-35 %B over 2 h, and data was 
collected using a Top15 method for MS/MS scans. Comparative proteome abundance and 
data analysis was performed using MaxQuant software (Version 1.3.0.5) (Cox and Mann, 
2008), with Andromeda used for database searching and Perseus used to organise the data 
(Version 1.4.1.3). Carbamidomethylation of cysteines was set as a fixed modification, 
while oxidation of methionines and acetylation of N-termini were set as variable 
modifications. The maximum peptide/protein false discovery rates (FDR) were set to 1% 
based on comparison to a reverse database. The Label-Free Quantification (LFQ) 
algorithm was used to generate normalised spectral intensities and infer relative protein 
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abundance. Proteins that matched to a contaminants database or the reverse database were 
removed and proteins were only retained in final analysis if detected in at least three 
replicates from at least one sample. Quantitative analysis was performed using a t-test to 
compare pairs of samples, and proteins with significant change in abundance (p value 
<0.05; fold change ≥2) were included in the quantitative results. Qualitative analysis was 
also performed, to detect proteins that were found in at least 3 replicates of a particular 
condition, but undetectable in the other sample condition. 
 Gliotoxin Feeding Experiments Using A. fumigatus 
A. fumigatus strains were cultured in Sabouraud dextrose broth (25 ml) at 37 oC, for 21 
h. At 21 h the gliotoxin related metabolite was added to the cultures, and a 1 ml aliquot 
of the supernatant was removed. Cultures were incubated for a further 15, 60 and 180 min 
and an aliquot (1 ml) of the supernatant was removed at each time point. A control sample 
was treated the same except nothing was spiked into the culture. The 1 ml aliquots of 
supernatant from each time point were subjected to organic extraction (Section 2.2.12) at 
a 1:1 ratio of chloroform. The organic extracts were dried overnight in a fume hood until 
all chloroform had evaporated. The dried extract was resuspended in HPLC grade 
methanol (50 µl). Extracts (1 µl) were then analysed by LC-MS (Section 2.2.16.4) to 
determine whether the gliotoxin related metabolite had been taken up or converted by A. 
fumigatus. 
 Generation of mono(methylthio)gliotoxin (MmGT) using Methyl Iodide 
5 mg gliotoxin (3 mg/ml in MeOH) was reduced to dithiol gliotoxin with 50 µl TCEP 
Bond-Breaker Solution. 5 µl Maleimide Conjugation Buffer (0.083 M sodium phosphate, 
0.1M EDTA, 0.9 M NaCl, pH 7.2) was added to minimise sulfhydral oxidation to 
disulfides during the methylation reaction. The sample was evaporated in a Speedivac for 
30 min at medium heat to 400 µl. 30 µl Iodomethane (0.5 M in MeOH) was then added 
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to the dithiol GT. The sample was then covered in aluminium foil to protect from the light 
an incubated at room temperature for 20 min with gentle shaking.  
 Mono(methylthio)gliotoxin Conjugate Generation 
Lyophilised maleimide KLH (Pierce) or sulfo-SMCC BSA (Pierce) was resuspended at 
1 mg/ml in degassed ddH2O. 500 µl of the MmGT solution was immediately added 
dropwise to 5 mg of the maleimide KLH or sulfo-SMCC BSA. The reaction was left to 
incubate overnight at room temperature. The sample was then centrifuged at 13,000 x g 
for 2 min to remove precipitated immunogen. This precipitate was then combined with 
the final sample for immunisation. The MmGT-KLH sample was concentrated to 1 mg/ml 
using an Amicon Ultra Centrifugal Filter Unit (Merck Millipore). 
 Optimisation of MmGT-BSA Antigen ELISA Plate Coating 
Concentration and Sera Dilutions 
Microtitre plates were coated with a titred range of MmGT-BSA concentrations, starting 
x gat 2 µg/ml, and double diluted down to 0.015 μg/ml. Control plates were also prepared 
coated with a titred range of SMCC-BSA. Plates were sealed and incubated overnight at 
37 °C for 2 h. Plates were then washed using a plate washer (Programme: BTL4: 4 X 300 
μl) with ELISA Wash Buffer (Section 2.1.17.2). The residual Wash Buffer was tapped 
out of the wells. 200 μl Blocking Solution (Section 2.1.17.5) was added to each well and 
the plates were incubated at 37 °C for 2 h. The blocking buffer was removed from the 
wells and plates were inverted and dried for 2 h at 37 °C. MmGT-KLH antisera (from 
mice A-C) was diluted in ELISA Sera and Calibrator Diluent (Section 2.1.17.3) at various 
dilutions. 100 μM BmGT was prepared in this buffer also. An antigen control was 
prepared by adding 1.2 % DMSO to ELISA Sera and Calibrator Diluent. 50 μl 100 μM 
MmGT or 1.2 % DMSO in diluent was added to the corresponding wells followed by 50 
μl of the sera dilutions. The plates were incubated at 37 °C for 1 h. Plates were then 
106 
 
washed using the plate washer (BTL4) and 100 μl Anti-Mouse IgG-HRP diluted 1/2000 
in antibody diluent was added to each well. Plates were incubated while sealed at 37° for 
1 h. Plates were washed with using the plate washer (BTL4) and tapped on tissue to 
remove excess wash buffer. 100 µl TMB Substrate (pre-incubated at R.T for 30 min) was 
then added to each well. The plates were incubated at room temperature for 10 min. The 
reaction was terminated by the addition of 100 μl ELISA stop solution (Section 2.1.17.6). 
The absorbance was measured at wavelengths of 450 and 630 nm. The optimum coating 
concentration was determined for the MmGT-BSA antigen based on consistent 
absorbance values which fell within the dynamic range of the assay.  
 Statistical Analysis 
All data was analysed using built-in GraphPad prism version  5.01 functions, as 
specified. The level of significance was set at p < 0.05 (*), p < 0.001 (**), and p < 0.0001 
(***), unless otherwise stated. Post-hoc comparisons between groups were performed 
using the Bonferroni multiple comparisons test, unless otherwise stated. 
 Software Graphing 
All graphs were compiled using Graphpad Prism version 5.01, unless otherwise 
stated. 
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Chapter 3  
Genetic modification of Afu2g11120 (gtmA) in A. fumigatus 
 
 
 
 
 
 
 
 
 
3.1 Introduction 
ETP bis-thiomethylation is a widespread mechanism found in filamentous fungi which 
produce these disulfide containing metabolites. However, the enzyme which is 
responsible for this process has remained elusive (Boente and Kirby, 1991; Tan et al., 
2004; Guo et al., 2009; Park et al., 2011). In addition, although O, C and N-directed 
methyltransferases are routinely identified and characterised within fungal secondary 
metabolite pathways, S-directed methyltransferases have been largely unexplored 
(Liscombe et al., 2012). S-methyltransferases have only been definitively classified in 
relation to detoxification mechanisms and primary metabolism, although this activity has 
long been implicated in numerous secondary metabolite pathways (Boente and Kirby, 
1991; Kirby et al., 1980; Taylor, 1963). Recently, the Streptomyces lasaliensis S-
adenosyl-L-methionine (SAM) dependent methyltransferase Ecm18 has been shown to 
catalyze the conversion of  a disulfide bond in the precursor antibiotic triostatin A to the 
thioacetal bridge of the nonribosomal dipsipeptide echinomycin (Hotta et al., 2014). This 
appears to be the only published example of thiol-directed methyltransferase involvement 
in secondary metabolism. 
S-methylation of dithiol metabolites also extends to bacteria; Streptomyces 
clavuligerus has been shown to produce a bis-thiomethylated derivative of the 
dithiolpyrrolone antibiotic, holomycin (Li et al., 2012). This thiomethylation mechanism 
has been posited as an additional or backup strategy to disulfide bridge closure for self-
protection during holomycin biosynthesis. It has been proposed that S-methylation of 
biosynthetic intermediates, or possibly shunt metabolites, protect cellular components 
against these reactive species (Guo et al., 2013; Li et al., 2012). 
Prior to the work described in this chapter, an RNA-Seq analysis identified three 
methyltransferases which were highly increased in expression following gliotoxin 
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exposure (O’Keeffe et al., 2014). The identification of an uncharacterised 
methyltransferase encoding gene, Afu2g11120, which is highly upregulated upon 
gliotoxin exposure warranted further investigation. Afu2g11120 encodes an 
uncharacterised protein with predicted methyltransferase activity. The presence of the 
superfamily domain SSF53335 indicated that the protein is a predicted S-adenosyl-L-
methionine-dependent methyltransferase. The gli gene cluster which contains all the 
genes required for gliotoxin biosynthesis is located on chromosome 6 and Afu2g11120 is 
located outside of this gliotoxin biosynthetic cluster (Gardiner and Howlett, 2005). 
Gene deletion is a valuable reverse-genetic technique for the study of gene function 
and virulence in filamentous fungi such as Aspergillus fumigatus (Wiemann and Keller, 
2013). The most commonly used method for gene deletion is the replacement of some, or 
all, of the open reading frame (ORF) of interest with a selection marker. A. fumigatus 
auxotrophic markers such as pyrG have been used for transformation. However, in some 
cases, these procedures can affect the growth rate of the organism even when the strains 
are complemented with the adequate gene (Díez et al., 1987). A reduction in growth rate 
can have a negative effect on secondary metabolite volumetric production due to the 
reduced biomass of the cultures. It is also possible that the use of auxotrophic markers 
could enhance secondary metabolite production through a reduction in protein or total 
RNA synthesis, in turn providing more NADPH and other precursors. Consequently, 
these precursors could feed into secondary metabolite pathways (Martin, 2015). 
Dominant selection through the use of drug resistance markers is more common and 
allows for the transformation of prototrophic strains. Two drug resistance markers are 
commonly used for selection of transformants: hph and ptrA. The hph cassette encodes 
hygromycin B phosphotransferase which confers resistance to hygromycin and the 
product of ptrA provides resistance to pyrithiamine (Cullen et al., 1987; Kubodera et al., 
2002). 
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The use of a split-marker approach greatly improves the recovery of homologous 
integrants. In short, two hybrid DNA constructs are used for co-transformation. Each is 
comprised of a fusion product of one of the flanking sequences of the targeted gene with 
an incomplete portion of the drug resistance cassette. These drug resistance sequences 
overlap for approximately 600 bp. Neither marker fragment encodes sufficient sequences 
to reconstitute the functional resistance protein. Therefore, acquisition of drug resistance 
requires homologous recombination of the marker halves within their overlapping 
sequences (Figure 3.1). The highest probability for this event occurs when the fragment 
DNAs are in proximity to one another; for example, during integration at the target locus. 
This promotes a triple recombination event, replacing the target gene and reconstituting 
the functional drug resistance marker. Nonhomologous recombination events result in the 
integration of single non-functional cassettes into random locations within the genome 
and do not generate resistant transformants. To ensure that the phenotype of subsequent 
mutants is due to the deletion of the targeted gene, rather than a spontaneous secondary 
mutation, reintroduction of a wild-type allele of the gene using a second selection marker 
can be performed (Nielsen et al., 2006). 
 
Figure 3.1. Illustration of the split-marker method for A. fumigatus gene deletion by 
targeted homologous recombination. 
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Reverse genetic analysis has been used to classify the role of several 
uncharacterised genes which are associated with secondary metabolism in A. fumigatus 
(Gallagher et al., 2012; Davis et al., 2011). This method has been applied in the work 
presented in this chapter to generate an Afu2g11120 mutant strain in order to study the 
impact of gene deletion on gliotoxin and/or bis(methyl)gliotoxin biosynthesis and 
resistance. As will be described in Chapter 4, functional characterisation of this gene 
resulted in its renaming as gliotoxin thiomethyltransferase A (gtmA). Consequently, this 
nomenclature will be used throughout this thesis for convenience and clarity.  
The overall objectives presented in this chapter were to:  
(i) Uncover the optimal growth conditions suitable for the examination of 
bis(methyl)gliotoxin biosynthesis in A. fumigatus.  
(ii) Create and utilise replacement constructs for the targeted deletion, 
complementation and GFP labelling of gtmA in order to elucidate the function 
of this gene in A. fumigatus wild-type ATCC26933 and the gliotoxin sensitive 
mutants  ΔgliA (Owens et al., 2015) and ΔgliT (Schrettl et al., 2010). 
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3.2 Results 
 
3.2.1 RP-HPLC analysis confirms that bis(methyl)gliotoxin is produced at low 
levels by A. fumigatus 
In order to determine the production levels of gliotoxin (GT) and bis(methyl)gliotoxin 
(BmGT), culture supernatants of A. fumigatus wild-type ATCC26933 were collected after 
growth in Czapeks Dox broth (CDB), Aspergillus minimal media (AMM) and yeast 
glucose (YG) broth in triplicate (72 h; 37 °C). The culture supernatants were then 
subjected to organic extraction followed by RP-HPLC analysis (Section 2.2.12).  
Commercial standards of gliotoxin and bis(methyl)gliotoxin were analysed by 
RP-HPLC (Section 2.2.15). As shown in Figure 3.2, gliotoxin eluted with a retention time 
(RT) of 20.42 min and bis(methyl)gliotoxin eluted with a RT of 20.06 min. Comparison 
of the metabolite profiles from A. fumigatus in different growth conditions indicated that 
Czapeks Dox broth was the most suitable media for the production of gliotoxin and 
bis(methyl)gliotoxin (Figure 3.3). Bis(methyl)gliotoxin was shown to elute slightly 
earlier than gliotoxin by RP-HPLC. Additionally, the amount of bis(methyl)gliotoxin was 
shown to be substantially lower than the gliotoxin concentration in all of the media 
conditions tested.  
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 Figure 3.2. Representative RP-HPLC chromatograms highlighting gliotoxin and 
bis(methyl)gliotoxin production in various media conditions: Czapeks Dox broth (CDB), 
Aspergillus minimal media (AMM) and yeast glucose (YG). Absorbance was monitored 
at 254 nm.  
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Figure 3.3. Relative amounts of gliotoxin and bis(methyl)gliotoxin in Czapeks Dox 
(CDB), Aspergillus Minimal Media (AMM) and Yeast Glucose (YG) liquid media. 
Cultures were incubated in triplicate at 37 °C, 200 rpm shaking for 72 h. Of the media 
conditions tested, CDB was shown to produce the highest amounts of gliotoxin and 
bis(methyl)gliotoxin after the 72 h incubation period.  
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3.2.2 Generation of replacement constructs for the transformation of gtmA 
In order to determine the function of gtmA, a gene deletion strategy was employed (Figure 
3.4). Protoplast transformations were performed using the background strain 
ATTC26933. This background has been previously used to characterise the roles of 
several genes within the gliotoxin biosynthetic cluster, such as gliT (Schrettl et al., 2010) 
and gliK (Gallagher et al., 2012). The A. fumigatus strain was co-transformed with two 
DNA constructs, each of which contained an incomplete fragment of the pyrithiamine 
(ptrA) resistance gene excised from the plasmid pSK275. These fragments were fused to 
1.02 kb and 1.08 kb of gtmA flanking sequences. The fragments shared a 538-bp overlap 
within the ptrA cassette, serving as a potential recombination site during transformation. 
During transformation, homologous integration of each fragment into the genome 
flanking gtmA allows recombination of the ptrA fragments and generation of the intact 
resistance gene at the site of recombination.  
Two rounds of PCR generated each fragment. Initially, each flanking region was 
amplified from ATCC26933 genomic DNA the primers gtmA-P1and gtmA-P2 for 
flanking region A (1.15 kb), and gtmA-P3 and gtmA-P4 for flanking region B (1.10 kb) 
(Figure 3.5). Following gel-purification, the fragments were digested with AgeI and KpnI, 
respectively. The ptrA selection marker was released from plasmid pSK275 by digestion 
with AgeI and KpnI (Figure 3.6), and ligated with the two flanking regions, A and B, 
described above. Two overlapping fragments were amplified from the ligation product 
using primers gtmA-P5 and PTRoptrA2 for fragment C (2.4-kb); and primers gtmA-P6 
and PTRoptrA1 for fragment D (2.2-kb) (Figure 3.7). Subsequently, ATCC26933 was 
transformed simultaneously with the overlapping fragments C and D. The PCR products 
were gel-purified to remove any non-specific products and then concentrated prior to 
protoplast transformation.
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 Figure 3.4. Schem
atic outlining the strategy used in the deletion of gtm
A in A. fum
igatus using the pyrithiam
ine resistance m
arker
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Figure 3.5. PCR products of the flanking regions of gtmA. Lane M: Molecular weight 
marker (NEB) (Section 2.1.8.1.8), Lane 1-3: PCR 1 (1164 bp) is the 5’ flanking region of 
gtmA, Lane 4-6: PCR 2 (1107 bp) is the 3’ flanking region of gtmA. 
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Figure 3.6. Lane M: Molecular weight marker (NEB) (Section 2.1.8.1.8), Lane 1: 
Restriction digestion of pSK275 with the enzymes AgeI and KpnI. The ptrA selection 
marker was released (1946 bp) and ligated to the 5’and 3’ flanking regions of gtmA.  
 
 
 
 
 
 
 
 
118 
 
  
 
Figure 3.7. Final gtmA-ptrA gene deletion constructs. Lane M: Molecular weight marker 
(NEB) (Section 2.1.8.1.8), Lane 1: PCR 3 (2395 bp) is the 5’ flanking region of gtmA 
fused to half of the ptrA selection marker, Lane 2: PCR 4 (2196 bp) is the 3’ flanking 
region of gtmA fused to the second half of the ptrA selection marker. 
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3.2.3 Generation of DIG-labelled probe by PCR for ΔgtmA transformant 
identification 
A single 5’ upstream probe was prepared by PCR amplification for use in Southern blot 
analysis. As described in Section 2.1.10.6.9, the probe contained DIG-labelled 
nucleotides which facilitated detection using Southern blot analysis. A 5’ probe was made 
using primers gtmA_P5 and gtmA_P2 which detected a region just upstream of gtmA 
(Figure 3.8). 
 
 
 
Figure 3.8. Generation of DIG-labelled nucleotide probe which facilitated ΔgtmA 
detection with Southern blot analysis. A 5’ probe was made using primers gtmA_P5 and 
gtmA_P2 which detected a region just upstream of gtmA. Lane M: Molecular weight 
marker (NEB) (Section 2.1.8.1.8), Lane 1; DIG labelled nucleotide probe, Lane 2; 
positive control using standard dNTPs.  
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3.2.4 Protoplast transformation facilitated the deletion of gtmA from A. 
fumigatusATCC26933 
The constructs from Section 3.2.2 were transformed into protoplasts of A. fumigatus 
ATCC26933. Approximately 3 μg of each 5’ and 3’ construct was used per 
transformation event. The transformation procedure was carried out as described in 
Section 2.2.3. The resultant transformants were selected on agar plates containing 
pyrithiamine (100 ng/ml). The colonies that grew on these plates were considered 
resistant and, therefore, predicted to have reconstituted ptrA incorporated into the 
genome. 
For the transformation event, eight colonies were observed on pyrithiamine 
selection plates. Genomic DNA from these colonies was digested using an XhoI 
restriction enzyme. These were screened by Southern analysis using a 5’ probe (Section 
3.2.3). Figure 3.9 illustrates the Southern strategy which was employed in order to 
confirm ΔgtmA deletion. The mutant band (ΔgtmA; 3.99 kb) was present in colonies 7 
and 8 (Figure 3.10).  These two colonies were selected for single spore isolation. The 
single spore isolates of colonies 7 and 8 were digested with XhoI and a second round of 
Southern blot analysis using the 5’ probe was performed. This confirmed the single 
integration of the ΔgtmA deletion cassette at the correct locus (Figure 3.11). To further 
confirm the absence of the wild-type locus from these transformants, PCR analysis 
(Section 2.2.2.2) was performed using primers gtmA_P5 and gtmA_P6 (Table 2.4). The 
predicted fragment size of 4.1 kb was observed for the mutants in comparison to 3 kb for 
the wild-type strain (Figure 3.12).  
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Figure 3.9. Schematic illustrating the Southern blot strategy employed to confirm the 
deletion of gtmA. The XhoI digested gDNA was screened using a 5’ probe. A correct gene 
deletion event would result in a band of 3.99 kb. However, the wild-type XhoI digested 
gDNA would be 3.07 kb.  
 
 
Figure 3.10. Southern analysis of potential ΔgtmA transformants. Here, the 5’ DIG-
labelled probe was used to detect the predicted presence of a 3.99 kb fragment in XhoI 
digested genomic DNA. Lane 1 - 8: genomic DNA from potential ΔgtmA transformants, 
Lane 9: WT positive control samples (3.07 kb). M; Molecular weight marker (Roche VII) 
(Section 2.1.8.1.7). 
122 
 
  
 
 
 
Figure 3.11. Second round Southern analysis of single spore isolates of ΔgtmA 
transformants. Here, the 5’ DIG-labelled probe was used to detect the predicted presence 
of a 3.99 kb fragment in XhoI digested genomic DNA. Lane 2 - 6: Single spore isolates 
of potential mutant strain from colonies 7 and 8, Lane 1 and 7: Wild-type positive control 
samples (3.07 kb), M; Molecular weight marker (Roche VII) (Section 2.1.8.1.7). 
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Figure 3.12. PCR analysis of genomic DNA extracted from wild-type and ΔgtmA 
transformants. M: Molecular weight marker (NEB) (Section 2.1.8.1.8), Lanes 1-3: ΔgtmA 
colony 7 single spore isolates, Lane 4: Wild-type, Lanes 5-6 ΔgtmA colony 8 single spore 
isolates 
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3.2.5 Complementation of gtmA into ΔgtmA 
Once gtmA had been successfully deleted it was necessary to reintroduce the gene into 
the genome of A. fumigatus ΔgtmA::ptrA. This ensured that the phenotype which was 
observed could be solely attributed to the product of gtmA. The complementation method 
for gtmA reintroduction is described in Section 2.2.3.2. 
3.2.6 Generation of a Complementation Construct 
To complement ΔgtmA, a PCR fragment containing the gtmA locus, including promoter 
and terminator, was amplified using primers gtmA-P5 and gtmA-P6. This was then 
inserted into the pCR® 2.1-TOPO® TA vector (TOPOgtmA) (Figure 3.13). The hph 
resistance cassette was digested from the plasmid pAN7-1 (Figure 3.14) and cloned into 
TOPOgtmA through the single EcoRII site in said plasmid, thus producing a 
TOPOgtmAhph vector (Figure 3.15).  
The final vector, TOPOgtmAhph, was linearized with NotI and transformed into 
the ΔgtmA mutant strain. In order to confirm the correct cloning of gtmA and hph, a 
diagnostic digest was performed on potential plasmids. This established that the 
constructs were cloned correctly as NcoI yielded the predicted three fragments: 4262, 
3214 and 1086 bp. 
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 Figure 3.13. Amplification of gtmA, including 5’ and 3’ flanking regions, for TOPO 
cloning. Lane M: Molecular weight marker (NEB) (Section 2.1.8.1.8), Lane 1: gtmA 
amplified using primers gtmA-P5 and gtmA-P6 (3022 bp) 
 
Figure 3.14. Restriction digestion of the hph resistance gene from the plasmid pAN7-1. 
M; Molecular weight marker (NEB) (Section 2.1.8.1.8), Lane 1: pAN7-1 digestion with 
the restriction enzymes BamHI and MfeI resulted in the release of the hph hygromycin 
resistance gene (1605 bp).  
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Figure 3.15. Linearization and diagnostic digestion of the TOPOgtmAhph plasmid. M: 
Molecular weight marker (NEB) (Section 2.1.8.1.8), Lane 1: Linearization of the 
TOPOgtmAhph plasmid using NotI (8562 bp). Digestion using NcoI yielded the predicted 
three fragments 4262, 3214 and 1086 bp. These fragments confirm that both of the 
plasmids were accurately cloned and suitable for complementation. 
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3.2.7 Southern blot Analysis of Transformants from A. fumigatus gtmAC 
Complementation 
Figure 3.16 illustrates the Southern strategy employed to confirm gtmAC 
complementation. Genomic DNA from all potential transformants was digested with 
XhoI and probed with the 5’ probe. Southern blot analysis (Section 2.2.4) identified two 
putative complemented transformants, termed 2 and 4 (Figure 3.17). Both the predicted 
fragment size of 3.99 kb and a single ectopic integration fragment of 7.5 kb were detected 
in these colonies when analysed by Southern blot.  
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 Figure 3.16. Schematic illustrating the Southern blot strategy employed for confirming 
the complementation of gtmA. The XhoI digested gDNA was screened using a 5’ probe. 
A correct single ectopic complementation event would result in a band of 3.99 kb (ΔgtmA) 
and a second single integration (7.5 kb). The wild-type XhoI digested gDNA would be 
3.07 kb.  
 
 
Figure 3.17. Southern blot of gtmAC transformants. M: Molecular weight marker (Roche 
VII) (Section 2.1.8.1.7), Lanes 1-5: potential transformants, Lane 6: ΔgtmA (3.99 kb), 
Lane 7: Wild-type gDNA (3.07 kb) 
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3.2.8 RT-PCR Analysis of gtmA Expression following exposure to exogenous 
gliotoxin 
The deletion of A. fumigatus gtmA from ATCC26933 and its subsequent 
complementation was confirmed by Southern analysis (Section 3.2.7). RT-PCR was 
employed to support that the deletion of gtmA resulted in the abolition of gtmA expression 
in ∆gtmA and that the restoration of gtmA expression was evident in gtmAc. Both wild-
type and mutant strains were cultured in Sabouraud Dextrose liquid broth and incubated 
at 37 °C for 21 h. This was followed by the addition of gliotoxin at a final concentration 
5 μg/ml for 3 h. Gliotoxin was added to the cultures to induce the expression of gtmA. 
Total RNA was extracted and subjected to cDNA synthesis (Section 2.2.5.3). RT-PCR 
was carried out using the primers gtmA-qPCR-F and gtmA-qPCR-R (Table 2.4). 
Expression of gtmA was evident in A. fumigatus wild-type and the complemented strain 
gtmAc and absent from ∆gtmA. This confirmed that gtmA expression was restored in the 
complemented strain (Figure 3.18). The slightly higher gtmA expression in the 
complemented strain (Figure 3.18) may be due to the ectopic integration of the gene in 
its non-native location.  
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Figure 3.18. Confirmation of the absence of gtmA expression in A. fumigatus ∆gtmA and 
its restoration in gtmAc by RT-PCR (n = 3 biological replicates per condition) following 
gliotoxin exposure (5 μg/ml for 3 h). Calm cDNA is used as cDNA control (Burns et al., 
2005). POS represents amplification of genomic DNA. NEG: no cDNA or DNA present 
in amplification reactions. 
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3.2.9 Deletion of gtmA in the gliotoxin sensitive mutant backgrounds ΔgliT and 
ΔgliA 
The gtmA gene was also deleted in the gliotoxin sensitive mutant backgrounds ΔgliT and 
ΔgliA. As these gene deletions were also carried out in the ATCC26933 background, the 
results could be compared to the ΔgtmA single mutant. However, ΔgliT and ΔgliA were 
prepared using the pyrithiamine resistance gene ptrA. As such, the hygromycin resistance 
gene (hph) from the plasmid pAN7-1 had to be used for the ΔgliT::ΔgtmA and 
ΔgliA::ΔgtmA mutant selections. As shown in Figure 3.19, A. fumigatus ΔgliT and ΔgliA 
were co-transformed with two DNA constructs, each of which contained an incomplete 
fragment of hph. These fragments were fused to 1.1 kb and 1.1 kb of gtmA flanking 
sequences. These marker fragments shared a 572 bp overlap within the hph cassette which 
served as a potential recombination site during transformation. Throughout 
transformation, homologous integration of each fragment into the genome flanking gtmA 
allowed the recombination of the hph fragments and the generation of an intact resistance 
gene at the site of recombination.  
Two rounds of PCR generated each fragment. Initially, each flanking region was 
amplified from ATCC26933 genomic DNA using the primers gtmA-P1and gtmA_HYG-
P2 for flanking region A (1.15 kb) and gtmA_HYG-P3 and gtmA-P4 for flanking region 
B (1.10 kb). Following gel-purification the fragments were digested with XhoI and SbfI, 
respectively. The hph selection marker was released from plasmid pAN7-1 by digestion 
with XhoI and SbfI and ligated with the two flanking regions, A and B. Two overlapping 
fragments were amplified from the ligation product using primers gtmA-P5 and 
PTRoptrA2 for fragment C (2.32 kb), and primers gtmA-P6 and PTRoptrA1 for fragment 
D (2.76 kb) (Figure 3.20). The PCR products were gel-purified to remove any non-
specific products and then concentrated prior to protoplast transformation. Finally, ΔgliT 
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and ΔgliA were independently transformed in concert with the two overlapping 
fragments. 
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 Figure 3.19. Schem
atic outlining the strategy used in the deletion of gtm
A in A. fum
igatus Δ
gliT (Schrettl et al., 2010) and Δ
gliA (O
w
ens et al., 2015) 
using the hygrom
ycin resistance m
arker.
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Figure 3.20. Final gtmA-hph gene deletion constructs. Lane M: Molecular weight marker 
(NEB) (Section 2.1.8.1.8), Lane 1: PCR 3 (2756 bp) is the 5’ flanking region of gtmA 
fused to half of the hph selection marker, Lane 2: PCR 4 (2317 bp) is the 3’ flanking 
region of gtmA fused to the second half of the hph selection marker.  
 
 
 
 
 
135 
   
3.2.10 Transformation and selection for deletion of gtmA from A. fumigatus 
ATCC26933 ΔgliT and ΔgliA 
The transformation procedure was carried out as described in Section 2.2.3. 
Approximately 3 μg of both 5’ and 3’ construct were used per transformation event. The 
resultant transformants were selected on agar plates containing hygromycin (100 μg/ml). 
The colonies that grew on these were considered resistant and, therefore, predicted to 
have reconstituted hph incorporated into the genome. 
For the transformation event, 12 ΔgliT background and 9 ΔgliA background 
colonies were observed on hygromycin selection plates. Genomic DNA from these 
transformants was screened by Southern analysis using a 5’ probe (Section 3.2.3). Figure 
3.21 illustrates the Southern strategy employed to confirm ΔgliT::ΔgtmA and 
ΔgliA::ΔgtmA deletions. The mutant band (ΔgtmA; 1.83 kb) was present in two 
ΔgliT::ΔgtmA transformants and one ΔgliA::ΔgtmA transformant. These three colonies 
were selected for single spore isolation. Single spore isolates of ΔgliT::ΔgtmA (3) and 
ΔgliA::ΔgtmA (2) were digested with XhoI and a second round of Southern blot analysis 
using the 5’ probe was performed. This confirmed the single integration of the ΔgtmA 
deletion cassette at the correct locus (Figure 3.22)  
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 Figure 3.21. Schematic illustrating the Southern blot strategy employed for confirming 
the deletion of gtmA in ΔgliT and ΔgliA, respectively. The XhoI digested gDNA was 
screened using a 5’ probe. A correct gene deletion event should result in a band of 1.83 
kb. The wild-type XhoI digested gDNA would be 3.07 kb.  
 
Figure 3.22. Identification of A. fumigatus ΔgliT::ΔgtmA and ΔgliA::ΔgtmA in second 
round Southern analysis of single spore isolates of ΔgtmA-hph transformants. Here, the 
5’ DIG-labelled probe was used to detect the predicted presence of a 1.83 kb fragment in 
XhoI digested genomic DNA. Lane 1 - 3: Single spore isolates of potential ΔgliT::ΔgtmA 
mutant strains, Lanes 4-5; Single spore isolates of potential ΔgliA::ΔgtmA mutant strains, 
Lane 6; ΔgliT positive control  (3.07 kb), Lane 7; ΔgliA positive control (3.07 kb). 
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3.2.11 Generation of gtmA-eGFP Gene Fusion Construct 
The pUCGH eGFP vector containing hph (Langfelder et al., 2001) under the control of a 
Potef  constitutive promoter was digested with the enzymes KpnI and XmaI. This released 
the Potef promoter from the vector and facilitated the cloning of gtmA under the control 
of its native promoter into the pUCGH vector. The gtmA gene with both 1 kb upstream 
and the stop codon removed was amplified from A. fumigatus 26933 DNA (2036 bp) 
using the primers gtmA_GFP_F and gtmA_GFP_R. This construct was then double 
digested with KpnI and XmaI, gel purified and, finally, ligated to the digested pUCGH 
vector. An outline of the pUCGHgtmA vector is shown in Figure 3.23. The final vector 
(pUCGHgtmA) was linearized with KpnI and transformed into A. fumigatus ΔgtmA. This 
strategy targeted the gtmA-egfp-hph construct to the original gtmA locus of the ΔgtmA 
mutant. 6 µg of the linearised construct was transformed into ΔgtmA protoplasts.  
 
3.2.12 Southern blot Analysis of A. fumigatus gtmA-eGFP Transformants 
Figure 3.24 illustrates the Southern strategy employed to confirm gtmA-eGFP insertion 
into ΔgtmA. Genomic DNA from all four potential transformants was digested with XhoI 
and probed with the 5’ probe. Southern blot analysis (Section 2.2.4) identified a single 
transformant with gtmA-GFP insertion at the correct locus (Colony 4). This transformant 
had the predicted fragment size of 4.73 kb when analysed by Southern blot (Figure 3.25).  
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3.2.13 Transformation of A. fumigatus ΔgtmA::gtmA-eGFP with a Histone 2A 
monomeric red fluorescent protein fusion (H2A::mRFP) plasmid 
In order to visualise the nuclei of ΔgtmA:gtmA-eGFP during confocal microscopy, a 
Histone 2A monomeric red fluorescent protein fusion (H2A::mRFP) plasmid (Sarikaya 
Bayram et al., 2010) was linearised using EcoRI (5 µg) and transformed into 
ΔgtmA:gtmA-eGFP protoplasts. The resultant transformants were selected for on agar 
plates containing phelomycin (100 μg/ml) at 30 °C and screened for mRFP expression by 
confocal microscopy. 
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Figure 3.23. Plasmid map of pUCGH-gtmA. This vector contains the hph gene for 
hygromycin selection which is indicated by the red region. Restriction sites, KpnI and 
XmaI, facilitated the cloning of gtmA with its promoter sequence (green) in frame with 
the eGFP gene (blue). 
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 Figure 3.24. Schematic outlining the insertion of gtmA-eGFP into A. fumigatus ΔgtmA. 
A single homologous recombination between the 5’ flanking region results in the 
insertion of the construct into the 5’ flanking region of ΔgtmA, directly before the ptrA 
selection marker used to generate A. fumigatus ΔgtmA: gtmA-eGFP (4.73 kb). 
 
Figure 3.25. Identification of A. fumigatus ΔgtmA: gtmA-eGFP by Southern analysis. 
Second round Southern analysis of single spore isolates of ΔgtmA::gtmA-eGFP 
transformants. Here, the 5’ DIG-labelled probe was used to detect the predicted presence 
of a 4.73 kb fragment in XhoI digested genomic DNA. Lane 1 - 4: Single spore isolates 
of potential ΔgtmA::gtmA-eGFP transformants, Lane 5; Wild-type positive control 
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3.3 Discussion  
 
The work presented in this chapter describes the deletion of gtmA in A. fumigatus 
ATCC26933 wild-type, ΔgliA and ΔgliT. A. fumigatus ΔgtmA was complemented to 
restore gtmA function. Semi-quantitative RT-PCR confirmed expression of A. fumigatus 
gtmA in A. fumigatus ATCC26933 and gtmAC; expression was absent in A. fumigatus 
ΔgtmA after gliotoxin exposure. The gtmA gene was also fused to eGFP and transformed 
into ΔgtmA under the control of the native promoter.  
The split bipartite method (Nielsen et al., 2006) was employed in the deletion of 
A. fumigatus gtmA, a putative methyltransferase that has been previously shown to be 
highly expressed during gliotoxin exposure. Two constructs containing partial fragments 
of the pyrithiamine resistant gene, ptrA were generated according to this method. The 
constructs were transformed into protoplasts from A. fumigatus ATCC26933. A further 
two constructs were generated containing partial fragments of the hygromycin resistance 
gene, hph. These constructs were used to transform ΔgliA and ΔgliT mutant backgrounds 
to generate two double gene deletion mutants; A. fumigatus ΔgliT::ΔgtmA and 
ΔgliA::ΔgtmA, respectively.  
A complementation construct was prepared containing gtmA and the selection 
marker hph. This was transformed into ΔgtmA. Five transformants were obtained and 
screened by Southern blot following restriction digest with XhoI. Two of the 
transformants displayed the fragment pattern 3.99 kb and 7.5 kb, indicating the generation 
of gtmAC. The hygromycin resistance gene, hph, has been successfully used to 
complement other gene deletions in A. fumigatus where it has been co-transformed as a 
plasmid along with the complementation construct. The advantage of a single construct 
containing the gene to be complemented and the resistance marker is that it rules out the 
situation whereby the resistance marker randomly integrates into the genome. 
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Semi-quantitative Reverse Transcriptase PCR (RT-PCR) was undertaken to 
assess A. fumigatus gtmA expression in gtmAC and its absence of expression in ΔgtmA. 
cDNA was prepared from RNA extracted from A. fumigatus ATCC26933, ΔgtmA, and 
gtmAC. Expression of A. fumigatus gtmA was confirmed in ATCC26933 and gtmAC whilst 
no expression was observed in ΔgtmA. This confirmed the successful deletion of A. 
fumigatus gtmA in ATCC26933 and complementation of ΔgtmA. 
In addition, the ΔgtmA mutant was transformed with a construct containing gtmA 
under its native promoter fused to eGFP. As gtmA is known to be induced by gliotoxin 
exposure, the generation of this strain should facilitate localisation and expression studies 
to be carried out on this uncharacterised protein.  
 
 
 
 
 
 
 
 
 
 
 
 
143 
   
  
 
 
 
 
Chapter 4 
Functional characterisation of gtmA – an uncharacterised 
methyltransferase encoded by A. fumigatus 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1 Introduction 
A. fumigatus gtmA has been identified as a putative methyltransferase of unknown 
function and specificity which is highly upregulated upon gliotoxin exposure (O’Keeffe 
et al., 2014). Chapter 3 detailed the deletion of gtmA from A. fumigatus, facilitating the 
comparative phenotypic analysis between wild-type and ΔgtmA. This data should aid in 
the identification of the specific role of gtmA in response to gliotoxin exposure. 
Characterisation of the gtmA null mutant will determine whether this enzyme plays a role 
in gliotoxin S-methylation or the biosynthesis of gliotoxin. In addition, the ΔgtmA: gtmA-
eGFP strain will uncover the cellular localisation of this protein. This characterisation 
will involve subjecting the mutant and corresponding wild-type strain to the following: 
The thiol-methyltransferase activity of A. fumigatus upon exposure to exogenous 
gliotoxin suggests a possible detoxification role of this enzyme in response to exogenous 
thiols (Li et al., 2012). Using a NMR-based comparative metabolomics method, 17 gliZ-
dependent metabolites were shown to be produced by A. fumigatus and 7 of these 
metabolites were shown to contain thiomethyl groups (Forseth et al., 2011). It is possible 
that a single S-methyltransferase is responsible for the thiomethylation of these gliZ 
dependent metabolites. It is also conceivable that thiomethylation has a biosynthetic role 
in the stabilisation of the gliotoxin scaffold or shunt intermediates during gliotoxin 
biosynthesis.  
The overall objectives of the work presented in this chapter were to:  
(i) Determine if Afu2g11120, gtmA, has a role in bis(methyl)gliotoxin 
biosynthesis and/or gliotoxin biosynthesis, through comparative metabolite 
profile analysis of wild-type ΔgtmA and the complemented strain generated in 
Chapter 3.  
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(ii) Observe any phenotype associated with A. fumigatus gtmA in comparison to 
the corresponding wild-type under various conditions of oxidative stress or 
gliotoxin resistance through a series of phenotypic assays.  
(iii) Perform quantitative proteomic analysis of the wild-type and ΔgtmA strain in 
response to either gliotoxin or bis(methyl)gliotoxin exposure.  
(iv) Confocal microscopy to uncover the localisation of GtmA-eGFP upon 
gliotoxin exposure. 
(v) Perform quantitative proteomic analysis of the wild-type, ΔgtmA and 
complemented strain under secondary metabolite producing conditions. 
(vi)  Perform a phylogenetic analysis on the GtmA protein across the fungal 
kingdom.  
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4.2 Results 
 
 Analysis of A. fumigatus wild-type, ∆gtmA and gtmAc metabolite profiles by 
LC-MS/MS 
The alignment of total ion chromatographs (TIC) of wild-type, ∆gtmA and gtmAc culture 
supernatant organic extracts was performed and revealed a single significant difference 
in the metabolite profiles. Reference standards of pure gliotoxin (GT) and 
bis(methyl)gliotoxin (BmGT) were also analysed alongside these samples. Wild-type and 
gtmAc extracts produced spectra with a dominant peak at the retention time of 6.5 min. 
However, this was absent in ∆gtmA. This peak was attributable to the elution of 
bis(methyl)gliotoxin as confirmed by the presence of the precursor ion, (M + H)+ = 357.1, 
and characteristic product ions, (M + H)+ = 309, 243, 215 (Domingo et al., 2012). LC-
MS/MS analysis also certified that gliotoxin was produced by wild-type, ∆gtmA and 
gtmAc. Extracted ion chromatograms of bis(methyl)gliotoxin (m/z 357) and gliotoxin 
(m/z 327) for A. fumigatus wild-type, ∆gtmA and gtmAc are shown in Figure 4.1.  This 
confirmed that bis(methyl)gliotoxin production was abolished in A. fumigatus  ∆gtmA 
and restored in the complemented strain (gtmAc).  
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Figure 4.1. H
igh sensitivity LC
-M
S analysis confirm
s com
plete abrogation and restoration of bis(m
ethyl)gliotoxin biosynthesis in A. fum
igatus ∆gtm
A 
and gtm
A
c, respectively. G
liotoxin (m
/z 327) w
as detected in A. fum
igatus w
ild-type, ∆gtm
A and gtm
A
c
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 Comparative metabolite profiling of A. fumigatus wild-type, ∆gtmA and 
gtmAc by RP-HPLC 
In order to elucidate the effect of gtmA absence on A. fumigatus, secondary metabolite 
production culture supernatants of A. fumigatus wild-type, ∆gtmA and gtmAc were 
collected after growth (triplicate) in Czapeks Dox broth (CDB) at 200 rpm for 72 hr, 37 
°C and, also, 7 d, 37 °C. The supernatants were then subjected to organic extraction prior 
to RP-HPLC analysis (Section 2.2.12).  Reference standards of pure gliotoxin (GT) and 
bis(methyl)gliotoxin (BmGT) were also analysed alongside these samples by LC-MS and 
RP-HPLC (Section 2.2.16.4). Interestingly, as shown in Figures 4.2 and 4.3, a significant 
increase in gliotoxin production was evident in A. fumigatus ∆gtmA in comparison with 
the wild-type following culture in Czapeks-Dox media for both 72 h (p<0.0056) and  7 d 
(p<0.0001).  No other metabolites were shown to be significantly altered by the absence 
of gtmA. 
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 Figure 4.2. Comparative RP-HPLC analysis of A. fumigatus wild-type, ∆gtmA and 
gtmAc. Gliotoxin and bis(methyl)gliotoxin were the only metabolites significantly altered 
across all three replicates (BmGT RT = 20.1, GT RT = 20.4). Absorbance was monitored 
at 254 nm. 
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 Figure 4.3. Deletion of gtmA significantly increases gliotoxin biosynthesis at day 3 (A) 
(p<0.0056) and day 7 (B) (p<0.0001) culture supernatants. gtmA complementation 
restores wild-type gliotoxin biosynthesis levels. The depicted values are from three 
independent samples. GT and BmGT levels in ΔgtmA and gtmAC are relative to the wild-
type at day 3 and day 7. Error bars are SDs from the mean.  
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 Phenotypic Analysis of A. fumigatus ΔgtmA in Response to Exogenous 
gliotoxin  
In order to assess a possible role for gtmA in protection against gliotoxin-induced toxicity 
(Li et al., 2012), comparative phenotypic analysis of A. fumigatus ΔgtmA and wild-type 
was performed as described in Section 2.2.6. This analysis would determine any altered 
phenotype observed in the mutant strain thus identifying a role for gtmA expression in A. 
fumigatus following gliotoxin exposure. 
In order to assess whether the loss of gtmA affected the growth rate of A. fumigatus 
ΔgtmA, the mutant was grown alongside the wild-type on Czapeks Dox agar alone -  no 
difference in the growth rate between the two strains was observed. As shown in Figure 
4.4, no significant difference in the growth rate of A. fumigatus ΔgtmA and the wild-type 
was observed for any of the concentrations of gliotoxin tested (0 – 10 µg/ml). However, 
growth of A. fumigatus ∆gliT (Schrettl et al., 2010) was completely inhibited upon 
exposure to 10 µg/ml gliotoxin. 
 Phenotypic Analysis of A. fumigatus ΔgtmA in Response to Hydrogen 
Peroxide  
In the interest of assessing a possible role for gtmA in protection against hydrogen 
peroxide (H2O2) induced oxidative stress, comparative phenotypic analysis of A. 
fumigatus ΔgtmA and wild-type was performed as described in Section 2.2.6.  
As shown in Figure 4.5, no significant difference in the growth rate of A. 
fumigatus ΔgtmA and wild-type was observed for any of the concentrations of H2O2 
tested (0 – 2 mM). This result suggested that gtmA does not play a role in the protection 
against H2O2 induced oxidative stress.  
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Figure 4.4. Exogenous gliotoxin (0 – 10 µg/ml) does not inhibit the growth of A. 
fumigatus ∆gtmA in comparison with the wild-type strain despite the growth of ∆gliT 
being completely inhibited at 10 µg/ml gliotoxin. Growth in ΔgtmA and ΔgliT are relative 
to the wild-type. The depicted values are from three independent samples. Error bars are 
SDs from the mean.  
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Figure 4.5. A. fumigatus wild-type and ∆gtmA respond identically to H2O2-induced 
oxidative stress (0 – 2 mM). No radial growth difference was noted at any of the 
concentrations tested.  
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 In Vivo Gliotoxin Bisthiomethylation by A. fumigatus 
Species which produce gliotoxin have been previously shown to take up this metabolite 
and convert it to its bisthiomethylated form (Kirby et al., 1980). A. fumigatus was treated 
with gliotoxin for 3 h (5 μg/ml final) as described in Section 2.2.17. Time point samples 
were taken every 30 min. The samples were organically extracted, as outlined in Section 
2.2.12, and analysed by LC-MS. Figure 4.6 shows that the production of 
bis(methyl)gliotoxin (m/z 357) from spiked gliotoxin is evident in A. fumigatus 
ATCC26933. No bis(methyl)gliotoxin was detectable in the samples prior to gliotoxin 
treatment. Exogenously added gliotoxin (5 µg/ml) was taken up by A. fumigatus 
ATCC26933 and was converted to bis(methyl)gliotoxin over the course of 3 h. This was 
subsequently secreted into the culture medium over 3 h. Exogenously-added gliotoxin (5 
μg/ml final) was taken up, but not converted, to bis(methyl)gliotoxin in A. fumigatus 
∆gtmA whilst gtmA complementation restored the ability to biosynthesize 
bis(methyl)gliotoxin from exogenous gliotoxin. This result indicated that gtmA is directly, 
and likely solely responsible for the conversion of exogenously added gliotoxin to 
bis(methyl)gliotoxin. 
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 Figure 4.6. A. fumigatus converts exogenously-added gliotoxin to bis(methyl)gliotoxin 
in a time-dependent manner. Exogenously-added gliotoxin (5 μg/ml final) is taken up, but 
not converted to, bis(methyl)gliotoxin in A. fumigatus ∆gtmA whilst gtmA 
complementation restores the ability to biosynthesize bis(methyl)gliotoxin from 
exogenous gliotoxin. Graph depicts the levels of GT and BmGT in organically extracted 
culture supernatants. The depicted values are averaged from three independent samples.
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 In Vitro Enzyme-Mediated Gliotoxin Bismethylation 
A. fumigatus wild-type, ΔgliT (Schrettl et al., 2010) and ∆gtmA mycelial lysates were 
obtained following 24 hr growth in Sabouraud-Dextrose media (21 h culture followed by 
3 h supplementation with gliotoxin (5 mg/ml) or MeOH for 3 h. Mycelia were snap-frozen 
and ground in liquid N2 and lysates were prepared as described in Section 2.2.16.5. 
Protein lysates were clarified by centrifugation prior to use in assays. Reaction mixtures 
comprised relevant lysate (20 µl), PBS (54 µl), SAM (25 mg/ml in PBS; 6 µl) and 
NADPH (60 mM; 10 µl). Negative controls used 20 µl lysis buffer in place of lysate. As 
demonstrated by Owens et al. (2015), lysates from A. fumigatus ΔgliT were shown to 
exhibit significantly elevated bisthiomethylation activity (p<0.0013) in comparison with 
those of wild-type A. fumigatus following prior gliotoxin exposure. Relevantly, ΔgtmA 
lysates did not exhibit any bisthiomethylation activity (Figure 4.7).  
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Figure 4.7. Detection of bis-thiomethylation activity by LC-MS exclusively in A. 
fumigatus ∆gliT protein lysates. Following gliotoxin induction (5 μg/ml for 3 h), protein 
lysates from A. fumigatus ∆gliT exhibit significantly elevated bis-thiomethylation activity 
(p<0.0013) when compared to wild-type A. fumigatus lysates. No bis(methyl)gliotoxin 
was detected in the ∆gtmA gliotoxin-exposed lysates. The depicted values are from three 
independent extracts. Error bars show calculated SD from the mean.   
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 Confocal microscopy reveals that GtmA-eGFP is localised throughout the 
cytosol following gliotoxin exposure 
As described in Section 2.2.8, the ΔgtmA::gtmA-eGFP::H2A-mRFP strain was prepared 
for confocal microscopy analysis. The results revealed that GtmA::eGFP accumulates in 
the cytosol of A. fumigatus following gliotoxin exposure (5 µg/ml, 3h) (Figure 4.8). 
Histone 2A monomeric red fluorescent protein fusion (H2A::mRFP), which was also 
transformed into this strain, clearly visualised the nuclei. No eGFP signal was detectable 
in either the methanol control or the ΔgtmA strain exposed to gliotoxin which contains no 
eGFP or mRFP. 
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 Figure 4.8. eG
FP labelling of G
tm
A
 (G
tm
A
::eG
FP) revealed the rapid accum
ulation of this enzym
e to the cytosol follow
ing 3h gliotoxin exposure (5 
µg/m
l). H
istone 2A
 m
onom
eric red fluorescent protein fusion (H
2A
::m
R
FP) visualizes the nuclei. The G
tm
A
::eG
FP signal w
as not detectable in the 
M
eO
H
 controls. A
: B
right-field, eG
FP and m
R
FP signal overlay. B
: eG
FP and m
R
FP signal overlay.
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 Comparative proteomic analysis of A. fumigatus wild-type and ∆gtmA 
exposed to gliotoxin  
In order to elucidate the effect of exogenous gliotoxin exposure on the proteome of ∆gtmA 
following exposure to exogenous gliotoxin, quantitative label-free proteomics was carried 
out as described in Section 2.2.16.5. A. fumigatus wild-type and ΔgtmA were exposed to 
either gliotoxin (5 µg/ml) or a methanol control for 3 h following 21 h growth in 
Sabouraud-Dextrose broth. Mycelia was harvested and lysed and the samples were 
processed. A total of 8 proteins were uniquely detected in the wild-type samples exposed 
to gliotoxin when compared to the control. 12 proteins were detected with a significantly 
higher abundance upon gliotoxin treatment (Table 4.1). A total of 4 proteins were 
uniquely detected in the A. fumigatus ∆gtmA samples exposed to gliotoxin in comparison 
with the control. 7 proteins were detected with a significantly higher abundance upon 
gliotoxin treatment (Table 4.2).The quantitative proteomic results indicated A. fumigatus 
wild-type (Table 4.1) and ΔgtmA (Table 4.2) respond to gliotoxin exposure by increasing 
the abundance of Yap1 dependent catalases and gli-cluster encoded gliotoxin biosynthetic 
enzymes. Both strains exhibited a significantly increased abundance of mycelial catalase 
Cat1 (wild-type/∆gtmA: log2 3.552/ log2 3.435), GliT (log2 5.125/ log2 4.869) and the 
bifunctional catalase-peroxidase Cat2 (log2 1.947/ log2 1.205). This indicated that both 
the wild-type and ΔgtmA strains have a very similar proteomic response to gliotoxin. 
Notably, GtmA is highly abundant in the wild-type samples following gliotoxin exposure 
whereas it is completely absent in A. fumigatus ∆gtmA.  
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T
able 4.1. Proteins w
ith increased abundance (or uniquely detected) in A. fum
igatus w
ild-type w
ith gliotoxin com
pared to w
ild-type w
ith m
ethanol. 
D
ata sorted by fold change, in descending order. 
Protein D
escription 
 
 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage [%
] 
Protein ID
s 
Putative zinc knuckle transcription factor; transcript induced by 
exposure to hum
an airw
ay epithelial cells 
U
nique 
N
/A
 
2 
4.6 
A
FU
A
_3G
10840 
H
as dom
ain(s) w
ith predicted hydrolase activity 
U
nique 
N
/A
 
5 
28 
A
FU
A
_5G
12770 
Predicted O
-m
ethyltransferase, encoded in the putative gliotoxin 
biosynthetic gene cluster. G
liM
. 
U
nique 
N
/A
 
8 
20.9 
A
FU
A
_6G
09680 
G
lutathione S-transferase encoded in the gliotoxin biosynthetic gene 
cluster; not involved in self-protection against gliotoxin. G
liG
. 
U
nique  
N
/A
 
4 
29.2 
A
FU
A
_6G
09690 
O
rtholog(s) have role in circadian rhythm
, hyphal grow
th and cytosol 
localization 
U
nique 
N
/A
 
3 
3.4 
 
A
FU
A
_1G
13060 
H
as dom
ain(s) w
ith predicted oxidoreductase activity and role in 
m
etabolic process 
U
nique 
N
/A
 
3 
7.8 
A
FU
A
_5G
10180 
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Protein D
escription 
 
 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage [%
] 
Protein ID
s 
O
rtholog(s) have cytoplasm
 localization 
U
nique 
N
/A
 
4 
15 
A
FU
A
_5G
11760 
H
as dom
ain(s) w
ith predicted oxidoreductase activity and role in 
m
etabolic process 
U
nique 
N
/A
 
11 
22 
A
FU
A
_6G
03490 
G
liotoxin sulfhydryl oxidase required for gliotoxin biosynthesis; 
encoded in gliotoxin biosynthetic gene cluster; involved in self-
protection against exogenous gliotoxin; G
liT
. 
5.125 
5.97E-05 
13 
62.9 
A
FU
A
_6G
09740 
H
as dom
ain(s) w
ith predicted m
ethyltransferase activity. G
tm
A
. 
4.991 
5.34E-06 
10 
44.7 
A
FU
A
_2G
11120 
U
ncharacterized O
R
F 
4.379 
7.92E-04 
6 
31.3 
A
FU
A
_6G
09745 
Predicted m
ethyltransferase, encoded in the putative gliotoxin 
biosynthetic gene cluster. G
liN
. 
3.990 
1.48E-04 
17 
72 
A
FU
A
_6G
09720 
 
M
ycelial catalase; induced in hyphae exposed to neutrophils; protein 
induced in am
photericin B
 and H
2O
2; stuA
-dependent up-regulation 
3.552 
1.70E-07 
13 
26.4 
A
FU
A
_3G
02270 
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Protein D
escription 
 
 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage [%
] 
Protein ID
s 
in developm
entally com
petent hyphae; hypoxia repressed; SrbA
-
regulated; repressed by gliotoxin exposure 
G
lyoxalase fam
ily protein 
2.574 
3.19E-03 
3 
16.9 
A
FU
A
_7G
05015 
Putative bifunctional catalase-peroxidase; induction in response to 
hydrogen peroxide Y
ap1-dependent; transcript induced by exposure to 
hum
an airw
ay epithelial cells; SrbA
-regulated during hypoxia 
1.947 
7.47E-05 
34 
63.6 
A
FU
A
_8G
01670 
Putative fructosyl am
ine; transcript induced by voriconazole 
1.913 
1.78E-02 
11 
32.2 
A
FU
A
_6G
03440 
Putative m
ethoxylase 
 
1.830 
2.84E-02 
9 
42.1 
A
FU
A
_3G
15010 
ThiJ/PfpI fam
ily protein; abundant in conidia 
1.649 
5.91E-04 
4 
22.5 
A
FU
A
_5G
01430 
O
rtholog(s) have intracellular localization 
1.529 
1.86E-03 
11 
52.8 
A
FU
A
_3G
13140 
Putative p-nitroreductase fam
ily protein; protein induced by heat 
shock; Y
ap1-dependent induction in response to hydrogen peroxide; 
induced by gliotoxin exposure 
1.278 
4.19E-02 
6 
35.5 
A
FU
A
_5G
09910 
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T
able 4.2. Proteins w
ith increased abundance (or unique to) A. fum
igatus Δgtm
A w
ith gliotoxin (5 μg/m
l; 3 h) com
pared to Δgtm
A w
ith m
ethanol. D
ata 
sorted by fold change, in descending order. 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage [%
] 
Protein ID
s 
O
rtholog(s) have cytosol, nucleus localization 
U
nique 
N
/A
 
4 
18.3 
A
FU
A
_6G
12780 
H
as dom
ain(s) w
ith predicted hydrolase activity 
U
nique 
N
/A
 
5 
28 
A
FU
A
_5G
12770 
Predicted O
-m
ethyltransferase, encoded in the putative gliotoxin 
biosynthetic gene cluster. G
liM
. 
U
nique 
N
/A
 
8 
20.9 
A
FU
A
_6G
09680 
G
lutathione S-transferase encoded in the gliotoxin biosynthetic gene 
cluster; required for gliotoxin biosynthesis; G
liG
. 
U
nique 
N
/A
 
4 
29.2 
A
FU
A
_6G
09690 
G
liotoxin sulfhydryl oxidase required for gliotoxin biosynthesis; 
involved in self-protection against exogenous gliotoxin; G
liT
. 
4.879 
6.26E-06 
13 
62.9 
A
FU
A
_6G
09740 
U
ncharacterized O
R
F, G
liN
 
4.023 
3.99E-03 
17 
72 
A
FU
A
_6G
09720 
M
ycelial catalase; induced in hyphae exposed to neutrophils; protein 
induced in am
photericin B
 and H
2 O
2 ; stuA
-dependent up-regulation 
3.435 
9.95E-06 
13 
26.4 
A
FU
A
_3G
02270 
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Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage [%
] 
Protein ID
s 
in developm
entally com
petent hyphae; hypoxia repressed; SrbA
-
regulated; repressed by gliotoxin exposure 
O
rtholog of Aspergillus brasiliensis: A
spbr1_0199026, N
eosartorya 
fischeri N
RRL 181 
3.178 
5.30E-03 
6 
31.3 
A
FU
A
_6G
09745 
G
lyoxalase fam
ily protein 
 
2.367 
2.28E-03 
3 
16.9 
A
FU
A
_7G
05015 
Putative bifunctional catalase-peroxidase; induction in response to 
hydrogen peroxide Y
ap1-dependent; SrbA
-regulated during hypoxia. 2.028 
1.44E-04 
34 
63.6 
A
FU
A
_8G
01670 
O
rtholog(s) have intracellular localization 
1.205 
8.98E-03 
11 
52.8 
A
FU
A
_3G
13140 
165 
 
 
 
 Comparative proteomic analysis of A. fumigatus wild-type and ∆gtmA 
exposed to bis(methyl)gliotoxin compared to a methanol control 
In order to elucidate the effect of exogenous bis(methyl)gliotoxin exposure on the 
proteome of ∆gtmA following exposure to exogenous bis(methyl)gliotoxin, quantitative 
label-free proteomics was carried out as outlined in Section 2.2.16.5. Briefly, A. fumigatus 
wild-type and ΔgtmA were exposed to either bis(methyl)gliotoxin (5 µg/ml) or a methanol 
control for 3 h following 21 h growth in Sabouraud-Dextrose broth. Mycelia were 
harvested and lysed and the samples were processed. LFQ proteomics analysis revealed 
that exogenous bis(methyl)gliotoxin exposure resulted in a significantly increased 
abundance of GliT, log2 1.985 fold increase, and GtmA, log2 1.933 fold increase, in A. 
fumigatus wild-type. It also highlighted that the abundance of only 4 other proteins were 
significantly altered (unique or increased) (Table 4.3). Of all the proteins to undergo 
differential abundance (bis(methyl)gliotoxin versus methanol exposure), GliT and GtmA 
abundance was observed to be the most significantly altered. Moreover, no other gli 
cluster-encoded proteins were found to exhibit an altered abundance following 
bis(methyl)gliotoxin exposure when compared to the  methanol control. ∆gtmA also 
showed an increased abundance of GliT (log2 1.985 fold increase) in response to 
bis(methyl)gliotoxin. (Table 4.4)
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T
able 4.3. Proteins w
ith increased abundance, or unique to, A. fum
igatus w
ild-type w
ith Bm
G
T (5 μg/m
l; 3 h) com
pared to w
ild-type w
ith m
ethanol. 
D
ata sorted by fold change, in descending order. 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence [%
] 
Protein ID
s 
H
as dom
ain(s) w
ith predicted oxidoreductase activity and role in 
m
etabolic process 
U
nique 
N
/A
 
3 
7.8 
A
FU
A
_5G
10180 
O
rtholog(s) have cytoplasm
 localization 
U
nique 
N
/A
 
4 
15 
A
FU
A
_5G
11760 
H
as dom
ain(s) w
ith predicted m
ethyltransferase activity. G
tm
A
. 
1.933 
5.01E-05 
10 
44.7 
A
FU
A
_2G
11120 
G
liotoxin sulfhydryl oxidase required for gliotoxin biosynthesis; 
encoded in gliotoxin biosynthetic gene cluster; involved in self-
protection against exogenous gliotoxin; G
liT
. 
1.985 
8.69E-03 
13 
62.9 
A
FU
A
_6G
09740 
C
onidial cell w
all hydrophobin involved in conidial cell w
all 
com
position; not required for norm
al rodlet layer; protein 
repressed by am
photericin B
; upregulated in biofilm
 vs 
planktonic culture; repressed by exposure to artem
isinin 
1.930 
1.59E-02 
4 
52.1 
A
FU
A
_1G
17250 
167 
 
 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence [%
] 
Protein ID
s 
N
on-hem
e Fe(II) and alpha-ketoglutarate-dependent dioxygenase; 
phytanoyl-C
oA
 dioxygenase fam
ily protein; catalyses the 
conversion of fum
itrem
orgin B
 to verruculogen 
1.045 
1.38E-02 
13 
56.7 
A
FU
A
_8G
00230 
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T
able 4.4. Proteins w
ith increased abundance, or unique to, A. fum
igatus w
ith Bm
G
T (5 μg/m
l; 3 h) com
pared to w
ild-type w
ith m
ethanol. D
ata sorted 
by fold change, in descending order. 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
[%
] 
Protein ID
s 
Transcript up-regulated in conidia exposed to neutrophils 
U
nique 
N
/A
 
3 
44.4 
A
FU
A
_2G
13590 
O
rtholog(s) have G
olgi apparatus, endoplasm
ic reticulum
 localization 
U
nique 
N
/A
 
3 
23.4 
A
FU
A
_4G
07390 
G
liotoxin sulfhydryl oxidase required for gliotoxin biosynthesis; 
encoded in gliotoxin biosynthetic gene cluster; involved in self-
protection against exogenous gliotoxin; G
liT
 
1.678 
2.16E-02 
13 
62.9 
A
FU
A
_6G
09740 
 
 
O
rtholog of A. nidulans FG
SC
 A4: A
N
5353, A. niger C
BS 513.88: 
A
n02g05680, 
1.032 
1.78E-03 
5 
25.2 
A
FU
A
_6G
14470 
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 Label-free quantitative (LFQ) proteomics reveals elevated abundance of 
gli-encoded enzymes in A. fumigatus ∆gtmA 
In order to elucidate the effect of the abrogation of gtmA expression on the proteome of 
A. fumigatus during incubation in secondary metabolite producing conditions (Section 
4.2.2), quantitative label-free proteomics was carried out as described in Section 2.2.16.5. 
A. fumigatus wild-type, ΔgtmA and gtmAc were cultured in Czapeks-Dox broth for 72 h, 
200 rpm. The cultures were not exposed to gliotoxin for this experiment. Mycelia were 
harvested and lysed and the samples were processed.  
The analysis revealed a significantly increased abundance (p< 0.05) of GliM (log2 
1.467 fold), GliP (log2 1.399 fold) and GliF (log2 1.297 fold) in ΔgtmA when compared 
to the wild-type (Table 2.5). This led to the conclusion that, in the absence of GtmA and 
abrogated bis(methyl)gliotoxin formation, expression of the gli cluster is significantly 
induced by endogenous gliotoxin in comparison with the wild-type strain. Notably, the 
unique presence of 7 proteins and significantly increased abundance of 18 additional 
proteins was observed in A. fumigatus ΔgtmA protein lysates (Table 4.5). As 
demonstrated in Table 4.7, GtmA presence is restored in A. fumigatus gtmAc 
thus confirming the result observed following Southern analysis of the complementation 
of gtmA deletion (Section 3.2.7). Importantly, when the proteome of the wild-type versus 
gtmAc was analysed, GliM, GliP and GliF were not differentially abundant which 
unambiguously confirms that gtmA complementation restored gli cluster regulation to that 
of the A. fumigatus wild-type (Table 4.7). Moreover, GliM, GliN and GliF abundance 
was significantly higher (log2 1.324, 1.115 and 1.475, respectively) in A. fumigatus 
ΔgtmA than in gtmAc, convincingly demonstrating that gtmA loss augments gli cluster-
encoded enzyme levels.   
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T
able 4.5. Proteins w
ith increased abundance (or unique) in A. fum
igatus Δgtm
A strains grow
n for 72 h in C
zapeks D
ox M
edia com
pared to w
ild-
type. D
ata sorted by fold change, in descending order. 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence [%
] 
Protein ID
s 
O
rtholog of A
. oryzae R
IB
40 : A
O
090701000613, 
N
eosartorya fischeri N
R
R
L 181 : N
FIA
_094160 
U
nique 
N
/A
 
4 
6.6 
A
FU
A
_8G
00730 
O
rtholog(s) have role in austinol biosynthetic process, 
dehydroaustinol biosynthetic process, sporocarp developm
ent 
involved in sexual reproduction 
U
nique 
N
/A
 
4 
13.5 
A
FU
A
_6G
13970 
Putative cyclophilin; peptidyl-prolyl cis-trans isom
erase-like 
protein 
U
nique 
N
/A
 
3 
23 
A
FU
A
_6G
02140 
O
rtholog(s) have role in cellular response to drug, nuclear-
transcribed m
R
N
A
 catabolic process, rR
N
A
 processing, 
U
nique 
N
/A
 
2 
16.6 
A
FU
A
_5G
13470 
171 
 
 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence [%
] 
Protein ID
s 
ribosom
al large subunit assem
bly and nucleolus, nucleoplasm
, 
preribosom
e, large subunit precursor localization 
Predicted am
inopeptidase, m
etalloexopeptidase; encoded in 
the fm
a (fum
agillin) secondary m
etabolite gene cluster 
U
nique 
N
/A
 
2 
11.8 
A
FU
A
_8G
00460 
O
rtholog(s) have role in ascospore form
ation, sporocarp 
developm
ent involved in sexual reproduction and nucleus 
localization 
U
nique 
N
/A
 
4 
7.2 
A
FU
A
_1G
15810 
Predicted O
-m
ethyltransferase, encoded in the putative 
gliotoxin biosynthetic gene cluster, G
liM
 
1.467 
1.97E-03 
 
4 
11.6 
A
FU
A
_6G
09680 
O
rtholog(s) have D
N
A
 binding, D
N
A
-directed R
N
A
 
polym
erase activity, R
N
A
 binding activity and role in 
chrom
atin silencing by sm
all R
N
A
, transcription from
 R
N
A
 
polym
erase II prom
oter 
1.457 
3.21E-03 
13 
12.4 
A
FU
A
_7G
01920 
172 
 
 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence [%
] 
Protein ID
s 
Tubulin beta-2 subunit; predicted gene pair w
ith 
A
FU
A
_1G
10910 (tubA
) 
1.409 
4.00E-03 
13 
32.8 
A
FU
A
_7G
00250 
N
on-ribosom
al peptide synthetase encoded in the gliotoxin 
biosynthetic gene cluster; regulated by the transcription factor 
StuA
; expression increases in vivo, G
liP 
1.399 
4.42E-03 
 
5 
3.5 
A
FU
A
_6G
09660 
O
rtholog(s) have cytosol, nucleus localization 
1.366 
3.07E-02 
4 
14.8 
A
FU
A
_1G
06780 
O
rtholog(s) have cytoplasm
ic m
R
N
A
 processing body 
localization 
1.350 
2.54E-02 
3 
5.7 
A
FU
A
_3G
10220 
H
as dom
ain(s) w
ith predicted nucleotide binding, 
oxidoreductase activity and role in m
etabolic process 
1.329 
1.48E-02 
10 
67 
A
FU
A
_1G
00990 
 
Predicted cytochrom
e P450 m
onooxygenase, encoded in the 
putative gliotoxin biosynthetic gene cluster, G
liF 
1.297 
1.67E-02 
6 
16.3 
A
FU
A
_6G
09730 
173 
 
 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence [%
] 
Protein ID
s 
Thiazole biosynthesis enzym
e; hypoxia induced protein; 
induced by gliotoxin exposure 
1.361 
3.31E-03 
12 
38.3 
A
FU
A
_6G
08360 
A
nthranilate phosphoribosyl transferase; no hum
an hom
olog 
1.185 
3.89E-03 
4 
16.1 
A
FU
A
_4G
11980 
O
rtholog of A. nidulans FG
SC
 A4: A
N
3605, A. niger C
BS 
513.88: A
n03g02780 
1.150 
4.22E-03 
6 
26.5 
A
FU
A
_4G
12710 
M
olecular chaperone; conidia-enriched protein 
1.128 
2.16E-02 
36 
63.2 
A
FU
A
_1G
07440 
O
rtholog of A. nidulans FG
SC
 A4: A
N
8072, A. oryzae RIB40: 
A
O
090003001347 
1.111 
2.39E-03 
 
4 
21.3 
A
FU
A
_5G
01770 
Eukaryotic translation initiation factor eIF4A
; A
TP-dependent 
R
N
A
 helicase; protein induced by heat shock; predicted gene 
pair w
ith A
FU
A
_5G
02410 
1.106 
2.44E-02 
16 
53.2 
A
FU
A
_3G
08160 
Putative m
alate synthase; protein abundant in conidia 
1.103 
3.74E-02 
5 
11.5 
A
FU
A
_6G
03540 
174 
 
 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence [%
] 
Protein ID
s 
Putative m
itogen-activated protein kinase (M
A
PK
) 
1.097 
2.44E-02 
9 
31.7 
A
FU
A
_6G
12820 
C
lathrin, heavy chain; transcript dow
nregulated in response to 
am
photericin B
 
1.128 
1.10E-03 
53 
48 
A
FU
A
_4G
07700 
O
rtholog(s) have cytoplasm
 localization 
1.065 
2.59E-02 
16 
35 
A
FU
A
_1G
03400 
Septin; unique to filam
entous fungi; localizes to long tubular 
structures w
ithin hyphae and to new
ly form
ed septa 
1.059 
4.67E-02 
 
4 
7.1 
A
FU
A
_3G
07015 
O
rtholog(s) have preprotein binding activity, role in conidium
 
form
ation, hyphal grow
th, protein targeting to m
itochondrion 
and m
itochondrial outer m
em
brane translocase com
plex 
localization 
1.034 
1.73E-02 
6 
13.3 
A
FU
A
_2G
01660 
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T
able 4.6. Proteins w
ith decreased abundance (or absent) in A. fum
igatus Δgtm
A strains grow
n for 72 h in C
zapeks D
ox M
edia com
pared to w
ild-type. 
D
ata sorted by fold change, in descending order. 
  Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
[%
] 
Protein ID
s 
O
rtholog(s) have cytosol, nucleus localization 
A
bsent 
N
/A
 
2 
14.9 
A
FU
A
_1G
10960 
H
as dom
ain(s) w
ith predicted m
ethyltransferase activity 
A
bsent 
N
/A
 
10 
41 
A
FU
A
_2G
11120 
O
rtholog(s) have enzym
e activator activity, hem
e binding activity, role in 
ergosterol biosynthetic process, regulation of ergosterol biosynthetic 
process and endoplasm
ic reticulum
, endosom
e localization 
A
bsent 
N
/A
 
2 
19.4 
A
FU
A
_3G
10490 
O
rtholog of S. cerevisiae: Y
ER
010C
, A. nidulans FG
SC
 A
4: A
N
10700, 
A. niger C
B
S 513.88: A
n04g05730 
A
bsent 
N
/A
 
2 
8.2 
A
FU
A
_4G
10940 
O
rtholog of A. nidulans FG
SC
 A4: A
N
7836, A. oryzae RIB40: 
A
O
090003000833 
A
bsent 
N
/A
 
4 
14.6 
A
FU
A
_7G
01060 
176 
 
 
 
Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
[%
] 
Protein ID
s 
O
rtholog(s) have R
N
A
 polym
erase II core binding, TFIIF-class binding 
transcription factor activity, chrom
atin binding activity 
A
bsent 
N
/A
 
4 
10.4 
A
FU
A
_2G
11190 
Protein of unknow
n function identified by m
ass spectrom
etry 
A
bsent 
N
/A
 
2 
9.8 
A
FU
A
_2G
14370 
Putative N
IPSN
A
P fam
ily protein 
A
bsent 
N
/A
 
3 
9.9 
A
FU
A
_3G
06660 
O
rtholog(s) have A
M
P deam
inase activity, role in guanine salvage, purine 
nucleotide m
etabolic process and cytosol localization 
A
bsent 
N
/A
 
3 
2.3 
A
FU
A
_8G
02860 
O
rtholog of N
eosartorya fischeri N
RRL 181: N
FIA
_105510, Aspergillus 
w
entii: A
spw
e1_0166738 
-1.649 
2.23E-02 
 
2 
19.8 
A
FU
A
_4G
10560 
Putative class III fam
ily 18 chitinase 
-1.646 
2.38E-02 
2 
7.6 
A
FU
A
_7G
05140 
C
onserved protein, predicted adhesin; expression induced in biofilm
 
-1.083 
4.42E-02 
9 
12.9 
A
FU
A
_7G
05340 
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T
able 4.7. Proteins w
ith increased abundance (or uniquely detected) in A. fum
igatus Δgtm
A com
pared to gtm
A
c grow
n for 72 h in C
zapeks D
ox 
M
edia. D
ata sorted by fold change, in descending order. 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
  Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Putative hydrolase; m
em
ber of the pseurotin A
 gene cluster 
U
nique 
N
/A
 
2 
5.5 
A
FU
A
_8G
00570 
O
rtholog(s) have cell septum
, fungal-type vacuole, late endosom
e, plasm
a 
m
em
brane localization 
U
nique 
N
/A
 
2 
17.8 
A
FU
A
_6G
11270 
O
rtholog of A. nidulans FG
SC
 A4: A
N
5204, A. niger C
BS 513.88: 
A
n07g09060 
U
nique 
N
/A
 
2 
7.7 
A
FU
A
_6G
07370 
O
rtholog(s) have role in m
R
N
A
 export from
 nucleus and nucleus 
localization 
U
nique 
N
/A
 
4 
1.3 
A
FU
A
_4G
10780 
Putative secreted am
inopeptidase; predicted signal sequence for secretion 
U
nique 
N
/A
 
3 
13.6 
A
FU
A
_4G
04210 
O
rtholog(s) have nitronate m
onooxygenase activity and role in 
denitrification pathw
ay, detoxification of nitrogen com
pound 
U
nique 
N
/A
 
5 
20.3 
A
FU
A
_2G
17430 
O
rtholog(s) have nuclear pore localization 
U
nique 
N
/A
 
       3 
5.4 
A
FU
A
_2G
08560 
O
rtholog of N
eosartorya fischeri N
RRL 181: N
FIA
_064340 
1.650 
4.06E-02        4 
14.5 
A
FU
A
_3G
12982 
178 
 
 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
  Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Predicted O
-m
ethyltransferase, encoded in the putative gliotoxin 
biosynthetic gene cluster, G
liM
 
1.324 
3.60E-03 4 
11.6 
A
FU
A
_6G
09680 
Predicted cytochrom
e P450 m
onooxygenase, encoded in the putative 
gliotoxin biosynthetic gene cluster, G
liF 
1.475 
1.48E-02 
 
6 
16.3 
A
FU
A
_6G
09730 
Protein of unknow
n function; transcript dow
nregulated in response to 
voriconazole 
1.283 
2.65E-02 10 
39.1 
A
FU
A
_4G
14380 
O
rtholog of A. fum
igatus Af293: A
fu6g09720/gliN
, A
fu8g00550, A. niger 
C
BS 513.88: A
n07g05460 
1.151 
2.10E-02 3 
16.5 
A
FU
A
_5G
13860 
Predicted m
ethyltransferase, encoded in the putative gliotoxin biosynthetic 
gene cluster, G
liN
 
1.115 
3.33E-02 18 
74.8 
A
FU
A
_6G
09720 
O
rtholog(s) have cytoplasm
 localization 
1.084 
4.69E-02 16 
35 
A
FU
A
_1G
03400 
B
aeyer-V
illiger m
onooxygenase (B
V
M
O
); hypoxia induced protein; 
encoded in the fm
a (fum
agillin) secondary m
etabolite gene cluster 
1.079 
2.69E-02 43 
62.3 
A
FU
A
_8G
00440 
179 
 
 
 
T
able 4.8. Proteins w
ith decreased abundance (or absent) in A. fum
igatus Δgtm
A com
pared to gtm
A
c grow
n for 72 h in C
zapeks D
ox M
edia. D
ata 
sorted by fold change, in descending order. 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
O
rtholog(s) have role in positive regulation of R
N
A
 polym
erase II 
transcriptional preinitiation com
plex assem
bly, proteasom
e regulatory 
particle assem
bly, ubiquitin-dependent protein catabolic process 
A
bsent 
N
/A
 
 
2 
6.7 
A
FU
A
_1G
06170 
O
rtholog(s) have cytosol, nucleus localization 
A
bsent 
N
/A
 
2 
14.9 
A
FU
A
_1G
10960 
H
as dom
ain(s) w
ith predicted m
ethyltransferase activity 
A
bsent 
N
/A
 
10 
41 
A
FU
A
_2G
11120 
O
rtholog(s) have R
N
A
 polym
erase II core binding, TFIIF-class binding 
transcription factor activity, chrom
atin binding activity 
A
bsent 
N
/A
 
4 
10.4 
A
FU
A
_2G
11190 
Putative class V
 chitin synthase; required for norm
al hyphal grow
th, 
conidiation and norm
al conidiophore developm
ent; m
utants have 
decreased chitin content 
A
bsent 
N
/A
 
6 
4.9 
A
FU
A
_2G
13440 
180 
 
 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
O
rtholog(s) have enzym
e activator activity, hem
e binding activity, role 
in ergosterol biosynthetic process, regulation of ergosterol biosynthetic 
process and endoplasm
ic reticulum
, endosom
e localization 
A
bsent 
N
/A
 
2 
19.4 
A
FU
A
_3G
10490 
O
rtholog of A. nidulans FG
SC
 A4: A
N
5509, A
N
2837, A
N
2029, A. 
oryzae RIB40 : A
O
090023000015 
A
bsent 
N
/A
 
2 
4.5 
A
FU
A
_4G
00200 
O
rtholog(s) have G
olgi apparatus localization 
A
bsent 
N
/A
 
3 
14 
A
FU
A
_1G
05730 
Protein of unknow
n function identified by m
ass spectrom
etry 
A
bsent 
N
/A
 
2 
9.8 
A
FU
A
_2G
14370 
Putative N
IPSN
A
P fam
ily protein; transcript up-regulated in conidia 
exposed to neutrophils 
A
bsent 
N
/A
 
3 
9.9 
A
FU
A
_3G
06660 
Putative 30-kilodalton heat shock protein; conidia-enriched protein; 
protein levels increase in response to am
photericin B
 and hydrogen 
peroxide 
A
bsent 
N
/A
 
2 
17.8 
A
FU
A
_3G
14540 
181 
 
 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Putative oxidosqualene:lanosterol cyclase (O
SLC
) w
ith a role in 
protostadienol biosynthesis; SrbA
-regulated during hypoxia 
A
bsent 
N
/A
 
2 
3.5 
A
FU
A
_5G
04080 
G
alactofuranosyltransferase involved in biosynthesis of galactofuranose 
antigen of cell w
all O
-glycan 
A
bsent 
N
/A
 
4 
9.9 
A
FU
A
_6G
02120 
O
rtholog of A. nidulans FG
SC
 A4: A
N
3716, A. niger C
BS 513.88 : 
A
n08g10710 
A
bsent 
N
/A
 
3 
7.4 
A
FU
A
_6G
12770 
H
as dom
ain(s) w
ith predicted catalytic activity, pyridoxal phosphate 
binding activity 
A
bsent 
N
/A
 
4 
13.5 
A
FU
A
_7G
01590 
O
rtholog(s) have A
M
P deam
inase activity, role in guanine salvage, 
purine nucleotide m
etabolic process and cytosol localization 
A
bsent 
N
/A
 
3 
2.3 
A
FU
A
_8G
02860 
Putative coenzym
e A
 transferase; transcript induced by exposure to 
hum
an airw
ay epithelial cells 
A
bsent 
N
/A
 
2 
5.7 
A
FU
A
_8G
05580 
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Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
O
rtholog(s) have endoplasm
ic reticulum
, extracellular region 
localization 
-1.753 
2.23E-02 
4 
12.3 
A
FU
A
_2G
16720 
Protein w
ith Y
ap1-dependent induction in response to hydrogen 
peroxide; calcium
 dow
nregulated; induced by gliotoxin exposure 
-1.513 
4.54E-03 
9 
41 
A
FU
A
_5G
14680 
O
rtholog(s) have role in m
itochondrial respiratory chain com
plex I 
assem
bly and m
itochondrial m
em
brane localization 
-1.132 
1.82E-02 
6 
38.6 
A
FU
A
_6G
12280 
Putative pyruvate decarboxylase w
ith a predicted role in pyruvate 
m
etabolism
; reacts w
ith rabbit im
m
unosera exposed to A. fum
igatus 
conidia; higher expression in 48 h biofilm
 vs planktonic cells; protein 
increases during hypoxia 
-1.123 
1.33E-02 
14 
37.6 
A
FU
A
_3G
11070 
Putative am
ino acid perm
ease; transcript up-regulated in conidia 
exposed to neutrophils and by grow
th on B
SA
 as a sole nitrogen source 
-1.106 
1.81E-02 
5 
8.4 
A
FU
A
_7G
04290 
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2 (Fold 
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p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
O
rtholog of A. nidulans FG
SC
 A4 : A
N
2953, A. niger C
BS 513.88 : 
A
n02g11360, 
-1.035 
1.18E-02 
10 
40.6 
A
FU
A
_3G
07890 
R
as G
TPase; hypoxia repressed protein 
-1.000 
5.31E-03 
6 
35.8 
A
FU
A
_1G
02190 
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 GtmA phylogeny 
Phylogenetic analysis of GtmA was carried out in collaboration with Dr David Fitzpatrick 
of Maynooth University. As described in Section 4.2.11, using A. fumigatus GtmA as a 
query sequence, 124 homologs in 103 fungal genomes were located. GtmA orthology was 
inferred using three approaches. Firstly, proteins which shared a bidirectional best hit to 
A. fumigatus GtmA, AFUA_2G11120, were located (Figure 4.9). Secondly, a GtmA 
phylogenetic tree was reconstructed (Figure 4.10). Finally, the synteny around GtmA 
homologs was viewed to confirm orthology (Figure 4.11). All proteins that share a 
bidirectional BlastP hit with A. fumigatus GtmA are located in a single clade (Figure 4.9, 
clade-A). It is worth noting that all homologs were from the Ascomycota phylum. No 
homologs in the Basidiomycota, Chytridmycota or Zygomycota phyla were identified 
(Figure 4.9). Database searches showed that species belonging to the Taphrinomycotina 
subphylum and CTG clade, Candida albicans and close relatives (Fitzpatrick et al., 2006), 
contain GtmA homologs although no homologs were located in species that have 
undergone a whole genome duplication (WGD) or close relatives of WGD species such 
as Kluyveromyces lactis and Ashbya gossypii (Figure 4.9). 
All species belonging to the filamentous ascomycetes (Pezizomycotina 
subphylum), with the exceptions of Uniocarpus reesii, Verticillium dahliae and 
Verticillium alboatrum, contain a homolog of GtmA (Figure 4.9). Furthermore, most 
Pezizomycotina species contain multiple GtmA homologs. For example, A. fumigatus has 
two homologs, AFUA_4G14510 and AFUA_6G08850. According to AspGD 
(http://www.aspgd.org/), AFUA_4G14510 is annotated as an uncharacterized protein 
with predicted methyltransferase activity whilst AFUA_6G08850 is a ubiquinone 
biosynthesis methyltransferase (Vödisch et al., 2011). 
 
 
  
Figure 4.9. Maximum likelihood phylogenetic tree of GtmA homologs. Species with blue 
coloured branches belong to the Taphrinomycotina and Saccharomycotina subphyla. Red 
branches indicate species belonging to the Pezizomycotina subphylum. A. fumigatus 
homologs are coloured in blue for reference purposes. All proteins that share a 
bidirectional best hit with A. fumigatus GtmA (AFUA_2G11120) are located in clade-C 
and are indicated with an *. Clade-B contains species belonging to the Eurotiales order 
exclusively. GtmA orthologs are found in clade-C. 
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Figure 4.10. Fungal species phylogeny modified from (Medina et al., 2011). The 
presence and absence of GtmA is indicated. Species are deemed to contain an ortholog if 
they share a best bi-directional hit with A. fumigatus GtmA (AFUA_2G11120) and are 
located in the GtmA monophyletic clade (clade-c) in Figure 4.10. 
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Figure 4.11. Synteny around GtmA in Eurotiales species relative to A. fumigatus. A. 
fumigatus accession numbers are shown for reference. Orthologs are arranged in pillars. 
Coloured boxes indicate that synteny is conserved. Grey boxes indicate that an ortholog 
is present but in a different part of the genome. Continuous black lines indicate that the 
ortholog is missing. 
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 4.3 Discussion 
The deletion of gtmA from the genome of A. fumigatus ATCC26933 provided an 
opportunity to functionally investigate a role for gtmA. It has been proposed (Li et al., 
2012) that bis-thiomethylation represents a back-up detoxification strategy to the GliT-
mediated gliotoxin self-protection system in A. fumigatus (Schrettl et al., 2010; Scharf et 
al., 2010). Furthermore, it has been speculated, not unreasonably, that the gli cluster-
encoded GliN may be responsible for gliotoxin bis-thiomethylation (Li and Walsh, 2011). 
The work presented in this chapter shows that, unlike the gliotoxin oxidoreductase GliT, 
GtmA is not essential for gliotoxin biosynthesis or self-protection in A. fumigatus. The 
inability to detect bis(methyl)gliotoxin formation by A. fumigatus ∆gtmA also effectively 
excludes a role for either GliM or GliN in gliotoxin bis-thiomethylation and suggests that 
these enzymes are responsible for unrelated functionalities during gliotoxin biosynthesis. 
Previously it has been demonstrated that Gliocladium deliquescens could convert 
exogenous gliotoxin to bis(methyl)gliotoxin (Kirby et al., 1980) – indeed, this metabolite 
has been identified to be endogenously produced by many fungal species (Amitani et al., 
1995; Guimarães et al., 2010; Intaraudom et al., 2013; Li et al., 2006; Van der Pyl et al., 
1992; Sun et al., 2011). In this thesis, it is shown that added gliotoxin (5 µg/ml) is taken 
up by A. fumigatus ATCC26933 over the course of 3 h and then converted to 
bis(methyl)gliotoxin which is then secreted into the culture medium over the 3 h period. 
Although A. fumigatus ∆gtmA does not have this bis(methyl)gliotoxin conversion ability, 
it responds in the same manner as the wild-type to exogenous gliotoxin presence. This is 
further supported on the proteomic level as both the wild-type and ΔgtmA strains respond 
almost identically to gliotoxin exposure. If bis(methyl)gliotoxin formation played a 
significant role in the detoxification of intracellular gliotoxin, the ΔgtmA strain would be 
expected to be more sensitive to gliotoxin than the wild-type. Since this is not observed, 
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 it further underpins our hypothesis that GtmA activity is not directly involved in self-
protection against gliotoxin.  
However, despite endogenous or exogenous gliotoxin clearly undergoing 
conversion to bis(methyl)gliotoxin in A. fumigatus, initial attempts to detect bis-
thiomethylation activity in wild-type lysates was unsuccessful. Interestingly, in vitro 
bis(methyl)gliotoxin formation was readily detectable by LC-MS in reaction mixtures 
containing TCEP-reduced gliotoxin, SAM and A. fumigatus ∆gliT mycelial lysates 
(Owens et al. 2015). As such, GliT absence facilitated GtmA-mediated gliotoxin 
bisthiomethylation, inferring that dithiogliotoxin is a co-substrate for both enzymes. A. 
fumigatus ∆gtmA mycelial lysates did not have any gliotoxin bisthiomethylation activity 
(Figure 4.12).  
To the best of our knowledge, this is the first fungal thiomethyltransferase, and 
only bis-thiomethyltransferase, to be identified to date. The thiomethyltransferase 
(PpSABATH1) identified in a bryophyte P. patens, which can monomethylate a range of 
thiol-containing compounds including thiobenzoic acid in a SAM-dependent manner, has 
been proposed to play a role in the detoxification of xenobiotic thiols  (Zhao et al., 2012). 
However, deletion of gtmA from A. fumigatus, which completely abrogated 
bis(methyl)gliotoxin production, did not result in the acquisition of a gliotoxin- or H2O2-
sensitive phenotype. This leads us to conclude that GtmA is not primarily involved in the 
detoxification of gliotoxin or related biosynthetic intermediates (Forseth et al., 2011) as 
has previously been proposed (Li et al., 2012). While we cannot exclude the possibility 
that GliT activity compensates for the absence of GtmA, we consider that a counter-
balance for the positive regulation of gli cluster expression by gliotoxin (Cramer et al., 
2006; Davis et al., 2011; Schrettl et al., 2010) presented an alternative purpose for 
bis(methyl)gliotoxin formation. In fact, formerly, no consideration had been given to a 
mechanism by which gliotoxin-induced gli cluster activity could be attenuated. These 
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 data suggest that bis(methyl)gliotoxin biosynthesis via GtmA, instead of GliT-catalyzed 
de novo gliotoxin formation, represents a post-biosynthetic “off-switch” for gliotoxin 
biosynthesis and leads to diminution of gli cluster expression and consequent diminished 
gliotoxin biosynthesis (Figure 4.12). This hypothesis is underpinned by the increased 
abundance of key gliotoxin biosynthetic enzymes (GliP, GliM and GliF) in A. fumigatus 
∆gtmA, in comparison with wild-type or gtmAc, under conditions permissive for gliotoxin 
biosynthesis. It is also established by the significant elevation (p<0.0056) in gliotoxin 
production in A. fumigatus ∆gtmA under identical conditions. Moreover, the positive 
regulation of gtmA expression and GtmA abundance by exposure to elevated gliotoxin 
levels further consolidates the biological role of this enzyme in attenuating gli cluster 
activity and gliotoxin biosynthesis. Notably, the significantly elevated abundance of 
gliotoxin-related biosynthetic enzymes excludes the possibility that increased gliotoxin 
biosynthesis is simply due to an absence of “competing” bis(methyl)gliotoxin 
biosynthesis (Table 4.5). In essence, ETP bis-thiomethylation in A. fumigatus may 
represent a strategy for suppressing ETP biosynthesis as opposed to, or in addition to, 
acting as an alternative self-protection strategy. Nonetheless, the removal of 
dithiogliotoxin by bis-thiomethylation likely confers some indirect element of self-
protection against this reactive biosynthetic intermediate. Just as A. fumigatus ∆gtmA 
facilitates gliotoxin over-production, deletion mutants of gtmA orthologs in other ETP-
producing fungi may result in similar outcomes in addition to attenuating the bis-
thiomethylation of reactive biosynthetic intermediates (Forseth et al., 2011). 
Compellingly, the overexpression of RsmA, a Yap-like bZIP transcriptional enhancer, in 
A. fumigatus (OErsmA) resulted in increased gliT expression and enhanced production of 
gliotoxin, resulting in the effective abolition of bis(methyl)gliotoxin formation 
(Sekonyela et al., 2013). Our observation that GtmA is the SAM-dependent 
methyltransferase which bis-thiomethylates GT-(SH)2 is in complete accordance with 
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 these investigations and provides a definitive explanation for the loss of 
bis(methyl)gliotoxin formation by A. fumigatus OErsmA.  
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Figure 4.12. Model of GtmA-mediated regulation gliotoxin biosynthesis. Gliotoxin 
induces gli cluster expression and acts to potentiate its own biosynthesis. The toxic 
biosynthetic intermediate, GT-(SH)2 (dithiol gliotoxin), is a shared substrate between 
GliT and GtmA and is either converted to gliotoxin or bis(methyl)gliotoxin. Gliotoxin 
production is suppressed by increased conversion to bis(methyl)gliotoxin which occurs 
due to an increased GtmA abundance once gliotoxin levels increase (gliotoxin 
significantly induces gtmA expression and GtmA abundance). The consequent depletion 
of gliotoxin may lead to a reduction in gli cluster expression and gli enzyme abundance. 
Bis(methyl)gliotoxin may also promote self- and gliotoxin-formation to dissipate reactive 
GT-(SH)2. 
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 Localisation of gtmA on chromosome 2, distal to the gli cluster on chromosome 6 
(Cramer et al., 2006) is highly relevant to assigning a role for gtmA in either self-
protection against a toxic biosynthetic intermediate or, as a regulator of gliotoxin 
production. It has been proposed that the co-localization of genes within metabolite-
encoding clusters has evolved to protect against toxic biosynthetic intermediates (McGary 
et al., 2013). Our demonstration that gtmA deletion completely abrogates 
bis(methyl)gliotoxin formation without enhancing sensitivity to exogenous gliotoxin is in 
accordance with this proposal, strongly implicating an alternative function for GtmA in 
gliotoxin biosynthesis. Moreover, our data endorse the key role of GliT, located within 
the gli cluster, in mediating self-protection against reactive dithiogliotoxin.  
 The ΔgtmA::gtmA-eGFP::H2A-mRFP strain was analysed by confocal 
microscopy analysis (Section 4.2.7). The results revealed that GtmA::eGFP accumulates 
in the cytosol of A. fumigatus following exposure to 5 µg/ml gliotoxin for 3 h (Figure 
4.8). Cytosolic localisation is a feature of methyltransferases involved in the 
detoxification of thiol compounds in other organisms. The thiol methyltransferase from 
Euglena gracilis (Drotar et al., 1987) and the methyl chloride transferase form E. 
muricata (Wuosmaa and Hager, 1990) are also localized in the cytosol. These are 
involved in the general detoxification of thiols and halides. The cytosolic location of these 
enzymes gives them rapid access to their substrates. In contrast, the fungal methyl 
chloride transferase, which is not involved in detoxification (Harper, 1993) and which 
differs from our TMT in substrate preference (Saxena et al., 1998), is membrane-bound. 
This work represents the first characterisation of an enzyme responsible for non-
ribosomal peptide bis-thiomethylation in microbial secondary metabolism whereby 
GtmA catalyzes bis(methyl)gliotoxin biosynthesis in A. fumigatus. The data suggests that 
bis(methyl)gliotoxin production may act as a negative regulatory mechanism for gli 
cluster expression by disrupting the gliotoxin-mediated gli cluster positive feedback 
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 system – a model which may be applicable to all ETPs synthesised by various filamentous 
fungi. Unusually, gtmA is located outside the gli cluster despite the fact that 
bis(methyl)gliotoxin production is conserved across all gliotoxin-producing species.  
GtmA orthology was inferred using three approaches: Firstly, proteins were 
located that shared a bidirectional best hit to A. fumigatus GtmA (AFUA_2G11120). 
Secondly, a GtmA phylogenetic tree was reconstructed (Figure 4.10). Finally the synteny 
around GtmA homologs was viewed to confirm orthology (Figure 4.11). All proteins that 
share a bidirectional BlastP hit with A. fumigatus GtmA are located in a single clade 
(Figure 4.9, clade-A). Based on the GtmA phylogeny, paralogs seem to have arisen in a 
species/lineage dependent manner as some species, such as A. niger and Nectria 
haematococca, contain multiple homologs (4 and 6, respectively) while others, such as 
A. nidulans, contain a single GtmA homolog. The most robust manner to ascertain 
orthology is through phylogenetic reconstruction and confirmation by synteny. 
Phylogenetic analysis inferred a GtmA ortholog clade containing A. clavatus, N. fischeri, 
A. fumigatus, A. niger and A. carbonarius (Figure 4.9). These species, along with 
Penicillium chrysogenum, A. terreus, A. oryzae, A. flavus and A. nidulans, all belong to 
the Eurotiales order (Figure 4.9, clade-B). A. terreus and P. chrysogenum both contain 
proteins that have reciprocal best blast hits to A. fumigatus GtmA, yet, neither is found 
within the GtmA ortholog clade (Figure 4.9). However, based on our synteny analysis, it 
is confirmed that both species possess orthologs of GtmA (Figure 4.11). In accordance 
with the phylogeny and reciprocal best-hit strategy, there are two scenarios which explain 
the evolutionary history of GtmA. Firstly, GtmA is the result of a duplication of the 
ortholog of AFUA_4G14510 in the last common ancestor of all these species. Species-
specific losses of GtmA have since occurred in A. terreus, A. oryzae, A. flavus and A. 
nidulans. Alternatively, AFUA_4G14510 may be the result of GtmA duplication with 
subsequent retention of the GtmA paralog and loss of the GtmA ortholog in these species. 
206 
 
 The presence of GtmA orthologs in fungi non-permissive for gliotoxin biosynthesis (e.g., 
A. niger) is interesting and perhaps represents a self-protection mechanism in these 
species. 
 In summary, we have identified the first bis-thiomethyltransferase and 
demonstrated its role in the bis-thiomethylation of dithiol gliotoxin (Figure 4.12) 
therefore proposing that it primarily acts as a molecular switch to attenuate gli cluster 
expression and, consequently, gliotoxin biosynthesis in A. fumigatus.  
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Chapter 5 
Recombinant Expression and Structural Elucidation of 
Gliotoxin Thiomethyltransferase A 
 
 
 
 
 
 
 
 
 
 
 5.1 Introduction 
The mechanism responsible for bis-thiomethyl ETP biosynthesis is of substantial interest 
due to the clear value of these natural products. Furthermore, SAM-dependent 
methyltransferases have been established as highly versatile enzymes for applications in 
biocatalysis, metabolic engineering, chemical biology and other areas of biotechnology 
(Struck et al., 2012). The chemospecific and regiospecific methylation of natural products 
using classical chemical alkylating agents requires multistep reactions which can be 
costly and time consuming (Wessjohann et al., 2013). However, despite the fact that a 
vast number of natural product methyltransferases have been characterised, thiol directed 
NPMTs remain a largely unclassified group of biosynthetic enzymes (Liscombe et al., 
2012).  
The ability to express and purify desired recombinant proteins in large quantities 
has facilitated the rapid biochemical characterization of a variety of enzymes. Escherichia 
coli is one of the organisms of choice for the production of recombinant proteins. Its use 
as a cell factory is well-established and it has become the most popular expression 
platform (Gräslund et al., 2008). For this reason, there are many molecular tools and 
protocols at hand for the high-level production of heterologous proteins; these include a 
vast catalog of expression plasmids, a great number of engineered strains and many 
cultivation strategies (Rosano and Ceccarelli, 2014).  
Affinity-tagged protein purification is a widely used method for the purification 
of proteins of interest. The two most commonly used tags are the polyhistidine tag, which 
generally consists of six histidine residues, and GST (Kimple et al., 2013). Proteins tagged 
with histidine bind strongly with metal ions such as Ni2+, Co2+, Cu2+, and Zn2+. They are 
purified by binding to a metal ion immobilized on a support resin through the IMAC 
method (immobilized metal ion affinity chromatography). For GST tags, the purification 
principle is based on the binding of GST to glutathione immobilized on the support resin. 
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 After sample impurities are washed from the resin, the bound GST-tagged protein is 
eluted by reduced glutathione. The GST protein has a molecular mass of 26 kDa and is 
most often fused to the target protein at the N-terminus. The GST protein is a dimer in 
solution and, thus, the fusion protein dimerizes as well. The use of GST as a fusion tag is 
desirable because it can act as a chaperone to facilitate protein folding and, consequently, 
the fusion protein can often be expressed as a soluble protein rather than in inclusion 
bodies (Lichty et al., 2005; Harper et al., 2011).  
Several methods are currently used to determine the structure of a protein. These 
include X-ray crystallography, NMR spectroscopy and electron microscopy. Each 
method has both advantages and disadvantages. In each of these methods many pieces of 
information are used to create the final atomic model based on experimental data about 
the structure of the molecule (Egli, 2010).  In the case of X-ray crystallography, this is 
the X-ray diffraction pattern. Most of the structures included in the Protein Data Bank 
(PDB) archive were determined using X-ray crystallography (Callaway, 2014). For this 
method, the protein is purified and crystallized and then subjected to an intense beam of 
X-rays. The proteins in the crystal diffract the X-ray beam into a characteristic pattern of 
spots which are then analyzed to determine the distribution of electrons in the protein. 
The resulting map of the electron density is then interpreted to determine the location of 
each atom (Wlodawer et al., 2008). 
X-ray crystallography can provide very detailed atomic information: it shows 
every atom in a protein or nucleic acid along with atomic details of ligands, inhibitors, 
ions, and other molecules which are incorporated into the crystal (Egli, 2010). However, 
the process of crystallization is difficult and can impose limitations on the types of 
proteins that may be studied by this method. For example, X-ray crystallography is an 
excellent method for determining the structures of rigid proteins that form nice, ordered 
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 crystals. Conversely, flexible proteins are far more difficult to study with this method as 
crystallography relies on having a large quantity of molecules aligned in exactly the same 
orientation. Flexible portions of protein will often be invisible in crystallographic electron 
density maps since their electron density will be smeared over a large space (Pflugrath, 
1999; Wlodawer et al., 2008). 
Despite tremendous progress in experimental determination of protein three-
dimensional structures, it has not kept pace with the explosive growth of sequence 
information that results from massively parallel sequencing technology (Marks et al., 
2012). As a result of this there are many more protein sequences than protein three-
dimensional structures - the gap is widening rather than diminishing. Many proteins 
contain enough information in their amino acid sequence to determine their three-
dimensional structure, thus opening the possibility of predicting three-dimensional 
structure from sequence (Stolte et al., 2015). 
Critical Assessment of protein Structure Prediction (CASP) is a community-wide, 
worldwide experiment for protein structure prediction which takes place every two years. 
CASP provides research groups with the opportunity to objectively test their structure 
prediction methods (Boutros et al., 2014). I-TASSER (Iterative Threading ASSEmbly 
Refinement) is a hierarchical method for protein structure and function prediction (Yang 
et al., 2015). First, structural templates are identified from the PDB by multiple threading 
approach LOMETS. Following this, full-length atomic models are then constructed using 
iterative template fragment assembly simulations. Finally, function inslights of the target 
are derived by threading the 3D models through the protein function database BioLiP. I-
TASSER was ranked as the No. 1 server for protein structure prediction in recent CASP7, 
CASP8, CASP9, CASP10, and CASP11 experiments (Zhang, 2008; Roy et al., 2010; 
Yang et al., 2015). 
210 
 
 The overall objectives of the work presented in this chapter were to:   
(vii) Recombinantly express GtmA as a GST tagged fusion protein, cleave off the 
GST tag and purify the active protein at high yields and purity. 
(viii) Carry out activity analysis on GtmA using a variety of substrate and cofactor 
concentrations in order to determine both the kinetics and the oligomeric state 
of GtmA.  
(ix) Predict the structure of GtmA using the latest computational methods and 
carry out any subsequent database predictions on this enzyme. 
(x) Prepare sufficient quantities of this enzyme for crystallography studies, carry 
out crystallisation trials on this enzyme and determine the structure of GtmA. 
(xi) Use the GtmA structural and computational data to carry out targeted site 
directed mutagenesis on this enzyme. 
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 5.2 Results 
5.2.1 Recombinant expression of GtmA in E. coli 
Primers GtmA_F and GtmA_R (Table 2.4) were designed to amplify the gtmA coding 
sequence and, also, to incorporate two restriction sites, XhoI and HindIII, into the forward 
and reverse primers in order to allow for directional cloning into the pEX_N_GST vector. 
GT treated A. fumigatus ATCC26933 cDNA (Section 2.2.5) was used as a template for 
the PCR amplification of the gtmA gene.  
The gtmA gene was predicted to have three introns (186 bp). The difference in the 
gtmA cDNA and gDNA was discernible by gel electrophoresis (Figure 5.1). The 
amplified gtmA cDNA (880 bp) was visible as a slightly lower band than the gtmA gDNA 
1066 bp. The gtmA cDNA product was digested with XhoI and HindIII  and then gel 
extracted.  
 
 
 
Figure 5.1. Amplification of gtmA coding sequence from A. fumigatus GT induced 
cDNA. Lane 1: cDNA, Lane 2: gDNA positive control, Lane 3: Negative control.  
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 The gtmA product was cloned into the pEX_N_GST vector and transformed into 
E. coli BL21 (DE3) competent cells for expression. The resulting colonies were tested for 
integration of the DNA by restriction digest using XhoI and HindIII. The resulting 
colonies were first screened by PCR (Figure 5.2) for successful integration of the gtmA 
gene (Figure 5.3). A positive colony with the expected 880 bp amplification product was 
then screened by restriction digestion using XhoI and HindIII. The correct digestion 
pattern for the insertion of gtmA cDNA into the pEX_N_GST vector was observed (5159 
bp, 870 bp).  
 
 
 
Figure 5.2. Colony PCR on gtmA-pEX_N_GST transformants. Colonies 4 and 5 contain 
the predicted 880 bp band indicating successful gtmA integration. Lane 8: gDNA positive 
control. Lane 9: negative control.  
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Figure 5.3. gtmA-pEX_N_GST digestion to confirm gtmA integration. Lane 1: Single 
digestion with XhoI, Lane 2: Double digestion using XhoI and HindIII.  
 
The plasmid was sequenced to confirm that gtmA remained in frame in order to 
enable protein expression.  Sequence analysis was performed on a commercial basis 
(Source Bioscience) and was compared to the predicted sequence according to CADRE 
(http://www.cadre-genomes.org.uk) with ID AFUA_2G11120. The sequencing of the 
gtmA cDNA confirmed the correct sequence of gtmA. Interestingly, the three CADRE 
predicted introns were incorrectly annotated - the actual gtmA sequence encodes 287 
amino acids rather than the 266 predicted by the CADRE annotation. The correct GtmA 
amino acid sequence is shown in Figure 5.4.  
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 Identities Positives Gaps 
256/287(89%) 259/287(90%) 21/287(7%) 
Query  1    MSKSDYIQNMFQTKSFVDRYKYTEKLTGLYAQTLVDYSGVANTSQKPLVVLDNACGIGAV  60 
            MSKSDYIQNMFQTKSFVDRYKYTEKLTGLYAQTLVDYSGVANTSQKPLVVLDNACGIGAV 
Sbjct  1    MSKSDYIQNMFQTKSFVDRYKYTEKLTGLYAQTLVDYSGVANTSQKPLVVLDNACGIGAV  60 
 
Query  61   SSVLNHTLQDEAKKTWKLTCGDLSEGMLETTKRRLQDEGWVNAETKIVNALDTGLPDGHY  120 
            SSVLNHTLQDEAKKTWKLTCGDLSEGMLETTKRRLQDEGWVNAETKIVNAL          
Sbjct  61   SSVLNHTLQDEAKKTWKLTCGDLSEGMLETTKRRLQDEGWVNAETKIVNAL---------  111 
 
Query  121  THVFVAFGFQSFPDANAALKECFRILASGGILASSTWQNFNWIPIMKAAIETIPGNLPFP  180 
                           RILASGGILASSTWQNFNWIPIMKAAIETIPGNLPFP 
Sbjct  112  ------------PELSRRQRRLERILASGGILASSTWQNFNWIPIMKAAIETIPGNLPFP  159 
 
Query  181  TQKEFIALHNAGWDSESYIQSELEKLGFRDVKVIPVPKETSIPIDEFFEVCMMIIPYLLP  240 
            TQKEFIALHNAGWDSESYIQSELEKLGFRDVKVIPVPKETSIPIDEFFEVCMMIIPYLLP 
Sbjct  160  TQKEFIALHNAGWDSESYIQSELEKLGFRDVKVIPVPKETSIPIDEFFEVCMMIIPYLLP  219 
 
Query  241  KFWTEEQRESHEKDVPMVLRQYLQDTYGANGQVPLEAVALITTGLKP  287 
            KFWTEEQRESHEKDVPMVLRQYLQDTYGANGQVPLEAVALITTGLKP 
Sbjct  220  KFWTEEQRESHEKDVPMVLRQYLQDTYGANGQVPLEAVALITTGLKP  266 
Figure 5.4. Alignment of the confirmed GtmA amino acid sequence (Query) against the 
CADRE annotated amino acid sequence (Sbjct). Incorrect annotation of the three intron 
regions resulted in a predicted sequence of 266 amino acids whilst the confirmed 
sequence contains 287 amino acids. 
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 5.2.2 SDS-PAGE, Western Blot and Mass Spectrometry Analysis of GST-GtmA 
Detection of GST-GtmA protein expression was carried out by induction using IPTG 
followed by SDS-PAGE and Western Blot analysis. Small scale cultures were induced 
and grown for 3 h – samples were taken pre-induction and also at hourly time points. As 
shown in Figure 5.5, both the SDS-PAGE and Western Blot analysis resulted in a band 
with an approximate molecular mass of 58 kDa, agreeing with the prediction for the 
recombinant GST-GtmA fusion protein. The pellet and supernatant extracts from the E. 
coli cell lysate were separated. This confirmed that the GST-GtmA protein was present 
in both the soluble and insoluble fractions. The SDS-PAGE band corresponding to the 
GST-GtmA protein was excised, digested and analysed by LC-MS as described in 
Section 2.2.16.1. This analysis confirmed the identity of the band as GtmA (15% protein 
sequence coverage) (Figure 5.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
216 
 
  
 
 
Figure 5.5. Time course small scale induction of GST-GtmA expression over 3 h in LB 
broth using 1 mM IPTG. Lane 1: 0 h IPTG soluble fraction. Lane 2: 0 h IPTG insoluble 
fraction. 1 h IPTG soluble fraction. 1 h IPTG insoluble fraction. 2 h IPTG soluble fraction. 
2 h IPTG insoluble fraction. 3 h IPTG soluble fraction. 3 h IPTG insoluble fraction. B: 
Below: Western Blot of cell lysates displaying band with an approximate molecular mass 
of 58 kDa in the IPTG induced samples, agreeing with the predicted mass for the 
recombinant GST-GtmA fusion protein. 
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Figure 5.6. LC-MS confirmation of GtmA expression by LC-MS. 15% sequence 
coverage of GtmA was detected.  
 
5.2.3 Large Scale Expression and Purification of GST-GtmA from E. coli 
As outlined in Section 2.2.7.1, 10 L of GST-GtmA was induced overnight at 30 °C. The 
resulting cells were pelleted and lysed as described in Section 2.2.7.3. Glutathione-
Sepharose affinity chromatography was first carried out to purify the GST-GtmA from 
the cell lysate (Figure 5.7). This was carried out as highlighted in Section 2.2.11.1. 10 L 
of E. coli lysate yielded 140 mg of GST-GtmA. The GST tag was then removed from 
GST-GtmA using TEV protease. The cleavage of GST-GtmA was monitored by SDS-
PAGE (Figure 5.8). Following dialysis against 20 mM Tris HCL, 20 mM NaCl, pH 8.0, 
the cleaved sample was subjected to Q-Sepharose anion exchange chromatography to 
remove the free GST tag from the sample. As shown in Figure 5.9, the anion exchange 1 
ml fractions containing GST (as indicated by anti-GST signal by immunoblot) were 
excluded from the final pooled sample. The final pooled fraction containing cleaved 
GtmA was concentrated to 2 mg/ml and simultaneously buffer exchanged into 50 mM 
Tris HCl, 50 mM NaCl, pH 7.4. The final sample was subjected to SDS-PAGE. This 
indicated a single band at approximately 32 kDa which corresponded to the molecular 
mass of GtmA (Figure 5.10). 
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Figure 5.7. Large scale purification of GST-GtmA from E. coli lysates using GSH-
Sepharose affinity chromatography. The red lines indicate the eluted GST-GtmA from 
the crude E. coli cell lysate.  
 
Figure 5.8. Large scale expression, purification and TEV cleavage of GST-GtmA. Lane 
1: GST-GtmA lysate, Lane 2: GST-GtmA flow through, Lane 3: GST-GtmA affinity 
purified using GSH agarose, Lane 4: GST-GtmA cleavage 1 h (37 °C), Lane 5: GST-
GtmA cleavage 2 h (37 °C). Lane 6: GST-GtmA cleavage overnight at 4°C.  
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Figure 5.9. Large scale purification of GtmA from free GST using Q-Sepharose anion 
exchange chromatography. Blue line: Anti-GST immunoblot illustrating the absence of 
GST signal in the first peak of the chromatogram. 
 
Figure 5.10. SDS-PAGE analysis of large scale anion exchange purification of GtmA 
from free GST. Lane 1: GST-GtmA. Lane 2: GtmA purified by anion exchange 
chromatography 
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 5.2.4 Size Exclusion Chromatography Analysis of recombinant GtmA 
As illustrated in Figure 5.10, purified and concentrated GtmA (1 mg) was loaded onto a 
Superdex 200 10/300 GL column (GE Healthcare, Germany). Figure 5.10 shows GtmA 
analysed by size exclusion chromatography (SEC) as a single, monodisperse peak. This 
indicated that, following GSH-Sepharose affinity chromatography and anion exchange 
chromatography, the resulting protein was at high purity. A selection of molecular mass 
calibrants (BSA, Ovalbumin and Lysozyme) were applied to the column in order to 
uncover the oligomeric state of the methyltransferase. The GtmA peak eluted after the 
BSA (66.5 kDa) and Ovalbumin (42.7 kDa) proteins, indicating that GtmA is present as 
the monomeric form in solution (Figure 5.11).  
 
 
Figure 5.10. GtmA analysis by size exclusion chromatography showing a single peak at 
15.2 min.  
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Figure 5.11. Size exclusion of GtmA alongside commercial protein standards (GE 
Healthcare Life Sciences). This indicated that the GtmA protein is present as a monomer.  
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 5.2.5 Activity analysis of GtmA 
Purified GtmA was tested for bisthiomethyltransferase activity. The reaction consisted of 
60 µl PBS, 6 µl SAM (25 mg/ml in PBS) and 10 µl TCEP reduced GT (1 mg/ml). 5 µl 
GtmA (2 mg/ml) was added to the reaction. For the control sample, the 6 µl SAM was 
substituted with 6 µl PBS. The samples were incubated at 37 °C for 1 h and processed for 
LC-MS analysis as described in Section 2.2.16.4. As shown in Figure 5.12, the addition 
of recombinant GtmA and SAM to the reaction resulted in the conversion of dithiol 
gliotoxin (m/z 329) to bis(methyl)gliotoxin (m/z 357). This conversion did not occur when 
SAM was excluded from the reaction.  
 
Figure 5.12. Recombinant GtmA converts dithiol gliotoxin to bis(methyl)gliotoxin in a 
SAM dependent manner. Dithiol gliotoxin (rGT) (m/z 329) is present in the control 
sample which does not contain SAM. The addition of SAM and GtmA to the reaction 
results in the formation of bis(methyl)gliotoxin (m/z 357). 
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 5.2.6 GtmA bisthiomethyltransferase activity occurs sequentially 
GtmA methyltransferase activity was monitored by RP-HPLC in 50 mM Tris HCl, 50 
mM NaCl, pH 7.4 using a range of SAM concentrations (100 µM to 400 µM) and 500 
µM dithiol GT. The samples were incubated at 37 °C for 1 h. As shown in Figure 5.13, 
increasing the SAM concentration results in the conversion of dithiol gliotoxin (green 
peak) to monomethylgliotoxin (orange peak) followed by the generation of 
bis(methyl)gliotoxin (red peak). This indicated that MmGT generation occurs first and is 
followed by bis(methyl)gliotoxin generation. This was also confirmed by LC-MS (Figure 
5.14). The putative MmGT peak was fraction-collected and analysed by LC-MS to 
confirm the identity of this compound (Figure 5.15).  
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Figure 5.13. GtmA mediated bisthiomethylation occurs sequentially. The addition of 
increasing amounts of SAM (100 µM to 400 µM) results in the increased formation of 
bis(methyl)gliotoxin (red) compared to monomethylgliotoxin (orange). Dithiol gliotoxin 
is shown in green. 
225 
 
  
Figure 5.14. Activity analysis in the presence of limiting amounts of SAM, whereby a 
putative monodethiomono(methylthio)gliotoxin (MmGT) form is detectable, reveals that 
this reaction may proceed in a sequential manner with MmGT formation preceding that 
of bis(methyl)gliotoxin. 
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Figure 5.15. Potential LC-MS fragmentation pattern of MmGT. m/z 295 and m/z 309 
fragments. The existence of m/z 295 fragment confirms that the CH3 is located on the 
sulfhydral of MmGT.  
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 5.2.7 Sporidesmin A is not converted to the bis-thiomethyl form by GtmA 
Sporidesmin A is an ETP produced by Pithomyces chartarum. Sporidesmin D, a 
bisthiomethyl form of this metabolite, is also produced by this ascomycete. To test the 
specificity of GtmA for dithiol GT, A. fumigatus was exposed to sporidesmin A under 
conditions which promote bis(methyl)gliotoxin formation. As shown in Figure 5.16, after 
3 h sporidesmin exposure, no sporidesmin D is detectable in the A. fumigatus culture 
supernatant. This indicated that GtmA shows specificity towards dithiol GT and not all 
thiol containing ETPs. This experiment was also carried out with purified GtmA and 
TCEP reduced sporidesmin A. No sporidesmin D was detected in the samples.  
 
Figure 5.16. Sporidesmin (m/z 474) is not converted to bis-thiomethylsporidesmin by A. 
fumigatus wild-type under conditions (3 h exposure) which promote bis(methyl)gliotoxin 
formation. 
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 5.2.8 SAH does not act as a GtmA inhibitor 
The majority of SAM-dependent methyltransferases are known to be inhibited by SAH, 
the methyl-depleted version of SAM (Hendricks et al., 2004). GtmA was pre-incubated 
with SAH for 30 min (400 µM) to determine if this metabolite had an inhibitory effect on 
the dithiol gliotoxin bisthiomethylation activity. Dithiol gliotoxin was added and the 
reactions were incubated at 37 °C for 1 h. No significant difference was noted for the 
bis(methyl)gliotoxin peak area in the assay samples containing SAH or control samples 
as detected by RP-HPLC (Figure 5.17). This result suggested that GtmA was resistant to 
SAH mediated feedback inhibition. 
 
Figure 5.17. SAH does not significantly inhibit the activity of GtmA. A: RP-HPLC 
standards of dithiol gliotoxin and bis(methyl)gliotoxin showing the respective retention 
times. B: GtmA without added SAH. C: GtmA with SAH (400 µM) added to the reaction.  
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 5.2.9 GtmA 3D Structure Prediction using I-TASSER 
I-TASSER (Iterative Threading ASSEmbly Refinement) is a hierarchical method for 
protein structure and function prediction. The confidence of each model is quantitatively 
measured using a ‘C-score’ that is calculated based on the significance of threading 
template alignments and the convergence parameters of the structure assembly 
simulations (Roy et al., 2010) 
The GtmA amino acid sequence (Section 5.2.2) was sent to the I-TASSER server. 
This program uses the templates of the highest significance in the threading alignments, 
the significance of which are measured by the Z-score (the difference between the raw 
and average scores in the unit of standard deviation). The top matching PDB structures 
used for comparison were 4OBW (yeast Coq5 in the SAM bound form), 1VL5 (A putative 
methyltransferase, BH2331, from Bacillus halodurans C-125), 4OBX (yeast Coq5 in the 
apo form), 2YQZ (Hypothetical methyltransferase TTHA0223 from Thermus 
thermophilus HB8 complexed with SAM) and 3CCF (putative methyltransferase 
(YP_321342.1) from Anabaena variabilis ATCC 29413). The structure shown in Figure 
5.18 was the best predicted GtmA structural model with a C-score of -0.89; C-score is 
typically in the range of [-5, 2], where a C-score of a higher value signifies a model with 
a higher confidence and vice-versa. The structure had an estimated root-mean-square 
deviation (RMSD) of 8.1 ± 4.4 Å. 
Figure 5.19 details the local accuracy and predicted normalized B-factor of the 
GtmA model. The local accuracy is defined as the distance deviation (in Angstroms) 
between residue positions in the model and the native structure. Since the native structure 
is unknown, the distance errors in the plot are estimated by ResQ using support vector 
regression which makes use of the coverage of threading alignment, divergence of I-
TASSER simulation decoys and sequence-based secondary structure and solvent 
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 accessibility predictions. Large-scale benchmark tests show that the estimated local 
quality has an average error of 1.4 Angstrom units and AUC score of 0.89 for well-
predicted I-TASSER models (Roy et al., 2010). 
B-factor is a value to indicate the extent of the inherent thermal mobility of 
residues/atoms in proteins. The normalized B-factor for a target protein is defined as z-
score-based normalization of the raw B-factor values. The normalized B-factor (called B-
factor profile, BFP) is predicted using a combination of both template-based assignment 
and profile-based prediction. Based on the distributions and predictions of the BFP, 
residues with BFP values higher than 0 are less stable in experimental structures (Zhang, 
2008; Roy et al., 2010). 
TM-align was used to identify proteins which were structurally close to the GtmA 
model. This program uses TM-score as a metric for measuring the structural similarity of 
two protein models. This analysis is favoured over traditional metrics such as RMSD. 
This is due to the fact that TM-score measures the global fold similarity and is less 
sensitive to the local structural variations. Also, the magnitude of TM-score for random 
structure pairs is length-independent. TM-score has the value in [0, 1], where 1 indicates 
a perfect match between two structures. Following strict statistics of structures in the 
PDB, scores below 0.17 correspond to randomly chosen unrelated proteins whereas a 
score higher than 0.5 generally assumes the same fold in SCOP/CATH (Zhang, 2008).  
Figure 5.20 shows this GtmA model overlaid with the salicylic acid carboxyl 
methyltransferase (SAMT) from Clarkia breweri. This protein had the highest TM-score 
of 0.741. In addition, the GtmA model was overlaid with the yeast C-methyltransferase 
Coq5, which had a TM-score of 0.723.  
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Figure 5.20. GtmA overlaid with A: the salicylic acid carboxyl methyltransferase 
(SAMT) from Clarkia breweri (TM-score 0.741) and B: the yeast C-methyltransferase 
Coq5 (TM-score 0.723). These proteins were calculated to be structurally close to GtmA.  
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 The GtmA SAH binding site was predicted using COACH, a meta-server 
approach that combines multiple function annotation results from the COFACTOR, TM-
SITE and S-SITE programs. Beginning with the given structure of target proteins, 
COACH generated complementary ligand binding site predictions using the comparative 
methods -  TM-SITE and S-SITE - which recognize ligand-binding templates from the 
BioLiP protein function database by binding-specific substructure and sequence profile 
comparisons. These predictions were combined with results from other methods 
(including COFACTOR, FINDSITE and ConCavity) to generate final ligand binding site 
predictions. The I-TASSER generated 3D model of GtmA was fed into the COACH 
pipeline for ligand-binding site prediction. The PDB structure 4NEC (Echinomycin 
methyltransferase Ecm18) was selected as a model for the GtmA structure (Hotta et al., 
2014).  Based on this analysis, the GtmA residues which may interact with SAH were 
shown to be 7,11,24,54,55,56,82,83,84,108,109,110,126,127,128 and 132. These SAH 
interacting residues were illustrated using LIGPLOT+ as shown in Figure 5.21. The 
dithiol gliotoxin binding residues could not be predicted using this method (Roy et al., 
2010; Zhang, 2008; Laskowski and Swindells, 2011).
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 5.2.10 Crystallisation of GtmA 
Purified GtmA was concentrated to 15 mg/ml in 50 mM Tris HCl, 50 mM NaCl, pH 7.4. 
The protein (40 mg total) was snap frozen in liquid nitrogen and was then sent to the 
Helmholtz Centre for Infection Research for crystallisation trials. The initial 
crystallization conditions of GtmA were determined with the vapor diffusion method in 
a sitting drop 96-well format with the JCSG Core Suites I–IV. Drops were set up using a 
dispensing robot (Honeybee, Zinsser Analytic) mixing 0.1 µL of GtmA solution (15 mg 
mL-1) with 0.1 µL of reservoir solution equilibrated against 70 µL reservoir solution. The 
screens were stored at 20 °C in an automated imaging system (Formulatrix). Crystals of 
different morphology appeared with various precipitants which were optimized with 
respect to pH and component concentrations. The final condition of GtmA crystals 
contained 0.2 M Ammonium acetate, 0.1 M tri-Sodium Citrate pH 5.84, 26% (w/v) PEG 
4000. Apo crystals of GtmA were cryoprotected in reservoir solution supplemented with 
20 %(v/v) glycerol, flash cooled in liquid nitrogen and tested on an X-ray home source 
including a Saturn 944+ CCD detector (Rigaku). Well-diffracting crystals of GtmA were 
sent to a synchrotron (Bessy II, HZB, Berlin, Germany) for data collection. Crystals of 
the seleno-L-methionine-labelled protein were obtained by keeping the composition of 
the crystallization solution the same as for native protein. High-quality crystals appeared 
after 7 days (Figure 5.22).  
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Figure 5.22. A: GtmA apo crystals imaged after 7 days by the automatic imaging system. 
B: Magnified image of a single GtmA crystal with dimensions.  
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 5.2.11 Preparation of seleno-L-methionine-labeled GtmA 
SeMet incorporation and multiwavelength anomalous diffraction (MAD) phasing are 
routinely used and have become the norm in protein crystallography. Production of 
seleno-L-methionine-labelled GtmA was achieved by cultivation of E. coli BL21 (DE3) 
cells in artificial medium suppressing L-methionine biosynthesis as described in Section 
2.1.2.4. Purification steps were performed as for the native protein (Section 5.2.3). Figure 
5.23 shows the SDS-PAGE analysis of the purification steps. The identity of the proteins 
and the incorporation of seleno- L -methionine were confirmed by ESI mass-
spectrometric analysis. 5 mg of SeMet GtmA was concentrated to 15 mg/ml for 
crystallisation trials.  
 
Figure 5.23. Expression and purification of SeMet-GtmA. GST-SeMet-GtmA was first 
purified by GSH-Sepharose affinity chromatography. The protein was then cleaved using 
TEV protease and purified by size exclusion chromatography. Fractions containing Se-
Met-GtmA (5 mg) were pooled and concentrated. Lane 1: Uninduced sample, Lane 2: 
Induced sample, Lane 3-7: fractions eluted from GSH affinity chromatography. Lane 8: 
TEV cleaved GtmA and GST. The double bands indicate the Se-Met-GST cleaved from 
GtmA and endogenous GST.  
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 5.2.12 Data collection, data processing, structure solution and refinement 
Diffraction data for seleno-L-methionine-labeled and native GtmA apo form crystals were 
collected at the BESSY II Synchrotron (HZB, Berlin, Germany) using a Pilatus 2M 
detector (Dectris). A native dataset was collected from a different GtmA apo-crystal at a 
wavelength of 2.1 Å. All data were indexed and integrated with XDS (Kabsch, 2010) and 
scaled with AIMLESS (Evans, 2011) from the CCP4 program suite (Winn et al., 2011). 
For the MAD data, hkl2map (Pape and Schneider, 2004) was used to employ SHELXC 
(Sheldrick, 2010) in extraction of the anomalous signal and SHELXD (Schneider and 
Sheldrick, 2002) in locating the anomalous scatterers, before SHELXE was used for 
density modification and automated model building. Since native data extended to a 
resolution of 2.05 Å, MAD data and native data were combined. An initial model was 
generated using arp/Warp 7.0 (Langer et al., 2008). Data were processed with XDS and 
Aimless. Manual adjustment of all models was done in COOT (Emsley and Cowtan, 
2004) which included the placement of ions. Figures were prepared with PyMOL. Data 
collection and refinement statistics are presented in Table 5.1. Indexing and integration 
with XDS (Kabsch, 2010) revealed that the investigated GtmA crystals belonged to space 
group P62.  
Table 5.1. GtmA Crystallography Model Statistics and General Data 
R Values Rwork 23.37 Rfree 26.27 
Space Group P62 
Cell 94.74   94.74   53.76        90      90     120 
Resolution Low 82.06 
Resolution High 2.05 
Number of Reflections  17398 
Number of Datasets 4 
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 5.2.13 GtmA Structure as determined by X-Ray Crystallography 
Based on the X-ray crystallography data gathered in Section 5.2.12, a structural model of 
GtmA was constructed. This structure is shown in Figure 5.24. The overall apo structure 
of the GtmA monomer consists of a globular domain which contains the extended sheet 
characteristic of all other SAM-dependent methyltransferases (Cheng and Blumenthal, 
1999) and a unique -helical cap that forms the top one-third of the active site cavity. These 
structures confirmed that GtmA possesses the expected class I AdoMet-dependent MTase 
core fold which consists of a seven-stranded β sheet flanked on each side by three α 
helices. Class I MTases bind AdoMet (or the demethylated product AdoHcy) at the same 
methyl donor site in their structures reflecting their shared AdoMet dependence. 
However, they must have diverse active sites to accommodate their wide variety of 
acceptor substrates (Schubert et al., 2003). 
 Several loops and the N-terminus (residues 0-24) of GtmA are absent from the 
structure. This happens when regions of protein molecules in the protein crystal are 
disordered, mobile or "floppy" and, as such, do not generate an interpretable X-ray 
diffraction pattern. The N-terminal part of methyltransferases are generally flexible, 
facilitating the entry of the substrates and cofactor into the active site and the exit of the 
reaction products. As shown in Figure 5.25, the I-TASSER generate GtmA model was 
overlaid with the crystallographic model.  This allowed for a comparison of the 
effectiveness of the computer generated models. Also, the loops which are absent from 
the crystal structure can be modelled in based on the I-TASSER model (Figure 5.26). 
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Figure 5.25. Overlay of GtmA model based on the crystallographic structural data (blue) 
with the I-TASSER generated GtmA model (green). Flexible regions of the GtmA 
structure which were not resolved by X-ray crystallography are shown in red within the 
I-TASSER model.   
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Figure 5.26. Detailed overlay of the GtmA model based on the crystallographic structural 
data (blue) with the I-TASSER generated GtmA model (green). Flexible regions of the 
GtmA structure which were not resolved by X-ray crystallography are shown in red 
within the I-TASSER model.  Several conserved regions of the methyltransferase 
structure were predicted accurately by I-TASSER.  
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 5.2.14 PDBeFold pairwise comparison and 3D alignment of GtmA against similar 
protein structures 
PDBeFold structure alignment is based on identification of residues occupying 
“equivalent” geometrical positions (Mcwilliam et al., 2009). The PDBefold service is a 
very powerful structure alignment tool which can perform both pairwise and multiple 
three dimensional alignment. The results of the Secondary Structure Matching are sorted 
based on the Q Score (Cα-alignment), P score (taking into account RMSD, number of 
aligned residues, number of gaps, number of matched Secondary Structure Elements and 
the SSE match score), Z score (based on Gaussian Statistics), RMSD and % Sequence 
Identity. The structural relatedness of the proteins involves consideration of average root-
mean-square deviation (RMSD) of Cα atoms and Z-score between structures. The GtmA 
coordinates from the structure shown in Section 5.2.10 were uploaded to the server. 
PDBeFold structural similarity searches were conducted using WWW interface at 
http://www.ebi.ac.uk/msd-srv/ssm/. 
 The structural alignment results indicated that the best structural matches to GtmA 
were an N-methyltransferase NodS from Bradyrhizobium japonicum (PDB: 3OFK) [Q-
Score 0.27] and, also, the N-terminal methyltransferase-like domain of anamorsin from 
Homo sapiens (PDB: 4M7R) [Q-Score 0.18]. GtmA overlaid with these other structures 
is illustrated in Figure 5.27.  
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Figure 5.27. Overlay of GtmA model based on the structural data (blue) with A: N- 
methyltransferase NodS from Bradyrhizobium japonicum (PDB: 3OFK) and B: the N-
terminal methyltransferase-like domain of anamorsin from Homo sapiens (PDB: 4M7R).  
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 5.2.15 Alignment of GtmA with other methyltransferases 
Multiple sequence alignment of GtmA with other methyltransferases was carried out 
using Jalview. A ClustalWS alignment was selected in the parameters and the resulting 
illustrations were exported. Figure 5.28 shows the alignment of GtmA with an A. niger 
GtmA homolog (MT) which has been shown to also bisthiomethylate dithiol gliotoxin, a 
methyltransferase from Methanosarcina mazei (3MGG), a C-methyltransferase from 
Saccharomyces cerevisiae (Coq5) and the rebeccamycin 4′-O-methyltransferase (RebM) 
from Lechevalieria aerocolonigenes. This alignment was used to identify conserved 
motifs which are found across the entire family of methyltransferases. GtmA was also 
aligned solely with A. niger MTII (MacKenzie et al., 2005, Manzanares et al., 2015) in 
order to highlight the similarity between these two methyltransferases (Figure 5.29). In 
addition to the high sequence similarity (51%), 71% of GtmA residues have substitutions 
with amino acids with similar characteristics. Zappo colours were used in the alignment 
illustrations as described in Table 5.3.  
 
 
Table 5.3. Legend for the Zappo colour scheme. Residues are coloured according to 
their physico-chemical properties as follows: 
Residues Description Colour 
ILVAM Aliphatic/hydrophobic residues Pink 
FWY Aromatic Orange 
KRH Positive Red 
DE Negative Green 
STNQ Hydrophilic Blue 
PG Proline/Glycine (conformationally special) Magenta 
C Cysteine Yellow 
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5.2.16 Cloning of gtmA into Pet19m 
In order to express GtmA as a His-tagged protein the gtmA gene was cloned into Pet19m 
from pEX-N-GST using the primers stated in Table 2.4. Pet19m contained a His6 affinity 
tag which facilitated rapid purification of GtmA from cell lysates. Amplified gtmA and 
Pet19m were digested using the restriction enzymes NdeI and XhoI and ligated using 
Promega rapid DNA ligase. Colonies were screened by PCR as described in Section 
2.2.2.2. Correct cloning was verified by sequencing. GtmA was expressed and purified 
as described in Section 5.2.3, however, NiNTA affinity resin was used instead of GSH-
Sepharose. The samples containing protein were tested by SDS-PAGE (Figure 5.30). The 
fractions containing His-GtmA were pooled and this His-tag was cleaved using TEV 
protease while simultaneously carrying out dialysis of the sample into 50 mM Tris-HCl, 
50 mM NaCl, pH 7.4. 110 mg of purified, cleaved GtmA was prepared for further 
crystallisation trials. This was snap frozen in liquid nitrogen and sent to the Helmholtz 
Infection Centre.  
 
Figure 5.30. SDS-PAGE analysis of fractions containing His-GtmA. 5 µl was loaded per 
well.  M; protein molecular mass marker, Lane 1: Induced His6-GtmA lysate, Lane 2: 
NiNTA column flow through, Lane 3-9: His6-GtmA fractions eluted from NiNTA resin 
(approximately 32 kDa) 
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5.2.17 Site Directed Mutagenesis of Selected GtmA Residues 
Single GtmA residues which may be important for the activity of this enzyme were 
selected by using a combination of the structural data and modelling from Section 5.2.13 
and also by analysing the alignment of A. fumigatus GtmA and A. niger MT-II (Section 
5.2.15). Conserved residues within the putative SAM binding domain and putative SAH 
interacting residues identified by the COACH analysis (Figure 5.21) were avoided as they 
have been extensively characterised previously in other methyltransferases. The 
following residues were selected for mutagenesis using a QuickChange XL Site-Directed 
Mutagenesis Kit (Section 2.2.7.2): Trp157 to Val, Trp162 to Val, Asp159 to Val, and 
Phe185 to Gly and Phe127 to Val. Successful single amino acid mutagenesis was 
confirmed by sequencing the mutated plasmids. The recombinant GtmA mutants were 
then expressed and purified as shown in Figure 5.31. The locations of these selected 
residues within the GtmA structure are shown in Figure 5.32.  
 
Figure 5.31. Recombinant expression and purification of GtmA with single amino acid 
mutations (1 µg loaded per well). 1: GtmA wild-type, 2: GtmA W157V, 3: GtmA 
W162V, 4: GtmA N159V, 5: GtmA F185G, 6: GtmA F127V. 
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Figure 5.32. The location of G
tm
A
 residues selected for site directed m
utagenesis highlighted in red. Trp157 to V
al, Trp162 to V
al, A
sp159 to V
al, 
and Phe185 to G
ly and Phe127 to V
al. These residues w
ere selected for m
utagenesis as they are conserved betw
een G
tm
A
 and M
TII (Figure 5.29) and 
contain prom
inent side chains w
hich m
ay form
 part of the G
tm
A
 ligand binding site. 
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5.2.18 RP-HPLC Analysis of GtmA Mutants 
GtmA methyltransferase activity of the GtmA mutants was monitored by RP-HPLC in 
50 mM Tris HCl, 50 mM NaCl, pH 7.4 using 750 µM SAM and 300 µM dithiol GT. 1 
µM of purified enzyme was added to each reaction. The samples were incubated at 37 °C 
for 1 h prior to RP-HPLC analysis. The resulting chromatograms are shown in Figure 
5.33. Wild-type GtmA converted all of the dithiol gliotoxin in the reaction (green) to 
bis(methyl)gliotoxin (red). The F185G GtmA mutation had no apparent effect on the 
activity of the enzyme.  W157V had a significant effect on the activity of the enzyme. As 
shown in Figure 5.33, the conversion of dithiol gliotoxin to bis(methyl)gliotoxin is 
significantly diminished when this enzyme is used to effect catalysis. Almost no 
bis(methyl)gliotoxin (red) is generated by this enzyme and, also, low quantities of 
mono(methylthio)gliotoxin (orange). W162V and F127V also resulted in a significant 
decrease in GtmA activity. Notably, an extra peak (pink) was apparent in the GtmA 
F127V supernatants which eluted just after the mono(methylthio)gliotoxin peak. This 
peak may represent mono(methylthio)gliotoxin which has been methylated on the 
opposite sulfhydral. GtmA N159V had an unusual effect on enzyme activity. Although 
activity was diminished in this mutant when compared to the wild-type, almost no 
mono(methylthio)gliotoxin was detected in the supernatants whereas significant amounts 
of bis(methyl)gliotoxin were present. 
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Figure 5.33. RP-HPLC chromatograms of GtmA wild-type, GtmA W157V, GtmA 
W162V, GtmA N159V, GtmA F185G, GtmA F127V and a No GtmA control incubated 
with dithiol gliotoxin and SAM. Dithiol gliotoxin (green), mono(methylthio)gliotoxin 
(orange), mono(methylthio)gliotoxin * (pink), bis(methyl)gliotoxin (red).  
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5.3 Discussion 
In this chapter the first identified ETP bisthiomethyltransferase, GtmA, was 
recombinantly expressed in E. coli, purified and characterised. The structure was also 
solved using X-ray crystallography and residues which are important for the catalytic 
activity of this enzyme were identified. 
As described in Section 5.2.1, GtmA was expressed as a fusion protein with a 
glutathione S-transferase (GST) moiety located at the N-terminus. The GST fusion 
protein was affinity purified by immobilised glutathione and impurities were removed. 
The fusion protein was then eluted using reduced glutathione. The GST affinity tag was 
then removed by using the site-specific TEV protease which recognised the sequence 
located between the GST moiety and GtmA. Size exclusion chromatography of GtmA 
alongside a selection of molecular mass calibrants showed that this enzyme is present in 
solution as a monomer. This analysis also indicated that the enzyme was purified to 
homogeneity, which is essential for protein structural analysis. The majority of NPMTs 
characterised to date have been shown to be dimeric although several monomers have 
been identified also (Liscombe et al., 2012). The dimerization interface of 
methyltransferase homodimers can be quite extensive. For example, the dimerization 
interface of the methyltransferase RdmB involved in anthracycline biosynthesis in 
Streptomyces purpurascens comprises of 3600 Å2 or 23% of the total monomer surface 
while Catechol-O-methyltransferase  (COMT) buries about 30% of the total surface area 
of the dimer (Jansson et al., 2003; Zubieta, 2002). 
Activity analysis of GtmA showed that the cleaved protein was capable of rapidly 
S-methylating dithiol gliotoxin to bis(methyl)gliotoxin in the presence of the methyl 
donor SAM. It was also shown that, under SAM limiting conditions, a monomethyl 
version of gliotoxin (mono(methylthio)gliotoxin) is produced. This suggested that the 
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production of bis(methyl)gliotoxin is preceded by a singly methylated 
mono(methylthio)gliotoxin intermediate. Increasing the SAM concentration in the 
reaction resulted in the conversion of mono(methylthio)gliotoxin to bis(methyl)gliotoxin. 
Similarly, the plantazolicin N-methyltransferase BamL which dimethylates the N-
terminus of this antibiotic is also capable of producing a monoalkylated intermediate 
under limiting conditions of SAM (Hao et al., 2015). Following mutagenesis of 
Tyr182Phe in BamL the enzyme primarily yields a monomethylated product instead of 
the dimethylated product. Importantly, the authors also obtained co-crystal structures with 
the monomethylated product which showed that this substrate sits in the active site with 
a nearly identical conformation as the corresponding desmethyl substrate. The active site 
pocket is predominantly hydrophobic (formed by Phe20, Leu130, and Leu134) and 
accommodates both forms of the substrate for the two distinct methyl-transfer reactions 
(Hao et al., 2015). A similar structural arrangement may occur in GtmA to accommodate 
both the dithiol and monomethylated gliotoxin. 
In order to check the specificity of GtmA for other metabolites the ETP 
sporidesmin was reduced with TCEP to its dithiol form and incubated with GtmA in the 
presence of SAM. No sporidesmin D (a bisthiomethyl form of this metabolite) was 
detected in the reaction following LC-MS analysis. This modification was also carried 
attempted by exposing A. fumigatus sporidesmin A under conditions which promote 
bis(methyl)gliotoxin formation. Similarly, no sporidesmin D was detected. This indicated 
the specificity of GtmA for dithiol gliotoxin and suggests that GtmA is not a general 
defence against thiol-containing metabolites.  
SAH has been shown to be a potent feedback inhibitor of SAM-dependent 
methyltransferases (Lee et al., 2005). Interestingly, this inhibition does not occur for 
GtmA, which appears to be resistant to SAH-mediated inhibition. This may be due to the 
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fact that GtmA catalyses the transfer of two methyl groups, which means that if SAH was 
capable of inhibiting the enzyme, this would affect its ability to rapidly bind a second 
SAM molecule for the second methyl transfer. Similarly, the plantazolicin N-
methyltransferase BamL which dimethylates the N-terminus of this antibiotic is also 
resistant to SAH by-product inhibition (Lee et al., 2013b).  
 The structure of GtmA was predicted computationally using I-TASSER. Based 
on this analysis the overall structure of GtmA was predicted to consist of a globular 
domain containing the extended β-sheet characteristic of all other SAM-dependent 
methyltransferases (Cheng and Blumenthal, 1999) and a helical cap that forms the top 
one-third of the active site cavity. Based on the generated 3D model, GtmA was proposed 
be a structural analog of the salicylic acid carboxyl methyltransferase (SAMT) from C. 
breweri (Zubieta et al., 2001) and the yeast C-methyltransferase Coq5 (Dai et al., 2014). 
Interestingly, these proteins exist as homodimers in solution whereas the SEC data in 
Section 5.2.4 shows that GtmA likely functions as a monomer (Zubieta et al., 2003; Dai 
et al., 2014). 
GtmA (40 mg) was expressed, purified to high purity and concentrated to 15 
mg/ml for crystallisation trials which were carried out at the Helmholtz Centre for 
Infection Research. As the structure could not be solved by molecular replacement, a 
SeMet-substituted protein was produced by inhibiting methionine biosynthesis in amino 
acid supplemented minimal medium. Crystals of SeMet-substituted GtmA were obtained 
using the same conditions as for wildtype enzyme. The apo-GtmA structure was solved 
to 2.1 Å using multiwavelength anomalous dispersion (MAD) phasing.  
In order to test the conformity between the computationally derived I-TASSER 
GtmA model and the GtmA structure as determined by X-ray crystallography the two 
structures were overlaid as shown in Figures 5.25 and 5.26. This illustrated the accuracy 
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of computational methods in predicting conserved domains of structures as several folds 
within the GtmA crystallographic model were accurately depicted in the GtmA 
computational model.  Some folds were not accurately predicted in the I-TASSER model. 
These included the α-helices between residues 224-239 and 253-261 and the β sheets 
between residues 211-222 and 76-80.  
As shown in Figure 5.26, several loops (e.g. residues 83-115) and the N-terminus 
(residues 0-24) of GtmA are absent from the structure. Since X-ray crystallography relies 
on obtaining crystals with many proteins in exactly identical positions, flexible proteins 
can be problematic. Regions in a protein that move are generally not observed in X-ray 
structures, so coordinates for these regions are not included in the structural model.  
Figure 5.19 indicated that several regions of the GtmA structure are predicted to have 
high normalized B-factors. The B-factor can be thought of as a measure of how much an 
atom oscillates or vibrates around the position specified in the model which indicates 
flexibility in these regions. Consequently residues 69-75, 93-102, 239-251 and 265-271 
which are predicted to have high normalised B-factors by I-TASSER are regions of the 
GtmA crystallographic structure which have missing density. This suggests that these 
regions are missing from the GtmA model due to the flexibility of the structure. An 
advantage of the I-TASSER model is that regions which are missing in the GtmA 
crystallographic model can be overlaid with the I-TASSER model to show the putative 
folds in these regions. As shown in Figure 5.26, residues 83-115 are likely to form an α-
helix followed by an extended loop which possibly acts as a substrate “gatekeeping” loop 
which changes conformation and becomes ordered upon SAM or dithiol gliotoxin 
binding. This region may play a role in substrate access and recognition as shown 
previously for other methyltransferases (Lim et al., 2001). 
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The putative N-terminus (residues 0-24) of GtmA is also shown in the I-TASSER 
model as a loop which may partially shield the active site. Most NPMTs also have an 
active site ‘cover’ contributed by several inserts in the fold and many have insertions 
between β5 and α2- α3, and between β6 and β7 (Vidgren et al., 1994; Fu et al., 1996).  
The N-terminal part of methyltransferases are generally flexible, facilitating the entry of 
the substrates and cofactor into the active site and the exit of the reaction products. This 
region may also be stabilised in the substrate bound form, however, in the crystal structure 
of Hma, a methyltransferase involved in keto- and methoxymycolates in Mycobacterium 
tuberculosis, helical stabilisation of the flexible N-terminal extremities did not seem to 
depend on the presence of a cofactor (Boissier et al., 2006). 
NPMTs usually methylate their substrates through an SN2-like nucleophilic 
substitution reaction that is categorized by three distinct mechanisms: 1) proximity and 
desolvation (PD) effects, 2) general acid-base catalysis and 3) metal-dependent 
mechanism (Liscombe et al., 2012). To elucidate the catalytic mechanism, structural and 
biochemical approaches have a strong contribution to identify whether pivotal residues 
or metal ions exist or not. 
DnrK is considered to use a PD mechanism because the mutagenesis of Tyr142, 
a key residue nearby the catalytic centre, did not dramatically reduce the enzyme activity 
(Jansson et al., 2004). As for general acid-base catalysis, many methyltransferases have 
been structurally and biochemically characterized to use a general base in active site for 
catalysis (Liscombe et al., 2012). Several plant O-methyltransferases such as the caffeic 
acid/5-hydroxyferulic acid 3/5-O-methyltransferase (COMT) from alfalfa and PRMT3, a 
protein Arg N-methyltransferase from rat use a catalytic His as a general base (Zubieta, 
2002; Zhang et al., 2000). 
259 
 
  
NovP and MycE utilize a divalent ion to coordinate substrate and a nearby residue 
abstracts a proton from the methyl acceptor. Therefore, understanding the roles of crucial 
residues near the active centre from a structural perspective seems to be indispensable in 
NPMTs (Gómez García et al., 2010). For the echinomycin methyltransferase Ecm18, 
which converts a disulfide bond into a thioacetal group, the structure of this enzyme 
shows that the methionyl sulfur atom of SAH, the transferred methyl group, and the 
nucleophilic sulfur atom of the substrate are present in a linear arrangement. Unlike the 
situation in most other SAM-MTases, where the nucleophile is a carbon, nitrogen, or 
oxygen atom that may require activation through deprotonation, the nucleophile in the 
Ecm 18-catalyzed methyl transfer reaction is an electron-rich sulfur atom of a disulfide 
bond. Thus, activation of the sulfur atom as a nucleophile is perhaps not required for the 
methyl transfer reaction to proceed. Instead, the Ecm 18-catalyzed methyl transfer 
reaction is likely to be driven by the proximity effect (Hotta et al., 2014).  
The crystal structure of the methyltransferase YecO from Haemophilus influenzae 
(HI0319) is proposed to undergo a conformational transition following substrate binding 
as access to the active site cavity is blocked. The aromatic residues Phe17 and Phe19 after 
the disordered N-terminus region block access to the cavity. These residues may provide 
a flexible gate that enables a substrate molecule to enter the cavity. Closure of this gate 
may then desolvate the substrate and ensure catalysis. The exquisite arrangement of the 
residues that delineate the cavity supports the notion that it is designed to be small, so that 
only a highly specific, small substrate may be accommodated (Lim et al., 2001). GtmA 
methyl-transfer may proceed by either proximity and desolvation effects or general acid-
base catalysis. More detailed structural analysis with bound SAM/SAH or substrate will 
elucidate this catalytic mechanism.  
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As detailed in Section 5.2.14 the PDBefold structural alignments indicated that 
the best structural matches to GtmA were an N- methyltransferase NodS from 
Bradyrhizobium japonicum (PDB: 3OFK) [Q-Score 0.27] and also the N-terminal 
methyltransferase-like domain of anamorsin from Homo sapiens (PDB: 4M7R) [Q-Score 
0.18] (Cakici et al., 2010; Song et al., 2014). Despite the low sequence identity (10-15%) 
of these proteins several regions of these methyltransferases overlap as shown in Figure 
5.27. Indeed, this method of structure comparison highlights how the chemical properties 
of residues should be given preference over residue identity in structure and function 
analysis. Residue identity may play a much less significant role in protein structure than 
often believed and the role of residue identity in protein function may often be 
overestimated.  
 Multiple sequence alignment of GtmA with other SAM-dependent 
methyltransferases was carried out using Jalview. This was carried out to identify 
conserved residues which may be essential for the catalytic activity of SAM-dependent 
methyltransferases. Based on this analysis several highly conserved residues (G56, G58, 
L64, G99, L146, G149, G150) were identified. Glycine is a conformationally special 
residue, which explains the conservation of this residue across functionally diverse 
members of this family. The Zappo colour scheme used in the alignment also highlighted 
which residues have conserved physicochemical properties. For example, V17 is 
substituted by leucine in the methyltransferase from Methanosarcina mazei (3MGG) and 
by alanine in the C-methyltransferase from Saccharomyces cerevisiae (Coq5), however, 
these are all aliphatic/hydrophobic residues. This may suggest that a residue with such 
characteristics is crucial in this position. The universal glycine-rich motif (often referred 
to as motif I) E/DXGXGXG in SAM-MTases is found as DNAGGIG in GtmA, with a 
minor variation of Ala54 instead of a glycine (Kozbial and Mushegian, 2005).  
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 The sequence alignment of A. fumigatus GtmA with an A. niger GtmA homolog 
(MTII) indicated the residues within this sequence which have a high degree of 
conservation (Figure 5.29) (MacKenzie et al., 2005). Considering both of these 
methyltransferases catalyse the same reaction residues which are essential for controlling 
substrate specificity or catalysis are likely to be conserved. In combination with the 
crystallographic data shown in Figure 5.32 the five residues W157V, W162V, N159V, 
F185G, and F127V were selected for mutagenesis. These residues are conserved in A. 
fumigatus GtmA and A. niger MTII.  
 Attempts to cocrystallise GtmA in the presence of SAM, SAH, dithiol gliotoxin 
or bis(methyl)gliotoxin were unsuccessful. It was noted that following GST tag cleavage 
from GtmA using TEV protease, 11 residues (GAIAGAPDLKL) remain on the N-
terminus before methionine. This may impede cocrystal formation by limiting certain 
crystal packing arrangements. For this reason GtmA was expressed as a His-tagged 
protein the vector Pet19m. Following His6 affinity tag cleavage using TEV, only two 
residues (GH) remain before the N-terminal methionine. This vector was successfully 
used previously to express the ergothioneine-biosynthetic methyltransferase EgtD and 
crystallise it in the presence of its substrate and SAH (Vit et al., 2014, 2015). This, 110 
mg of purified, cleaved GtmA was prepared for further crystallisation trials. 
 Following the successful expression of the wild-type GtmA using the His vector, 
this sequence was used as a template for site-directed mutagenesis as described in Section 
5.2.17. RP-HPLC analysis on the respective GtmA mutants indicated that four of the 
mutants had significantly reduced dithiol gliotoxin bisthiomethylation activity compared 
to the wild-type protein. F185G had no effect on the activity of GtmA. Although this 
result did not identify a catalytic residue it confirmed that mutant enzymes were purified 
to the same degree as wild-type GtmA. As shown in Figure 5.33 the conversion of dithiol 
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gliotoxin to bis(methyl)gliotoxin is depleted in the W157V mutant. Almost no 
bis(methyl)gliotoxin (red) is generated by this mutant and low quantities of 
mono(methylthio)gliotoxin (orange) were evident. 
W162V and F127V also resulted in a decrease in GtmA activity. Notably, an extra 
peak (pink) was apparent in the GtmA F127V supernatants which eluted just after the 
mono(methylthio)gliotoxin peak. This peak may represent mono(methylthio)gliotoxin 
which has been methylated on the opposite sulfhydral. This mutation may have resulted 
in a widening of the substrate binding pocket such that it facilitates dithiol GT in the 
opposite orientation. GtmA N159V had a particularly unusual effect on enzyme activity. 
Although activity was diminished in this mutant compared to the wild-type, almost no 
mono(methylthio)gliotoxin was detected in the supernatants whereas significant amounts 
of bis(methyl)gliotoxin were present. In the mutants where catalytic activity is decreased 
(F157V, W162V, F127V) significant amounts of monomethylated gliotoxin is generated. 
The N159V mutation may increase the GtmA affinity for monomethylgliotoxin such that 
the enzyme preferentially binds this intermediate instead of dithiol gliotoxin. It is also 
possible that this mutant is unable to efficiently release the monomethylated intermediate, 
resulting in the two methylation steps occurring consecutively. As mentioned previously, 
GtmA catalysis may proceed through proximity and desolvation effects or by general 
acid-base catalysis. Based on this mutagenesis result, the residue N159 could act as a 
general base in GtmA, however the activity of the enzyme is still quite substantial in the 
N159V mutant. A co-crystal structure of GtmA with dithiol gliotoxin bound or docked 
into the GtmA structure will be essential to elucidate the exact roles of the above residues 
and carry out more targeted mutagenesis on this enzyme.  
Overall the data presented in this chapter have characterised GtmA-mediated 
thiomethylation on both the enzymatic and structural level. The enzyme was 
263 
 
  
recombinantly expressed to high yields and purity to facilitate enzymatic and structural 
studies. The power of in-silico structural modelling was also demonstrated in this chapter. 
The GtmA model generated by the I-TASSER suite of programs was reasonably accurate, 
considering the low sequence similarity of GtmA to any other structurally elucidated 
methyltransferase. The structural data facilitated guided site-directed mutagenesis to 
modify specific residues which may be located in the substrate binding site of this 
enzyme. Four of the single residue changes had drastic effects on GtmA activity. As 
described in Chapter 4, GtmA has 124 homologs in 103 fungal genomes. As GtmA is the 
first member of this family to be structurally elucidated this work will facilitate a future 
in-depth analysis of this family of methyltransferases and their applications in 
biocatalysis, metabolic engineering, chemical biology and other areas of biotechnology. 
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Chapter 6 
Systems effects of gliotoxin bisthiomethylation in 
Aspergillus fumigatus 
 
 
 
 
 
 
 
 
 
  
6.1 Introduction 
As described in Chapter 4, GtmA has become specialised and is associated with the 
regulation of gliotoxin production in A. fumigatus. The deletion of gtmA results in no 
additional sensitivity to exogenous gliotoxin (Dolan et al., 2014). Chapter 5 detailed the 
recombinant expression and structural elucidation of this methyltransferase. Residues 
which are important to the catalytic activity of this enzyme were also uncovered. 
Interestingly, GtmA was shown to be resistant to SAH mediated competitive inhibition 
(Figure 5.2.8), a negative feedback mechanism which affects the majority of SAM 
dependent methyltransferases (Lee et al., 2005).  
Based on the results from Chapter 4, the deletion of gtmA from A. fumigatus 
completely abrogated bis(methyl)gliotoxin production. However, it did not result in the 
acquisition of a gliotoxin- or H2O2-sensitive phenotype. This led us to conclude that 
GtmA is not primarily involved in the detoxification of gliotoxin or related biosynthetic 
intermediates (Forseth et al., 2011) as has been previously proposed (Li et al., 2012). 
There remained the possibility that GliT activity actively compensates for the absence of 
GtmA in A. fumigatus ΔgtmA, masking the protective role of GtmA during gliotoxin 
exposure. As illustrated in Chapter 3, the deletion of gtmA was carried out in the gliotoxin 
sensitive mutants, ΔgliA and ΔgliT. This facilitated an investigation into the redundancy 
of GtmA as a defensive strategy against gliotoxin in A. fumigatus.  
The data from Chapter 4 also showed that A. fumigatus ΔgtmA produces more 
gliotoxin than the wild-type and that several gli-cluster encoded gliotoxin biosynthetic 
enzymes are more abundant in this mutant under secondary metabolite producing 
conditions. This led to an investigation into the effect of this gliotoxin production 
alteration on the levels of primary and unrelated secondary metabolites produced by A. 
fumigatus.  
265 
 
  
Many cellular components which are more commonly associated with primary 
metabolism are required for NRPS and PKS (Sheridan et al., 2015). These include, 
amongst others, S-adenosylmethionine (SAM), isoprenyl and mevalonyl moieties, 
NADPH, glutathione (GSH), malonyl CoA and acetyl CoA (Yasmin et al., 2012; Davis 
et al., 2011: Scharf et al., 2011; Haas, 2012). This suggests significant interplay between 
what is currently considered to be primary and secondary metabolism. The 
bisthiomethylation of gliotoxin by A. fumigatus demands two molecules of SAM per 
gliotoxin molecule. It has previously been shown that the methyl cycle is significantly 
altered in ΔgliT when exposed to gliotoxin (O’Keeffe et al., 2014).  
 In addition to the clear interactions between primary and secondary metabolism 
described above, there are also several examples of cross-talk amongst gene clusters 
which direct the synthesis of fungal natural products. Overexpression of the A. fumigatus 
putative Zn(II)2Cys6 transcription factor hasA (which is part of the hexadehydro-
astechrome (HAS) biosynthetic gene cluster) also resulted in the production of large 
amounts of fumitremorgins compared to the wild-type strain (Yin et al., 2013). Deletion 
of the HAS NRPS in a background overexpressing hasA (OE::hasAΔhasD) resulted in 
significantly increased fumitremorgin production. The authors hypothesised that the 
diversion of tryptophan and prenylation activity from HAS production towards 
fumitremorgin biosynthesis may occur in OE::hasAΔhasD due to the inability of this 
mutant to utilise the pathway intermediates from HAS production. As fumitremorgins are 
potent tremorgenic mycotoxins this may account for the increased virulence of the 
OE::hasAΔhasD strain compared to wild-type (Yin et al., 2013). 
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The overall objectives of the work presented in this chapter were to:   
(i) Determine if Afu2g11120, gtmA, has a secondary role in self-protection 
against gliotoxin using the ΔgliT::ΔgtmA and ΔgliA::ΔgtmA double mutant 
strains.  
(ii) Observe any phenotype associated with A. fumigatus ΔgliT::ΔgtmA and 
ΔgliA::ΔgtmA in comparison to the corresponding single deletion mutants 
under various conditions of oxidative stress or gliotoxin resistance through a 
series of phenotypic assays.  
(iii) Evaluate any connection between SAM utilisation and gliotoxin 
bisthiomethylation utilising a series of A. fumigatus deletion mutants.  
(iv) Perform quantitative proteomic analysis of the ΔgliT and ΔgliT::ΔgtmA strain 
in response to gliotoxin exposure. 
(v) Carry out late stage culture (28 d) metabolomics and proteomics on A. 
fumigatus wild-type, ∆gtmA and gtmAc in order for further functionally 
characterise this methyltransferase as bisthiomethylation of gliotoxin is a 
process which occurs late in terms of fungal growth.  
 
 
 
 
 
 
 
 
 
 
267 
 
  
6.2 Results 
6.2.1 Phenotypic Analysis of A. fumigatus ΔgliT::ΔgtmA and ΔgliA::ΔgtmA in 
Response to Gliotoxin 
Plate assays were performed to determine the response of both ΔgliT::ΔgtmA and 
ΔgliA::ΔgtmA to exogenous GT exposure. All strains were grown on Czapeks Dox agar 
plates with a range of GT concentrations (0 – 20 µg/ml) (Section 2.2.6). Radial growth 
was observed at 24 h time points and the plates were imaged at 72 h (Figure 6.1). Upon 
exposure to gliotoxin, both A. fumigatus ΔgliT::ΔgtmA (p < 0.0001) and ΔgliA::ΔgtmA (p 
< 0.0021) exhibited a decrease in growth in comparison with their single deletion 
counterparts. In particular, ΔgliT::ΔgtmA was shown to be extremely sensitive to 
exogenous gliotoxin exposure. The reduction in radial growth of these mutants is 
represented in Figure 6.2. 
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Figure 6.1. Deletion of gtmA does not result in gliotoxin sensitivity when compared to A. 
fumigatus wild-type. Deletion of gtmA in the gliotoxin sensitive strains ΔgliT and ΔgliA 
resulted in double mutants with an increased sensitivity to gliotoxin exposure. A. 
fumigatus ΔgliT::ΔgtmA was shown to be particularly sensitive to exogenous gliotoxin 
whereby the radial growth of this mutant was inhibited at 2.5 µg/ml gliotoxin.
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Figure 6.2. G
raphical representation of Figure 6.1.  Exposure of selected A. fum
igatus strains to 0 – 20 µg/m
l exogenous gliotoxin.  The depicted values 
are from
 three independent sam
ples. Error bars are SD
s from
 the m
ean.
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6.2.2 Bis(methyl)gliotoxin production is severely affected by the absence of gliT 
or gliA 
Czapeks Dox media (100 ml) was inoculated with 106/ml conidia from A. fumigatus wild-
type, gene deletion and complementation strains (triplicate) and the cultures were 
incubated at 37 °C, shaking 200 rpm for 21 h. Following this, 500 µl methanol was added 
and the cultures were incubated for a further 3 h before the supernatants were harvested. 
As highlighted in Section 2.2.16.4, the supernatants were organically extracted and then 
analysed by LC-MS. The results revealed that the levels of bis(methyl)gliotoxin detected 
in the ΔgliT or ΔgliA mutant supernatants were significantly lower than in the wild-type 
strain (Figure 6.3). This demonstrated that endogenously produced bis(methyl)gliotoxin 
was not produced or effluxed by either ΔgliT or ΔgliA to the same degree as in the wild-
type strain. No bis(methyl)gliotoxin was detectable in A. fumigatus ΔgtmA, ΔgliT::ΔgtmA 
and ΔgliA::ΔgtmA. In line with previous data, the ΔgtmA mutant produced significantly 
more gliotoxin than the wild-type strain at 24 h (Figure 6.4).  
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Figure 6.3. LC-MS detection of bis(methyl)gliotoxin (m/z 357) signal intensity in the 
culture supernatants of A. fumigatus wild-type, ΔgliT and ΔgliA following 24 h growth in 
Czapeks Dox liquid media (triplicate). Both the ΔgliT (p = 0.0129) and ΔgliA (p = 0.0088) 
mutants were shown to secrete significantly reduced bis(methyl)gliotoxin in comparison 
with the wild-type at this time point. Error bars show calculated SD from the mean. 
 
Figure 6.4. LC-MS detection of gliotoxin (m/z 327) signal intensity in the culture 
supernatants of A. fumigatus wild-type, ΔgtmA and gtmAc following 24 h growth in 
Czapeks Dox liquid media (triplicate). ΔgtmA was shown to secrete a significantly 
increased (p = 0.0058) amount of gliotoxin when compared to the wild-type at the same 
time point. The levels were restored in the complement (gtmAc) strain. Error bars show 
calculated SD from the mean. 
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6.2.3 ΔgliT produces significantly more bis(methyl)gliotoxin than wild-type or 
ΔgliA following exogenous gliotoxin exposure 
Czapeks-Dox media (100 ml) was inoculated with 106/ml conidia from A. fumigatus wild-
type, gene deletion and complemented strains (triplicate) and the cultures were incubated 
at 37 °C, shaking 200 rpm for 21 h. Gliotoxin (5 µg/ml final conc.) was then added and 
the cultures were incubated for a further 3 h before the supernatants were harvested and 
organically extracted as described in Section 2.2.16.4. They were then analysed by LC-
MS. The results demonstrated that the levels of bis(methyl)gliotoxin detected in the ΔgliT 
mutant supernatants were significantly higher  (p = 0.0039) than in that of the wild-type 
or ΔgliA strain (Figure 6.5).  
  
 
Figure 6.5. LC-MS detection of bis(methyl)gliotoxin (m/z 357) signal intensity in the 
culture supernatants of A. fumigatus wild-type, ΔgliT and ΔgliA following 21 h growth in 
Czapeks Dox liquid media and, subsequently, gliotoxin exposure (5 µg/ml) for 3 h 
(triplicate). A. fumigatus ΔgliT was shown to secrete significantly increased (p = 0.0039) 
bis(methyl)gliotoxin compared to the wild-type at this time point. The levels of 
bis(methyl)gliotoxin were not significantly altered between ΔgliA and the wild-type 
strain. Error bars show calculated SD from the mean. 
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6.2.4 Detection and quantification of S-adenosylmethionine from A. fumigatus 
mycelial lysates 
Mycelia were harvested from the cultures as described in Section 6.2.2. In accordance 
with Section 2.2.14, mycelia were then snap frozen in liquid N2 and, following this, SAM 
was extracted. A SAM commercial standard was used to obtain the retention time and 
fragmentation pattern of this metabolite. As revealed in Figure 6.6, the comparison of 
SAM levels across the gli-cluster deletion strains revealed a close link between gtmA 
activity and cellular SAM availability following gliotoxin exposure. Due to the absence 
of bis-thiomethylation, the ΔgtmA mutant was shown to have significantly (p = 0.0021) 
higher cellular SAM levels than the wild-type strain after gliotoxin exposure. The SAM 
levels were restored to wild-type levels in the gtmAC complement strain.  Notably, the 
severe SAM depletion which was identified in ΔgliT following gliotoxin exposure (p = 
0.0001) was alleviated in the double deletion mutant ΔgliT::ΔgtmA. A. fumigatus 
ΔgliA::ΔgtmA was also shown to retain higher levels of cellular SAM than ΔgliA 
following gliotoxin exposure: however, this was not as drastic as the changes seen in 
ΔgliT vs. ΔgliT::ΔgtmA. The corresponding LC-MS chromatograms for these samples are 
shown in Figure 6.7. 
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Figure 6.6. SAM detection in A. fumigatus wild-type and selected mutants (triplicate) 
after 21 h growth in Czapeks Dox liquid media followed by 3 h exposure to A: Control 
(MeOH) or B: Gliotoxin exposure (5 µg/ml final). Compared with the wild-type, 
significantly higher cellular SAM was detectable in ΔgliT (p = 0.0093), ΔgliA (p = 
0.0003), ΔgliT::ΔgtmA (p = 0.0003) and ΔgliA::ΔgtmA (p = 0.0021). GT exposure results 
in highly significant SAM depletion in ΔgliT (p = 0.0001). This SAM depletion does not 
occur in the ΔgliT::ΔgtmA mutant. SAM levels were also significantly reduced in ΔgliA 
upon gliotoxin exposure (p = 0.0100). In comparison, this reduction was not significant 
in the ΔgliA::ΔgtmA double mutant. Finally, SAM depletion did not occur in ΔgtmA to 
the same degree as in the wild-type or complemented strain (p = 0.0021). Error bars show 
calculated SD from the mean.
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6.2.5 Following gliotoxin exposure ΔgliT:ΔgtmA  may accumulate high levels of 
intracellular dithiol gliotoxin 
Sabouraud dextrose media (50 ml) was inoculated with 106/ml conidia from A. fumigatus 
wild-type and gene deletion mutants in triplicate and incubated at 37 °C, shaking 200 rpm 
for 21 h. The cultures were exposed to either 2.5 µg/ml gliotoxin or a 250 µl methanol 
control and then incubated for a further 3 h. Mycelia were harvested and snap frozen in 
liquid nitrogen. The supernatants were harvested and organically extracted as illustrated 
in Section 2.2.15. Finally, they were analysed by RP-HPLC. It was established that the 
levels of extracellular gliotoxin and bis(methyl)gliotoxin (GT/BmGT) in the mutants 
correlated with the level of gliotoxin sensitivity which was observed in the mutants 
(Figure 6.8 and Figure 6.9). ΔgliT::ΔgtmA has significantly lower extracellular 
GT/BmGT than ΔgliT after 3 h (p = 0.0118). This suggests that the gliotoxin is 
accumulating intracellularly in the dithiol form, which cannot pass out of the cell. It has 
been shown previously that gliotoxin is reduced and actively concentrated in P388D1 
cells in a glutathione-dependent manner, facilitating gliotoxin toxicity (Bernardo et al., 
2003). 
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Figure 6.8. Exposure of wild-type and mutant strains to 2.5 µg/ml gliotoxin for 3 h and 
quantification of the remaining GT/BmGT in the organically extracted supernatant. 
Bis(methyl)gliotoxin (10.5 min) is the first peak followed by GT (10.8 min)  
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Figure 6.9. Exposure of wild-type and mutant strains (triplicate) to 2.5 µg/ml gliotoxin 
for 3 h and quantification of the remaining GT/BmGT in the organically extracted 
supernatants. The bars represent the combined intensity of GT/BmGT signal on the RP-
HPLC 280 nm chromatogram. ΔgliT::ΔgtmA has significantly lower extracellular 
GT/BmGT than ΔgliT after 3 h (p = 0.0118). This would suggest that, due to its inability 
to methylate or oxidise dithiol gliotoxin, ΔgliT::ΔgtmA is accumulating more intracellular 
dithiol gliotoxin than any of the other mutants. This correlates with the highest gliotoxin 
sensitivity seen in this strain. Intracellular GT or BmGT could not be detected. Error bars 
show calculated SD from the mean. 
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6.2.6 Quantitative Proteomic Analysis of ΔgliT vs. ΔgliT:gtmA exposed gliotoxin 
Gliotoxin sensitivity assays (Figure 6.1) demonstrated that ΔgliT::ΔgtmA is extremely 
sensitive to exogenous gliotoxin but, unlike A. fumigatus ΔgliT, this mutant did not 
undergo SAM depletion following gliotoxin exposure (Figure 6.6). In addition, the 
amount of gliotoxin remaining in the supernatant of ΔgliT::ΔgtmA when exposed to 
gliotoxin is significantly lower than that of the other mutants. This suggested that the 
likely mechanism of increased gliotoxin sensitivity in this mutant is the intracellular 
accumulation of dithiol gliotoxin. As ΔgliT::ΔgtmA is significantly more sensitive to 
gliotoxin than ΔgliT, the proteomic response of these mutants in response to either 
gliotoxin or a methanol control was examined. The snap-frozen mycelial samples from 
Section 6.2.5 were processed as demonstrated in Section 2.2.16.5 and were then analysed 
by quantitative proteomics in triplicate. This may help elucidate whether the increased 
gliotoxin sensitivity of ΔgliT::ΔgtmA was manifested on the proteomic level.  
A total of 2136 proteins were detected in the ΔgliT::ΔgtmA vs ΔgliT gliotoxin 
treatment. 24 proteins were uniquely detected in the ΔgliT::ΔgtmA mutant under gliotoxin 
exposure and 37 proteins were significantly more abundant in this mutant. Under the same 
conditions, 12 proteins were uniquely detected in the ΔgliT mutant and 22 proteins were 
shown to be significantly more abundant in this mutant. As shown in Table 6.1, it appears 
that proteins most significantly increased in abundance in ΔgliT::ΔgtmA upon gliotoxin 
exposure are encoded by the gliotoxin biosynthetic cluster. Four gliotoxin biosynthetic 
enzymes, GliG (AFUA_6G09690; 4.52528), GliN (AFUA_6G09720; 3.2664), GliH 
(AFUA_6G09745; 2.7334) and GliM (AFUA_6G09680; 2.52137), were highly abundant 
in this mutant when compared to ΔgliT. GliP (AFUA_6G09660) was also uniquely 
detected in the ΔgliT::ΔgtmA mutant. Notably, a putative cysteine synthase (CysB) 
(AFUA_4G03930; 1.89937) was also significantly more abundant. 
280 
 
  
Several proteins which are associated with driving protein translation and folding 
were shown to be significantly more abundant in the ΔgliT::ΔgtmA mutant. These include 
Prefoldin subunit 3, putative (AFUA_2G02230; 1.36956) and a putative mitochondrial 
DnaJ chaperone (Mdj1) (AFUA_2G11750; 1.57627). Additionally, Seryl-tRNA 
synthetase (AFUA_3G12640), D-3-phosphoglycerate dehydrogenase (AFUA_2G04490) 
were uniquely detected in this condition. 
An increased abundance of proteins which are commonly associated with mRNA 
synthesis was evident in the ΔgliT::ΔgtmA mutant. These included the polymerase (RNA) 
II (DNA directed) polypeptide D (AFUA_3G08040; Unique), Pre-mRNA splicing factor 
Dim1 (AFUA_3G12290; Unique), an uncharacterized protein (AFUA_2G03210; 
Unique) with orthologs involved in the positive regulation of transcription from RNA 
polymerase II promoter, SWI-SNF complex subunit (Snf5), putative (AFUA_2G16840; 
Unique), THO complex subunit Tho1, putative (AFUA_4G04330; Unique). 
` Additionally, proteins which are associated with mitochondrial activity and 
vacuolar transport were found to be more abundant. These included the mitochondrial 
F1F0-ATP synthase g subunit (AFUA_1G16280;   1.27137), Mitochondrial 2-
oxodicarboxylate carrier protein, putative (AFUA_1G09660; 1.48277), mitochondrial 
import receptor subunit (Tom20), putative (AFUA_6G11380; Unique), a putative 
vacuolar transporter chaperone Vtc4 (AFUA_2G09040; 1.42043) and a vacuolar 
armadillo repeat protein Vac8, putative (AFUA_5G13540; 1.38502). The acid 
phosphatases AphA (AFUA_5G01330; 2.0362) and PhoA (AFUA_1G03570; 1.05516) 
were significantly more abundant in the double mutant. 
Proteins which have previously been shown to be upregulated by gliotoxin 
exposure were more abundant in ΔgliT::ΔgtmA (Dolan et al., 2014). These included a 
ThiJ/PfpI family protein which is abundant in conidia (AFUA_5G01430; 1.50109) and a 
protein of unknown function induced by hypoxia (AFUA_6G11850; 1.57101). 
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As shown in Table 6.2, the majority of proteins detected as significantly less 
abundant in the ΔgliT::ΔgtmA mutant were shown to be associated with the ribosome. 
These included the 40S ribosomal protein S19 (AFUA_1G05340; 1.64506), the ribosome 
assembly and transport protein Srp40, putative (AFUA_1G04370; 1.50622), the nascent 
polypeptide-associated complex (NAC) subunit beta (AFUA_6G02750; 1.35069), 40S 
ribosomal protein S6 (AFUA_4G10800; 1.32211), 40S ribosomal protein S17 
(AFUA_2G10300; 1.26034), 40S ribosomal protein S26 (AFUA_1G06770; 1.1822), 40S 
ribosomal protein S5 (AFUA_1G15020; 1.12063), 60S ribosomal protein L37a 
(AFUA_2G16880; 1.12053), the ribosome associated DnaJ chaperone Zuotin 
(AFUA_4G03650; 1.09331), the ribosomal protein S13p/S18e (AFUA_6G13550; 
1.05296), Nucleoporin NUP49/NSP49, putative (AFUA_6G10730; 1.0383), and the 
ribosomal S30/ubiquitin fusion protein (AFUA_6G02450; 1.00763).  
The thiol methyltransferase GtmA (AFUA_2G11120) was not detectable in the 
ΔgliT::ΔgtmA mutant whereas it was highly abundant in ΔgliT upon gliotoxin exposure. 
As described above, proteins induced by hypoxia were more abundant in ΔgliT::ΔgtmA. 
In support of these data, a hypoxia repressed protein (AFUA_2G15290; 1.89792) with a 
glutathione-dependent formaldehyde-activating enzyme domain was significantly less 
abundant in this mutant. 
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 dehydrogenase; transcript up-regulated in conidia 
exposed to neutrophils 
 
1.05527 
4.0845E-02 
 
13 
43.3 
A
FU
B
_065590 
A
cid phosphatase PhoA
 
1.05516 
1.4299E-03 
6 
15 
A
FU
A
_1G
03570 
 
 
 
 
 
 
Phosphatidylglycerol specific phospholipase C
, putative 
1.05015 
3.9238E-02 
11 
34.3 
A
FU
A
_7G
04910 
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Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Secreted protein of unknow
n function 
1.04991 
5.4175E-03 
4 
19.2 
A
FU
A
_6G
02010 
 
 
 
 
 
 
C
ell w
all glucanase, putative 
1.00409 
1.6853E-02 
4 
15.1 
A
FU
A
_6G
08510 
 
 
 
 
 
 
A
ldehyde reductase (A
K
R
1), putative 
1.00253 
1.2992E-03 
20 
81.7 
A
FU
A
_6G
10260 
  
 
 
 
 
                   
289 
 
 
 
T
able 6.2. Proteins w
ith decreased abundance in A. fum
igatus ΔgliT:gtm
A com
pared to ΔgliT grow
n for 21 h in Sabouraud D
extrose M
edia  follow
ed 
by 2.5 µg/m
l gliotoxin exposure for 3 h. D
ata sorted by fold change, in descending order. 
 
Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
H
as dom
ain(s) w
ith predicted catalytic activity and role in trehalose 
biosynthetic process 
 
A
bsent 
N
/A
 
 
6 
13.5 
A
FU
A
_7G
03940 
Putative frequenin w
ith hom
ology to S. cerevisiae Frq1p;has four EF-hand 
calcium
 binding dom
ains 
A
bsent 
N
/A
 
3 
19.5 
A
FU
A
_6G
14240 
 
 
 
 
 
 
O
rtholog(s) have m
itochondrion localization. Translation elongation factor 
G
2, putative 
A
bsent 
N
/A
 
5 
12.3 
A
FU
A
_5G
07140 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted 2-dehydropantoate 2-reductase activity, 
N
A
D
P binding activity, role in oxidation-reduction process, pantothenate 
biosynthetic process and cytoplasm
 localization 
A
bsent 
N
/A
 
2 
9.4 
A
FU
A
_4G
13960 
 
 
 
 
 
 
O
rtholog(s) have role in ascospore-type prospore m
em
brane assem
bly, late 
endosom
e to vacuole transport, protein retention in G
olgi apparatus, protein 
targeting to vacuole 
A
bsent 
N
/A
 
9 
3.7 
A
FU
A
_4G
11560 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted 4-hydroxyphenylpyruvate dioxygenase 
activity and role in arom
atic am
ino acid fam
ily m
etabolic process, 
oxidation-reduction process 
A
bsent 
N
/A
 
 
5 
18 
A
FU
A
_4G
10620 
 
 
 
 
 
 
C
A
SC
3/B
arentsz eIF4A
III binding B
tz dom
ain  
A
bsent 
N
/A
 
4 
6.8 
A
FU
A
_3G
05830 
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Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Putative phosphoketolase;calcium
 dow
nregulated 
A
bsent 
N
/A
 
 
4 
5.3 
A
FU
A
_3G
00370 
Putative nonsense-m
ediated m
R
N
A
 decay protein 
A
bsent 
N
/A
 
 
5 
12.2 
A
FU
A
_2G
16750 
G
liotoxin Thiom
ethyltransferase A
 (G
tm
A
) 
A
bsent 
N
/A
 
 
10 
45.1 
A
FU
A
_2G
11120 
H
as dom
ain(s) w
ith predicted A
TP binding, protein serine/threonine kinase 
activity and role in protein phosphorylation 
A
bsent 
N
/A
 
 
3 
4.1 
A
FU
A
_1G
09620 
 
 
 
 
 
 
Serine/threonine protein kinase related to the PK
A
 catalytic 
subunit;involved in cA
M
P signaling 
A
bsent 
N
/A
 
 
5 
8.7 
A
FU
A
_1G
06400 
 
 
 
 
 
 
C
-8 sterol isom
erase, involved in sterol biosynthesis;upregulated in 48h 
biofilm
 vs planktonic culture;SrbA
-regulated during hypoxia 
A
bsent 
N
/A
 
 
2 
20.1 
A
FU
A
_1G
04720 
 
 
 
 
 
 
C
onidia-enriched protein of unknow
n function; transcript dow
nregulated in 
response to voriconazole; hypoxia repressed protein 
-1.89792 
7.7642E-04 
5 
69.1 
A
FU
A
_2G
15290 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted role in nuclear m
R
N
A
 splicing, via 
spliceosom
e and nucleus localization, m
R
N
A
 splicing factor (Prp1/Zer1), 
putative 
-1.81827 
3.3116E-02 
6 
8.3 
A
FU
A
_2G
06070 
 
 
 
 
 
 
40S ribosom
al protein S19 
-1.64506 
2.3371E-04 
 
5 
25.8 
A
FU
A
_1G
05340 
R
ibosom
e assem
bly and transport protein Srp40, putative 
-1.50622 
5.9257E-03 
2 
5.7 
A
FU
A
_1G
04370 
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Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
N
ascent polypeptide-associated com
plex (N
A
C
) subunit beta; protein level 
decreases upon heat shock 
-1.35069 
1.0968E-03 
13 
55.4 
A
FU
A
_6G
02750 
 
 
 
 
 
 
40S ribosom
al protein S6 
-1.32211 
2.0131E-03 
 
10 
34.2 
A
FU
A
_4G
10800 
40S ribosom
al protein S17 
-1.26034 
3.7943E-02 
 
7 
35.4 
A
FU
A
_2G
10300 
Putative zinc-dependent alcohol dehydrogenase; predicted gene pair w
ith 
A
FU
A
_A
_7G
01010 (adh1);protein induced by hydrogen peroxide; reacts 
w
ith rabbit im
m
unosera exposed to A. fum
igatus conidia; calcium
 
dow
nregulated 
-1.21622 
1.7292E-02 
20 
72 
A
FU
A
_5G
06240 
 
 
 
 
 
 
40S ribosom
al protein S26 
 
-1.1822 
1.1508E-02 
4 
37.8 
A
FU
A
_1G
06770 
H
ypothetical protein 
-1.17746 
2.7839E-02 
5 
16.1 
A
FU
A
_8G
03950 
 
 
 
 
 
 
40S ribosom
al protein S5; reacts w
ith rabbit im
m
unosera exposed to A. 
fum
igatus conidia 
-1.12063 
4.6129E-03 
14 
60.2 
A
FU
A
_1G
15020 
 
 
 
 
 
 
60S ribosom
al protein L37a 
-1.12053 
8.2945E-03 
 
5 
48.9 
A
FU
A
_2G
16880 
Putative fatty acid elongase w
ith a predicted role in fatty acid biosynthesis; 
induced by exposure to artem
isinin 
-1.10096 
1.3282E-02 
2 
7.8 
A
FU
A
_5G
02760 
 
 
 
 
 
 
R
ibosom
e associated D
naJ chaperone Zuotin 
-1.09331 
3.0942E-03 
14 
42.8 
A
FU
A
_4G
03650 
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Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
R
ibosom
al protein S13p/S18e 
 
-1.05296 
6.9708E-03 
8 
52.8 
A
FU
A
_6G
13550 
A
TP dependent R
N
A
 helicase (D
bp1), putative 
-1.05164 
7.0398E-03 
 
24 
49.9 
A
FU
A
_4G
07660 
N
ucleoporin N
U
P49/N
SP49, putative 
-1.0383 
3.4327E-02 
6 
16.6 
A
FU
A
_6G
10730 
H
as dom
ain(s) w
ith predicted exonuclease activity, nucleic acid binding, 
nucleotide binding, zinc ion binding activity and intracellular localization 
-1.02234 
3.5262E-02 
7 
24.1 
A
FU
A
_5G
02160 
 
 
 
 
 
 
C
opper resistance protein C
rd2, putative 
-1.02119 
4.3498E-03 
 
4 
42.3 
A
FU
A
_4G
04318 
R
ibosom
al S30/ubiquitin fusion 
-1.00763 
5.4432E-03 
 
2 
17.7 
A
FU
A
_6G
02450 
O
rtholog(s) have glutam
ate-5-sem
ialdehyde dehydrogenase activity, role in 
proline biosynthetic process and cytoplasm
, nucleus localization 
-1.00457 
2.4349E-02 
15 
49.1 
A
FU
A
_2G
07350 
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6.2.7 Late stage culture metabolomics reveals that gtmA may also influence the 
biosynthesis of other secondary metabolites 
A. fumigatus wild-type, ∆gtmA and gtmAc strains were grown in quadruplicate in Czapeks 
dox broth, 200 rpm, 72 h; 37 °C. The conical flasks were then transferred to a 37°C static 
incubator whereby the cultures were incubated for a further 25 days (a total of 28 days 
incubation) in darkness. The culture supernatants were then organically extracted using 
chloroform and analysed by RP-HPLC (Section 2.2.15). The results showed the 
significant decrease in four compounds detected at the 254 nm and 351 nm (Figure 6.10 
and 6.12). These compounds were fraction collected based on their respective retention 
times (RT) and analysed by LC-MS. Their identities were then elucidated based on their 
m/z values and fragmentation patterns. Based on this analysis, the compounds pseurotin 
A (p = 0.0035) (Figure 6.11) and fumagillin (p = 0.00154) (Figure 6.13) were produced 
at significantly decreased levels in the ∆gtmA strain. The levels of these metabolites were 
restored in the gtmAc strain. This suggested that GtmA activity may influence the 
production of other secondary metabolites through the production of bis(methyl)gliotoxin 
or, alternatively, by influencing the induction of the gli-gene cluster through the 
mechanism described in Section 4.3.  
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Figure 6.10. RP-HPLC chromatogram (254 nm) where a single compound (RT: 9.9 min) 
was shown to be detected at a significantly reduced intensity (p = 0.0035) in the A. 
fumigatus ∆gtmA. The levels of this metabolite were restored in the gtmAc strain. 
 
Figure 6.11. The LC-MS fragmentation pattern of the compound in Figure 6.10 confirms 
its identity as pseurotin A. 
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Figure 6.12. RP-HPLC chromatogram (351 nm) where an 18.2 min compound was 
shown to be detected at a significantly reduced intensity in the A. fumigatus ∆gtmA (p = 
0.00194). The levels of this metabolite were restored in the gtmAc strain. The compounds 
at RT 9.2 min and 13.6 min could not be identified by mass spectrometry analysis.  
 
Figure 6.13. The LC-MS fragmentation pattern of the compound in Figure 6.12 confirms 
its identity as fumagillin. 
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6.2.8 Addition of bis(methyl)gliotoxin to ∆gtmA does not restore wild-type levels 
of pseurotin A production 
In order to uncover whether the absence of bis(methyl)gliotoxin was directly responsible 
for the metabolite alterations uncovered in Section 6.2.7, bis(methyl)gliotoxin (10 µg/ml 
final) was added to ∆gtmA prior to static incubation for 25 days (quadruplicate). Methanol 
was added as a control. As outlined in Figure 6.14, this did not result in the restoration of 
wild-type pseurotin A production, indicating that bis(methyl)gliotoxin does not directly 
alter the production of these metabolites.  
 
 
Figure 6.14. Exogenous addition of methanol or bis(methyl)gliotoxin (10 µg/ml) to A. 
fumigatus ∆gtmA (quadruplicate) prior to static incubation for 25 days does not result in 
the restoration of pseurotin A production levels to that of the wild-type strain. Bars 
represent pseurotin A RP-HPLC intensity (mAU) at 254 nm.   
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6.2.9 Quantitative proteomics of late-stage cultures reveals that the absence of 
gtmA expression leads to widespread proteomic alterations 
The RP-HPLC chromatograms shown in Figures 6.10 and 6.11 demonstrated that A. 
fumigatus ΔgtmA has an altered secondary metabolite profile in comparison with that of 
the wild-type or gtmAC cultured in the same conditions. In order to elucidate the 
involvement of GtmA activity in this metabolite profile alteration, quantitative 
comparative proteomic analysis was carried out. The snap frozen mycelial samples from 
Section 6.2.7 were processed as detailed in Section 2.2.16.5. These samples were then 
analysed by quantitative proteomics in quadruplicate. A total of 1648 proteins were 
detected in the wild type vs. ΔgtmA analysis. 59 proteins were uniquely detected in the 
wild-type and 135 proteins were significantly more abundant in this strain. Two proteins 
were uniquely detected in A. fumigatus ΔgtmA under this condition and 88 proteins were 
significantly more abundant in this mutant. Due to the large number of proteins altered in 
abundance, this dataset was cross referenced with the gtmAC vs. ΔgtmA dataset in order 
to confirm which of these changes were directly due to the absence of ΔgtmA. Based on 
this enrichment, 44 proteins were uniquely detected in the wild-type and 92 proteins were 
significantly more abundant in this strain. Two proteins were uniquely detected in A. 
fumigatus ΔgtmA under this condition and 70 proteins were significantly more abundant 
in this mutant.  
Four proteins encoded by the gliotoxin cluster were shown to be significantly 
more abundant in ΔgtmA compared to the wild type. The MFS gliotoxin efflux transporter 
GliA (AFUA_6G09710; 1.82652), the membrane dipeptidase GliJ (AFUA_6G09650; 
1.66652), a predicted O-methyltransferase GliM (AFUA_6G09680; 1.62724) and the 
glutathione S-transferase GliG (AFUA_6G09690; 1.40425) were increased in abundance 
in ΔgtmA. Additionally, a putative short chain dehydrogenase (AFUA_4G08710; 
1.37478) and a ThiJ/PfpI family protein (AFUA_5G01430; 1.93416), which were 
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previously shown to be induced by gliotoxin exposure were more abundant in this 
condition.   
Proteins which had previously been shown to be induced by hypoxia exposure 
were significantly more abundant in the ΔgtmA mutant compared to the wild type 
(Vödisch et al., 2011). These include a putative transaldolase (AFUA_5G09230; 
1.58072), a putative glyceraldehyde 3-phosphate dehydrogenase (AFUA_5G01030; 
1.34405), an argininosuccinate lyase (AFUA_3G07790; 1.34137), a 6-phosphogluconate 
dehydrogenase (AFUA_6G08050; 1.31184), a putative mevalonate kinase 
(AFUA_4G07780; 1.07826) and an essential 1,3-beta-glucanosyltransferase 
(AFUA_2G05340; 1.0025). Additionally, glutathione synthase (AFUA_5G06610; 
1.67077) was more abundant which is an ortholog of the S. cerevisiae GSH2 glutathione 
biosynthetic protein, which is induced by oxidative stress in this organism (Sugiyama et 
al., 2000).  
Proteins formerly shown to be induced by neutrophil exposure were also more 
abundant in ΔgtmA (Sugui et al., 2008). These included a putative carbon-nitrogen family 
hydrolase (AFUA_5G02350; 1.567), a putative short chain dehydrogenase 
(AFUA_4G08710; 1.37478), ZrfB, a low affinity plasma membrane zinc transporter 
(AFUA_2G0386; 1.30673), a putative myo-inositol-phosphate synthase 
(AFUA_2G01010 - 1.21826), an aldehyde reductase (AKR1) (AFUA_6G10260; 
1.09358) and a putative amino acid permease (Gap1) (AFUA_7G04290; 1.03424). 
Mannitol 2-dehydrogenase which has a predicted role in mannitol metabolism 
(AFUA_4G14450; 1.52766) was also more abundant. Mannitol is an important virulence 
determinant of pathogenic fungi. Its high antioxidant capacity aids in suppressing the 
reactive oxygen species mediated attacks from neutrophils (Wyatt et al., 2014). 
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Four transporter proteins were found to be significantly more abundant in ΔgtmA. 
These were an ABC transporter AbcC (AFUA_1G14330; 2.4345), a putative MFS 
monocarboxylate transporter (AFUA_3G03320; 2.29482) and the ABC multidrug 
transporter Mdr1 (AFUA_5G06070; 2.19999).  
Aminoacyl-tRNA synthetases are central enzymes in protein translation which 
provide the charged tRNAs needed for protein synthesis (Guo et al., 2010). Tyrosyl-tRNA 
synthetase (AFUA_5G10640; 2.85558), Glutamyl-tRNA (Gln) amidotransferase, subunit 
A (AFUA_2G00410; 1.93045), Seryl-tRNA synthetase (AFUA_5G05490; 1.22428), 
Putative valyl-tRNA synthetase (AFUA_8G04800; 1.22314), Isoleucyl-tRNA synthetase 
(AFUA_1G13710; 1.10632) and a putative Lysyl-tRNA synthetase (AFUA_6G07640; 
1.05645) were significantly more abundant in in the ΔgtmA mutant compared to the wild 
type. 
Several cell wall- related proteins were increased in abundance in A. fumigatus 
ΔgtmA. These included the GPI-anchored cell wall beta-1,3-endoglucanase Bgt2 
(AFUA_3G00270; 1.35218) and three beta(1-3)glucanosyltransferases which belong to 
the 7-member GEL family (Gastebois et al., 2010; Fontaine et al., 2003); Gel 5 
(AFUA_8G02130; 1.23988), Gel3 (AFUA_2G12850; 1.00391), and Gel4 
(AFUA_2G05340; 1.0025). 
An intertwined secondary metabolite supercluster on chromosome 8 of A. 
fumigatus (AFUA_8G00100-00720) has been found to encode for at least three bioactive 
metabolites, fumitremorgin, pseurotin, and fumagillin (Wiemann et al., 2013). Several 
proteins encoded by this supercluster were significantly decreased in abundance in A. 
fumigatus ΔgtmA.  
Four proteins involved in the synthesis of fumitremorgins were significantly 
decreased in abundance in ΔgtmA. FtmPT1 (AFUA_8G00210; Unique) and FtmPT2 
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(AFUA_8G00250; Unique), two prenyltransferases involved in fumitremorgin B 
biosynthesis, FtmD, an O-methyltransferase involved in fumitremorgin B synthesis 
(AFUA_8G00200; Unique), and FtmF, an alpha-ketoglutarate-dependent dioxygenase 
which catalyses the conversion of fumitremorgin B to verruculogen (AFUA_8G00230; 
4.32466), 
Seven proteins associated with fumagillin biosynthesis were significantly less 
abundant. These were the fumagillin polyketide synthase (Fma-PKS)  (AFUA_8G00370; 
Unique), the fumagillin oxidoreductase FmaG (AFUA_8G00510; Unique), the 
fumagillin phytanoyl-CoA-oxidase FmaF (AFUA_8G00480; 4.17772), FmaD, the 
fumagillin O-methyltransferase (AFUA_8G00390; 3.85167), a hypoxia induced protein; 
encoded in the fma  gene cluster (AFUA_8G00430; 3.24847), FmaC, a putative 
fumagillin alpha/beta hydrolase (AFUA_8G00380; 3.16375) and a putative O-
methyltransferase; encoded in the fma gene cluster (AFUA_8G00400; 2.85247). 
Six proteins identified with pseurotin A biosynthesis were significantly less 
abundant. PsoB, a putative pseurotin A alpha/beta hydrolase (AFUA_8G00530; Unique), 
PsoD, a putative pseurotin A P450 monooxygenase (AFUA_8G00560; Unique), PsoC, a 
putative pseurotin A methyltransferase (AFUA_8G00550; 3.28917), PsoA, the pseurotin 
A non-ribosomal peptide synthetase (AFUA_8G00540; 1.60039), a pseurotin A dual-
functional mono- oxygenase/methyltransferase PsoE (AFUA_8G00580; Unique) and 
PsoF, a putative pseurotin A dual methyltransferase/monooxygenase (AFUA_8G00440; 
2.74114). 
Two proteins shown previously to be repressed by gliotoxin exposure were shown 
to be significantly decreased in abundance in the ΔgtmA mutant when compared to the 
wild type (Carberry et al., 2012). These were a mitochondrial peroxiredoxin 
(AFUA_4G08580; 1.96889) with predicted role in cell redox homeostasis regulation and 
a putative alcohol dehydrogenase (AFUA_7G01000; 1.17862) involved in ethanol 
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metabolism. A putative thioredoxin (AFUA_8G01090; Unique) and an M repeat protein 
(AFUA_6G08660; 1.99673), which were shown to be hypoxia repressed were also 
decreased in expression (Vödisch et al., 2011). The thiol methyltransferase GtmA was 
uniquely detected in the wild-type condition and abundance was restored in the 
complemented strain. 
Several cell wall associated proteins were also decreased in abundance in the 
ΔgtmA mutant in comparison with the wild type. These included the conidial hydrophobin 
RodA (AFUA_5G09580; Unique), a putative antigenic cell wall galactomannoprotein 
(AFUA_4G00870; Unique), a putative glycophosphatidylinositol (GPI)-anchored cell 
wall protein MP-2 (AFUA_2G05150; Unique) and a putative phiA family cell wall 
protein (AFUA_3G03060; 1.5461). 
Several mitochondrial-associated proteins were less abundant in ΔgtmA. These 
included the mitochondrial F1F0-ATP synthase g subunit (AFUA_1G16280; Unique), an 
uncharacterized protein (AFUA_1G13195; Unique) with orthologs involved in cristae 
formation and integral to mitochondrial inner membrane, a putative iron-sulfur cluster 
biosynthesis protein extrinsic to mitochondrial inner membrane (AFUA_3G06492, 
Unique), a putative mitochondrial intermembrane space translocase subunit 
(AFUA_1G04470; 1.97737), a putative mitochondrial peroxiredoxin (AFUA_4G08580; 
1.96889) with a predicted role in cell redox homeostasis regulation, a putative prohibitin 
(AFUA_2G09090; 1.5947) with orthologs involved in mitochondrion inheritance, a 
putative mitochondrial 2-oxodicarboxylate carrier protein (AFUA_1G09660; 1.56908), a 
putative adenylate kinase with mitochondrial intermembrane space localization 
(AFUA_1G07530; 1.4474), a putative outer mitochondrial membrane protein porin 
(AFUA_4G06910; 1.31711), a putative mitochondrial genome maintenance protein 
Mgm101 (AFUA_2G09560; 1.26767), a mitochondrial glycerol-3-phosphate 
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dehydrogenase (AFUA_1G08810; 1.19813) and a putative mitochondrial processing 
peptidase alpha subunit with a role in protein processing involved in protein targeting to 
mitochondrion (AFUA_1G11870; 1.1768) . 
Interestingly, several hypoxia induced proteins were decreased in abundance in 
the ΔgtmA mutant (Blatzer et al., 2011). These included a gamma-glutamyltranspeptidase 
(AFUA_4G13580, Unique); SrbA-regulated during hypoxia, Putative flavohemoprotein 
(AFUA_4G03410; 1.42304), Putative outer mitochondrial membrane protein porin 
(AFUA_4G06910; 1.31711), Ubiquinol-cytochrome c reductase iron-sulphur subunit 
precursor (AFUA_5G10610; 1.19224) with a predicted role in oxidative phosphorylation, 
an aspartic acid endopeptidase (AFUA_3G11400; 1.18445) and a thiamine biosynthesis 
protein (AFUA_5G02470; 1.11766),  
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able 6.3. Proteins w
ith increased abundance in A. fum
igatus Δgtm
A com
pared to w
ild-type and gtm
A
c grow
n for 28 days in C
zapeks D
ox m
edia. D
ata 
sorted by fold change, in descending order. 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
H
ypothetical protein 
U
nique 
N
/A
 
2  
8.5 
 
A
FU
A
_5G
10240 
D
naJ dom
ain protein Psi, putative 
U
nique 
N
/A
 
7  
22.6 
 
A
FU
A
_5G
07340 
H
as dom
ain(s) w
ith predicted oxidoreductase activity and role in oxidation-
reduction process 
2.85624 
 
8.19E-04 
 
9  
36.2 
 
A
FU
A
_2G
01410 
 
 
 
 
 
 
Tyrosyl-tR
N
A
 synthetase 
2.85558 
 
1.49E-02 
 
10  
34.5 
 
A
FU
A
_5G
10640 
Putative A
B
C
 transporter; m
utation causes increased azole sensitivity 
2.4345 
 
1.20E-02 
 
18  
16.2 
 
A
FU
A
_1G
14330 
M
FS m
onocarboxylate transporter, putative 
2.29482 
 
6.99E-04 
 
2  
4.5 
 
A
FU
A
_3G
03320 
A
B
C
 m
ultidrug transporter M
dr1 
2.19999 
 
5.97E-04 
 
25  
25 
 
A
FU
A
_5G
06070 
H
as dom
ain(s) w
ith predicted catalytic activity, pyridoxal phosphate binding 
activity and role in m
etabolic process 
2.09468 
 
4.09E-04 
 
12  
38 
 
A
FU
A
_2G
13295 
G
lycerate dehydrogenase 
2.01153 
1.59E-04 
7 
28 
A
FU
A
_1G
13630 
ThiJ/PfpI fam
ily protein; abundant in conidia 
 
1.93416 
5.71E-05 
9 
55.1 
A
FU
A
_5G
01430 
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Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
G
lutam
yl-tR
N
A
(G
ln) am
idotransferase, subunit A
 
1.93045 
2.75E-03 
12 
34.5 
A
FU
B
_092380 
M
FS gliotoxin efflux transporter G
liA
, encoded in the putative gliotoxin 
biosynthetic gene cluster 
1.82652 
 
1.09E-04 
 
4  
9.2 
 
A
FU
A
_6G
09710 
 
 
 
 
 
 
Zinc-binding oxidoreductase ToxD
, putative 
1.76982 
 
5.73E-06 
 
16  
69.7 
 
A
FU
A
_6G
10120 
Transesterase (LovD
), putative 
1.73026 
 
4.44E-04 
 
11  
43.1 
 
A
FU
A
_5G
00920 
Putative extracellular aspartic endopeptidase; acid protease; predicted signal 
sequence for secretion; allergen A
sp f 10;transcript induced by grow
th on 
hydrogen peroxide and by grow
th on B
SA
 as a sole nitrogen source 
1.70013 
 
1.75E-02 
 
10  
41 
 
A
FU
A
_5G
13300 
 
 
 
 
 
 
G
lutathione synthetase, putative 
1.67077 
 
1.39E-05 
 
17  
49.2 
 
A
FU
A
_5G
06610 
M
em
brane dipeptidase G
liJ, encoded in the putative gliotoxin biosynthetic 
gene cluster; higher expression in biofilm
 
1.66652 
 
2.19E-02 
 
7  
30.2 
 
A
FU
A
_6G
09650 
 
 
 
 
 
 
R
A
S sm
all m
onom
eric G
TPase R
asA
 
1.65165 
 
1.29E-03 
 
14  
72.8 
 
A
FU
A
_5G
11230 
Predicted O
-m
ethyltransferase G
liM
, encoded in the putative gliotoxin 
biosynthetic gene cluster 
1.62724 
 
1.26E-02 
 
16  
52 
 
A
FU
A
_6G
09680 
 
 
 
 
 
 
60S ribosom
e biogenesis protein Sqt1, putative 
1.62446 
 
5.79E-03 
 
7  
23.3 
 
A
FU
A
_5G
07390 
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Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
H
as dom
ain(s) w
ith predicted U
D
P-N
-acetylm
uram
ate dehydrogenase activity, 
flavin adenine dinucleotide binding activity and role in oxidation-reduction 
process 
1.61997 
 
1.26E-03 
 
10  
18.3 
 
A
FU
A
_1G
00980 
 
 
 
 
 
 
 
Putative transaldolase; abundant protein in conidia and m
ycelia; protein induced 
by hydrogen peroxide and hypoxia 
1.58072 
 
1.59E-04 
 
29  
86.4 
 
A
FU
A
_5G
09230 
 
 
 
 
 
 
Putative carbon-nitrogen fam
ily hydrolase; transcript up-regulated in conidia 
exposed to neutrophils 
1.567 
 
9.08E-03 
 
4  
19 
 
A
FU
A
_5G
02350 
 
 
 
 
 
 
Putative polyketide synthase 
1.55075 
 
1.15E-02 
 
55  
36.8 
 
A
FU
A
_1G
01010 
 
H
as dom
ain(s) w
ith predicted oxidoreductase activity and role in oxidation-
reduction process 
1.54785 
 
3.55E-03 
 
32  
57.7 
 
A
FU
A
_7G
06810 
 
 
 
 
 
 
 
M
annitol 2-dehydrogenase w
ith a predicted role in m
annitol m
etabolism
 
1.52766 
 
1.07E-03 
 
28  
85.7 
 
A
FU
A
_4G
14450 
N
A
D
H
-dependent flavin oxidoreductase, putative 
1.48197 
 
5.84E-04 
 
29  
83.7 
 
A
FU
B
_049990 
 
N
onribosom
al peptide synthase SidE 
1.46547 
 
3.85E-03 
 
34  
21.9 
 
A
FU
A
_3G
03350 
H
as dom
ain(s) w
ith predicted hydrolase activity 
1.42593 
 
5.66E-03 
 
5  
36.5 
 
A
FU
A
_5G
13840 
G
lutathione S-transferase encoded in the gliotoxin biosynthetic gene cluster; 
required for gliotoxin biosynthesis 
1.40425 
 
1.31E-02 
 
18  
87.9 
 
A
FU
A
_6G
09690 
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Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Plasm
a m
em
brane H
+-A
TPase Pm
a1 
1.3888 
 
1.02E-05 
 
40  
47.8 
 
A
FU
A
_3G
07640 
Putative short chain dehydrogenase; transcriptionally up-regulated in conidia 
exposed to neutrophils; induced by gliotoxin exposure 
1.37478 
 
9.33E-03 
 
10  
47.7 
 
A
FU
A
_4G
08710 
 
 
 
 
 
 
H
ypothetical protein 
1.36026 
1.87E-02 
5 
43.9 
A
FU
A
_5G
01420 
G
PI-anchored cell w
all beta-1,3-endoglucanase EglC
 
1.35218 
 
7.27E-03 
 
10  
27.1 
 
A
FU
A
_3G
00270 
Putative glyceraldehyde 3-phosphate dehydrogenase, hypoxia induced protein 
1.34405 
 
2.56E-04 
 
35  
87.3 
 
A
FU
A
_5G
01030 
 
A
rgininosuccinate lyase; hypoxia induced protein 
1.34137 
 
3.29E-04 
 
17  
50.5 
 
A
FU
A
_3G
07790 
Putative U
D
P-galactopyranose m
utase, enzym
e in the first step of 
galactofuranose biosynthesis; m
utant unm
asks m
annan residues on the cell 
surface, w
hich is thought to contribute to increased cell adhesion 
1.3312 
 
3.72E-04 
 
26  
64.1 
 
A
FU
A
_3G
12690 
 
 
 
 
 
 
6-phosphogluconate dehydrogenase; conidia-enriched protein; protein induced 
by heat shock; reacts w
ith rabbit im
m
unosera exposed to conidia; hypoxia-
induced protein; transcript induced by exposure to hum
an airw
ay epithelial 
cells 
1.31184 
 
5.88E-05 
 
33  
74.4 
 
A
FU
A
_6G
08050 
 
 
 
 
 
 
ZrfB
, low
 affinity plasm
a m
em
brane zinc transporter; induced by zinc 
depletion, ZafA
-dependent; overexpression decreases zinc uptake, hem
e 
biosynthesis and triacetylfusarinine C
 (TA
FC
) siderophore production; induced 
in neutrophil-exposed conidia 
1.30673 
 
1.01E-02 
 
8  
33.7 
 
A
FU
A
_2G
0386 
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Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
A
ldehyde reductase, has dom
ain(s) w
ith predicted oxidoreductase activity and 
role in oxidation-reduction process 
1.29593 
 
2.29E-03 
 
9  
34.2 
 
A
FU
A
_2G
02950 
 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted N
-acetyltransferase activity and role in 
m
etabolic process 
1.28379 
 
1.55E-04 
 
8  
56.2 
 
A
FU
A
_7g00850 
 
 
 
 
 
 
Y
jgH
 fam
ily protein 
1.25488 
 
1.80E-03 
 
8  
59.6 
 
A
FU
A
_3G
02253 
N
A
D
PH
 cytochrom
e P450 reductase (C
prA
), putative 
1.24203 
4.90E-05 
32 
65.6 
A
FU
A
_6G
10990 
 
 
 
 
 
 
Putative beta(1-3)glucanosyltransferase, belongs to the 7-m
em
ber G
EL fam
ily 
1.23988 
 
1.34E-04 
 
4  
8.8 
 
A
FU
A
_8G
02130 
H
as dom
ain(s) w
ith predicted A
TP binding, serine-tR
N
A
 ligase activity, role 
in seryl-tR
N
A
 am
inoacylation and cytoplasm
 localization 
1.22428 
 
1.04E-04 
 
23  
56.1 
 
A
FU
A
_5G
05490 
 
 
 
 
 
 
Putative valyl-tR
N
A
 synthetase; transcript induced by exposure to hum
an 
airw
ay epithelial cells 
1.22314 
 
1.16E-04 
 
28  
36.3 
 
A
FU
A
_8G
04800 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted nucleotide binding activity 
1.21908 
 
2.18E-04 
 
6  
38.2 
 
A
FU
A
_2G
02490 
Putative m
yo-inositol-phosphate synthase; transcript up-regulated in conidia 
exposed to neutrophils 
1.21826 
 
3.95E-03 
 
22  
68.5 
 
A
FU
A
_2G
01010 
 
 
 
 
 
 
Phosphoribosylform
ylglycinam
idine synthase, O
rtholog(s) have role in purine 
nucleotide biosynthetic process and cytoplasm
 localization 
1.21743 
 
1.12E-03 
 
39  
51.1 
 
A
FU
A
_5G
02720 
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Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
 
 
 
 
 
 
A
m
idase; secreted protein; fibrinogen-binding 
1.21641 
 
3.92E-02 
 
13  
36.3 
 
A
FU
A
_5G
10490 
D
-xylulokinase sim
ilar to xkiA
 
1.19871 
 
3.27E-04 
 
19  
45.7 
 
A
FU
A
_5G
09840 
H
as dom
ain(s) w
ith predicted pyridoxal phosphate binding, threonine synthase 
activity and role in threonine biosynthetic process 
1.19834 
 
2.15E-02 
 
10  
28.7 
 
A
FU
A
_3G
08980 
 
 
 
 
 
 
Putative pyridoxine biosynthesis protein 
1.17091 
 
4.45E-03 
 
24  
82.8 
 
A
FU
A
_5G
08090 
Putative adenosine kinase 
1.15756 
 
4.96E-03 
 
23  
80.8 
 
A
FU
A
_5G
06390 
Thiam
in pyrophosphokinase-related protein 
1.15446 
3.88E-03 
9 
43.5 
A
FU
A
_5G
11110 
 
R
an G
TPase activating protein 1 (R
N
A
1 protein) 
1.1377 
 
2.60E-03 
 
18  
58.3 
 
A
FU
A
_3G
07680 
Septin; unique to filam
entous fungi; localizes to long tubular structures w
ithin 
hyphae and to new
ly form
ed septa 
1.13412 
 
1.26E-02 
 
6  
10.5 
 
A
FU
A
_3G
07015 
 
 
 
 
 
 
Isoleucyl-tR
N
A
 synthetase, cytoplasm
ic 
1.10632 
 
2.72E-02 
 
33  
38.1 
 
A
FU
A
_1G
13710 
A
ldehyde reductase (A
K
R
1), putative, transcript up-regulated in conidia 
exposed to neutrophils and to hum
an airw
ay epithelial cells 
1.09358 
 
4.82E-05 
 
27  
85 
 
A
FU
A
_6G
10260 
 
 
 
 
 
 
C
ytosine deam
inase-uracil phosphoribosyltransferase fusion protein; transcript 
induced by exposure to hum
an airw
ay epithelial cells 
1.09242 
 
1.52E-03 
 
12  
60.3 
 
A
FU
A
_5G
05460 
309 
 
 
 
Protein D
escription 
L
og
2 (Fold 
Increase) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
M
evalonate kinase Erg12; SrbA
-regulated during hypoxia 
1.07826 
 
3.01E-03 
 
13  
33.8 
 
A
FU
A
_4G
07780 
H
istone H
4 arginine m
ethyltransferase R
m
tA
 
1.06182 
 
4.71E-04 
 
9  
28.1 
 
A
FU
A
_1G
06190 
H
as dom
ain(s) w
ith predicted A
TP binding, lysine-tR
N
A
 ligase activity, 
nucleic acid binding activity, role in lysyl-tR
N
A
 am
inoacylation and 
cytoplasm
 localization 
1.05645 
 
1.30E-04 
 
19  
35.5 
 
A
FU
A
_6G
07640 
 
 
 
 
 
 
Putative adenosylhom
ocysteinase;protein induced by heat shock 
1.05614 
 
2.10E-03 
 
31  
72.2 
 
A
FU
A
_1G
10130 
H
ypothetical protein 
1.03521 
1.61E-03 
20 
16.9 
A
FU
A
_1G
07090 
Putative am
ino acid perm
ease (G
ap1); transcript up-regulated in conidia 
exposed to neutrophils and by grow
th on B
SA
 as a sole nitrogen source 
1.03424 
 
7.12E-05 
 
9  
20.4 
 
A
FU
A
_7G
04290 
Putative extracellular lipase; repressed by exposure to artem
isinin 
1.03203 
 
4.13E-03 
 
7  
30.1 
 
A
FU
A
_5G
02040 
H
ypothetical protein 
1.02294 
 
7.75E-03 
 
14  
47.6 
 
A
FU
A
_1G
15260 
O
rtholog(s) have R
an G
TPase binding activity, role in G
1/S transition of 
m
itotic cell cycle, R
N
A
 export from
 nucleus, protein im
port into nucleus, 
ubiquitin-dependent protein catabolic process and cytoplasm
, nucleus 
localization 
1.01922 
 
6.25E-03 
 
9  
45.3 
 
A
FU
A
_5G
12180 
 
 
 
 
 
 
1,3-beta-glucanosyltransferase G
el3, belongs to the 7-m
em
ber G
EL fam
ily 
1.00391 
 
4.13E-05 
 
15  
43 
 
A
FU
A
_2G
12850 
Essential 1,3-beta-glucanosyltransferase, G
PI-anchored to the plasm
a 
m
em
brane; constitutively expressed during hyphal grow
th; hypoxia induced 
protein 
1.0025 
 
5.43E-03 
 
16  
33.6 
 
A
FU
A
_2G
05340 
310 
 
 
 
T
able 6.4. Proteins w
ith decreased abundance in A. fum
igatus Δgtm
A com
pared to w
ild-type and gtm
A
c grow
n for 28 days in C
zapeks D
ox m
edia. D
ata 
sorted by fold change, in descending order. 
 
Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
H
as dom
ain(s) w
ith predicted iron ion binding, iron-sulfur cluster binding 
activity and role in iron-sulfur cluster assem
bly 
 
A
bsent 
N
/A
 
 
5 
33.1 
A
FU
A
_1G
04680 
O
rtholog(s) have role in cristae form
ation and integral to m
itochondrial inner 
m
em
brane, m
itochondrial crista junction localization 
A
bsent 
N
/A
 
3 
34.1 
A
FU
A
_1G
13195 
 
 
 
 
 
 
Protein of unknow
n function; abundant in conidia 
A
bsent 
N
/A
 
11 
45 
A
FU
A
_1G
13670 
 
 
 
 
 
 
A
llergen A
sp f 4;higher expression in biofilm
 vs planktonic cells; transcript 
induced by grow
th on hydrogen peroxide 
A
bsent 
N
/A
 
5 
23 
A
FU
A
_4G
13960 
 
 
 
 
 
 
Putative glycophosphatidylinositol (G
PI)-anchored cell w
all protein; putative 
adhesin; antigenic galactom
annoprotein; induced by exposure to artem
isinin 
A
bsent 
N
/A
 
3 
5.9 
A
FU
A
_2G
05150 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted m
ethyltransferase activity; G
tm
A
 
A
bsent 
N
/A
 
 
8 
42.1 
A
FU
A
_2G
11120 
H
as dom
ain(s) w
ith predicted electron carrier activity, protein disulfide 
oxidoreductase activity and role in cell redox hom
eostasis 
A
bsent 
N
/A
 
 
4 
18.8 
A
FU
A
_2G
15180 
O
rtholog(s) have enzym
e activator activity, role in iron-sulfur cluster assem
bly 
and extrinsic to m
itochondrial inner m
em
brane, m
itochondrial m
atrix 
localization 
A
bsent 
N
/A
 
 
4 
28.5 
A
FU
A
_3G
06492 
 
 
 
 
 
 
311 
 
 
 
Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
H
as dom
ain(s) w
ith predicted oxidoreductase activity, acting on a sulfur group 
of donors, oxygen as acceptor activity and role in oxidation-reduction process, 
prenylcysteine catabolic process 
A
bsent 
N
/A
 
 
10 
18.1 
A
FU
A
_3G
09330 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted m
etal ion binding activity; class II 
aldolase/adducin dom
ain protein 
A
bsent 
N
/A
 
 
11 
52.5 
A
FU
A
_3G
09800 
 
 
 
 
 
 
Putative succinate-sem
ialdehyde dehydrogenase 
A
bsent 
N
/A
 
 
10 
21.1 
A
FU
A
_4G
08170 
C
onserved hypothetical protein 
A
bsent 
N
/A
 
 
2 
19.8 
A
FU
A
_4G
10560 
G
am
m
a-glutam
yltranspeptidase; SrbA
-regulated during hypoxia 
A
bsent 
N
/A
 
 
2 
5.3 
A
FU
A
_4G
13580 
C
onidial hydrophobin; conidial surface associated; required for form
ation of 
the rodlet layer of conidia 
A
bsent 
N
/A
 
 
5 
52.2 
A
FU
A
_5G
09580 
 
 
 
 
 
 
Protein of unknow
n function 
A
bsent 
N
/A
 
 
12 
35.4 
A
FU
A
_5G
14930 
Protein of unknow
n function 
A
bsent 
N
/A
 
 
2 
18.5 
A
FU
A
_6G
10450 
H
as dom
ain(s) w
ith predicted nucleic acid binding, nucleotide binding activity 
A
bsent 
N
/A
 
 
4 
22 
A
FU
A
_7G
05260 
Putative prenyltransferase involved in fum
itrem
orgin B
 biosynthesis 
A
bsent 
N
/A
 
 
16 
39.8 
A
FU
A
_8G
00250 
Polyketide synthase (PK
S), encoded in the fm
a (fum
agillin) secondary 
m
etabolite gene cluster; required for fum
agillin biosynthesis 
A
bsent 
N
/A
 
 
27 
15.4 
A
FU
A
_8G
00370 
  
312 
 
 
 
Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Protein of unknow
n function 
A
bsent 
N
/A
 
8 
18.2 
A
FU
A
_8G
00630 
M
FS m
ultidrug transporter, putative 
A
bsent 
N
/A
 
 
4 
5.8 
A
FU
A
_8G
00940 
Putative thioredoxin; hypoxia repressed protein 
A
bsent 
N
/A
 
 
7 
71.6 
A
FU
A
_8G
01090 
H
as dom
ain(s) w
ith predicted oxidoreductase activity, acting on the aldehyde 
or oxo group of donors, N
A
D
 or N
A
D
P as acceptor activity and role in 
oxidation-reduction process 
A
bsent 
N
/A
 
 
9 
19.9 
A
FU
A
_8G
02310 
 
 
 
 
 
 
Putative coenzym
e A
 transferase; transcript induced by exposure to hum
an 
airw
ay epithelial cells 
A
bsent 
N
/A
 
 
8 
21.1 
A
FU
A
_8G
05580 
 
 
 
 
 
 
translation elongation factor eEF-1, gam
m
a subunit, putative 
A
bsent 
N
/A
 
 
9 
36.7 
A
FU
A
_8G
00580 
Putative brevianam
ide F prenyltransferase, predicted to convert brevianam
ide 
F to tryprostatin B
; involved in the biosynthesis of fum
itrem
orgins 
A
bsent 
N
/A
 
 
13 
32.3 
A
FU
A
_8G
00210 
 
 
 
 
 
 
Putative O
-m
ethyltransferase w
ith a predicted role in fum
itrem
orgin B
 
synthesis 
A
bsent 
N
/A
 
 
22 
68.9 
A
FU
A
_8G
00200 
  
H
as dom
ain(s) w
ith predicted structural m
olecule activity, role in intracellular 
protein transport, vesicle-m
ediated transport and C
O
PI vesicle coat localization A
bsent 
N
/A
 
9 
11.1 
A
FU
A
_1G
10970 
 
 
 
 
 
 
O
rtholog(s) have proton-transporting A
TPase activity, rotational m
echanism
, 
structural m
olecule activity and role in A
TP synthesis coupled proton 
transport, cristae form
ation, protein oligom
erization 
A
bsent 
N
/A
 
3  
26 
 
A
FU
A
_1G
16280 
313 
 
 
 
Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
H
as dom
ain(s) w
ith predicted catalytic activity and role in m
etabolic process 
A
bsent 
N
/A
 
23  
79.1 
A
FU
A
_2G
00540 
N
A
D
H
-ubiquinone oxidoreductase 49 kD
a subunit 
A
bsent 
N
/A
 
7 
22.1 
 
A
FU
A
_2G
13710 
Putative FA
D
 binding m
onooxygenase; calcium
 dow
nregulated 
A
bsent 
N
/A
 
6  
16.3 
 
A
FU
A
_3G
03280 
B
A
R
 adaptor protein R
V
S167, putative, calcium
 induced 
A
bsent 
N
/A
 
7  
20.7 
 
A
FU
A
_3G
14230 
A
ntigenic cell w
all galactom
annoprotein, putative 
A
bsent 
N
/A
 
2  
15.8 
 
A
FU
A
_4G
00870 
H
as dom
ain(s) w
ith predicted 4 iron, 4 sulfur cluster binding, N
A
D
H
 
dehydrogenase (ubiquinone) activity, quinone binding activity and role in 
oxidation-reduction process 
 
A
bsent 
N
/A
 
2  
11.7 
 
A
FU
A
_4G
05860 
Protein of unknow
n function identified by m
ass spectrom
etry 
A
bsent 
N
/A
 
2 
4  
A
FU
A
_4G
08030 
H
as dom
ain(s) w
ith predicted actin binding activity and intracellular 
localization 
A
bsent 
N
/A
 
4  
50.8 
 
A
FU
A
_5G
11200 
H
as dom
ain(s) w
ith predicted sulfuric ester hydrolase activity and role in 
m
etabolic process 
A
bsent 
N
/A
 
12  
25.4 
 
A
FU
A
_5G
12940 
H
as dom
ain(s) w
ith predicted nucleotide binding, oxidoreductase activity and 
role in oxidation-reduction process 
A
bsent 
N
/A
 
4  
20.7 
 
A
FU
A
_6G
09140 
    
314 
 
 
 
Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
H
as dom
ain(s) w
ith predicted electron carrier activity, hem
e binding, 
oxidoreductase activity, acting on paired donors, w
ith incorporation or 
reduction of m
olecular oxygen activity and role in oxidation-reduction process 
A
bsent 
N
/A
 
7 
19 
 
A
FU
A
_8G
00510 
 
 
 
 
 
 
Putative alpha/beta hydrolase; m
em
ber of the pseurotin A
 gene cluster; 
hypoxia induced protein 
A
bsent 
N
/A
 
16  
42.9 
 
A
FU
A
_8G
00530 
Putative P450 m
onooxygenase; m
em
ber of the pseurotin A
 gene cluster; 
transcript induced by voriconazole 
A
bsent 
N
/A
 
4  
10.6 
A
FU
A
_8G
00560 
  
Putative chitinase w
ith a predicted role in the degradation and recycling of 
fungal chitin during autolysis; N
-term
inal signal peptide that targets to the 
secretory pathw
ay 
A
bsent 
N
/A
 
6  
23.6 
 
A
FU
A
_8G
01410 
   
C
onserved hypothetical protein 
A
bsent 
N
/A
 
3 
7.7 
 
A
FU
A
_8G
01980 
N
on-hem
e Fe(II) and alpha-ketoglutarate-dependent dioxygenase; phytanoyl-
C
oA
 dioxygenase fam
ily protein; catalyses the conversion of fum
itrem
orgin B
 
to verruculogen 
 
-4.32466 
 
1.20E-05 
 
21  
87.3 
 
A
FU
A
_8G
00230 
Putative iron-dependent oxygenase; encoded in the fm
a (fum
agillin) secondary 
m
etabolite gene cluster 
-4.17772 
 
3.18E-03 
 
12  
46.8 
 
A
FU
A
_8G
00480 
Predicted O
-m
ethyltransferase; encoded in the fm
a (fum
agillin) secondary 
m
etabolite gene cluster 
 
-3.85167 
 
1.01E-04 
 
11  
70.6 
 
A
FU
A
_8G
00390 
IgE-binding protein 
-3.76683 
2.05E-04 
3 
34.5 
A
FU
A
_6G
00430 
315 
 
 
 
Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Putative m
ethyl transferase; m
em
ber of the pseurotin A
 gene cluster; conidia-
enriched protein; hypoxia induced protein 
-3.28917 
 
9.98E-05 
 
28  
79.7 
 
A
FU
A
_8G
00550 
C
ysteine-rich secreted protein  
-3.27599 
 
4.28E-05 
 
15  
63.3 
 
A
FU
A
_7G
01060 
H
ypoxia induced protein; encoded in the fm
a (fum
agillin) secondary 
m
etabolite gene cluster 
-3.24847 
 
6.95E-06 
 
12  
84.7 
 
A
FU
A
_8G
00430 
Putative alpha/beta hydrolase; encoded in the fm
a (fum
agillin) secondary 
m
etabolite gene cluster 
-3.16375 
 
1.38E-05 
 
15  
78.4 
 
A
FU
A
_8G
00380 
Protein of unknow
n function; transcript dow
nregulated in response to 
voriconazole 
-2.96915 
 
1.79E-02 
 
11  
41 
 
A
FU
A
_4G
14380 
Putative secreted 1,4-beta-D
-glucan glucanhydrolase 
-2.90284 
 
1.49E-04 
 
27  
53.3 
 
A
FU
A
_7G
06140 
Protein of unknow
n function; encoded in the fm
a (fum
agillin) secondary 
m
etabolite gene cluster 
-2.85247 
 
6.11E-04 
 
10  
45.1 
 
A
FU
A
_8G
00400 
H
ypothetical protein 
-2.82667 
 
4.14E-03 
 
7  
62.3 
 
A
FU
A
_2G
11860 
B
aeyer-V
illiger m
onooxygenase (B
V
M
O
); hypoxia induced protein; encoded 
in the fm
a (fum
agillin) secondary m
etabolite gene cluster 
-2.74114 
 
6.34E-05 
 
41  
63.4 
 
A
FU
A
_8G
00440 
Putative theta class glutathione S-transferase 
-2.25371 
 
4.53E-03 
 
10  
64.4 
 
A
FU
A
_4G
14530 
 
A
llergen A
sp f 13;putative alkaline serine protease; higher expression in 
biofilm
 vs planktonic cells; transcript induced by grow
th on hydrogen peroxide -2.06535 
 
6.01E-04 
 
8  
81.6 
 
A
FU
A
_2G
12630 
316 
 
 
 
Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Putative G
TP cyclohydrolase II;transcript up-regulated in conidia exposed to 
neutrophils 
-2.05509 
 
3.52E-03 
 
13  
43.8 
 
A
FU
A
_2G
01220 
H
as dom
ain(s) w
ith predicted peroxidase activity 
-2.02461 
 
1.66E-03 
 
10  
32.6 
 
A
FU
A
_4G
02780 
O
rtholog of A. nidulans A
N
3906; hypoxia repressed protein 
-1.99673 
 
2.21E-03 
 
49  
48.1 
 
A
FU
A
_6G
08660 
A
llergen A
sp f 8;putative ribosom
al protein P2;transcript induced by grow
th 
on hydrogen peroxide and m
enadione 
-1.97795 
 
5.13E-03 
 
7  
82 
 
A
FU
A
_2G
10100 
(O
rtholog(s) have protein transporter activity, unfolded protein binding activity 
and role in protein im
port into m
itochondrial inner m
em
brane 
-1.97737 
 
9.85E-03 
 
4  
50.5 
 
A
FU
A
_1G
04470 
M
itochondrial peroxiredoxin; predicted role in cell redox hom
eostasis 
regulation; protein levels increase w
ith am
photericin B
 and H
2O
2 exposure; 
transcript up-regulated in conidia exposed to neutrophils; repressed by 
gliotoxin exposure 
-1.96889 
 
1.96E-02 
 
16  
84.5 
 
A
FU
A
_4G
08580 
    
Putative FK
506-binding protein (FK
B
P)-type peptidyl-prolyl cis-trans 
isom
erase; transcript induced by exposure to hum
an airw
ay epithelial cells 
-1.85773 
 
1.55E-05 
 
11  
93.8 
 
A
FU
A
_6G
12170 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted zinc ion binding activity, role in ER
 to G
olgi 
vesicle-m
ediated transport, intracellular protein transport and C
O
PII vesicle 
coat localization 
-1.84388 
 
2.71E-02 
 
10  
15.2 
 
A
FU
A
_6G
12830 
 
 
 
 
 
 
A
sp-hem
olysin;hem
olytic 
toxin; 
highly 
secreted; 
enriched 
in 
conidia; 
expression increases in vivo; binds lysophosphatidylcholine 
-1.82658 
1.50E-03 
10 
71.9 
A
FU
A
_3G
00590 
317 
 
 
 
Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Transcript up-regulated in conidia exposed to neutrophils 
-1.81415 
1.73E-03 
3 
13.9 
A
FU
A
_4G
07030 
Pathogenesis associated protein C
ap20 
-1.78879 
3.73E-02 
12 
70.1 
A
FU
A
_1G
06350 
Putative tripeptidyl-peptidase of the sedolisin fam
ily; predicted signal 
sequence for secretion 
-1.73219 
 
2.95E-02 
 
7  
12.3 
 
A
FU
A
_4G
14000 
G
uanyl-specific ribonuclease, putative 
-1.72977 
 
1.63E-02 
 
10  
34.1 
 
A
FU
B
_079800 
 
H
ypothetical protein 
-1.70645 
 
2.22E-03 
 
8  
66.5 
 
A
FU
A
_6G
00600 
Putative N
A
D
H
-ubiquinone oxidoreductase 39 kD
a subunit 
-1.63808 
 
5.32E-03 
 
12  
51.3 
 
A
FU
A
_6G
12790 
Putative enoyl-C
oA
 hydratase/isom
erase fam
ily protein w
ith a predicted role in 
beta oxidation of fatty acids; transcript up-regulated in conidia exposed to 
neutrophils 
 
-1.63382 
 
2.82E-03 
 
9  
34.7 
 
A
FU
A
_2G
10920 
N
on-ribosom
al peptide synthetase (N
R
PS); PK
S/N
R
PS hybrid; m
ultidom
ain 
protein; required for pseurotin A
 production; pseurotin A
 gene cluster m
em
ber; 
transcript induced by voriconazole; induced by hypoxia and in infected m
ouse 
lungs 
 
-1.60039 
 
7.06E-03 
 
105 
 
36.9 
 
A
FU
B
_086030 
O
rtholog(s) have role in m
itochondrion inheritance, negative regulation of 
proteolysis, protein folding, replicative cell aging and m
itochondrial inner 
m
em
brane localization 
 
-1.5947 
 
2.18E-03 
 
9  
31.8 
 
A
FU
A
_2G
09090 
318 
 
 
 
Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
O
rtholog(s) have dicarboxylic acid transm
em
brane transporter activity, role in 
m
itochondrial transport and m
itochondrial inner m
em
brane localization 
-1.56908 
 
2.64E-02 
 
5  
23.6 
 
A
FU
A
_1G
09660 
Putative alpha-glucosidase B
 
-1.55841 
1.95E-03 
30 
44.4 
A
FU
A
_1G
16250 
A
llergen A
sp f 34;putative phiA
 fam
ily cell w
all protein; induced calcium
; 
repressed by exposure to artem
isinin 
 
-1.5461 
 
3.85E-02 
 
7  
79.5 
 
A
FU
A
_3G
03060 
A
llergen A
sp f 29;putative thioredoxin 
-1.50915 
 
9.52E-03 
 
9  
82.7 
 
A
FU
A
_5G
11320 
H
as dom
ain(s) w
ith predicted oxidoreductase activity and role in oxidation-
reduction process 
-1.50563 
 
2.59E-02 
 
6  
27.8 
 
A
FU
A
_4G
12710 
Putative tropom
yosin 1;protein induced by hydrogen peroxide; reacts w
ith rabbit 
im
m
unosera exposed to A. fum
igatus conidia 
-1.50549 
 
2.05E-02 
 
17  
81.8 
 
A
FU
A
_7G
04210 
A
llergen A
sp f 1; ribonuclease m
itogillin fam
ily of cytotoxins; sim
ilar to 
restrictocin; inhibits protein synthesis in m
am
m
alian cells 
-1.48966 
 
1.08E-03 
 
10  
61.4 
 
A
FU
A
_5G
02330 
Putative N
A
D
H
 dehydrogenase; m
utation causes increased azole resistance 
-1.48604 
 
2.71E-02 
 
6  
42.1 
 
A
FU
A
_2G
10600 
Putative N
A
D
PH
 isocitrate dehydrogenase; transcript induced during conidial 
germ
ination 
-1.46226 
 
2.70E-02 
 
20  
58.2 
 
A
FU
A
_1G
12800 
 
 
 
 
 
 
O
rtholog(s) have adenylate kinase activity, role in A
D
P biosynthetic process, 
D
N
A
-dependent D
N
A
 replication initiation and m
itochondrial interm
em
brane 
space localization 
 
-1.4474 
 
-1.4474 
 
9  
47.5 
 
A
FU
A
_1G
07530 
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Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Putative flavohem
oprotein; protein induced by heat shock and hypoxia 
-1.42304 
 
3.39E-02 
12  
41.9 
 
A
FU
A
_4G
03410 
Putative glutathione transferase 
-1.4093 
 
2.46E-02 
 
7  
40.6 
 
A
FU
A
_3G
10830 
G
lycosyl hydrolase fam
ily 75 chitosanase; hydrolyzes beta-1,4-glycosidic 
linkage of chitosan; repressed by exposure to artem
isinin 
-1.3902 
 
4.01E-02 
 
10  
40.8 
 
A
FU
A
_4G
01290 
O
rtholog(s) have thiosulfate sulfurtransferase activity, role in tR
N
A
 w
obble 
position uridine thiolation and cytoplasm
 localization 
-1.38091 
 
5.01E-03 
 
11  
47.9 
 
A
FU
A
_7G
01370 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted transporter activity, role in transport and 
intracellular localization 
-1.36724 
 
9.32E-03 
 
10  
42.3 
 
A
FU
A
_3G
09910 
 
 
 
 
 
 
R
an-interacting protein M
og1, putative 
-1.32425 
 
9.02E-03 
 
9  
66.7 
 
A
FU
A
_6G
12430 
Putative outer m
itochondrial m
em
brane protein porin; hypoxia induced protein 
-1.31711 
 
3.51E-02 
 
12  
52.8 
 
A
FU
A
_4G
06910 
Protein w
ith Y
ap1-dependent induction in response to hydrogen peroxide; 
calcium
 dow
nregulated 
-1.30285 
 
2.42E-02 
 
7  
85.2 
 
A
FU
A
_1G
09890 
 
 
 
 
 
 
ThiJ/PfpI fam
ily protein 
-1.29656 
 
3.71E-03 
 
4  
13.1 
 
A
FU
A
_5G
02670 
R
hoG
A
P and Fes/C
IP4 dom
ain protein; calcium
 induced 
-1.28477 
 
2.91E-02 
 
11  
17.5 
 
A
FU
A
_7G
04300 
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Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
H
as dom
ain(s) w
ith predicted U
D
P-N
-acetylm
uram
ate dehydrogenase activity, 
flavin adenine dinucleotide binding activity and role in oxidation-reduction 
process 
-1.27887 
 
5.18E-03 
 
15  
46.4 
 
A
FU
A
_6G
14340 
 
 
 
 
 
 
M
itochondrial genom
e m
aintenance protein M
gm
101, putative 
-1.26767 
 
4.83E-02 
 
6  
30.9 
 
A
FU
A
_2G
09560 
Putative 
FK
506-binding 
protein 
(FK
B
P)-type 
peptidyl-prolyl 
cis-trans 
isom
erase 
-1.26433 
 
2.11E-03 
 
6  
60.4 
 
A
FU
A
_2G
03870 
  
Putative acylC
oA
 binding fam
ily protein 
-1.25198 
1.63E-04 
11 
70.3 
A
FU
A
_2G
11060 
H
as dom
ain(s) w
ith predicted structural m
olecule activity, role in intracellular 
protein transport, vesicle-m
ediated transport and C
O
PI vesicle coat localization -1.25084 
 
2.61E-02 
 
14  
19 
 
A
FU
A
_2G
02560 
 
 
 
 
 
 
Putative translation elongation factor EF-2 subunit; protein abundant in conidia; 
protein induced by heat shock 
-1.24914 
 
6.58E-03 
 
64  
75.9 
 
A
FU
A
_2G
13530 
 
 
 
 
 
 
H
ypothetical protein 
-1.24131 
 
1.03E-02 
 
10  
25.9 
 
A
FU
A
_5G
09640 
O
rtholog(s) have hydrolase activity, role in nucleotide m
etabolic process and 
cytoplasm
, nucleus localization 
-1.22323 
 
2.14E-02 
 
5  
38.5 
 
A
FU
A
_6G
12680 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted catalytic activity and role in m
etabolic process 
-1.20739 
 
4.69E-02 
 
6  
18.3 
 
A
FU
A
_1G
06780 
M
itochondrial glycerol-3-phosphate dehydrogenase; hypoxia repressed protein 
-1.19813 
2.06E-02 
25 
53.9 
A
FU
A
_1G
08810 
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Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
U
biquinol-cytochrom
e 
c 
reductase 
iron-sulphur 
subunit 
precursor 
w
ith 
a 
predicted role in oxidative phosphorylation; hypoxia induced protein; induced 
by exposure to artem
isinin; SrbA
-regulated during hypoxia 
-1.19224 
 
4.54E-04 
 
8  
40.6 
 
A
FU
A
_5G
10610 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted protein serine/threonine phosphatase activity, role 
in protein dephosphorylation and protein serine/threonine phosphatase com
plex 
localization 
 
-1.18685 
 
6.53E-03 
 
11  
34.7 
 
A
FU
A
_1G
09280 
H
ypothetical protein 
-1.18577 
 
4.05E-02 
 
22  
43.4 
 
A
FU
A
_6G
09920 
A
spartic 
acid 
endopeptidase; 
conidia-enriched 
protein; 
conidial 
surface 
associated; predicted signal secretion sequence; hypoxia induced protein; 
transcript up-regulated in conidia exposed to neutrophils and by grow
th on B
SA
 -1.18445 
 
2.82E-02 
 
21  
52.3 
 
A
FU
A
_3G
11400 
Putative 60S ribosom
al protein P0;reacts w
ith rabbit im
m
unosera exposed to A. 
fum
igatus conidia 
 
-1.18381 
 
3.58E-02 
 
10  
43.1 
 
A
FU
A
_1G
05080 
 
O
rtholog(s) have role in response to D
N
A
 dam
age stim
ulus 
-1.17873 
 
3.59E-02 
 
8  
25.2 
 
A
FU
A
_1G
13020 
Putative alcohol dehydrogenase involved in ethanol m
etabolism
; predicted gene 
pair w
ith A
FU
A
_A
_6G
11430 (A
ldA
);increased expression in biofilm
; induced 
by L-tyrosine; induced in neutrophil-exposed conidia; repressed by gliotoxin 
exposure 
-1.17862 
 
3.06E-02 
 
11  
26.4 
 
A
FU
A
_7G
01000 
 
 
 
 
 
 
O
rtholog(s) have m
etalloendopeptidase activity, role in protein processing 
involved in protein targeting to m
itochondrion and m
itochondrial processing 
peptidase com
plex localization 
-1.1768 
 
1.68E-02 
 
11  
29.8 
 
A
FU
A
_1G
11870 
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Protein D
escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
O
rtholog(s) have ubiquitin-protein ligase activity, role in free ubiquitin chain 
polym
erization, 
postreplication 
repair, 
protein 
polyubiquitination 
and 
cytoplasm
, nucleus, ubiquitin conjugating enzym
e com
plex localization 
-1.17177 
 
4.46E-02 
 
6  
38.8 
 
A
FU
A
_4G
12080 
 
 
 
 
 
 
O
rtholog of S. cerevisiae N
FS1;putative novel ncR
N
A
 A
FU
A
_-203 encoded 
w
ithin the intron 
-1.15836 
 
1.41E-02 
 
16  
46.6 
 
A
FU
A
_3G
14240 
 
 
 
 
 
 
H
as dom
ain(s) w
ith predicted oxidoreductase activity and role in cell redox 
hom
eostasis 
-1.14876 
 
2.37E-02 
 
11  
59.5 
 
A
FU
A
_6G
12500 
 
 
 
 
 
 
Thiam
ine biosynthesis protein, phoB
-regulated; protein induced by H
2O
2;reacts 
w
ith rabbit im
m
unosera exposed to conidia; hypoxia induced protein; transcript 
induced by exposure to hum
an airw
ay epithelial cells 
 
-1.11766 
 
4.54E-03 
 
20  
68.1 
 
A
FU
A
_5G
02470 
Putative extracellular serine carboxypeptidase; predicted signal sequence for 
secretion; induced by grow
th on B
SA
 as a sole nitrogen source 
-1.11575 
 
1.53E-02 
 
13  
32.3 
 
A
FU
A
_2G
17330 
 
 
 
 
 
 
O
rtholog(s) have carbonyl reductase (N
A
D
PH
) activity and cytoplasm
, nucleus 
localization 
-1.10991 
 
9.48E-03 
 
8  
21.9 
 
A
FU
A
_2G
10280 
Putative fum
arate hydratase; reacts w
ith rabbit im
m
unosera exposed to A. 
fum
igatus conidia 
-1.0972 
 
2.37E-02 
 
17  
46 
 
A
FU
A
_6G
02470 
 
 
 
 
 
 
Putative 40S ribosom
al protein S0 
-1.08214 
 
1.98E-02 
 
9  
40.7 
 
A
FU
A
_3G
13320 
Endonuclease/exonuclease/phosphatase fam
ily protein 
-1.07779 
 
1.13E-02 
 
15  
56.3 
 
A
FU
A
_2G
16830 
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escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
Putative 
2,3-bisphosphoglycerate-independent 
phosphoglycerate 
m
utase; 
protein abundant in conidia; transcript induced by exposure to hum
an airw
ay 
epithelial cells 
-1.07141 
 
1.74E-02 
 
12  
32.7 
 
A
FU
A
_3G
09290 
 
 
 
 
 
 
G
TP-binding protein Y
chF 
-1.06875 
 
1.51E-02 
 
19  
59.9 
 
A
FU
A
_1G
09800 
O
rtholog(s) have ubiquitin binding activity, role in late endosom
e to vacuole 
transport, protein targeting to vacuole and ESC
R
T-0 com
plex localization 
-1.06689 
 
4.68E-02 
 
6  
12.3 
 
A
FU
A
_2G
04670 
m
R
N
A
 binding post-transcriptional regulator (C
sx1), putative 
-1.05534 
 
4.16E-02 
 
9  
30.1 
 
A
FU
A
_7G
02230 
Putative polyA
D
P-ribose polym
erase (PA
R
P) 
-1.05271 
7.65E-03 
13 
24.7 
A
FU
A
_5G
07320 
C
alm
odulin 
-1.05167 
 
5.05E-03 
 
16  
98.7 
 
A
FU
A
_4G
10050 
A
lpha/beta hydrolase 
-1.03265 
 
3.93E-02 
 
8  
25.4 
 
A
FU
A
_1G
05590 
Putative fam
ily 18 (class V
) chitinase; secreted protein 
-1.01758 
 
2.53E-03 
 
6  
21.6 
 
A
FU
A
_3G
11280 
Phosducin fam
ily protein  
-1.01644 
 
4.60E-03 
 
4  
75.9 
 
A
FU
A
_2G
02550 
O
rtholog(s) have G
-protein beta/gam
m
a-subunit com
plex binding, actin binding 
activity, role in positive regulation of transcription from
 R
N
A
 polym
erase II 
prom
oter by pherom
ones, protein folding and cytoplasm
 localization 
 
-1.01409 
 
7.29E-03 
 
5  
17.9 
 
A
FU
A
_2G
02550 
Putative m
icrotubule associated protein 
-1.01289 
 
6.56E-03 
 
10  
42.8 
 
A
FU
A
_3G
11860 
K
aryopherin alpha subunit 
-1.01042 
2.30E-03 
13 
34.1 
A
FU
A
_2G
16090 
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escription 
L
og
2 (Fold 
D
ecrease) 
p-value 
Peptides 
Sequence 
coverage 
[%
] 
Protein ID
s 
O
rtholog(s) have urease activity and role in urea catabolic process 
 
-1.00997 
1.92E-02 
13 
24.8 
A
FU
A
_1G
04560 
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6.3 Discussion 
The deletion of gtmA in the A. fumigatusATCC26933 mutant backgrounds ΔgliT and ΔgliA 
(Section 3.2.9) facilitated an exploration of the underlying contribution of this 
methyltransferase to the self-protection against gliotoxin. Also, as SAM is a cofactor 
required for the thiomethylation of dithiol gliotoxin, the levels of this metabolite were 
quantified in various A. fumigatus deletion mutants upon gliotoxin exposure. Finally, late 
stage culture incubation was utilised to explore the interplay between GtmA activity and 
the production of other bioactive secondary metabolites produced by A. fumigatus.  
The data shown in Figure 6.1 indicated that ΔgliT::ΔgtmA is more sensitive to 
exogenous gliotoxin in comparison with A. fumigatus ΔgliT. In addition, ΔgliA:ΔgtmA 
was shown to be significantly more sensitive to gliotoxin than ΔgliA. This suggests that, 
when the primary method of self-protection is disabled, gtmA provided some level of 
resistance against gliotoxin. Data in Section 6.2.2 demonstrated that endogenous 
bis(methyl)gliotoxin production is severely affected by the absence of gliT or gliA (Figure 
6.3). The decreased production of bis(methyl)gliotoxin by ΔgliT is surprising considering 
that the absence of gliT should result in an increased substrate availability for GtmA. 
Deletion of the dithiol oxidase gene, hlmI, results in an increase in 
dimethyldihydroholomycin production in a holomycin overexpression background (Li et 
al., 2012). However, it was demonstrated that dimethyldihydroholomycin is produced at 
higher levels by Δhlml compared to the wild-type under secondary metabolite producing 
conditions (Li et al., 2012). The decreased production of bis(methyl)gliotoxin by ΔgliT 
may be due to the possibility that the bis(methyl)gliotoxin which is detected in the wild-
type culture supernatants may be largely a product of the conversion of exogenously 
effluxed gliotoxin which is re-taken up by A. fumigatus and converted to 
bis(methyl)gliotoxin by GtmA. This result might also be explained by pathway cellular 
compartmentalisation during gliotoxin biosynthesis which may limit the endogenously 
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produced dithiol gliotoxin reaching GtmA. Compartmentalisation in secondary 
metabolism has been demonstrated for several other natural product biosynthetic 
pathways (Lim and Keller, 2014). 
Furthermore, it was demonstrated in Section 6.2.3 that ΔgliT produces significantly 
more bis(methyl)gliotoxin than wild-type or ΔgliA following exogenous gliotoxin 
exposure. This suggested that the inability to oxidise dithiol gliotoxin to gliotoxin by GliT 
results in a higher substrate availability for GtmA. This in turn results in higher levels of 
bis(methyl)gliotoxin production upon gliotoxin exposure (Figure 6.15). The lower 
conversion by ΔgliA may be explained by this strain’s ability to oxidise gliotoxin; this 
may result in the reduction of the GtmA substrate availability. These data were in 
agreement with the SAM levels quantified in Section 6.2.4. The severe SAM depletion 
noted in ΔgliT following gliotoxin exposure (O’Keeffe et al., 2014) was alleviated in the 
double deletion mutant ΔgliT::ΔgtmA. A. fumigatus ΔgliA::ΔgtmA was also found to have 
higher remaining levels of cellular SAM than ΔgliA following gliotoxin exposure. These 
data support the RNAseq analysis of ΔgliT exposed to gliotoxin which revealed the 
significant up-regulated expression (p < 0.005) of genes involved in sulfur assimilation, 
methionine and SAM biosynthesis (O’Keeffe et al., 2014). The expression of 
methylenetetrahydrofolate reductase (mtrA), cobalamin-independent methionine 
synthase (metH) and S-adenosylmethionine synthetase (sasA) were significantly 
increased (p < 5 x 10-5 - 0.003) (Amich et al., 2010). Expression of the bZIP transcription 
factor, metR and S-adenosylhomocysteinase (sahA) was also up regulated (p < 0.00015-
0.001), as was that of glycine dehydrogenase (GDH; p <0.0056) and serine 
hydroxymethyltransferase (SHMT; p < 0.0001). GDH and SHMT act in concert with the 
folate cycle to transfer methyl groups to homocysteine (Hcy) for methionine biosynthesis 
(Suliman et al., 2007).  
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Figure 6.15. A: A. fumigatus wild-type responds to exogenous gliotoxin by a 
combination of GliT mediated dithiol gliotoxin oxidation and GliA-mediated export. 
GtmA-mediated bisthiomethylation and export also occur. B: In the ΔgliT strain the 
absence of GliT results in an increased GtmA substrate availability, which in turn results 
in maximal bisthiomethylation activity in the presence of exogenous GT. As each dithiol 
gliotoxin requires two SAM molecules, this process results in a rapid depletion of cellular 
SAM. 
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Overall, these observations reveal the impact of gliotoxin thiomethylation on the 
cellular levels of SAM and the importance of GliT for the control of sulfur metabolism 
during gliotoxin exposure. Moreover, these data directly implicate GtmA activity in the 
dysregulation of SAM:SAH levels and strongly implicate gliotoxin exposure as impacting 
on the methyl/methionine cycle within A. fumigatus in the absence of gliT (Owens et al., 
2015).  
Based on the above data, it is hypothesised that, following gliotoxin exposure, 
ΔgliT:ΔgtmA accumulates high levels of intracellular dithiol gliotoxin which cannot exit 
the cell by either oxidation (GliT) and subsequent efflux by GliA, or by GtmA-mediated 
bisthiomethylation. As shown in Section 6.2.5, this hypothesis is supported by the RP-
HPLC based gliotoxin uptake/efflux investigation. The gliotoxin sensitivity of A. 
fumigatus mutants is most significant where the removal of intracellular dithiol gliotoxin 
(Dolan et al., 2014) is hampered by a combined deficit of the inability to oxidise, efflux 
or bisthiomethylate this toxin. ΔgliT::ΔgtmA was shown to have the lowest levels of 
extracellular gliotoxin present following 3 h gliotoxin exposure; this is in complete 
agreement with the inability of this mutant to directly dissipate any dithiol gliotoxin which 
enters the cell. The fact that ΔgliA::ΔgliT is more sensitive to gliotoxin than ΔgliA (Wang 
et al., 2014) suggests that GliT is able to maintain a discrete level of intracellular gliotoxin 
in the oxidised state. This explains why ΔgliT converts more added gliotoxin to 
bis(methyl)gliotoxin than ΔgliA (Figure 6.8) and why ΔgliT::ΔgtmA is more sensitive to 
gliotoxin than ΔgliA::ΔgtmA.  
Figure 6.1 demonstrated that ΔgliT::ΔgtmA is very sensitive to exogenous 
gliotoxin compared to A. fumigatus ΔgliT. These results, in combination with the 
gliotoxin uptake and conversion data in Section 6.2.5, suggested that the increased 
accumulation of intracellular gliotoxin (as dithiol gliotoxin) may lead to toxicity in this 
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mutant. Considering that gliotoxin exposure results in the induction of gli-cluster 
expression (O’Keeffe et al., 2014) (possibly by intracellular accumulation), the 
heightened sensitivity of ΔgliT::ΔgtmA may also be the result of the over-activation of 
the gli-cluster leading to a sustained expression of these proteins. As described in Section 
6.2.6, upon exposure to gliotoxin for 3 h five gliotoxin biosynthesis enzymes (GliG, GliN, 
GliH, GliM and GliP) were found to be highly abundant in the ΔgliT::ΔgtmA mutant 
compared to ΔgliT. As these gliotoxin biosynthetic enzymes have been synthesised, it is 
plausible that the gliotoxin pathway could proceed to the penultimate step (dithiol 
gliotoxin) before being trapped in the cell due to the absence of both GliT and GtmA. 
This trapped dithiol gliotoxin may then further activate the gli-cluster. It is likely that this 
in-vivo-produced dithiol gliotoxin would contribute to cellular oxidative stress in 
conjunction with the exogenously-added gliotoxin, which undergoes intracellular GSH-
mediated reduction, hampering its export from the cell (Figure 6.16).  
A putative cysteine synthase (CysB) was significantly more abundant in the 
ΔgliT::ΔgtmA mutant compared to ΔgliT (Amich et al., 2013). A. fumigatus detoxifies 
oxidative threats via glutathione synthesis (Tekaia and Latgé, 2005). However, it has been 
shown that gliotoxin is actively concentrated in P388D1 cells in a glutathione-dependent 
manner and that this normally protective mechanism actually facilitates gliotoxin toxicity 
(Bernardo et al., 2003). An increased intracellular dithiol gliotoxin load in ΔgliT::ΔgtmA 
may result in a more substantial depletion of GSH compared to ΔgliT. In addition, the 
glutathione S-transferase GliG, responsible for transferring two GSH molecules onto the 
gliotoxin scaffold resulting in sulfurization of the metabolite was the protein with the 
most significant abundance increase in ΔgliT::ΔgtmA exposed to gliotoxin compared to 
ΔgliT. (Davis et al., 2011; Scharf et al., 2011). This may also contribute to the increase in 
CysB abundance in A. fumigatus ΔgliT::ΔgtmA due to GSH utilisation by this secondary 
metabolite biosynthetic pathway.  
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Figure 6.16. A: A. fumigatus ΔgliT responds to exogenous gliotoxin by effecting 
excessive bisthiomethylation on this metabolite, resulting in cellular SAM depletion. B: 
The highly sensitive A. fumigatus ΔgliT::ΔgtmA cannot remove intracellular accumulated 
dithiol gliotoxin by S-methylation or oxidation. This likely results in cell death as a result 
of the combined effect of gliotoxin toxicity and gli-cluster over-activation due to the 
sustained presence of dithiol gliotoxin. 
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The non-ribosomal peptide synthetase GliP was uniquely detected in the 
ΔgliT::ΔgtmA. Exposure of A. fumigatus to gliotoxin has been shown to induce the 
expression of genes in the gliotoxin biosynthetic cluster (Cramer et al., 2006). This was 
also shown on the proteomic level (Dolan et al., 2014), demonstrating that the pathway 
can be completely activated by this external signal (O’Keeffe et al., 2014). Also, the 
addition of gliotoxin to the culture medium of a gliP deficient mutant restored the 
expression of several gli-cluster genes in a dose-dependent manner from 500 ng/ml to 20 
µg/ml (Cramer et al., 2006). This further supports the idea that the intracellular 
accumulation of gliotoxin in ΔgliT::ΔgtmA results in higher gli-cluster induction. GliP 
activates and tethers L-Phe on thiolation domain 1 and L-Ser on thiolation domain 2 
before generating the L-Phe-L-Ser-S-T2 dipeptidyl enzyme intermediate (Balibar and 
Walsh, 2006). A D-3-phosphoglycerate dehydrogenase (AFUA_2G04490) which 
synthesizes L-serine from 3-phospho-D-glycerate was uniquely detected in ΔgliT::ΔgtmA 
exposed to gliotoxin vs. ΔgliT. In addition, Seryl-tRNA synthetase was uniquely detected 
in ΔgliT::ΔgtmA; this may be linked to increased serine utilisation in ΔgliT::ΔgtmA by 
GliP and concomitant depletion or competition for endogenous serine.  
It has been shown that, in response to a diverse range of stresses, fungi undergo a 
common response termed the “environmental stress response” (Moye-Rowley, 2003). 
This involves the expression of (i) heat shock proteins or chaperones that protect against 
protein unfolding, (ii) proteins with anti-oxidant functions (glutathione metabolism) that 
repair against oxidative stress induced damage, (iii) carbohydrate metabolism which 
generates metabolic energy required for stress adaptation. Protein synthesis and cellular 
growth is repressed indicating the requirement to preserve energy (Gasch et al., 2000). 
This response is evident in the A. fumigatus ΔgliT::ΔgtmA vs. A. fumigatus ΔgliT 
quantitative proteomic data.  
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A putative mitochondrial DnaJ chaperone (MDJ1) (AFUA_2G11750; 1.57627) 
was significantly more abundant in ΔgliT::ΔgtmA. In S. cerevisiae, MDJ1 has been 
localised to the mitochondrial matrix where it participates in the folding of certain 
imported proteins and may also help prevent heat induced protein aggregation. The lack 
of MDJ1 resulted in the reduced competence of mitochondria to properly fold imported 
monomeric proteins (Rowley et al., 1994). A putative prefoldin subunit 3 
(AFUA_2G02230; 1.36956) was also significantly more abundant. Prefoldin is a 
molecular chaperone that acts in conjunction with chaperonin to assist in the correct 
folding of other proteins in the crowded molecular environment that exists in living cells. 
Chaperonins are multisubunit toroidal assemblies which undergo major ATP-dependent 
conformational changes as part of the mechanism of facilitated folding (Vainberg et al., 
1998).  
A notable characteristic of neutrophil activation is the production of copious 
amounts of oxidants in a process known as the respiratory burst (Dahlgren and Karlsson, 
1999). Several genes are induced in-vivo to protect against this oxidative stress. Five 
proteins with increased abundance in ΔgliT::ΔgtmA exposed to gliotoxin were previously 
shown to have their transcripts up-regulated in conidia exposed to neutrophils (Sugui et 
al., 2008). These included AFUA_2G13590, a protein with a protease inhibitor 
propeptide domain, which are generally responsible for the modulation of zymogen 
folding and activity, the isocitrate lyase AcuD (AFUA_4G13510) and a putative acyl-
CoA dehydrogenase (AFUB_065590), a putative aldehyde reductase (AFUA_6G10260) 
and a putative glucosamine-6-phosphate deaminase (AFUA_8G04070). A hypoxia-
induced protein, AFUA_6G11850, was also increased in abundance. An uncharacterized 
protein with oxidoreductase activity (AFUA_2G02950) was also shown to be more 
abundant in this condition. 
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Proteins associated with energy providing pathways were also deregulated in 
ΔgliT::ΔgtmA, possibly as a result of stress adaptation. These included a mitochondrial 
2-oxodicarboxylate carrier protein (AFUA_1G09660; 1.48277), a mitochondrial F1F0-
ATP synthase g subunit (AFUA_1G16280; 1.27137), a putative mitochondrial import 
receptor subunit (Tom20) (AFUA_6G11380; Unique), the areA-dependent nitrogen-
scavenging enzyme L-amino acid oxidase LaoA (AFUA_7G06810; 1.24757) which 
enables Aspergilli to catabolise a broad spectrum of amino acids in nitrogen starvation 
condition, and the isocitrate lyase AcuD (AFUA_4G13510; 1.2476) which facilitates the 
growth of A. fumigatus on C2-generating carbon sources (Schöbel et al., 2007). The 
abundance of the allergen Aspf2 (AFUA_4G09580; 2.08334) was significantly more 
abundant in the ΔgliT::ΔgtmA mutant. This protein is known to be expressed under zinc 
limiting conditions and is required for fungal growth in extreme zinc-limiting media 
(Amich et al., 2010). 
As described above, oxidative stress leads to a general repressed expression of 
protein synthesis and cellular growth indicating the requirement to preserve energy 
(Gasch et al., 2000). This is represented in the proteomic data described in Section 6.2.6, 
which shows an enrichment of ribosome and ribosome associated proteins. 13 of the 24 
proteins detected as significantly decreased in abundance in A. fumigatus ΔgliT::ΔgtmA 
mutant compared to A. fumigatus ΔgliT are associated with the ribosome.  
Interestingly, the putative zinc-dependent alcohol dehydrogenase AlcC 
(AFUA_5G06240; 1.21622) was shown to be less abundant in this mutant compared to 
ΔgliT. The mRNA abundance of alcC was shown to be significantly increased in response 
to hypoxia, suggesting that alcC is the primary gene encoding an alcohol dehydrogenase 
that responds to hypoxia in A. fumigatus (Grahl et al., 2011). 
Overall the gliotoxin sensitivity data, SAM quantification and quantitative 
proteomic data suggest that, in the absence of GliT, GtmA plays a key role in protecting 
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against exogenous gliotoxin. The results also highlight the complexity of the interactions 
between primary and secondary metabolism in this organism. The intricate mechanism 
of gli-cluster positive feedback by intracellular dithiol gliotoxin was also explored by this 
analysis.  
The filamentous fungus A. terreus produces the ETP acetylaranotin (Guo et al., 
2013). Similar to gliotoxin, this metabolite and its derivatives have been shown to display 
an array of interesting bioactivities including the induction of apoptosis in cancer cell 
lines and antifungal activity (Guo et al., 2013; Choi et al., 2011; Suzuki et al., 2000). 
Extending the incubation duration of A. terreus cultures from 6 d to 42 d resulted in the 
production of four thiomethylated forms of acetlyaranotin. One of these forms 
(bisdethiobis(methylsulfanyl)apoaranotin) had not been characterised previously 
(Haritakun et al., 2012). As the generation of these thiomethylated forms of acetylaranotin 
was likely carried out by the A. terreus GtmA homolog, this experiment prompted us to 
explore the effect of extended culture incubation on A. fumigatus wild-type and ∆gtmA. 
As described in Section 6.2.7, A. fumigatus ∆gtmA 28 d cultures showed a 
significant decrease in the production of pseurotin A and fumagillin compared to the wild-
type strain. The levels of these metabolites were restored in the complemented strain. It 
was first explored if the absence of bisthiomethylgliotoxin was affecting the expression 
of the A. fumigatus chromosome 8 intertwined secondary metabolite supercluster 
(Wiemann et al., 2013). Bisthiomethylgliotoxin may act as a signal for the activation of 
other secondary metabolite clusters by an unknown mechanism which is not unlike the 
mechanism of gliotoxin induction of gli-cluster expression. As described in Section 6.2.8, 
the addition of exogenous bisthiomethylgliotoxin did not restore the production of the 
affected metabolites to wild-type levels, thus ruling out bisthiomethylgliotoxin-mediated 
induction of the supercluster.  
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This then prompted the analysis of the cultures by quantitative proteomics in order 
to study the modified metabolome of A. fumigatus ∆gtmA. As described in Section 6.2.9, 
the results showed that, after 28 d cultured in Czapeks Dox, ∆gtmA still has gli-cluster 
encoded proteins (GliA, GliM , GliJ and GliG) significantly increased in abundance 
compared to the wild-type. As described in Section 4.2.10, GliP, GliM and GliF were 
significantly increased in abundance in ∆gtmA compared to the wild-type after 72 h 
growth in Czapeks Dox broth. This indicated that the absence of gtmA results in a 
sustained induction of gli-cluster expression.  
Several proteins which have transcripts shown previously to be induced by 
hypoxia or by exposure to neutrophils were shown to be upregulated in ∆gtmA. Two 
proteins which are repressed by gliotoxin exposure and two which are repressed by 
hypoxia were significantly decreased in abundance in ΔgtmA (Vödisch et al., 2011). This 
may be a response to the sustained gliotoxin production in this mutant as the abundance 
of these proteins are returned to wild-type levels in the complemented strain.  
A clear result of the analysis was the large decrease in abundance of several 
proteins encoded by the chromosome 8 supercluster (Afu_8g00100-00720) (Wiemann et 
al., 2013). This was in agreement with the metabolomic analysis of culture supernatants 
from these samples (Section 6.2.7) which revealed the decreased production of pseurotin 
A and fumagillin. A total of 17 proteins from this cluster were detected as less abundant 
in ∆gtmA. Interestingly, 23 of the 136 proteins detected as significantly decreased in 
abundance in ΔgtmA are encoded on Chromosome 8. This is in comparison to 2 of the 72 
proteins detected as increased in abundance in ΔgtmA being encoded on Chromosome 8.  
In addition to the interactions between primary and secondary metabolism 
described above, there are also several examples of cross-talk amongst gene clusters 
which are responsible for the synthesis of fungal natural products. Over-expression of the 
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silent inp putative secondary metabolism cross-pathway regulator gene (scpR) in A. 
nidulans resulted in the overproduction of both the inp gene cluster and, also, production 
of the polyketide, asperfuranone. As no link had previously been described between these 
unrelated metabolites, this work highlighted some additional complexity of regulatory 
cross-talk in fungal secondary metabolism (Bergmann et al., 2010). Further recent 
findings are changing previously held views of distinct SM clusters encoding for a single 
class of, or closely related, secondary metabolites. A FAD-dependent monooxygenase 
(FqzB) which is encoded by the fumiquinazoline biosynthetic pathway in A. fumigatus 
was also shown to catalyse spiro-carbon formation in the indole alkaloid spirotryprostatin 
A via an epoxidation route. The authors speculated that these interactions between 
unrelated fungal natural product encoding cluster genes may be a strategy of natural 
product producers to generate structural diversity (Tsunematsu et al., 2013).  
Fumigaclavine C, an ergot alkaloid, was demonstrated to aid in oxidative stress 
defense in A. fumigatus whereby deletion of either of the NRP synthetase genes, pesL or 
pes1, resulted in abrogation of the metabolite (O'Hanlon et al., 2012). Loss of 
fumigaclavine C in A. fumigatus resulted in H2O2 sensitivity, suggestive of its role in 
oxidative stress defense. It should be noted that, in contrast to Claviceps purpurea 
(Haarmann et al., 2005), the role of an NRPS in alkaloid synthesis has yet to be proven 
in A. fumigatus. Loss of fumigaclavine C was accompanied by elevated levels of another 
class of SM, the fumitremorgins. The increased production of fumitremorgins such as 
TR-2, fumitremorgin C and verruculogen in response to fumigaclavine C diminution is 
indicative of cross-talk within the secondary metabolome. These authors have speculated 
that increased fumitremorgin levels are possibly caused by increased isoprene availability 
due to decreased prenylation of fumigaclavine A as a result of PesL/Pes1 absence 
(O’Hanlon et al., 2012). 
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Further to the observations regarding fumitremorgin and fumigaclavine 
biosynthesis (O’Hanlon et al., 2012), overexpression of the A. fumigatus putative 
Zn(II)2Cys6 transcription factor hasA (which is part of the hexadehydro-astechrome 
(HAS) biosynthetic gene cluster) also resulted in the production of large amounts of 
fumitremorgins compared to the wild-type strain. Deletion of the HAS NRPS in a 
background overexpressing hasA (OE::hasAΔhasD) resulted in significantly increased 
fumitremorgin production. The authors hypothesised that the diversion of tryptophan and 
prenylation activity from HAS production towards fumitremorgin biosynthesis may occur 
in OE::hasAΔhasD due to the inability of this mutant to utilise the pathway intermediates 
from HAS production. As fumitremorgins are potent tremorgenic mycotoxins this may 
account for the increased virulence of the OE::hasAΔhasD strain compared to wild-type 
(Yin et al., 2013).   
O’Keeffe et al. (2014) have demonstrated that an intact gliotoxin self-protection 
mechanism (Schrettl et al., 2010; Scharf et al., 2010), mediated by GliT, is essential to 
regulate the biosynthesis of apparently unrelated metabolites such as pseurotin A, 
fumagillin and fumitremorgins. Specifically, using RNA-seq these authors have 
demonstrated that gene cluster expression encoding the biosynthesis of helvolic acid, 
pseurotin A, fumagillin and fumitremorgins is significantly attenuated in A. fumigatus 
∆gliT upon gliotoxin exposure. 
Overall these data suggest that GtmA directs the production of 
bis(methyl)gliotoxin and that the deletion of this methyltransferase results in a 
deregulation of the gliotoxin biosynthetic pathway. When these A. fumigatus cultures are 
incubated for extended durations, the absence of GtmA has downstream effects on 
seemingly unrelated natural products produced by this organism. LaeA, a global regulator 
of secondary metabolism, controls the expression of gliotoxin, pseurotin A, fumagillin 
and the fumitremorgins (Bok and Keller, 2004). It is possible that the absence of GtmA 
338 
 
  
alters the activity of LaeA or other global regulators of secondary metabolism, which in 
turn impacts on the production of co-regulated secondary metabolites.  
Overall the data presented in this chapter suggests GtmA-mediated thiomethylation 
as an ancestral protection strategy against dithiol compounds. This ability is also shared 
by multiple Ascomycota such as A. nidulans and A. niger which do not synthesise ETPs. 
Data in this chapter also highlighted the metabolic cost of gliotoxin bisthiomethylation 
by A. fumigatus as this process demands two molecules of SAM per dithiol gliotoxin 
molecule. As SAM is an essential cellular cofactor that is required for cellular function, 
this is quite an expensive metabolic commitment. Quantitative proteomic data from 
ΔgliT: gtmA uncovered further details behind the elaborate mechanism of gli-cluster 
control in A. fumigatus – a process which remains to be elucidated. Also, late-stage culture 
proteomics and metabolomics reveals that GtmA activity affects the production of other 
secondary metabolites produced by A. fumigatus. Gliotoxin is a potent toxin with a very 
elaborate mechanism regulating its production. Targeting this pathway may serve as a 
mechanism to turn this toxin against its producer.
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Chapter 7 
Bis(methyl)gliotoxin as a biomarker for A. fumigatus 
Infection 
 
 
 
 
 
 
 
 
 
  
7.1 Introduction 
As described in Section 1.9, IA is the most commonly found invasive mould disease and 
is a major source of mortality in immunocompromised individuals. Incidences of IA have 
increased markedly over recent years (Perfect, 2013). It is well established that sensitive, 
nonculture-based diagnostic mechanisms which rapidly detect the onset of infection are 
of critical importance to permit the rational administration of antifungal drugs (Johnson 
et al., 2014). 
The detection of nonribosomal cyclic peptides and depsipeptides by MS may 
serve as highly specific fungal markers (Jegorov and Hajduch, 2006). Gliotoxin, which is 
produced by most A. fumigatus strains is present in plasma and serum (Fox and Howlett, 
2008). Also, its inactive derivative bis(methylthio)gliotoxin is recoverable from blood 
(Domingo et al., 2012). A recent report described the MS detection of a gliotoxin 
precursor, cyclo (L-Phe-L-Ser), in the lungs of mice which were colonised by A. 
fumigatus. This metabolite may serve as an alternative marker for the diagnosis of 
invasive aspergillosis (Sekonyela et al., 2013). Immunodetection of human IgG directed 
against the Aspergillus gliotoxin oxidoreductase may have potential as a diagnostic 
biomarker of IA in nonimmunocompromised individuals (Shi et al., 2012). 
The ELISA has been established as a robust method for clinical diagnostics. This 
technique relies on the interaction of the analyte with specific antibodies. A major 
advantage of competition ELISA is its high sensitivity to minimally expressed antigens 
in complex mixtures even when the detecting antibody is present in relatively small 
amounts (Gan and Patel, 2013). An inherent problem with producing antibodies against 
small molecules is that these molecules are too small to initiate an immune response on 
their own (Tuomola et al., 2000). In order to raise high affinity antibodies, the small 
molecule, or a modified version of the molecule (a hapten), is covalently bound to a 
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carrier protein to form an immunogenic toxin (hapten)–protein conjugate. Vaccination of 
an animal with the conjugate, when formulated with a suitable adjuvant, results in the in 
vivo production of a polyclonal suite of antibodies, some of which will be cross-reactive 
to the toxin (hapten) portion (epitope) of the immunogenic conjugate. The toxin-specific 
antibodies which are thereby generated are incorporated into various ELISA formats. 
These formats rely on the capture of the analyte by the antibodies and a resultant induction 
of change (e.g. color) which correlates with the level of analyte present in the sample 
(Singh et al., 2004). 
Several chemistries have successfully been utilised to create hapten-protein 
conjugates (Lu et al., 2006; Fox et al., 2004). A common method for coupling these 
haptens to carrier proteins involves the use of a heterobifunctional crosslinker containing 
an N-Hydroxysuccinimide (NHS) ester and a maleimide group. This type of crosslinker 
allows better control over the coupling process than homobifunctional or zero-length 
conjugation methods as it incorporates a 2- or 3-step reaction strategy which is directed 
against two different functional targets. In this approach, the carrier protein is initially 
activated with the crosslinker through its amine groups. It is subsequently purified to 
remove excess reactants and, finally, it is crosslinked to a hapten molecule containing a 
sulfhydryl group. One of the most useful reagents for this conjugation approach is 
sulfosuccinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate (sulfo-SMCC) 
(Kafi et al., 2009). 
The reactions associated with a sulfo-SMCC conjugation are shown in Figure 7.1. 
This crosslinking reagent mediates the conjugation of a carrier protein through primary 
amino groups to a peptide or other hapten through sulfhydryl groups. It contains both a 
reasonably long spacer and an extremely stable maleimide group which is due to the 
adjacent cyclohexane ring in its cross-bridge. The active N-hydroxysulfosuccinimide 
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ester (sulfo-NHS) end of sulfo- SMCC is first reacted with available primary amino 
groups on the carrier protein. This reaction results in the formation of an amide bond 
between the protein and the crosslinker with the release of sulfo-NHS as a by-product. 
The carrier protein is then isolated by gel filtration in order to remove excess reagents. At 
this point, the purified carrier possesses modifications which were generated by the 
crosslinker. This results in a number of reactive maleimide groups projecting from its 
surface. The maleimide portion of sulfo-SMCC is a thiol-reactive group that can be used 
in a secondary step to conjugate with a free sulfhydryl (i.e., a cysteine residue) on a 
peptide or other hapten, resulting in a stable thioether bond. A disadvantage to using 
SMCC, or other NHS–maleimide type crosslinkers with hindered ring structures, is the 
relatively high immunogenicity of the cross-bridge. A PEG group used as a cross-bridge 
in a heterobifunctional reagent to prepare immunogen conjugates will result in non-
immunogenic modifications on the carrier protein and, thus, no antibody production 
against the polyether linker (Hermanson, 2008). 
Due to its intrinsic immunogenicity, KLH is a popular carrier protein and a 
frequent choice for the development of immunogen conjugates (Presicce et al., 2008). 
KLH contains an abundance of functional groups which are available for conjugation 
with hapten molecules. On a per-mole basis (using an average multi-subunit MW of 5 x 
106 Da), KLH has over 2,000 amines from lysine residues, over 700 sulfhydryls from 
cysteine groups and over 1,900 tyrosines. Activation of the protein with sulfo-SMCC 
typically results in 300–600 maleimide groups per molecule for coupling to sulfhydryl-
containing hapten (Hermanson, 2008). 
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Figure 7.1. NHS Ester-Maleimide Heterobifunctional Crosslinker-Mediated Hapten–
Carrier Conjugation. A common way of conjugating sulfhydryl-containing haptens to 
carrier proteins is to activate the carrier with sulfo-SMCC in order to create an 
intermediate maleimide derivative. The maleimide groups can then be coupled to thiols 
to form thioether bonds. 
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The aim of the work presented in this chapter was to explore the potential of the inactive 
derivative of gliotoxin, bis(methylthio)gliotoxin (BmGT), as a marker for A. fumigatus 
presence. NHS ester-maleimide mediated hapten–carrier conjugation requires that the 
hapten has a free sulfhydral group. However, bis(methylthio)gliotoxin does not possess 
any free sulfhydrals to avail of this conjugation chemistry. Furthermore, 
bis(methylthio)gliotoxin has no carboxyl groups which could be activated for 
carbodiimide conjugation using the popular crosslinker EDC. Due to the lack of 
functional groups which are available to conjugate bis(methylthio)gliotoxin to a carrier 
protein, traditional conjugation methodologies could not be used.  
Mono(methylthio)gliotoxin was shown in Chapter 5 to be an intermediate in the 
conversion of dithiol gliotoxin to bis(methylthio)gliotoxin (Section 5.2.6). Based on the 
similar structures of these metabolites, we hypothesise that it was likely that MmGT and 
bis(methylthio)gliotoxin have similar epitopes. These may result in antisera generation 
which is cross reactive to both of these metabolites. Mono(methylthio)gliotoxin has a free 
sulfhydryl available for NHS ester-maleimide mediated hapten–carrier conjugation. This 
infers that standard conjugation methodologies could be used to conjugate this hapten to 
a carrier protein such as bovine serum albumin (BSA) or keyhole limpet hemocyanin 
(KLH). An additional might lie in the fact that these antibodies may also be cross-reactive 
to gliotoxin. 
The overall objectives of the work presented in this chapter were to:   
(i) Explore the detection capabilities of gliotoxin and bis(methylthio)gliotoxin by 
RP-HPLC and LC-MS 
(ii) Develop and optimise a conjugation strategy to generate an immunogen to 
raise antisera against bis(methylthio)gliotoxin. 
(iii) Develop a competitive ELISA for bis(methylthio)gliotoxin detection. 
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7.2 Results 
7.2.1 Bis(methylthio)gliotoxin is detected at a higher intensity than gliotoxin by 
LC-MS, but not by RP-HPLC 
Commercial standards of gliotoxin and bis(methylthio)gliotoxin (5 µg) were analysed by 
RP-HPLC. As shown in Figure 7.2 A, 5 µg bis(methylthio)gliotoxin and gliotoxin were 
detected at similar intensities by RP-HPLC at 254 nm. In addition, the RP-HPLC analysis 
of organically extracted A. fumigatus Czapeks Dox broth 72 h culture supernatants 
indicated that the level of bis(methylthio)gliotoxin detected in the supernatants was 
significantly lower than that of gliotoxin (Figure 7.2, B). Although 
bis(methylthio)gliotoxin was detected at extremely low levels in culture supernatants by 
RP-HPLC, the same samples, when  analysed by electrospray LC-MS, showed a 
significantly higher intensity of detectable bis(methylthio)gliotoxin in comparison with 
gliotoxin (Figure 7.3). Serial dilutions of commercial bis(methylthio)gliotoxin and 
gliotoxin standards were analysed by LC-MS (Figure 7.4). Identical concentrations of 
each were analysed by LC-MS with bis(methylthio)gliotoxin proving to be consistently 
detectable at higher intensities than gliotoxin. This unusual property explains the 
differential detection of bis(methylthio)gliotoxin and gliotoxin by RP-HPLC and LC-MS, 
respectively.  
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Figure 7.2. A: RP-HPLC detection of gliotoxin and bis(methylthio)gliotoxin commercial 
standards. 5 µg of each standard was injected. Bis(methylthio)gliotoxin elutes at a slightly 
earlier retention time than gliotoxin. The compounds have similar mAU intensities at 254 
nm. B: A. fumigatus wild-type organically extracted Czapeks dox both 72 h culture 
supernatants showing the relative gliotoxin and bis(methylthio)gliotoxin intensities. 
Bis(methylthio)gliotoxin is present in culture supernatants at low levels when compared 
to gliotoxin. 
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Figure 7.3. LC-MS detection of gliotoxin and bis(methylthio)gliotoxin in A. fumigatus 
wild-type organically extracted culture supernatants. A: Base peak chromatogram of 
sample showing all compounds detected. B: Extracted ion chromatogram showing the 
overlaid extracted m/z 357 (BmGT) and 327 (GT) compound intensities. Note the 
significantly higher bis(methylthio)gliotoxin intensity which contrasts with that of 
gliotoxin.  
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Figure 7.4. A: Differential detection of serially diluted gliotoxin and 
bis(methylthio)gliotoxin commercial standards by LC-MS. Bis(methylthio)gliotoxin 
(red) is detected at a substantially greater intensity by electrospray LC-MS than gliotoxin 
(blue) by LC-MS. B: Bis(methylthio)gliotoxin and gliotoxin detection intensities plotted 
across the dilution series. 
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7.2.2 Strategy for the generation of antibodies against bis(methylthio)gliotoxin 
A. fumigatus GtmA generates mono(methylthio)gliotoxin as an intermediate in the 
generation of bis(methylthio)gliotoxin. The use of a high GtmA enzyme concentration 
and a low concentration of SAM cofactor resulted in the preferential generation of 
mono(methylthio)gliotoxin rather than bis(methylthio)gliotoxin (Section 5.2.6). Initially, 
mono(methylthio)gliotoxin generation for immunogen generation was carried out using 
the rGtmA protein with SAM as the methyl donor in the reaction. This method efficiently 
generated MmGT. However, as dithiol gliotoxin requires an organic solvent for solubility 
at high concentrations, a large reaction volume was necessary in order to maintain GtmA 
solubility and activity in the reaction. As additional steps were required to concentrate the 
sample after the methylation reaction, it resulted in a lower overall yield of MmGT. This 
highlighted the need to carry out the generation of MmGT using the alternative strategy 
which is illustrated in Figure 7.5. Methyl iodide is a methylation reagent which can be 
used to add methyl groups to substrates such as phenols, amines, thiols or carboxylic 
acids. This reagent is frequently used in a variety of studies to chemically synthesise ETPs 
and other biologically active secondary metabolites (Boyer et al., 2013). As such, it was 
used as a chemical alternative to GtmA in order to generate MmGT.  
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Figure 7.5. Strategy for the generation of the mono(methylthio)gliotoxin immunogen. 
MmGT has a free sulfhydral group available for NHS ester-maleimide mediated 
conjugation. This allows for the hapten to be conjugated to a large carrier protein for 
immunisation trials. 
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7.2.3 Generation of mono(methylthio)gliotoxin (MmGT) using Methyl Iodide 
Methyl iodide (Figure 7.6) is a widely employed methylation agent which is used in 
organic synthesis for the covalent modification of thiol groups. It is an excellent substrate 
for SN2 substitution reactions as it is sterically open for attack by nucleophiles (Bolt and 
Gansewendt, 1993). Figure 7.7 shows the optimisation of mono(methylthio)gliotoxin 
generation using methyl iodide as a methyl donor. The final optimised reaction conditions 
for mono(methylthio)gliotoxin generation are outlined in Section 2.2.18. Confirmation of 
mono(methylthio)gliotoxin generation was carried out by RP-HPLC fractionation of the 
metabolite followed by LC-MS analysis. The fragmentation patterns of ICH3 and GtmA 
generated mono(methylthio)gliotoxin were identical (Figure 7.8). Confirmation of 
available free thiol on mono(methylthio)gliotoxin was carried out by the addition of sulfo-
SMCC to the reaction. This reagent contains a sulfhydryl-reactive maleimide group 
(Figure 7.1). As outlined in Figure 7.9, the addition of sulfo-SMCC to the reaction 
resulted in a reduction in the mono(methylthio)gliotoxin peak but not the 
bis(methyl)gliotoxin peak; this was shown by RP-HPLC following reaction with sulfo-
SMCC. 
 
Figure 7.6. Structural formula of the methyl iodide (iodomethane) molecule, MeI, CH3I. 
Structural information (determined by microwave and infrared spectroscopy) (Lide, 
2007). 
351 
 
  
 
Figure 7.7. S-methylation of 3 mM dithiol gliotoxin using 5 mM Iodomethane (ICH3) at 
37°C as monitored by RP-HPLC. Increasing the reaction incubation time results in a 
sequential increase in the amount of mono(methylthio)gliotoxin and 
bis(methyl)gliotoxin. A: No ICH3, B: 15 min ICH3,C: 30 min ICH3, D: 60 min ICH3. 1: 
dithiol gliotoxin (rGT), 2: MmGT, 3: BmGT. 
352 
 
  
 
Figure 7.8. LC-MS fragmentation pattern of rGtmA and ICH3 generated 
mono(methylthio)gliotoxin. The identical LC-MS retention times and fragmentation 
patterns of mono(methylthio)gliotoxin are also shown with the potential source of the m/z 
295 and m/z 309 fragments. The existence of m/z 295 fragment confirms that the CH3 is 
located on the sulfhydral of mono(methylthio)gliotoxin. 
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Figure 7.9. A: Following the methylation reaction, bis(methylthio)gliotoxin elutes at RT 
20.1 min on the chromatogram: mono(methylthio)gliotoxin (19.2 min) and dithiol 
gliotoxin (18.3 min) are also present. B: Following the addition of SMCC to the reaction, 
the peaks for dithiol gliotoxin and mono(methylthio)gliotoxin are no longer detectable. 
This indicates that the mono(methylthio)gliotoxin compound has a free thiol which is 
capable of reacting with sulfo-SMCC.  
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7.2.4 Mono(methylthio)gliotoxin conjugation to BSA-sulfo-SMCC  
BSA-sulfo-SMCC was generated as described in Section 2.2.19. The 
mono(methylthio)gliotoxin generated in Section 7.2.3 was immediately added to the 
BSA-sulfo-SMCC and the reaction was left to incubate overnight at room temperature. 
Figure 7.10 shows that the addition of mono(methylthio)gliotoxin to BSA-sulfo-SMCC 
results in a decrease in free mono(methylthio)gliotoxin from the reaction. This was 
detected by RP-HPLC. No reduction in the mono(methylthio)gliotoxin peak was 
observed when sulfo-SMCC was omitted from the reaction therefore confirming that the 
hapten was covalently linked to the carrier protein. 
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Figure 7.10. A: In the control sample (MmGT + BSA Control (No SMCC), 
bis(methylthio)gliotoxin is detectable  at 20.1 min on the chromatogram -  MmGT ( RT 
19.2 min) and dithiol gliotoxin (18.3 min) are also visible. B: Following the addition of 
sulfo-SMCC-BSA to the reaction, the peaks for MmGT are reduced in the chromatogram. 
This indicates that the MmGT has covalently attached to the sulfo-SMCC-BSA.  
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7.2.5 SDS-PAGE Confirmation of MmGT-sulfo-SMCC-BSA Generation 
The covalent attachment of mono(methylthio)gliotoxin to the carrier protein (MmGT-
sulfo-SMCC-BSA) was predicted to have an increased molecular mass when compared 
to that of BSA-sulfo-SMCC alone. As confirmed by SDS-PAGE analysis, an increased 
molecular mass for the BSA-SMCC-MmGT immunogen in comparison with that of the 
BSA-SMCC control was evident (Figure 7.11). In contrast with the unconjugated BSA-
SMCC or BSA controls, the BSA-mono(methylthio)gliotoxin immunogen was visible as 
a higher band on the SDS-PAGE gel. As BSA contains one free cysteine sulfhydryl, the 
appearance of two separate protein bands in the BSA-SMCC-MmGT and BSA-SMCC 
lanes is likely due to the dimerization of BSA-SMCC through this free thiol group. This 
data further substantiates the success of the conjugation.  
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Figure 7.11. SDS-PAGE analysis demonstrating an increased Mr for the BSA-sSMCC-
MmGT conjugate (Lane 1) when compared to that of the BSA-SMCC control (Lane 2). 
The appearance of two bands in the BSA-sSMCC-MmGT / BSA-sSMCC lanes in 
comparison to the single unmodified BSA band (Lane 3) is likely due to the dimerization 
of BSA-sSMCC through its free thiol groups. 2 µg protein was loaded per well. 
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7.2.6 Generation of MmGT-KLH 
As described in Section 7.1, keyhole limpet hemocyanin, KLH, is a popular carrier protein 
and a common choice for developing immunogen conjugates. Furthermore, the 
employment of the KLH carrier protein for immunisation processes allows the MmGT-
sulfo-SMCC-BSA immunogen generated in Section 7.2.4 to be utilised in the screening 
of the resulting antisera for mono(methylthio)gliotoxin reactivity. Section 2.2.19 
describes the procedure which was adopted for KLH immunogen generation. RP-HPLC 
confirmed the successful generation of MmGT-sulfo-SMCC-KLH. Figure 7.12 shows 
that, following incubation with maleimide-KLH, the level of mono(methylthio)gliotoxin 
in the conjugation reaction drops over time. The SDS-PAGE electrophoresis bands of 
KLH and MmGT-KLH yielded non-conclusive results as the KLH protein is too large to 
move in the polyacrylamide gel (data not shown). As such, the sole purpose of RP-HPLC 
was to corroborate the success of this conjugation. 
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Figure 7.12. A: RP-HPLC chromatograms illustrating the reduction in the 
mono(methylthio)gliotoxin peak over the course of the conjugation reaction with 
maleimide KLH (0 h to O/N). B: A graphical representation of the MmGT peak area 
reduction (mAU, 254 nm) over the course of the conjugation reaction. 
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7.2.7 Immunisation of Mice with MmGT-KLH Immunogen 
MmGT-KLH at 1 mg/ml in PBS was provided to Dublin City University for murine 
immunisation. For primary immunisations and booster injections, 50 µl of Pam-Cys 
Adjuvant was added to 50 µl of immunogen. The mice received a single intraperitoneal 
injection of 100 µl each (50 μg immunogen/injection). This was repeated in three boosters 
each of which were administered over 3 week intervals. Following the third booster, tail 
bleeds were taken and the sera was fractionated. 20 µl sera per mouse was harvested for 
screening. 
7.2.8 Development of a Competitive ELISA for the screening of antibodies 
specific for bis(methylthio)gliotoxin from immunised mice 
A competitive ELISA was developed to screen the antisera generated in Section 7.2.7 for 
antibodies reactive to bis(methylthio)gliotoxin. The schematic for this assay is illustrated 
in Figure 7.13. This screening process would identify the immunised mouse (Section 
7.2.7) which would be most suitable to proceed to monoclonal BmGT antibody 
development.  MmGT-BSA was coated onto the ELISA plate and wells were blocked to 
prevent non-specific binding. Bis(methylthio)gliotoxin was then added to selected wells 
as a free competitor in order to determine whether this metabolite was capable of 
competing for the antibodies which bind to the MmGT-BSA coated ELISA plate. Sera, 
which potentially contained antibodies that are reactive against bis(methylthio)gliotoxin, 
was then added to the ELISA wells. After washing away the unbound antibody, any 
antibodies which were bound to the plate were detected by anti-mouse IgG-HRP. This 
detection was then visualised by the addition of HRP substrate, TMB and the signal 
measured photometrically at 450/ 620 nm. Following completion of the assay, a reduction 
in the binding signal in the wells containing added bis(methylthio)gliotoxin confirmed 
that the antisera contains antibodies which are specific for this metabolite. 
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7.2.9 Determination of working dilution of serum for competitive ELISA 
screening  
An indirect ELISA with a range of antiserum titres and MmGT-BSA coating was carried 
out to identify the optimal ELISA conditions. ELISA plates were coated with MmGT-
BSA at 1 μg/ml. After blocking, antisera dilutions of 1/40,000, 1/80,000, 1/120,000, 
1/160,000 and 1/200,000 were added to ELISA wells for mice A, B and C. As shown in 
Figure 7.14, the antisera dilution of 1/160,000 was deemed to be within the parameters of 
the assay (Delta OD < 2). This antisera dilution was used during further sera analysis by 
indirect competitive ELISA (Section 7.2.10). 
 
 
Figure 7.14. Optimisation of antiserum dilutions for polyclonal antibody analysis. The 
absorbance readings for the 1/40,000 to 1/120,000 were deemed to be outside of the assay 
parameters.  
 
363 
 
  
7.2.10 ELISA Testing of Tail-Bleeds from Mice (3) Immunised with MmGT-KLH 
Immunogen 
The optimised ELISA conditions are detailed in Section 2.2.20. Plates were coated with 
MmGT-BSA at 1 μg/ml. After blocking, a titre of free competing BmGT 0-150 μM was 
added to ELISA wells. Sera from mice A, B and C was then added to each well at a 1/ 
160,000 dilution. As shown in Figure 7.15, free BmGT significantly (p < 0.05) inhibited 
antibodies from sera A and C binding to the coated MmGT-BSA. Mouse C sera was 
shown to have the most significant (p = 0.001) reduction in signal following the addition 
of competing BmGT when compared with the DMSO control. The control plate coated 
with SMCC-BSA confirmed that the reaction was specific to the MmGT antigen. This 
result indicated that the Mouse C sera contained antibodies with an affinity for 
bis(methylthio)gliotoxin. Subsequently, based on the results of the various antisera 
dilutions and conditions tested, the ELISA was replicated using the Mouse C antisera 
which was diluted to 1/120,000 (Table 7.1). The addition of 100 µM 
bis(methylthio)gliotoxin to the reaction resulted in a significant depletion (p = 0.001) of 
the assay signal which contrasted with that of the DMSO control. 
 
 
 
 
 
364 
 
  
 
Figure 7.15. Linear regression analysis of competitive ELISA data from sera A, B and 
C.  Mouse C sera was shown to have the most significant ( p= 0.001) reduction in signal 
following the addition of competing BmGT.  
 
Table 7.1. Mouse C Sera competes with bis(methylthio)gliotoxin for MmGT-BSA  
Mouse C Sera 
(1 in 120,000) 
    
MmGT-BSA 
(µg/ml) 
100 uM 
BmGT 
100 uM 
BmGT 
0 uM BmGT 0 uM BmGT 
1 1.535 1.566 1.89 1.875 
0.5 2.004 1.914 2.193 2.218 
0.25 2.085 2.173 2.251 2.206 
0.125 2.12 2.208 2.383 2.424 
0.06125 2.318 2.067 2.421 2.564 
0.03 2.201 2.056 2.306 2.321 
0.015 2.038 1.852 1.926 1.9 
0 0.034 0.018 0.021 0.034 
 
 
 
365 
 
  
7.2.11 Mouse C Antisera Competes with bis(methylthio)gliotoxin but not TAFC 
for MmGT-Sulfo-SMCC-BSA 
Based on the results from the sera dilution optimisation carried out in Section 7.2.9, the 
selected antisera dilution was 1/120,000 and the MmGT-sSMCC-BSA coating 
concentration was 1 µg/ml. As shown in Figure 7.16, the concentration of competing free 
bis(methylthio)gliotoxin was titred down the plate. This demonstrated that the antisera 
contains antibodies which compete for bis(methylthio)gliotoxin in a dose dependent 
manner. No competition for bis(methylthio)gliotoxin was observed when the pre-bleed 
sera from mouse C was used or when sSMCC-BSA was coated on the plates. Critically, 
the addition of triacetylfusarinine C (TAFC), another small natural product of A. 
fumigatus, did not result in a reduction in the assay signal. Overall, these results confirm 
that mouse C, which was immunised with MmGT-sSMCC-KLH immunogen, generated 
antibodies which are reactive against bis(methylthio)gliotoxin. The spleen of mouse C 
was selected for harvesting for the generation monoclonal antibodies against 
bis(methylthio)gliotoxin.
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7.3 Discussion 
Recent literature has explored the potential of fungal secondary metabolites as specific 
methods to rapidly diagnose AI in patient samples (Johnson et al., 2014; Petrik et al., 
2012).  This chapter explored the potential of the ETP derivative bis(methylthio)gliotoxin 
to act as a marker for A. fumigatus and described a new method for generating antibodies 
which are specific for this metabolite.  
Bis(methylthio)gliotoxin was shown to have a superior sensitivity of detection to 
gliotoxin by LC-MS. However, this was not the case with RP-HPLC. The 
bisthiomethylation of dithiol gliotoxin is, essentially, a chemical derivatization of this 
metabolite.  Analyte chemical derivatization for liquid chromatography/electrospray 
ionization tandem mass spectrometry is routinely carried out to enhance the detection 
sensitivity for a variety of compounds (Santa et al., 2007). For example, ketones are 
neutral functional groups which have low ionization efficiencies in ESI. Hydroxylamine 
has been successfully utilised to derivatize ketones such as testosterone in order to 
enhance the ionization efficiency of these compounds (Borrey et al., 2007). The 
chemoselective derivatization of cellular thiols is an established technique in proteomics 
and metabolomics. This method is known to increase the dynamic range for low 
abundance metabolites and to reduce ionization suppression (Gori et al., 2014). It is likely 
that the bisthiomethylation of gliotoxin has the same effect on this metabolite resulting in 
enhanced detection by LC-MS. 
A recently developed HPLC-MS/MS method to detect gliotoxin in the serum of 
patients with suspected aspergillosis was shown to have a lower limit of quantification 
(LLOQ) of 10 ng mL-1. Of the 10 samples which tested positive by ELISA for the 
presence of galactomannan, five were shown to test positive for gliotoxin using this 
HPLC-MS/MS method (Cerqueira et al., 2014). Bis(methylthio)gliotoxin quantification 
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was not carried out on these samples. Considering the enhanced detectability of 
bis(methylthio)gliotoxin when compared to that of gliotoxin by electrospray MS, a rapid 
TCEP/ICH3 method which reduces and S-alkylates the gliotoxin in these samples may 
enhance the sensitivity of this assay. 
Gliotoxin is known to be extremely reactive and is capable of undergoing rapid 
cellular association. Using a variety of human cell lines, approximately 80% of the spiked 
toxin was shown to undergo cellular uptake in less than 1 min (Waring et al., 1994). It is 
possible that this rapid uptake hampers detection of the metabolite by reducing the 
detectable level of gliotoxin in biological fluids. Gliotoxin was shown to rapidly associate 
with whole blood resulting in less than 10 % recovery of the toxin when up to 20 µg was 
added. Interestingly, over 90% of bis(methylthio)gliotoxin spiked into blood was 
recoverable (Domingo et al., 2012). Although we have shown that 
bis(methylthio)gliotoxin is produced at substantially lower levels than gliotoxin, the non-
reactive nature of bis(methylthio)gliotoxin may result in this compound being readily 
detectable.  
Typically, small molecule detection has relied upon techniques such as liquid/gas 
chromatography in conjunction with UV absorbency/mass spectrometry detectors. 
Despite the high sensitivity of these methods, they require expensive instrumentation and 
highly trained users to interpret the data (Zhao et al., 2007). The ELISA has been 
established as a robust method of clinical diagnostics. One major advantage of 
competition ELISA is its high sensitivity to minimally expressed antigens in complex 
mixtures even when the detecting antibody is present in relatively small amounts (Gan 
and Patel, 2013). Antibody generation against small molecules can be a challenging task; 
bis(methylthio)gliotoxin contains no suitable functional groups for conjugation to a 
protein or carrier molecule. As a result, a synthetic strategy for the generation of a MmGT 
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hapten containing a single free thiol group was developed. It involved the selective S-
methylation of a single thiol group of dithiol gliotoxin through careful control of the 
reaction conditions. Mass spectral analysis was performed to confirm the correct 
molecular mass of the compound. This hapten was then conjugated to a KLH carrier 
protein and used for mouse immunisation. The conjugation of the hapten to the carrier 
protein was confirmed by RP-HPLC. The resulting tail bleeds were used to develop an 
immunoassay to detect bis(methylthio)gliotoxin. Specific anti-mycotoxin based 
antibodies have been used in competitive ELISA systems to detect the presence of these 
compounds in both feed and biological samples (Zhang et al., 2011). 
Gallagher et al. (1992) prepared hemisuccinate derivatives of sporidesmin A using 
succinic anhydride in which the disulfide moiety of this metabolite was preserved. These 
hemisuccinate derivatives were then conjugated to carrier proteins using the active ester 
method. The resulting sera was cross-reactive against both sporidesmin A and its 
bisthiomethylated derivative sporidesmin D (Briggs et al., 1994). We considered using 
this succinylation method to prepare bis(methylthio)gliotoxin haptens for conjugation to 
carrier proteins. However, considering that bis(methylthio)gliotoxin contains two free 
hydroxyl groups, treatment with succinic anhydride would generate reaction side-
products which would then have to be purified from the final sample by preparative RP-
HPLC. As such, a large amount of expensive starting material would be required. For this 
reason, we looked at an alternative hapten generation method using a mono-methylated 
derivative of gliotoxin. This method minimised the reaction starting material as few 
purification steps were necessary. Also, maleimide reaction chemistry is a highly 
established one-step mechanism for immunogen generation.  
The success of this strategy proves that using monomethylated ETPs maleimide 
coupled to carrier proteins is a viable method for the generation of antisera against 
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bisthiomethylated ETPs. This technique may be applicable for the whole family of ETPs 
in order to generate antibodies against stable methyl-derivatives.  
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Chapter 8 
Discussion 
 
 
 
 
 
 
 
  
Prior to the work presented in this thesis it was known that A. fumigatus produces a 
bisthiomethylated derivative of gliotoxin, bis(methyl)gliotoxin, by an uncharacterised 
enzymatic process. No methyltransferases which carry out such a transformation had 
previously been described in fungal secondary metabolism. The exact role of this 
mechanism and its contribution in protecting A. fumigatus against gliotoxin were also 
unknown. Additionally, it was shown that bis(methyl)gliotoxin can be recovered from 
blood, suggesting that this gliotoxin derivative is a potential biomarker for invasive fungal 
infection (Domingo et al., 2012).  
Afu2g11120 was identified as an uncharacterised methyltransferase, located 
outside of the gliotoxin biosynthetic gene cluster, which was highly upregulated in 
expression following gliotoxin exposure. Chapter 3 detailed the molecular techniques 
which facilitated an investigation into the role of this methyltransferase in 
bis(methyl)gliotoxin and/or gliotoxin biosynthesis. In Chapter 4, Afu2g11120 was shown 
to encode gliotoxin thiomethyltransferase A (gtmA), the methyltransferase responsible for 
bis(methyl)gliotoxin biosynthesis in A. fumigatus. Gliotoxin sensitivity assays and 
comparative quantitative proteomic analysis of A. fumigatus wild type and ΔgtmA showed 
that this mutant strain is not more sensitive to gliotoxin. This suggested that, despite the 
high induction of this gene following gliotoxin exposure (O’Keeffe et al., 2014), gtmA 
did not play a role in the self-protection of A. fumigatus against gliotoxin toxicity. The 
localisation of GtmA-eGFP throughout the cytosol was significant in that it suggested 
that this is a feature of previously characterised methyltransferases involved in the 
detoxification of thiol compounds.  
A combination of comparative quantitative proteomic analysis and metabolomics 
carried out on A. fumigatus wild-type, ΔgtmA and gtmAc indicated that several enzymes 
involved in gliotoxin biosynthesis are significantly more abundant in A. fumigatus ΔgtmA. 
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This in turn resulted in higher levels of gliotoxin production in this mutant. This suggested 
that gtmA was not involved in self-protection against this toxin but, instead, that GtmA 
was primarily involved in regulating the expression of the gliotoxin gene cluster.  
Phylogenetic analysis of GtmA identified 124 homologs in 103 fungal genomes, 
all of which were found in the Ascomycota phylum. This was significant in that ETP 
production has been shown to be limited to this fungal phylum (Patron et al., 2007). The 
identification of these GtmA homologs in other ascomycetes means that the substrates of 
these enzymes may be predicted based on the known ETPs produced by these species. 
For example A. terreus produces the ETP acetylaranotin. It also produces 
bisdethiobis(methylthio)-acetylaranotin; a bisthiomethylated derivative of acetylaranotin. 
Genome based deletion analysis was unable to identify the thiomethyltransferase 
responsible for this transformation. However, based on the GtmA phylogenetic analysis, 
the A. terreus gene ATEG_01465 is likely to encode the dithiol acetylaranotin 
thiomethyltransferase, which is located outside of the acetylaranotin biosynthetic gene 
cluster. This highlights both the power of in-silico analysis of secondary metabolite 
associated genes while and the importance of reverse genetics in functionally annotating 
uncharacterised proteins within secondary metabolism.  
As described in Chapter 5, the novelty of this enzyme justified its recombinant 
expression, enzyme activity analysis, structural studies and site directed mutagenesis for 
detailed biochemical characterisation. The data showed that the monomeric GtmA 
bisthiomethylates gliotoxin in two sequential steps producing mono(methylthio)gliotoxin 
as an intermediate during this transformation. Also, unlike the majority of characterised 
methyltransferases, GtmA was shown to be resistant to SAH mediated inhibition. 
The methyltransferases involved in rebeccamycin, aminocoumarin and CypM 
biosynthesis methylate a wide range of substrates (Zhang et al., 2006a; Anderle et al., 
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2007; Zhang and van der Donk, 2012). As GtmA did not S-methylate dithiol sporidesmin 
A, an ETP produced by P. chartarum, this indicated that GtmA shows some level of 
specificity against dithiol gliotoxin. It would be interesting to explore the extent of this 
substrate specificity by testing a variety of other ETPs such as sirodesmin A, 
acetylaranotin and hyalodendrin. Gliotoxin related metabolites such as acetylgliotoxin, 
gliotoxin E and gliotoxin G could also be tested to investigate if GtmA can S-methylate 
these slightly larger compounds (Van der Pyl et al., 1992; Forseth et al., 2011).  
RebM was the first NPMT shown to accept synthetic cofactors to generate a 
number of new rebeccamycin analogues (Zhang et al., 2006). Subsequently, BamL, the 
N-methyltransferase involved in plantazolicin biosynthesis, was shown to accept ethyl 
SAM and transfer a single ethyl group to desmethylPZN. Interestingly, although this 
enzyme is normally capable of transferring two methyl groups to desmethylPZN, 
diethylPZN or even monomethyl-monoethylPZN could not be generated (Lee et al., 
2013b). The discovery that NPMTs can also accept SAM analogues with alternative 
alkylating groups has expanded their biocatalytic repertoire, enabling broader 
bioalkylation reactions to be developed for biomolecular labelling and the development 
of natural product analogs (Klimašauskas and Weinhold, 2007). GtmA may also be 
capable of accepting synthetic cofactors which in turn could be used to generate synthetic 
ETPs with novel activities.  
The structural elucidation of NPMTs has advanced our understanding of both the 
molecular determinants for substrate specificity and the varied catalytic mechanisms of 
NPMTs, whilst also providing a foundation for structure based engineering to generate 
new enzymes with altered specificities (Liscombe et al., 2012). Prediction of the 3D 
structure of GtmA was carried out using I-TASSER. This program predicted that GtmA 
was structurally similar to the salicylic acid carboxyl methyltransferase (SAMT) from 
Clarkia breweri and the yeast C-methyltransferase Coq5.  
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X-ray crystallographic analysis of apo GtmA revealed that the true structure of 
the GtmA monomer consists of a globular domain which contains the extended sheet 
characteristic of all other SAM-dependent methyltransferases (Cheng and Blumenthal, 
1999) and a unique -helical cap that forms the top one-third of the active site cavity. The 
structure confirmed that GtmA possesses the expected class I AdoMet-dependent MTase 
core fold which consists of a seven-stranded β sheet flanked on each side by three a 
helices. Based on this structural data, targeted mutagenesis of GtmA revealed four 
residues (W157V, W162V, N159V and F127V) which when mutated significantly 
affected the activity of this enzyme. The exact role of these residues will be revealed in a 
cocrystal structure of GtmA bound to SAM and/or dithiol gliotoxin.  
Through protein engineering and directed evolution, it is also envisaged that new 
mutant MTases with altered regioselectivities and/or substrate specificities capable of 
effectively methylating a wider range of natural and unnatural substrates, for example, 
high- value pharmaceutical intermediates can be generated. To date most activity in this 
area has focused on the more common O- and N-methyltranserases (Liscombe et al., 
2012). The work described in this thesis highlights the potential of S-directed 
methyltransferases as future tools for both metabolic engineering and synthetic biology.  
 As natural product synthesis needs to produce larger quantities of target 
compounds, a constant supply of SAM in the form of a regeneration system is therefore 
crucial for the preparative use of NPMTs. It is a considerable drawback of SAM 
dependent reactions that this cofactor is unstable and degrades quickly under assay 
conditions. A practical and rapid method for the preparation of active SAM for 
chemoenzymatic synthesis has recently been described. This method uses the SAM- 
dependent chlorinase SalL to generate SAM in situ from L-Methionine and 5’-chloro-5’-
deoxyadenosine (ClDA) (Lipson et al., 2013). In addition, enzymatically active and stable 
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SAM analogs have been generated using metabolically engineered SalL and another 
halogenase, FDAS (Thomsen et al., 2013). As these recent developments address the 
sustainable production and stability of SAM, this may lead to rapid methyltransferase 
based biocatalysis in the coming years. 
Chapter 6 revealed that A. fumigatus ΔgliT::ΔgtmA is very sensitive to exogenous 
gliotoxin in comparison with A. fumigatus ΔgliT. This suggested that GliT activity 
effectively compensates for the absence of GtmA in A. fumigatus ΔgtmA and that GtmA 
may have been an ancestral protective strategy against gliotoxin and/or other ETPs prior 
to the acquisition of the gliotoxin cluster by this organism. The presence of a gtmA 
homolog (MTII) in A. niger supports this hypothesis as MTII has been shown to be 
involved in protection against gliotoxin and possibly other ETPs (Manzanares et al., 
2015). A. niger does not produce any ETPs which suggests that the role of MTII is purely 
as a self-protection strategy against dithiol compounds. Subsequent redundancy of this 
superseded protection mechanism in A. fumigatus may have resulted in the 
neofunctionalization of GtmA and its interlinked association with the gliotoxin 
biosynthetic gene cluster.  
Is GtmA wired in the network of A. fumigatus secondary metabolism? Gliotoxin 
bis-thiomethylation appears to be controlled by transcription factors involved in 
regulating A. fumigatus secondary metabolism. veA is a global regulator of secondary 
metabolism in A. fumigatus and gtmA was noted as significantly downregulated in a veA 
overexpression mutant (and also down-regulated in ∆veA) (Dhingra et al., 2013). Indeed, 
differentially regulated genes in these mutants were dramatically enriched for secondary 
metabolism-associated processes. In addition, stuA encodes a developmental 
transcription factor and regulates the expression of six secondary metabolite gene clusters 
in A. fumigatus (including gliotoxin) and gtmA was also differentially regulated in ∆stuA 
(Twumasi-Boateng et al., 2009). Interestingly, gtmA was downregulated at all time points 
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(up to 12 h) during co-incubation of A. fumigatus with human immature dendritic cells 
(Morton et al., 2011). Several gli-cluster genes were also downregulated during this 
interaction. This further suggests that, that although gtmA is located outside of the gli 
cluster, this gene is under the control of secondary metabolism-associated transcription 
factors.  
Quantitative proteomic analysis on A. fumigatus ΔgliT vs. ΔgliT:ΔgtmA following 
3 h gliotoxin exposure revealed that the highly sensitive ΔgliT:ΔgtmA mutant has several 
gliotoxin biosynthetic enzymes highly abundant at this time point when compared to 
ΔgliT. The exact mechanism as to how gliotoxin exposure induces the expression of the 
gliotoxin cluster is not understood. This work has shown that the abundance of several 
gliotoxin cluster encoded enzymes can be enhanced through the deletion of A. fumigatus 
GliT/GliA in combination with GtmA. This may occur due to the intracellular 
accumulation of gliotoxin in either the oxidised form or as dithiol gliotoxin which may 
then be directly potentiating the cluster induction signal.  
Gliotoxin may act as a specific elicitor of secondary metabolism as shown in other 
systems but the chemical and molecular complexity of these elicitation processes means 
that the precise mechanism of activation is poorly understood. The hypothetical 
mechanisms of elicitation of secondary metabolism in bacterial cells are shown in Figure 
8.1 (Abdelmohsen et al., 2015). Induction of the orsellinic acid gene cluster in A. nidulans 
by the bacterium Streptomyces rapamycinicus was shown to be dependent on the 
Saga/Ada complex containing the histone acetyltransferase proteins GcnE and the AdaB. 
A Saga/Ada-dependent increase of histone 3 acetylation at lysine 9 and 14 was shown to 
occur during this interaction between the fungus and bacterium. However, the exact 
nature of the bacterial signal remains to be elucidated (Nützmann et al., 2011). It is 
conceivable that gliotoxin mediated induction of the A. fumigatus gliotoxin biosynthetic 
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cluster may occur through a related mechanism. The plant specific messenger molecules 
jasmonic acid and its methyl ester, methyl jasmonate (MJ) have been shown to activate 
many classes of secondary metabolites in different plant species. This elicitation has been 
shown to be triggered by a variety of different signalling pathways and cascades. The 
activation of the Ca2+ cascade is an essential requirement for MJ-induced diterpene 
production in S. dulcis (Kurosaki and Taura, 2015). It has also been shown that Sdrac-1 
and Sdrac-2, Rac/Rop GTPase proteins of S. dulcis, rapidly translocate to microsomal 
fractions in response to MJ stimulation, thus implicating monomeric GTP-binding 
proteins in this process (Mitamura et al., 2011). Future work may examine the role of 
these characterised triggers in relation to gliotoxin cluster induction in A. fumigatus.  
SAM is severely depleted in A. fumigatus ΔgliT. However, this does not occur 
when gtmA is deleted in this genetic background (ΔgliT::ΔgtmA). This result established 
a direct link between the depletion of cellular SAM and gliotoxin bisthiomethylation. This 
result also highlighted the complexity of the A. fumigatus response to this toxin. It 
preferentially oxidises the toxin, and methylation appears to be a secondary process. 
Considering the metabolic expense of bisthiomethylation on SAM depletion in A. 
fumigatus ΔgliT and the fast, reversible nature of GliT mediated dithiol gliotoxin 
oxidation it is understandable that the process of dithiol bisthiomethylation may have 
been relegated to a backup strategy in A. fumigatus.  
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Figure 8.1. Hypothetical mechanisms of elicitation of secondary metabolism in bacterial 
cells, Elicitation may occur though the binding of elicitor to a specific receptor or its 
internalization, changes in the levels of intracellular molecules as a response to the 
elicitors or activation of either the metabolite activator or the metabolite gene cluster itself 
(via unknown mechanisms). CW= cell wall, CM=cytoplasmic membrane and 
P=promoter (Abdelmohsen et al., 2015). 
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Recent literature has highlighted the clear crosstalk and blurred lines between 
what has been characterised as primary and secondary metabolism (Sheridan et al., 2015). 
However, it is clear from this work that the flux of primary metabolites such as SAM into 
these specialised metabolic pathways is tightly regulated by the organism. Secondary 
metabolism has recently been described as biochemistry’s ‘Panda’s Thumb’, due to the 
loose enzyme specificity and rapid evolutionary innovations within these pathways (Bar-
Even and Salah Tawfik, 2013). As illustrated in Figure 8.2, enzymes operating within 
these secondary metabolite pathways are far from kinetic perfection. The selection 
pressure on these enzymes may not be to increase the catalytic rate but rather to optimise 
the regulation, control and localisation of these systems (Bar-Even et al., 2011). The 
interaction between GtmA and its substrate dithiol gliotoxin is likely to be a non-
optimised reaction akin to most within secondary metabolism. It is conceivable that if 
GtmA activity was as optimised as those found in primary metabolism, it would commit 
the majority of the pathway intermediate dithiol gliotoxin to the production of 
bis(methyl)gliotoxin instead of gliotoxin. Poor GtmA kinetics may be advantageous in 
this case as bis(methyl)gliotoxin appears to be a metabolically expensive inactive 
mycotoxin. It is also possible that substrate compartmentalisation within A. fumigatus 
limits GtmA access to dithiol gliotoxin. 
It was also revealed that in late stage cultures the absence of gtmA expression has 
profound effects on the levels of other secondary metabolites which are produced by A. 
fumigatus. The wild type phenotype was not restored following the addition of 
bis(methyl)gliotoxin into these cultures. This suggested that the deregulation of gli-
cluster expression in A. fumigatus ΔgtmA may result in crosstalk amongst secondary 
metabolite clusters within this organism. This phenomenon has been identified previously 
in A. fumigatus. Gliotoxin exposure has recently been shown to enhance conidiation by 
approximately 2.5-fold in A. nidulans; which suggests that this metabolite can operate as 
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a conserved signal affecting fungal development. This study also highlighted that the 
conidiation induction response to these metabolites occurs through fine-tuned oxidative 
stress regulation in the fungus (Zheng et al., 2014). As GtmA plays a role in regulating 
the induction of gliotoxin biosynthesis, the absence of this gene could, in theory, have an 
effect on the oxidative stress response of A. fumigatus. In turn, this could have an effect 
on the conidiation induction response in this organism. As fungal development and 
secondary metabolism are closely linked processes (Calvo et al., 2002), this altered 
gliotoxin cluster expression could result in the significant alterations evident in the ΔgtmA 
secondary metabolite biosynthesis during late stage culture incubation.  
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Figure 8.2. Enzymes operating within different metabolic groups have 
different kcat and kcat/KM values. All modules were classified into four central 
groups: Central-CE (carbohydrate-energy) metabolism, involving the main carbon and 
energy flow; Central-AFN (amino-acids, fatty-acids and nucleotide) 
metabolism; Intermediate metabolism, including the biosynthesis and degradation of 
various common cellular components, such as co-factors and co-enzymes 
and Secondary metabolism related to metabolites which are produced in specific cells or 
tissues, under specific conditions and/or in relatively limited quantities. The cumulative 
distribution of kcat values for enzyme-substrate pairs belonging to different metabolic 
contexts. The distributions are significantly different with p-value <0.0005, rank-sum test, 
except those of intermediate and specialized metabolisms (p-value <0.05) (Bar-Even et 
al., 2011).  
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In Chapter 7 a novel mono(methylthio)gliotoxin conjugate was generated. This 
was subsequently used to develop polyclonal antisera which were cross-reactive to 
bis(methyl)gliotoxin. A competitive ELISA was established to rapidly test the different 
mice where were immunised with the immunogen. This rapid method of antibody 
generation may be applicable all bisthiomethylated ETP derivatives.  
The definitive demonstration that GtmA is the only enzyme which bis-
thiomethylates GT-(SH)2 raises questions as to the function of both methyltransferases 
encoded within the gli cluster (Figure 8.3). The methyltransferase gliN was recently 
shown to encode the N-methyltransferase which inserts the N-CH3 in gliotoxin, 
conferring stability to the ETP, damping the spontaneous formation of tri- and 
tetrasulfides (Scharf et al., 2014a). GliM has been putatively annotated as an O-
methyltransferase but this may not be its actual function. GliM contains a winged helix-
turn-helix (HTH) DNA-binding domain. This domain consists of two wings, three 
α(alpha) helices, and three β(beta) strands and is frequently found in protein families such 
as the forkhead and E26 transformation-specific (ETS) transcription factors (Teichmann 
et al., 2012; Sharrocks, 2001). The winged-helix transcription factor CPCR1 and its 
interacting protein AcFKH1 positively regulate cephalosporin C biosynthesis in 
Acremonium chrysogenum (Schmitt et al., 2004a, 2004b). In addition, GipA, a 
C2H2 transcription factor which regulates gliA expression interdependently with gliZ, was 
shown to have a putative binding site within all the gliotoxin cluster encoded genes except 
gliM. This may suggest that gliM may have some level of independence from the gli-
cluster (Schoberle et al., 2014). 
Interestingly, the acetylaranotin cluster in A. terreus encodes a trimodular gene 
(ataIMG) with modules homologous to gliI, gliM and gliG, despite acetylaranotin not 
having any N or O-methyl groups. The authors state that this gliM homolog may be 
responsible for S-methylation but this is likely to be carried out by ATEG_01465 (Guo et 
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al., 2013). Also, the sirodesmin encoding cluster of L. maculans has both gliM and gliN 
homologs but like gliotoxin, this metabolite has only a single N-methyl group (Gardiner 
et al, 2004). It’s also possible that gliM encodes a putative O-methyltransferase which 
transiently modifies a gliotoxin biosynthetic intermediate/shunt metabolite. Indeed, such 
an intermediate, 6-benzyl-6-hydroxy-1-methoxy-3-methylenepiperazine-2,5-dione, has 
been identified by two groups following deletion of A. fumigatus gliG (Davis et al., 2011; 
Scharf et al., 2011).  
Figure 8.3 summarises the main contribution of this thesis to understanding the 
complexity of A. fumigatus secondary metabolism and ETP biosynthesis in general. 
GtmA is a thiol directed methyltransferase which synthesises bis(methyl)gliotoxin from 
dithiol gliotoxin. A combination of reverse genetics, metabolomics and quantitative 
proteomics were used to uncover the intricate feedback induction mechanism of gliotoxin 
biosynthesis and the role of GtmA in dissipating this signal. In addition, the apo crystal 
structure of GtmA was solved and this data will be used to direct future mechanistic 
studies of this unusual transformation. Furthermore, the role of gliotoxin 
bisthiomethylation as a self-protection mechanism against this toxin and the metabolic 
consequences of this transformation were also explored through the generation a series 
of A. fumigatus mutants. Finally, the potential of bis(methylthio)gliotoxin to act as a 
marker for A. fumigatus  was explored and a new method of generating antibodies which 
are specific for this metabolite was developed.  
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Figure 8.3. Gliotoxin biosynthesis, secretion, and regulation. A series of enzyme-
catalyzed steps convert phenylalanine and serine to gliotoxin or BmGT via the formation 
of reactive intermediates, bis-glutathionylation, degradation steps, methylation and 
oxidation. Please note that the precise order of some reaction steps, and gliM/H 
involvement, remains to be fully elucidated.  
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